
<html lang="en"     class="pb-page"  data-request-id="a8878ebc-e792-4146-9664-85a793cfc669"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2020.63.issue-15;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.0c00426;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Oligopeptides as Neuropeptide Y Y4 Receptor Ligands: Identification of a High-Affinity Tetrapeptide Agonist and a Hexapeptide Antagonist" /></meta><meta name="dc.Creator" content="Adam  Konieczny" /></meta><meta name="dc.Creator" content="Diana  Braun" /></meta><meta name="dc.Creator" content="David  Wifling" /></meta><meta name="dc.Creator" content="Günther  Bernhardt" /></meta><meta name="dc.Creator" content="Max  Keller" /></meta><meta name="dc.Description" content="Within the family of neuropeptide Y (NPY) receptors, the Y4 receptor (Y4R) is unique as it prefers pancreatic polypeptide over NPY and peptide YY. Today, low-molecular-weight Y4R ligands are lackin..." /></meta><meta name="Description" content="Within the family of neuropeptide Y (NPY) receptors, the Y4 receptor (Y4R) is unique as it prefers pancreatic polypeptide over NPY and peptide YY. Today, low-molecular-weight Y4R ligands are lackin..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 2, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c00426" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00426" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c00426" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00426" /></link>
        
    
    

<title>Oligopeptides as Neuropeptide Y Y4 Receptor Ligands: Identification of a High-Affinity Tetrapeptide Agonist and a Hexapeptide Antagonist | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c00426" /></meta><meta property="og:title" content="Oligopeptides as Neuropeptide Y Y4 Receptor Ligands: Identification of a High-Affinity Tetrapeptide Agonist and a Hexapeptide Antagonist" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00426/20200806/images/large/jm0c00426_0007.jpeg" /></meta><meta property="og:description" content="Within the family of neuropeptide Y (NPY) receptors, the Y4 receptor (Y4R) is unique as it prefers pancreatic polypeptide over NPY and peptide YY. Today, low-molecular-weight Y4R ligands are lacking, in particular antagonists. We synthesized a series of peptidic NPY Y4R ligands, derived from the hexapeptide acetyl-Arg-Tyr-Arg-Leu-Arg-Tyr-NH2 (1), reported to be a Y4R partial agonist with high affinity (pKi Y4R: 8.43). Peptide 1 was N-terminally extended as well as truncated and subjected to a d-amino acid scan, and Leu was replaced by different amino acids. Compounds were characterized by radioligand competition binding and functional studies (Cai2+ mobilization and β-arrestin 1/2 recruitment). N-terminal truncation of 1 resulted in a tetrapeptide (Arg-Leu-Arg-Tyr-NH2), being a Y4R partial agonist with unchanged Y4R affinity (pKi: 8.47). Remarkably, replacement of Leu in 1 and in derivatives of 1 by Trp turned Y4R agonism to antagonism, giving Y4R antagonists with pKi values ≤7.57." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c00426"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00426">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c00426&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c00426&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c00426&amp;href=/doi/10.1021/acs.jmedchem.0c00426" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 15</span><span class="cit-fg-pageRange">, 8198-8215</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/15" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c00413" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c00446" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Oligopeptides as Neuropeptide Y Y<sub>4</sub> Receptor Ligands: Identification of a High-Affinity Tetrapeptide Agonist and a Hexapeptide Antagonist</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Adam Konieczny</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Adam Konieczny</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Pharmacy, Faculty of Chemistry and Pharmacy, University of Regensburg, Universitätsstr. 31, D-93053 Regensburg, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Adam++Konieczny">Adam Konieczny</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Diana Braun</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Diana Braun</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Pharmacy, Faculty of Chemistry and Pharmacy, University of Regensburg, Universitätsstr. 31, D-93053 Regensburg, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Diana++Braun">Diana Braun</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">David Wifling</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David Wifling</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Pharmacy, Faculty of Chemistry and Pharmacy, University of Regensburg, Universitätsstr. 31, D-93053 Regensburg, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David++Wifling">David Wifling</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Günther Bernhardt</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Günther Bernhardt</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Pharmacy, Faculty of Chemistry and Pharmacy, University of Regensburg, Universitätsstr. 31, D-93053 Regensburg, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=G%C3%BCnther++Bernhardt">Günther Bernhardt</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6491-9874" title="Orcid link">http://orcid.org/0000-0001-6491-9874</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Max Keller</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Max Keller</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Pharmacy, Faculty of Chemistry and Pharmacy, University of Regensburg, Universitätsstr. 31, D-93053 Regensburg, Germany</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#e38e829bcd88868f8f8691a39691cd8786"><span class="__cf_email__" data-cfemail="4f222e3761242a23232a3d0f3a3d612b2a">[email protected]</span></a>. Phone: (+49) 941-9433329. Fax: (+49) 941-9434820.</span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Max++Keller">Max Keller</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8095-8627" title="Orcid link">http://orcid.org/0000-0002-8095-8627</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00426&amp;href=/doi/10.1021%2Facs.jmedchem.0c00426" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 15</span><span class="cit-pageRange">, 8198–8215</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 2, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>13 March 2020</li><li><span class="item_label"><b>Published</b> online</span>2 July 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 August 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c00426" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00426</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8198%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAdam%2BKonieczny%252C%2BDiana%2BBraun%252C%2BDavid%2BWifling%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D15%26contentID%3Dacs.jmedchem.0c00426%26title%3DOligopeptides%2Bas%2BNeuropeptide%2BY%2BY4%2BReceptor%2BLigands%253A%2BIdentification%2Bof%2Ba%2BHigh-Affinity%2BTetrapeptide%2BAgonist%2Band%2Ba%2BHexapeptide%2BAntagonist%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8215%26publicationDate%3DAugust%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c00426"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">685</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">2</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c00426" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Oligopeptides as Neuropeptide Y Y4 Receptor Ligands: Identification of a High-Affinity Tetrapeptide Agonist and a Hexapeptide Antagonist&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Adam&quot;,&quot;last_name&quot;:&quot;Konieczny&quot;},{&quot;first_name&quot;:&quot;Diana&quot;,&quot;last_name&quot;:&quot;Braun&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Wifling&quot;},{&quot;first_name&quot;:&quot;Günther&quot;,&quot;last_name&quot;:&quot;Bernhardt&quot;},{&quot;first_name&quot;:&quot;Max&quot;,&quot;last_name&quot;:&quot;Keller&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;02&quot;,&quot;issue&quot;:&quot;15&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;8198-8215&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c00426&quot;},&quot;abstract&quot;:&quot;Within the family of neuropeptide Y (NPY) receptors, the Y4 receptor (Y4R) is unique as it prefers pancreatic polypeptide over NPY and peptide YY. Today, low-molecular-weight Y4R ligands are lacking, in particular antagonists. We synthesized a series of peptidic NPY Y4R ligands, derived from the hexapeptide acetyl-Arg-Tyr-Arg-Leu-Arg-Tyr-NH2 (1), reported to be a Y4R partial agonist with high affinity (pKi Y4R: 8.43). Peptide 1 was N-terminally extended as well as truncated and subjected to a d-amino acid scan, and Leu was replaced by different amino acids. Compounds were characterized by radioligand competition binding and functional studies (Cai2+ mobilization and β-arrestin 1/2 recruitment). N-terminal truncation of 1 resulted in a tetrapeptide (Arg-Leu-Arg-Tyr-NH2), being a Y4R partial agonist with unchanged Y4R affinity (pKi: 8.47). Remarkably, replacement of Leu in 1 and in derivatives of 1 by Trp turned Y4R agonism to antagonism, giving Y4R antagonists with pKi values ≤7.57.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00426&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00426" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00426&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00426" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00426&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00426" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00426&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00426&amp;href=/doi/10.1021/acs.jmedchem.0c00426" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c00426" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c00426" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c00426%26sid%3Dliteratum%253Aachs%26pmid%3D32614182%26genre%3Darticle%26aulast%3DKonieczny%26date%3D2020%26atitle%3DOligopeptides%2Bas%2BNeuropeptide%2BY%2BY4%2BReceptor%2BLigands%253A%2BIdentification%2Bof%2Ba%2BHigh-Affinity%2BTetrapeptide%2BAgonist%2Band%2Ba%2BHexapeptide%2BAntagonist%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D15%26spage%3D8198%26epage%3D8215%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (4)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=290831" title="Monomers">Monomers</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/15" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/jmcmar.2020.63.issue-15/20200813/jmcmar.2020.63.issue-15.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00426/20200806/images/medium/jm0c00426_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00426/20200806/images/large/jm0c00426_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00426&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Within the family of neuropeptide Y (NPY) receptors, the Y<sub>4</sub> receptor (Y<sub>4</sub>R) is unique as it prefers pancreatic polypeptide over NPY and peptide YY. Today, low-molecular-weight Y<sub>4</sub>R ligands are lacking, in particular antagonists. We synthesized a series of peptidic NPY Y<sub>4</sub>R ligands, derived from the hexapeptide acetyl-Arg-Tyr-Arg-Leu-Arg-Tyr-NH<sub>2</sub> (<b>1</b>), reported to be a Y<sub>4</sub>R partial agonist with high affinity (p<i>K</i><sub>i</sub> Y<sub>4</sub>R: 8.43). Peptide <b>1</b> was N-terminally extended as well as truncated and subjected to a <span class="smallcaps smallerCapital">d</span>-amino acid scan, and Leu was replaced by different amino acids. Compounds were characterized by radioligand competition binding and functional studies (Ca<sub>i</sub><sup>2+</sup> mobilization and β-arrestin 1/2 recruitment). N-terminal truncation of <b>1</b> resulted in a tetrapeptide (Arg-Leu-Arg-Tyr-NH<sub>2</sub>), being a Y<sub>4</sub>R partial agonist with unchanged Y<sub>4</sub>R affinity (p<i>K</i><sub>i</sub>: 8.47). Remarkably, replacement of Leu in <b>1</b> and in derivatives of <b>1</b> by Trp turned Y<sub>4</sub>R agonism to antagonism, giving Y<sub>4</sub>R antagonists with p<i>K</i><sub>i</sub> values ≤7.57.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58311" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58311" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Neuropeptide Y receptors (YRs) are class A (rhodopsin-like) G-protein-coupled receptors (GPCRs) involved in the regulation of numerous central and peripheral biological processes. YRs are stimulated by the highly homologous peptides neuropeptide Y (NPY), peptide YY (PYY), and pancreatic polypeptide (PP), each consisting of 36 amino acids.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> Y<sub>4</sub>R is unique in the YR family because of its preferential binding of PP (for a primary structure, see <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) compared to the other subtypes (in human: Y<sub>1</sub>R, Y<sub>2</sub>R, and Y<sub>5</sub>R), which are favoring the endogenous agonists NPY and PYY.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> Stimulation of Y<sub>4</sub>R mediates a reduction in food intake and increases gastrointestinal motility; therefore, Y<sub>4</sub>R agonists are considered as potential antiobesity agents.<a onclick="showRef(event, 'ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7">(5−7)</a> Moreover, studies with Y<sub>4</sub>R knockout mice suggested Y<sub>4</sub>R as a potential target for the treatment of depression.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a> Although several peptidic Y<sub>4</sub>R agonists, representing mimics of the C-terminal fragment of hPP (···Leu<sup>31</sup>-Thr<sup>32</sup>-Arg<sup>33</sup>-Pro<sup>34</sup>-Arg<sup>35</sup>-Tyr<sup>36</sup>-NH<sub>2</sub>), which is crucial for Y<sub>4</sub>R binding,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> are available (e.g., compounds <b>1</b>–<b>6</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>),<a onclick="showRef(event, 'ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13">(11−13)</a> only few Y<sub>4</sub>R antagonists were reported. For example, compound <b>7</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>),<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> a dimer of the argininamide-type Y<sub>1</sub>R antagonist BIBP3226,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and analogues of the dimeric peptides <b>3</b> and <b>4</b>, containing aza-amino acids (structures not shown),<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> were described as Y<sub>4</sub>R antagonists exhibiting high to moderate Y<sub>4</sub>R affinity (<i>K</i><sub>i</sub> = 30–134 nM). However, a low-molecular-weight, selective Y<sub>4</sub>R antagonist, which could serve as a molecular tool to study the physiological role of Y<sub>4</sub>R, is missing to date.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00426/20200806/images/medium/jm0c00426_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00426/20200806/images/large/jm0c00426_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures and reported Y<sub>4</sub>R affinities of hPP, the Y<sub>4</sub>R (partial) agonists <b>1</b>–<b>6</b>, and the nonpeptide Y<sub>4</sub>R antagonist <b>7</b>. <sup>a</sup>Kuhn et al.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a><sup>b</sup>Kuhn et al.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a><sup>c</sup>Daniels et al.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a><sup>d</sup>Keller et al.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00426/20200806/images/large/jm0c00426_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00426&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Covalent dimerization of pentapeptide <b>2</b>, mimicking the C-terminus of hPP,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> via suberyl linkers, afforded Y<sub>4</sub>R partial agonists containing four arginine residues (e.g., compounds <b>3</b>–<b>5</b>, see <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). These dimeric peptides showed increased Y<sub>4</sub>R affinity compared to <b>2</b>.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Prompted by this finding, the linear hexapeptide <b>1</b> (UR-KK236), representing the N-terminally arginylated congener of pentapeptide <b>2</b>, was recently prepared to explore the importance of a third basic amino acid in small peptides, mimicking the C-terminus of hPP.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Interestingly, compound <b>1</b> exhibited considerably higher Y<sub>4</sub>R affinity compared to <b>2</b> (<i>K</i><sub>i</sub> (hY<sub>4</sub>R): 3.4 vs 337 nM).<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p">A tritiated analogue of peptide <b>5</b>, bearing a propionyl residue at the linker moiety, was described as a molecular tool to determine Y<sub>4</sub>R affinities.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Notably, replacement of the suberyl linker in <b>3</b> by rigid photochromic scaffolds was well tolerated with respect to Y<sub>4</sub>R binding; that is, this approach gave photochromic Y<sub>4</sub>R partial agonists with high Y<sub>4</sub>R affinity, supporting the hypothesis that the orthosteric binding pocket of Y<sub>4</sub>R is occupied by only one of the pentapeptide sequences.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><div class="NLM_p">Here, we describe the synthesis and pharmacological characterization of analogues of hexapeptide <b>1</b> (cf. <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) reported to be a partial Y<sub>4</sub>R agonist with high affinity and pronounced Y<sub>4</sub>R selectivity.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Compared to the C-terminal sequence of hPP, compound <b>1</b> contains Leu instead of Pro<sup>34</sup>, Tyr instead of Thr,<sup>32</sup> and Arg instead of Leu<sup>31</sup> (see <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). In order to gain more insights into the relevance of individual amino acids and the N-terminus in <b>1</b> for Y<sub>4</sub>R binding and activation, we replaced, for example, Leu by Trp or Pro, inserted various spacers between the N-terminal arginine and the adjacent Tyr, replaced Arg by its nonbasic congener citrulline, and prepared analogues with a free (nonacetylated) N-terminus (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). Moreover, various linear tetrapeptides were prepared, representing N-terminally truncated derivatives of <b>1</b>. All peptides were characterized with respect to Y<sub>4</sub>R affinity by radioligand competition binding, as well as in terms of Y<sub>4</sub>R agonism or antagonism in β-arrestin 1 and 2 recruitment assays and in a Ca<sup>2+</sup>–aequorin assay, measuring G-protein-mediated transient increase in cytosolic Ca<sup>2+</sup>.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00426/20200806/images/medium/jm0c00426_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00426/20200806/images/large/jm0c00426_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Peptide sequences of the lead compound <b>1</b> and the synthesized analogues <b>8</b>–<b>35</b>. Amino acid replacements or insertions are highlighted in blue (compared to <b>1</b>) and red (compared to compound <b>29</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00426/20200806/images/large/jm0c00426_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00426&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70583" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70583" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">The peptides were prepared on Sieber amide resins by manual solid-phase peptide synthesis (SPPS) according to the Fmoc strategy, applying repeated (double) coupling steps with HBTU/HOBt/<i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA) as coupling reagents (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). N-terminal acetylation (<b>9</b>, <b>12</b>, <b>15</b>, <b>17</b>–<b>19</b>, <b>21</b>, and <b>23</b>–<b>28</b>) and N-terminal succinylation (<b>20</b>) were performed by treatment of the Fmoc-deprotected, resin-bound peptide with acetic anhydride and succinic anhydride, respectively. The N-terminally methylated tetrapeptide <b>35</b> was obtained using Fmoc-NMe-Arg(Pbf)-OH as a building block, which was coupled as an N-terminal amino acid (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Peptides were cleaved from the resin using trifluoroacetic acid (TFA)/CH<sub>2</sub>Cl<sub>2</sub> 1:3 v/v [two times 20 min at room temperature (rt)], followed by treatment with TFA/H<sub>2</sub>O 95:5 v/v to achieve complete side-chain deprotection (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00426/20200806/images/medium/jm0c00426_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00426/20200806/images/large/jm0c00426_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of the Oligopeptides <b>8</b>–<b>35</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00426/20200806/images/large/jm0c00426_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00426&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) peptide elongation, amino acid coupling: Fmoc amino acid/HOBt/HBTU/DIPEA (5/5/4.9/10 equiv), DMF/NMP (8:2), 35 °C, and 2 × 45 min (“double” coupling); Fmoc deprotection: 20% piperidine in DMF/NMP (8:2), rt, and 2 × 10 min; (b) (1) TFA/CH<sub>2</sub>Cl<sub>2</sub> (1:3), rt, and 2 × 20 min; (2) TFA/H<sub>2</sub>O (95:5), rt, and 5 h; (c) acetic anhydride/DIPEA (10/10 equiv), DMF/NMP (8:2), 35 °C, and 45 min; (d) succinic anhydride/DIPEA (10/10 equiv), DMF/NMP (8:2), 35 °C, and 45 min; and (e) Fmoc-N(Me)-Arg(Pbf)-OH/HOBt/HBTU/DIPEA (5/5/4.9/10 equiv), DMF/NMP (8:2), 35 °C, and 24 h (single coupling); for overall yields of peptide syntheses, see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> NPY Receptor Binding</h3><div class="NLM_p">Y<sub>4</sub>R affinities of the synthesized peptides were determined by radioligand competition binding at live CHO-hY<sub>4</sub>R-G<sub>qi5</sub>-mtAEQ cells<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> using the previously described radioligand [<sup>3</sup>H]<b>37</b><a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> (<i>K</i><sub>d</sub> (hY<sub>4</sub>R): 0.68 nM; for structure, see Figure S1, <a href="/doi/suppl/10.1021/acs.jmedchem.0c00426/suppl_file/jm0c00426_si_001.pdf" class="ext-link">Supporting Information</a>). Radioligand displacement curves are shown in Figure S2 (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00426/suppl_file/jm0c00426_si_001.pdf" class="ext-link">Supporting Information</a>), and the obtained p<i>K</i><sub>i</sub> values are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. Removal of the acetyl group in <b>1</b>, resulting in compound <b>8</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>), did not affect the Y<sub>4</sub>R affinity, suggesting a minor role of the N-terminus of <b>1</b> for Y<sub>4</sub>R binding.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Y<sub>4</sub>R Binding Data of hPP, <b>1</b>, and Compounds <b>8</b>–<b>35</b>, as Well as Y<sub>1</sub>, Y<sub>2</sub>, and Y<sub>5</sub> Receptor Binding Data of Selected Compounds<a class="ref internalNav" href="#t1fn7" aria-label="g">g</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center" char="±">YR binding</th><th class="rowsep1 colsep0" colspan="3" align="center">selectivity toward Y<sub>4</sub>R [ratio <i>K</i><sub>i</sub> (Y<sub>1,2,5</sub>R)/<i>K</i><sub>i</sub> (Y<sub>4</sub>R)]</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cmpd.</th><th class="colsep0 rowsep0" align="center" char="±">p<i>K</i><sub>i</sub> ± SEM/<i>K</i><sub>i</sub> [nM] hY<sub>4</sub>R<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">p<i>K</i><sub>i</sub>/<i>K</i><sub>i</sub> [nM] hY<sub>1</sub>R<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">p<i>K</i><sub>i</sub>/<i>K</i><sub>i</sub> [nM] hY<sub>2</sub>R<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">p<i>K</i><sub>i</sub>/<i>K</i><sub>i</sub> [nM] hY<sub>5</sub>R<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">Y<sub>1</sub>R</th><th class="colsep0 rowsep0" align="center">Y<sub>2</sub>R</th><th class="colsep0 rowsep0" align="center">Y<sub>5</sub>R</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hPP</td><td class="colsep0 rowsep0" align="char" char="±">9.16 ± 0.03/0.69</td><td class="colsep0 rowsep0" align="left"><6.5<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a>/>300</td><td class="colsep0 rowsep0" align="left"><5.5<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a>/>3000</td><td class="colsep0 rowsep0" align="left"><8.0<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a>/>10</td><td class="colsep0 rowsep0" align="left">>430</td><td class="colsep0 rowsep0" align="left">>4300</td><td class="colsep0 rowsep0" align="left">>15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char="±">8.43 ± 0.04/3.6</td><td class="colsep0 rowsep0" align="left"><5.5<a class="ref internalNav" href="#t1fn6" aria-label="f">f</a>/>3000</td><td class="colsep0 rowsep0" align="left"><5.5<a class="ref internalNav" href="#t1fn6" aria-label="f">f</a>/>3000</td><td class="colsep0 rowsep0" align="left"><5.5<a class="ref internalNav" href="#t1fn6" aria-label="f">f</a>/>3000</td><td class="colsep0 rowsep0" align="left">>830</td><td class="colsep0 rowsep0" align="left">>830</td><td class="colsep0 rowsep0" align="left">>830</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="char" char="±">8.69 ± 0.01/2.0</td><td class="colsep0 rowsep0" align="left"><5.5/>3000</td><td class="colsep0 rowsep0" align="left"><5.0/>10,000</td><td class="colsep0 rowsep0" align="left"><5.5/>3000</td><td class="colsep0 rowsep0" align="left">>1500</td><td class="colsep0 rowsep0" align="left">>5000</td><td class="colsep0 rowsep0" align="left">>1500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="char" char="±">5.75 ± 0.06/1800</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="char" char="±">6.73 ± 0.07/190</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="char" char="±">6.64 ± 0.11/240</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="char" char="±">7.05 ± 0.13/97</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="char" char="±">7.57 ± 0.08/28</td><td class="colsep0 rowsep0" align="left"><5.5/>3000</td><td class="colsep0 rowsep0" align="left"><5.5/>3000</td><td class="colsep0 rowsep0" align="left"><5.0/>10,000</td><td class="colsep0 rowsep0" align="left">>110</td><td class="colsep0 rowsep0" align="left">>110</td><td class="colsep0 rowsep0" align="left">>360</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="char" char="±">8.35 ± 0.13/4.8</td><td class="colsep0 rowsep0" align="left"><5.5/>3000</td><td class="colsep0 rowsep0" align="left"><5.5/>3000</td><td class="colsep0 rowsep0" align="left"><5.0/>10,000</td><td class="colsep0 rowsep0" align="left">>630</td><td class="colsep0 rowsep0" align="left">>630</td><td class="colsep0 rowsep0" align="left">>2100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="char" char="±">6.93 ± 0.04/120</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="char" char="±">7.25 ± 0.15/63</td><td class="colsep0 rowsep0" align="left"><5.5/>3000</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">>48</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="char" char="±">8.86 ± 0.09/1.4</td><td class="colsep0 rowsep0" align="left"><6.0/>1000</td><td class="colsep0 rowsep0" align="left"><6.0/>1000</td><td class="colsep0 rowsep0" align="left"><6.0/>1000</td><td class="colsep0 rowsep0" align="left">>710</td><td class="colsep0 rowsep0" align="left">>710</td><td class="colsep0 rowsep0" align="left">>710</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="char" char="±">8.06 ± 0.06/8.9</td><td class="colsep0 rowsep0" align="left"><6.0/>1000</td><td class="colsep0 rowsep0" align="left"><5.0/>10,000</td><td class="colsep0 rowsep0" align="left"><6.0/>1000</td><td class="colsep0 rowsep0" align="left">>110</td><td class="colsep0 rowsep0" align="left">>1100</td><td class="colsep0 rowsep0" align="left">>110</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="char" char="±">8.12 ± 0.08/7.9</td><td class="colsep0 rowsep0" align="left"><5.5/>3000</td><td class="colsep0 rowsep0" align="left"><6.0/>1000</td><td class="colsep0 rowsep0" align="left"><5.5/>3000</td><td class="colsep0 rowsep0" align="left">>380</td><td class="colsep0 rowsep0" align="left">>130</td><td class="colsep0 rowsep0" align="left">>380</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="char" char="±">8.40 ± 0.04/4.0</td><td class="colsep0 rowsep0" align="left"><6.5/>300</td><td class="colsep0 rowsep0" align="left"><5.5/>3000</td><td class="colsep0 rowsep0" align="left"><5.0/>10,000</td><td class="colsep0 rowsep0" align="left">>75</td><td class="colsep0 rowsep0" align="left">>750</td><td class="colsep0 rowsep0" align="left">>2500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="char" char="±">7.85 ± 0.07/17</td><td class="colsep0 rowsep0" align="left"><5.5/>3000</td><td class="colsep0 rowsep0" align="left"><5.5/>3000</td><td class="colsep0 rowsep0" align="left"><5.0/>10,000</td><td class="colsep0 rowsep0" align="left">>180</td><td class="colsep0 rowsep0" align="left">>180</td><td class="colsep0 rowsep0" align="left">>590</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="char" char="±">8.79 ± 0.06/1.7</td><td class="colsep0 rowsep0" align="left"><6.0/>1000</td><td class="colsep0 rowsep0" align="left"><5.0/>10,000</td><td class="colsep0 rowsep0" align="left"><6.0/>1000</td><td class="colsep0 rowsep0" align="left">>590</td><td class="colsep0 rowsep0" align="left">>5900</td><td class="colsep0 rowsep0" align="left">>590</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="char" char="±">8.60 ± 0.05/2.8</td><td class="colsep0 rowsep0" align="left"><6.0/>1000</td><td class="colsep0 rowsep0" align="left"><5.5/>3000</td><td class="colsep0 rowsep0" align="left"><5.0/>10,000</td><td class="colsep0 rowsep0" align="left">>360</td><td class="colsep0 rowsep0" align="left">>1070</td><td class="colsep0 rowsep0" align="left">>3600</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="char" char="±">8.40 ± 0.02/4.3</td><td class="colsep0 rowsep0" align="left"><6.0/>1000</td><td class="colsep0 rowsep0" align="left"><6.0/>1000</td><td class="colsep0 rowsep0" align="left"><6.0/>1000</td><td class="colsep0 rowsep0" align="left">>230</td><td class="colsep0 rowsep0" align="left">>230</td><td class="colsep0 rowsep0" align="left">>230</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="char" char="±">7.55 ± 0.08/29</td><td class="colsep0 rowsep0" align="left"><5.5/>3000</td><td class="colsep0 rowsep0" align="left"><5.0/>10,000</td><td class="colsep0 rowsep0" align="left"><5.5/>3000</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>340</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="char" char="±">6.62 ± 0.09/250</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="char" char="±">7.51 ± 0.11/38</td><td class="colsep0 rowsep0" align="left"><6.0/>1000</td><td class="colsep0 rowsep0" align="left"><6.0/>1000</td><td class="colsep0 rowsep0" align="left"><6.0/>1000</td><td class="colsep0 rowsep0" align="left">>26</td><td class="colsep0 rowsep0" align="left">26</td><td class="colsep0 rowsep0" align="left">>26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="char" char="±">6.81 ± 0.09/160</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="char" char="±">8.47 ± 0.01/3.4</td><td class="colsep0 rowsep0" align="left"><5.0/>10,000</td><td class="colsep0 rowsep0" align="left"><5.0/>10,000</td><td class="colsep0 rowsep0" align="left"><5.0/>10,000</td><td class="colsep0 rowsep0" align="left">>2900</td><td class="colsep0 rowsep0" align="left">>2900</td><td class="colsep0 rowsep0" align="left">>2900</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="char" char="±">6.45 ± 0.04/350</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="char" char="±">8.13 ± 0.09/7.4</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="char" char="±">7.03 ± 0.14/93</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="char" char="±">5.88 ± 0.11/1300</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="char" char="±">5.81 ± 0.08/1500</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="char" char="±">8.41 ± 0.08/3.9</td><td class="colsep0 rowsep0" align="left"><5.5/>3000</td><td class="colsep0 rowsep0" align="left"><6.0/>1000</td><td class="colsep0 rowsep0" align="left"><5.0/>10,000</td><td class="colsep0 rowsep0" align="left">>770</td><td class="colsep0 rowsep0" align="left">>260</td><td class="colsep0 rowsep0" align="left">>2600</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Determined by competition binding at CHO-hY<sub>4</sub>R-mtAEQ-G<sub>qi5</sub> cells using[<sup>3</sup>H]<b>37</b> (<i>K</i><sub>d</sub> = 0.67 nM and <i>c</i> = 1 nM) as a radioligand.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Determined by competition binding at SK-N-MC neuroblastoma cells using[<sup>3</sup>H]<b>36</b> (<i>K</i><sub>d</sub> = 0.044 nM and <i>c</i> = 0.15 nM) as a radioligand (for structure, see Figure S1, <a href="/doi/suppl/10.1021/acs.jmedchem.0c00426/suppl_file/jm0c00426_si_001.pdf" class="ext-link">Supporting Information</a>).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">Determined by competition binding with [<sup>3</sup>H]propionyl-pNPY (<i>K</i><sub>d</sub> = 0.14 nM and <i>c</i> = 0.5 nM) at CHO-hY<sub>2</sub>R cells.</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">Determined by competition binding at HEC-1B-hY<sub>5</sub>R cells using [<sup>3</sup>H]propionyl-pNPY (<i>K</i><sub>d</sub> = 4.8 nM and <i>c</i> = 4 nM) as a radioligand.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></p></div><div class="footnote" id="t1fn5"><sup><sup>e</sup></sup><p class="last">p<i>K</i><sub>i</sub> values reported by Berlicki et al.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></p></div><div class="footnote" id="t1fn6"><sup><sup>f</sup></sup><p class="last">p<i>K</i><sub>i</sub> values reported by Kuhn et al.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></p></div><div class="footnote" id="t1fn7"><sup><sup>g</sup></sup><p class="last">Data represent mean values from three independent experiments performed in triplicate (SEM given for Y<sub>4</sub>R p<i>K</i><sub>i</sub> values). n.d.: not determined.</p></div></div></div><div class="NLM_p">Leu in position 4 of <b>1</b> was replaced by Pro, which is also present in position 34 in hPP (cf. <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), resulting in compound <b>9</b>, which displayed considerably lower Y<sub>4</sub>R affinity compared to <b>1</b> (p<i>K</i><sub>i</sub> values of <b>1</b> and <b>9</b>: 8.43 and 5.75, respectively). This suggested that the hexapeptidic Y<sub>4</sub>R ligands do not tolerate alterations (rigidization and reorientation) of the peptide backbone. Furthermore, Leu<sup>4</sup> in peptide <b>1</b> or in its equiactive, nonacetylated congener <b>8</b> was replaced by Gly (<b>10</b>), Ala (<b>11</b>), or the bulky aromatic amino acid Trp (<b>12</b>, <b>13</b>) to create a series of hexapeptides, bearing nonpolar amino acid residues of various sizes in position 4. Peptides <b>10</b>–<b>13</b> exhibited lower Y<sub>4</sub>R affinity compared to <b>1</b> or <b>8</b> (approximately 1–2 orders of magnitude, see <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), showing that Leu<sup>4</sup> in <b>1</b> or <b>8</b> is crucial with respect to high Y<sub>4</sub>R binding.</div><div class="NLM_p">In order to explore the importance of the three basic arginine residues in <b>1</b>, a citrulline scan was performed with respect to these arginines, affording compounds <b>14</b>, <b>15</b>, and <b>16</b> (cf. <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Whereas replacement of Arg<sup>1</sup> by citrulline (<b>14</b>) did not affect the Y<sub>4</sub>R affinity, incorporation of citrulline instead of Arg<sup>3</sup> (<b>15</b>) and Arg<sup>5</sup> (<b>16</b>) resulted in a decrease in Y<sub>4</sub>R affinity by more than a factor of 10 (see <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). This suggested a minor relevance of the basic side chain of Arg<sup>1</sup> for Y<sub>4</sub>R binding. However, as previously demonstrated,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> omitting Arg<sup>1</sup> in <b>1</b> (compound <b>2</b>) leads to a considerable decrease in Y<sub>4</sub>R affinity (see <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). Concerning Arg<sup>3</sup> and Arg<sup>5</sup>, the citrulline scan indicated that these two arginines are involved in key interactions with Y<sub>4</sub>R.</div><div class="NLM_p">Incorporation of Trp, Phe, or Gly instead of Tyr<sup>2</sup> in <b>1</b> afforded congeners (<b>17</b>–<b>19</b>) with Y<sub>4</sub>R binding constants comparable to that of <b>1</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), indicating that Tyr<sup>2</sup> in <b>1</b> plays a minor role for Y<sub>4</sub>R binding. N-terminal succinylation instead of acetylation as in <b>1</b> (peptide <b>20</b>) and omittance of Tyr<sup>2</sup> in <b>1</b> (compound <b>21</b>) did not or only slightly affect the Y<sub>4</sub>R affinity, being consistent with the aforementioned minor importance of the N-terminus of <b>1</b> as well as with a minor role of Tyr<sup>2</sup> for Y<sub>4</sub>R binding. Strikingly, replacement of the N-terminal Tyr in the previously reported pentapeptide <b>2</b> (cf. <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) by Trp (peptide <b>22</b>) led to a considerable increase in Y<sub>4</sub>R affinity (reported <i>K</i><sub>i</sub> of <b>2</b>: 337 nM,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> p<i>K</i><sub>i</sub> of <b>22</b>: 8.79). However, an N-terminal extension of <b>22</b> by one arginine (compound <b>17</b>) did not lead to a further increase in Y<sub>4</sub>R affinity.</div><div class="NLM_p">As aforementioned, the N-terminal extension of pentapeptide <b>2</b> (<i>K</i><sub>i</sub> (hY<sub>4</sub>R): 337 nM)<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> by one arginine, resulting in hexapeptide <b>1</b>, led to a considerable increase in Y<sub>4</sub>R affinity (<i>K</i><sub>i</sub>: 3.4 nM). Therefore, in order to explore whether an increased distance of the N-terminal Arg in <b>1</b> to the residual pentapeptide sequence (corresponding to <b>2</b>) can lead to an even further increased Y<sub>4</sub>R affinity, analogues of <b>1</b> were prepared, containing a glycine or a “GABA–glycine” spacer between Arg<sup>1</sup> and Tyr<sup>2</sup> (<b>23</b> and <b>24</b>, cf. <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). Compounds <b>23</b> and <b>24</b> showed Y<sub>4</sub>R affinities comparable to that of <b>1</b>. By contrast, insertion of Gly between Arg<sup>1</sup> and Trp<sup>2</sup> in <b>17</b>, yielding heptapeptide <b>25</b>, resulted in a more than 10-fold decrease in Y<sub>4</sub>R affinity (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Replacement of the C-terminal tyrosinamide in <b>25</b> by tryptophanamide, giving heptapeptide <b>26</b>, resulted in a further decrease in Y<sub>4</sub>R binding by approximately 1 order of magnitude. Likewise, replacement of the C-terminal tyrosinamide in <b>23</b> by tryptophanamide, affording heptapeptide <b>27</b>, led to a 10-fold decrease in Y<sub>4</sub>R affinity. Insertion of GABA between Arg<sup>1</sup> and Tyr<sup>2</sup> in hexapeptide <b>12</b>, resulting in peptide <b>28</b> (cf. <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>), resulted in almost unchanged Y<sub>4</sub>R binding (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><div class="NLM_p">As mentioned above, the N-terminal amino acids in the hexapeptide <b>1</b> (Arg<sup>1</sup>, Tyr<sup>2</sup>) seem to be less important for binding of <b>1</b> to Y<sub>4</sub>R. Therefore, tetrapeptide <b>29</b> was prepared as an N-terminally truncated variant of <b>1</b>. Compound <b>29</b> exhibited high Y<sub>4</sub>R affinity (p<i>K</i><sub>i</sub>: 8.47) comparable to that of <b>1</b> (p<i>K</i><sub>i</sub>: 8.43). This supported the hypothesis that two basic arginine residues, most likely mimicking Arg<sup>33</sup> and Arg<sup>35</sup> of hPP (cf. <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), both being crucial for Y<sub>4</sub>R binding of hPP,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> are sufficient in small peptides to achieve high Y<sub>4</sub>R affinity. Replacement of Leu in <b>29</b> by Trp, resulting in <b>30</b>, caused a considerable decrease in Y<sub>4</sub>R binding by 2 orders of magnitude. A <span class="smallcaps smallerCapital">d</span>-amino acid scan applied to tetrapeptide <b>29</b>, giving peptides <b>31</b>–<b>34</b> (cf. <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>), showed that inversion of the stereochemistry of the N-terminal Arg in <b>29</b> (compound <b>31</b>) was well tolerated (p<i>K</i><sub>i</sub> (Y<sub>4</sub>R) of <b>31</b>: 8.13). By contrast, in the case of all other amino acids in <b>29</b>, the inversion of the configuration resulted in a considerably lower Y<sub>4</sub>R affinity (tetrapeptides <b>32–34</b>). Finally, N<sup>α</sup>-methylation of the N-terminal Arg in <b>29</b> led to a congener (<b>35</b>), which exhibited the same Y<sub>4</sub>R affinity as <b>29</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><div class="NLM_p last">For the Y<sub>4</sub>R agonists <b>8</b>, <b>14</b>, <b>17</b>–<b>24</b>, <b>27</b>, <b>29</b>, and <b>35</b>, exhibiting high Y<sub>4</sub>R affinity (p<i>K</i><sub>i</sub> > 7.5), as well as for the antagonists <b>13</b> and <b>25</b>, complete YR selectivity profiles were determined (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Compounds <b>8</b>, <b>13</b>, <b>14</b>, <b>17</b>–<b>19</b>, <b>21</b>–<b>25</b>, <b>29</b>, and <b>35</b> showed high Y<sub>4</sub>R selectivity as Y<sub>1</sub>, Y<sub>2</sub>, and Y<sub>5</sub> receptor affinities were more than 100-fold lower compared to Y<sub>4</sub>R binding.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Functional Studies at the Human Y<sub>4</sub> Receptor</h3><div class="NLM_p">All compounds were investigated with respect to Y<sub>4</sub>R agonism in the β-arrestin 1 and 2 recruitment assays (HEK293T-ARRB1-Y<sub>4</sub>R and HEK293T-ARRB2-Y<sub>4</sub>R cells<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a>), and selected peptides (<b>1</b>, <b>8</b>–<b>13</b>, <b>15</b>, and <b>17</b>–<b>30</b>) were studied in a Ca<sup>2+</sup>–aequorin assay (CHO-hY<sub>4</sub>R-G<sub>qi5</sub>-mtAEQ cells<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a>). Except for compounds containing Trp instead of Leu (<b>12</b>, <b>13</b>, <b>25</b>, <b>26</b>, and <b>28</b>), the synthesized peptides elicited a response in the arrestin recruitment and in the Ca<sup>2+</sup>–aequorin assay (agonist mode). Complete concentration–effect curves (CEC) (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> and S3–S5, <a href="/doi/suppl/10.1021/acs.jmedchem.0c00426/suppl_file/jm0c00426_si_001.pdf" class="ext-link">Supporting Information</a>) were obtained for agonists (<b>1</b>, <b>8</b>, <b>14</b>, <b>16</b>–<b>24</b>, <b>27</b>, <b>29</b>, <b>31</b>, and <b>35</b>) exhibiting p<i>K</i><sub>i</sub> values >7.1 (radioligand competition binding) (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). The respective pEC<sub>50</sub> values, EC<sub>50</sub> values, and efficacies (relative to hPP) are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>. With efficacies (α) ranging from 0.35 to 0.91, compounds <b>1</b>, <b>8</b>, <b>14</b>, <b>16</b>–<b>24</b>, <b>27</b>, and <b>29</b> proved to be partial agonists irrespective of the type of functional assay (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Strikingly, the potencies (pEC<sub>50</sub>) of the partial agonists were throughout lower (1.5–2 orders of magnitude) than the respective p<i>K</i><sub>i</sub> values (radioligand competition binding) (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). This discrepancy can be mainly attributed to the absence and presence of sodium ions in the buffers used for binding and functional assays, respectively, as discussed previously.<a onclick="showRef(event, 'ref12 ref22'); return false;" href="javascript:void(0);" class="ref ref12 ref22">(12,22)</a></div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00426/20200806/images/medium/jm0c00426_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00426/20200806/images/large/jm0c00426_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. CECs of hPP, <b>1</b>, <b>13</b>, <b>17</b>, <b>23</b>, <b>25</b>, and <b>29</b> obtained from a hY<sub>4</sub>R β-arrestin 1 recruitment (A), hY<sub>4</sub>R β-arrestin 2 recruitment (B), and hY<sub>4</sub>R Ca<sup>2+</sup>–aequorin (C) assay performed with live HEK293T-ARRB1-Y<sub>4</sub>R cells, HEK293T-ARRB2-Y<sub>4</sub>R cells, and CHO-hY<sub>4</sub>-G<sub>qi5</sub>-mtAEQ cells, respectively. Data represent means ± SEM from at least three independent experiments, each performed in triplicate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00426/20200806/images/large/jm0c00426_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00426&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Agonistic (pEC<sub>50</sub> and EC<sub>50</sub>) or Antagonistic (p<i>K</i><sub>b</sub>) Activities of hPP, <b>1</b>, and <b>8</b>–<b>35</b><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">β-arrestin 1<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="2" align="center">β-arrestin 2<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="2" align="center">Ca<sup>2+</sup>–aequorin<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cmpd.</th><th class="colsep0 rowsep0" align="center">pEC<sub>50</sub> ± SEM/EC<sub>50</sub> [nM] or p<i>K</i><sub>b</sub> ± SEM</th><th class="colsep0 rowsep0" align="center">α ± SEM</th><th class="colsep0 rowsep0" align="center">pEC<sub>50</sub> ± SEM/EC<sub>50</sub> [nM] or p<i>K</i><sub>b</sub> ± SEM</th><th class="colsep0 rowsep0" align="center">α ± SEM</th><th class="colsep0 rowsep0" align="center">pEC<sub>50</sub> ± SEM/EC<sub>50</sub> [nM] or p<i>K</i><sub>b</sub> ± SEM</th><th class="colsep0 rowsep0" align="center">α ± SEM</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hPP</td><td class="colsep0 rowsep0" align="left">8.66 ± 0.01/2.4</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">8.37 ± 0.02/4.1</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">7.96 ± 0.01/10.6</td><td class="colsep0 rowsep0" align="left">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">6.79 ± 0.07/170</td><td class="colsep0 rowsep0" align="left">0.55 ± 0.02</td><td class="colsep0 rowsep0" align="left">6.95 ± 0.04/120</td><td class="colsep0 rowsep0" align="left">0.61 ± 0.01</td><td class="colsep0 rowsep0" align="left">6.74 ± 0.04/190</td><td class="colsep0 rowsep0" align="left">0.75 ± 0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">7.29 ± 0.04/51</td><td class="colsep0 rowsep0" align="left">0.71 ± 0.02</td><td class="colsep0 rowsep0" align="left">7.42 ± 0.05/38</td><td class="colsep0 rowsep0" align="left">0.73 ± 0.05</td><td class="colsep0 rowsep0" align="left">6.99 ± 0.02/100</td><td class="colsep0 rowsep0" align="left">0.61 ± 0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left"><4.50/>30,000</td><td class="colsep0 rowsep0" align="left">n.a.</td><td class="colsep0 rowsep0" align="left"><4.50/>30,000</td><td class="colsep0 rowsep0" align="left">n.a.</td><td class="colsep0 rowsep0" align="left"><4.50/>30,000</td><td class="colsep0 rowsep0" align="left">n.a.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left"><4.50/>30,000</td><td class="colsep0 rowsep0" align="left">n.a.</td><td class="colsep0 rowsep0" align="left"><4.50/>30,000</td><td class="colsep0 rowsep0" align="left">n.a.</td><td class="colsep0 rowsep0" align="left"><4.50/>30,000</td><td class="colsep0 rowsep0" align="left">n.a.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left"><4.50/>30,000</td><td class="colsep0 rowsep0" align="left">n.a.</td><td class="colsep0 rowsep0" align="left"><4.50/>30,000</td><td class="colsep0 rowsep0" align="left">n.a.</td><td class="colsep0 rowsep0" align="left"><4.50/>30,000</td><td class="colsep0 rowsep0" align="left">n.a.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left"><i>7.02 ± 0.02</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>6.85 ± 0.05</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>7.22</i> ± 0.02</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left"><i>7.14 ± 0.02</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>6.87 ± 0.04</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>7.32</i> ± 0.05</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">7.00 ± 0.08/100</td><td class="colsep0 rowsep0" align="left">0.88 ± 0.06</td><td class="colsep0 rowsep0" align="left">6.83 ± 0.04/150</td><td class="colsep0 rowsep0" align="left">0.64 ± 0.05</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left"><4.50/>30,000</td><td class="colsep0 rowsep0" align="left">n.a.</td><td class="colsep0 rowsep0" align="left"><4.50/>30,000</td><td class="colsep0 rowsep0" align="left">n.a.</td><td class="colsep0 rowsep0" align="left"><4.50/>30,000</td><td class="colsep0 rowsep0" align="left">n.a.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">5.97 ± 0.13/1070</td><td class="colsep0 rowsep0" align="left">0.61 ± 0.06</td><td class="colsep0 rowsep0" align="left">6.03 ± 0.08/930</td><td class="colsep0 rowsep0" align="left">0.86 ± 0.09</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">7.17 ± 0.06/67</td><td class="colsep0 rowsep0" align="left">0.79 ± 0.02</td><td class="colsep0 rowsep0" align="left">7.46 ± 0.03/35</td><td class="colsep0 rowsep0" align="left">0.68 ± 0.03</td><td class="colsep0 rowsep0" align="left">6.93 ± 0.02/120</td><td class="colsep0 rowsep0" align="left">0.61 ± 0.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">6.26 ± 0.08/550</td><td class="colsep0 rowsep0" align="left">0.65 ± 0.08</td><td class="colsep0 rowsep0" align="left">6.50 ± 0.04/320</td><td class="colsep0 rowsep0" align="left">0.63 ± 0.07</td><td class="colsep0 rowsep0" align="left">6.26 ± 0.01/550</td><td class="colsep0 rowsep0" align="left">0.58 ± 0.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">6.74 ± 0.09/180</td><td class="colsep0 rowsep0" align="left">0.57 ± 0.02</td><td class="colsep0 rowsep0" align="left">6.60 ± 0.08/250</td><td class="colsep0 rowsep0" align="left">0.60 ± 0.02</td><td class="colsep0 rowsep0" align="left">5.92 ± 0.06/1200</td><td class="colsep0 rowsep0" align="left">0.62 ± 0.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">6.34 ± 0.03/460</td><td class="colsep0 rowsep0" align="left">0.66 ± 0.13</td><td class="colsep0 rowsep0" align="left">6.37 ± 0.07/430</td><td class="colsep0 rowsep0" align="left">0.86 ± 0.06</td><td class="colsep0 rowsep0" align="left">6.21 ± 0.05/620</td><td class="colsep0 rowsep0" align="left">0.68 ± 0.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">6.22 ± 0.04/600</td><td class="colsep0 rowsep0" align="left">0.51 ± 0.07</td><td class="colsep0 rowsep0" align="left">6.29 ± 0.04/510</td><td class="colsep0 rowsep0" align="left">0.41 ± 0.06</td><td class="colsep0 rowsep0" align="left">5.60 ± 0.04/2500</td><td class="colsep0 rowsep0" align="left">0.49 ± 0.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">6.78 ± 0.07/160</td><td class="colsep0 rowsep0" align="left">0.91 ± 0.06</td><td class="colsep0 rowsep0" align="left">6.83 ± 0.07/140</td><td class="colsep0 rowsep0" align="left">0.70 ± 0.02</td><td class="colsep0 rowsep0" align="left">6.61 ± 0.08/250</td><td class="colsep0 rowsep0" align="left">0.74 ± 0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">6.79 ± 0.08/160</td><td class="colsep0 rowsep0" align="left">0.56 ± 0.02</td><td class="colsep0 rowsep0" align="left">7.29 ± 0.05/51</td><td class="colsep0 rowsep0" align="left">0.67 ± 0.01</td><td class="colsep0 rowsep0" align="left">6.97 ± 0.01/110</td><td class="colsep0 rowsep0" align="left">0.64 ± 0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">6.77 ± 0.05/170</td><td class="colsep0 rowsep0" align="left">0.64 ± 0.04</td><td class="colsep0 rowsep0" align="left">6.85 ± 0.04/140</td><td class="colsep0 rowsep0" align="left">0.67 ± 0.03</td><td class="colsep0 rowsep0" align="left">6.63 ± 0.02/230</td><td class="colsep0 rowsep0" align="left">0.54 ± 0.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left"><i>6.96 ± 0.05</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>7.01 ± 0.03</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>7.57</i> ± 0.07</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left"><i>6.10 ± 0.06</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>5.80 ± 0.08</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>6.46</i> ± 0.03</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">6.28 ± 0.04/520</td><td class="colsep0 rowsep0" align="left">0.35 ± 0.04</td><td class="colsep0 rowsep0" align="left">6.45 ± 0.03/360</td><td class="colsep0 rowsep0" align="left">0.47 ± 0.03</td><td class="colsep0 rowsep0" align="left">6.42 ± 0.06/380</td><td class="colsep0 rowsep0" align="left">0.45 ± 0.16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left"><i>6.22 ± 0.04</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>5.87 ± 0.05</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>6.91</i> ± 0.04</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">6.56 ± 0.01/280</td><td class="colsep0 rowsep0" align="left">0.81 ± 0.05</td><td class="colsep0 rowsep0" align="left">6.78 ± 0.02/170</td><td class="colsep0 rowsep0" align="left">0.84 ± 0.07</td><td class="colsep0 rowsep0" align="left">6.36 ± 0.01/440</td><td class="colsep0 rowsep0" align="left">0.54 ± 0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left"><4.50/>30,000</td><td class="colsep0 rowsep0" align="left">n.a.</td><td class="colsep0 rowsep0" align="left"><4.50/>30,000</td><td class="colsep0 rowsep0" align="left">n.a.</td><td class="colsep0 rowsep0" align="left"><4.50/>30,000</td><td class="colsep0 rowsep0" align="left">n.a.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">5.62 ± 0.08/2400</td><td class="colsep0 rowsep0" align="left">0.60 ± 0.03</td><td class="colsep0 rowsep0" align="left">5.33 ± 0.09/4800</td><td class="colsep0 rowsep0" align="left">1.02 ± 0.06</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left"><4.50/>30,000</td><td class="colsep0 rowsep0" align="left">n.a.</td><td class="colsep0 rowsep0" align="left"><4.50/>30,000</td><td class="colsep0 rowsep0" align="left">n.a.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left"><4.50/>30,000</td><td class="colsep0 rowsep0" align="left">n.a.</td><td class="colsep0 rowsep0" align="left"><4.50/>30,000</td><td class="colsep0 rowsep0" align="left">n.a.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left"><4.50/>30,000</td><td class="colsep0 rowsep0" align="left">n.a.</td><td class="colsep0 rowsep0" align="left"><4.50/>30,000</td><td class="colsep0 rowsep0" align="left">n.a.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">5.61 ± 0.1/2500</td><td class="colsep0 rowsep0" align="left">0.63 ± 0.05</td><td class="colsep0 rowsep0" align="left">5.93 ± 0.04/1200</td><td class="colsep0 rowsep0" align="left">0.97 ± 0.03</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Agonistic potencies (pEC<sub>50</sub> and EC<sub>50</sub>) and intrinsic activities α (relative to the maximum effect elicited by 1 μM hPP, α = 1) determined in a β-arrestin 1 and a β-arrestin 2 recruitment assay at HEK293T-ARRB1-Y<sub>4</sub>R cells and HEK293T-ARRB2-Y<sub>4</sub>R cells, respectively. When performed in an antagonist mode, the p<i>K</i><sub>b</sub> values (in italics) were obtained by inhibition of the effect elicited by 10 nM hPP.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Agonistic potencies (pEC<sub>50</sub> and EC<sub>50</sub>) and intrinsic activities α (relative to the maximum effect elicited by 1 μM hPP, α = 1) determined in a Ca<sup>2+</sup>–aequorin assay using CHO-hY<sub>4</sub>R-mtAEQ-G<sub>qi5</sub> cells. When performed in an antagonist mode, the p<i>K</i><sub>b</sub> values (in italics) were obtained by inhibition of the effect elicited by 100 nM hPP.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">Data represent mean values from three or four independent experiments (SEM given for pEC<sub>50</sub>, α, and p<i>K</i><sub>b</sub> values). n.a.: not applicable. n.d.: not determined.</p></div></div></div><div class="NLM_p">When comparing the potencies (pEC<sub>50</sub>) and efficacies obtained from the arrestin 1/2 recruitment and the Ca<sup>2+</sup>–aequorin assay, there were only minor differences (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>), showing that the investigated partial agonists were unbiased with respect to the activation of the G-protein pathway and β-arrestin 1/2 recruitment to Y<sub>4</sub>R.</div><div class="NLM_p">Peptides <b>12</b>, <b>13</b>, <b>25</b>, <b>26</b>, and <b>28</b>, which failed to elicit a response, when studied in the agonist mode (see Figure S6, <a href="/doi/suppl/10.1021/acs.jmedchem.0c00426/suppl_file/jm0c00426_si_001.pdf" class="ext-link">Supporting Information</a>), were investigated with respect to their antagonistic activities in the arrestin 1/2 recruitment and the Ca<sup>2+</sup>–aequorin assay. These compounds, which have in common a Trp instead of Leu in the parent compound <b>1</b>, were capable of completely inhibiting the responses induced by the endogenous agonist hPP (for inhibition curves, see <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A,C,D). The resulting pIC<sub>50</sub> values were converted to p<i>K</i><sub>b</sub> values, which are presented in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>. The differences between the p<i>K</i><sub>b</sub> and p<i>K</i><sub>i</sub> values (antagonists) were much lower compared to the aforementioned differences between the pEC<sub>50</sub> and p<i>K</i><sub>i</sub> values (partial agonists), being in agreement with the fact that the receptor affinity of antagonists is not increased in the absence of sodium.<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23,24)</a> Compound <b>13</b> was additionally studied with respect to its capability of rightward shifting the CEC of hPP (β-arrestin 1 and Ca<sup>2+</sup>–aequorin assay). Indeed, in the presence of <b>13</b> (10 μM), a rightward shift (approximately two log units) and no suppression of the CEC of hPP were observed (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B,E), supporting the hypothesis of a competitive interaction between hPP and <b>13</b>.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00426/20200806/images/medium/jm0c00426_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00426/20200806/images/large/jm0c00426_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Inhibitory effects of <b>12</b>, <b>13</b>, <b>25</b>, <b>26</b>, and <b>28</b> on hPP-stimulated hY<sub>4</sub>R activation determined in hY<sub>4</sub>R β-arrestin 1 (A,B), hY<sub>4</sub>R β-arrestin 2 (C), and hY<sub>4</sub>R Ca<sup>2+</sup>–aequorin (D,E) assay performed with live HEK293T-ARRB1-Y<sub>4</sub>R cells, HEK293T-ARRB2-Y<sub>4</sub>R cells, and CHO-hY<sub>4</sub>R-G<sub>qi5</sub>-mtAEQ cells, respectively. (A) Inhibition of β-arrestin 1 recruitment, elicited by 10 nM hPP, by <b>12</b>, <b>13</b>, <b>25</b>, <b>26</b>, and <b>28</b>. (B) Effect of <b>13</b> (10 μM) on the β-arrestin 1 recruitment CEC of hPP. The p<i>K</i><sub>b</sub> value of <b>13</b>, calculated based on the rightward shift of the CEC according to the Gaddum equation,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> amounted to 6.63 ± 0.03 (mean ± SEM from three independent experiments). (C) Inhibition of β-arrestin 2 recruitment, elicited by 10 nM hPP, by <b>12</b>, <b>13</b>, <b>25</b>, <b>26</b>, and <b>28</b>. (D) Inhibition of the intracellular Ca<sup>2+</sup> mobilization, induced by 100 nM hPP, by <b>12</b>, <b>13</b>, <b>25</b>, <b>26</b>, and <b>28</b>. (E) Effect of <b>13</b> (10 μM) on the intracellular Ca<sup>2+</sup> mobilization CEC of hPP. The p<i>K</i><sub>b</sub> value of <b>13</b>, calculated based on the rightward shift of the CEC according to the Gaddum equation,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> amounted to 7.05 ± 0.05 (mean ± SEM from three independent experiments). Data in A–E represent means ± SEM from at least three independent experiments performed in triplicate. Note: Because of higher apparent potencies of hPP in the arrestin assays (pEC<sub>50</sub> = 8.66 and 8.37, respectively), compared to the Ca<sup>2+</sup> aequorin assay (pEC<sub>50</sub> = 7.96), different hPP concentrations (10 vs 100 nM) were used for the antagonist mode.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00426/20200806/images/large/jm0c00426_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00426&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Induced-Fit Docking to the hY<sub>4</sub>R</h3><div class="NLM_p">Induced-fit docking to Y<sub>4</sub>R was performed with the Y<sub>4</sub>R agonists <b>1</b> and <b>29</b> and the Y<sub>4</sub>R and antagonist <b>13</b> using two different hY<sub>4</sub>R homology models: the model used for agonists <b>1</b> and <b>29</b> was generated based on an active state κ opioid receptor crystal structure (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6B73">6B73</a>)<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> (sequence similarity with the hY<sub>4</sub>R: 35%), and antagonist <b>13</b> was docked to a Y<sub>4</sub>R model generated from the recently solved inactive state hY<sub>1</sub>R crystal structure (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5ZBQ">5ZBQ</a>).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Docking poses corresponding to the lowest XP GlideScore are presented in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>. The agonists <b>1</b> and <b>29</b> exhibited comparable binding poses characterized by a deep location of the C-terminal tyrosinamide within the 7TM bundle, being in contact (H-bond) with Q222<sup>5.46</sup> of TM V (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A,B). This was in accordance with a previously reported Y<sub>4</sub>R binding mode of the agonist hPP, also indicating a deep entering of the C-terminal tyrosinamide into the orthosteric binding pocket.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> In contrast, the C-terminal tyrosinamide of antagonist <b>13</b> appeared to be located at the receptor surface (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>C). Moreover, Trp<sup>4</sup> and Arg<sup>5</sup> in <b>13</b> were located in the region, occupied by the side chain of the C-terminal tyrosine in the agonists <b>1</b> and <b>29</b>, reaching the conserved W278<sup>6.48</sup> (π–π stacking and π-cation interactions, respectively; not indicated in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>) at the bottom of the orthosteric binding pocket (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>C). Irrespective of the binding modes of <b>1</b>, <b>13</b>, and <b>29</b>, the basic arginine residues in all ligands showed interactions with the receptor (primarily acidic amino acids such as E203<sup>ECL2</sup>, E288<sup>6.58</sup>, D289<sup>6.59</sup>, and E293<sup>ECL3</sup>), which was consistent with the observed decrease in Y<sub>4</sub>R affinity (approximately 1.5 orders of magnitude) upon replacement of arginine by nonbasic citrulline [compounds <b>15</b> and <b>16</b> vs peptides <b>1</b> and <b>8</b> (cf. <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>); binding data, see <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>].</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00426/20200806/images/medium/jm0c00426_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00426/20200806/images/large/jm0c00426_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Induced-fit docking poses of the Y<sub>4</sub>R agonists <b>1</b> and <b>29</b> as well as of the antagonist <b>13</b> at the homology models of hY<sub>4</sub>R. (A) Binding pose of <b>1</b> (shown in cyan) at a Y<sub>4</sub>R homology model generated from the active state κ opioid receptor crystal structure (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6B73">6B73</a>, chain A).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> (B) Binding pose of <b>29</b> (shown in purple) at the active state Y<sub>4</sub>R homology model used for docking of <b>1</b> (A). (C) Binding pose of <b>13</b> (shown in green) at a Y<sub>4</sub>R homology model generated from the inactive state hY<sub>1</sub>R crystal structure (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5ZBQ">5ZBQ</a>).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Nitrogen and oxygen atoms are shown in blue and red, respectively. Carbon atoms of receptor amino acids are shown in gray. Yellow dashed lines indicate the H-bonds and salt bridges.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00426/20200806/images/large/jm0c00426_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00426&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In view of the experimentally proven antagonism of <b>13</b>, the identified binding pose of this Y<sub>4</sub>R ligand is probably incompatible with a contraction of the ligand binding pocket of the receptor required for GPCR activation.<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28,29)</a> This might be explained by the positioning of two amino acid residues of peptide <b>13</b> (Trp<sup>4</sup> and Arg<sup>5</sup>, oriented “parallelly”) deeply in the binding pocket, hindering a contraction of the 7TM bundle, instead of only one residue (C-terminal Tyr) as observed for the agonists <b>1</b> and <b>29</b>, allowing an inward motion of the TM domains (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). However, induced-fit docking studies, implicating numerous simplifications, cannot serve for a detailed analysis of the molecular determinants being responsible for the observed antagonism.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78871" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78871" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">To date, the smallest peptidic Y<sub>4</sub>R ligands with high affinity (p<i>K</i><sub>i</sub> > 8) have been hexapeptides such as <b>1</b> (acetyl-Arg-Tyr-Arg-Leu-Arg-Tyr-NH<sub>2</sub>). We discovered a tetrapeptide (<b>29</b>, Arg-Leu-Arg-Tyr-NH<sub>2</sub>), representing the smallest Y<sub>4</sub>R ligand with high affinity (p<i>K</i><sub>i</sub>: 8.47) known so far. Moreover, replacement of Leu<sup>4</sup> in <b>1</b> by Trp was identified as a striking structural modification turning Y<sub>4</sub>R agonism into antagonism (e.g., compounds <b>12</b> and <b>13</b>). These findings may support the development of low-molecular-weight nonpeptidic Y<sub>4</sub>R ligands, including antagonists. Such compounds, which are lacking to date, are considered advantageous over peptides in terms of in vivo studies and pharmacokinetics (crossing of the blood–brain barrier). Whereas Y<sub>4</sub>R antagonists are needed as pharmacological tools for a better understanding of the physiological role of the Y<sub>4</sub> receptor, Y<sub>4</sub>R agonists represent potential therapeutics to treat, for example, obesity.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35141" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35141" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> General Experimental Conditions</h3><div class="NLM_p last">Protected amino acids Fmoc-Tyr(<i>t</i>Bu)-OH, Fmoc-Leu-OH, Fmoc-Arg(Pbf)-OH, Fmoc-Trp-OH, Fmoc-Cit-OH, Fmoc-Phe-OH, and Fmoc-Gly-OH were purchased from Carbolution Chemicals (St. Ingbert, Germany). Fmoc-Sieber-PS-resin (0.59 mmol/g), HBTU, <i>N</i>-methyl-2-pyrrolidone (NMP) for peptide synthesis, Fmoc-(<span class="smallcaps smallerCapital">d</span>)-Tyr(<i>t</i>Bu)-OH, Fmoc-(<span class="smallcaps smallerCapital">d</span>)-Leu-Oh, and Fmoc-Pro-OH were obtained from Iris Biotech (Marktredwitz, Germany). Fmoc-GABA-OH, Fmoc-Ala-OH, MeOH, and TFA were from Merck (Darmstadt, Germany). HOBt hydrate, succinic anhydride, and dichloromethane (CH<sub>2</sub>Cl<sub>2</sub>) were purchased from Acros Organics/Fisher Scientific (Nidderau, Germany). DIPEA was obtained from ABCR (Karlsruhe, Germany) and dimethylformamide (DMF) for peptide synthesis, acetic anhydride, Fmoc-(<span class="smallcaps smallerCapital">d</span>)-Arg(Pbf)-OH, Fmoc-N(Me)-Arg(Pbf)-OH, gradient grade acetonitrile for high-performance liquid chromatography (HPLC), Triton-X-100, and piperidine were from Sigma-Aldrich (Taufkirchen, Germany). Human PP (hPP) and porcine neuropeptide Y (pNPY) were from SynPeptide (Shanghai, China). Coelenterazine h was purchased from Biotrend (Cologne, Germany). Bacitracin and bovine serum albumin (BSA) were from Serva (Heidelberg, Germany). Pierce <span class="smallcaps smallerCapital">d</span>-luciferin (monopotassium salt) was obtained from Thermo Fisher Scientific (Nidderau, Germany), and JNJ31020028 was purchased from Cayman Chemicals (Ann Arbor, USA). The syntheses of <b>7</b>,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> [<sup>3</sup>H]<b>36</b>,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> [<sup>3</sup>H]<b>37</b>,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> BIIE0246,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> and [<sup>3</sup>H]propionyl-pNPY<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> (used for Y<sub>5</sub>R binding studies) were described elsewhere. [<sup>3</sup>H]Propionyl-pNPY (specific activity: 37.5 Ci/mmol and radiochemical purity: 99%), used for Y<sub>2</sub>R binding studies, was prepared according to a previously reported procedure<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> with minor modifications [e.g., anhydrous NMP/DMF (30:70 v/v, 40 μL, supplemented with 0.05 μL of DIPEA) was used instead of 0.1 M sodium borate buffer pH 8.5 (135 μL) and propionyl-pNPY was used instead of pNPY for quantification; radiochemical yield: 26%]. Millipore water was consistently used for the preparation of stock solutions, buffers, and eluents for HPLC. Polypropylene reaction vessels (1.5 and 2 mL) from Sarstedt (Nümbrecht, Germany) were used to keep stock solutions and for small-scale reactions (e.g., activation of Fmoc-protected amino acids). NMR spectra were recorded on a Bruker AVANCE 600 instrument with cryogenic probe (<sup>1</sup>H: 600.3 MHz and <sup>13</sup>C: 150.9 MHz) (Bruker, Karlsruhe, Germany). NMR spectra were calibrated based on the solvent residual peaks (<sup>1</sup>H NMR, DMSO-<i>d</i><sub>6</sub>: δ = 2.50 ppm; <sup>13</sup>C NMR: DMSO-<i>d</i><sub>6</sub>: δ = 39.50 ppm), and data are reported as follows: <sup>1</sup>H NMR: chemical shift δ in ppm [multiplicity (s = singlet, d = doublet, t = triplet, m = multiplet, and br s = broad singlet); integral, coupling constant <i>J</i> in Hz], and <sup>13</sup>C NMR: chemical shift δ in ppm. High-resolution mass spectrometry (HRMS) was performed with an Agilent 6540 UHD accurate-mass Q-TOF LC/MS system linked to an Agilent 1290 analytical HPLC system (Agilent Technologies. Santa Clara, CA). Preparative HPLC was performed with a system from Knauer (Berlin, Germany) consisting of two K-1800 pumps and a K-2001 detector (in the following referred to as “system 1”) or with a Prep 150 LC system from Waters (Eschborn, Germany) comprising a Waters 2545 binary gradient module, a Waters 2489 UV/vis-detector, and a Waters fraction collector III (in the following referred to as “system 2”). A Kinetex XB-C18, 5 μm, 250 mm × 21 mm, from Phenomenex (Aschaffenburg, Germany) was used as a reverse-phase (RP) column at a flow rate of 20 mL/min using mixtures of 0.1% aqueous TFA and acetonitrile as the mobile phase. The detection wavelength of 220 nm was used throughout. Collected fractions were lyophilized using a Scanvac CoolSafe 100-9 freeze dryer (Labogene, Alleroed, Denmark) equipped with a RZ 6 rotary vane vacuum pump (Vacuubrand, Wertheim, Germany). Analytical HPLC analysis was performed with an Agilent 1100 system (Agilent Technologies) composed of a binary pump (G1312A), an autosampler (G1329A), a thermostated column compartment (G1316A), and a diode array detector (G1315B). A Kinetex XB-C18, 5 μm, 250 mm × 4.6 mm (Phenomenex), served as a stationary phase at a flow rate of 0.8 mL/min. Detection was performed at 220 nm, and the oven temperature was 25 °C. Mixtures of acetonitrile (A) and 0.1% aqueous TFA (B) were used as the mobile phase. The following linear gradient was applied: 0–25 min: A/B 10:90 to 30:70; 25–27 min: 30:70 to 95:5; and 27–35 min: 95:5 (isocratic). The injection volume was 50 μL. Retention (capacity) factors <i>k</i> were calculated from the retention times <i>t</i><sub>R</sub> according to <i>k</i> = (<i>t</i><sub>R</sub> – <i>t</i><sub>0</sub>)/<i>t</i><sub>0</sub> (<i>t</i><sub>0</sub> = dead time).</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Compound Characterization</h3><div class="NLM_p">Except for compounds <b>12</b>, <b>21</b>, <b>26</b>, and <b>30</b>, all target compounds were characterized by <sup>1</sup>H, <sup>13</sup>C, and 2D NMR (HSQC, HMBC, and <sup>1</sup>H COSY) spectroscopy, HRMS, and RP-HPLC. Compounds <b>12</b>, <b>21</b>, <b>26</b>, and <b>30</b> were characterized by <sup>1</sup>H NMR, HRMS, and RP-HPLC. HPLC purities of all target compounds were ≥96%. The analytical data of <b>8</b>–<b>35</b> are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Analytical Characterization of Peptides <b>8</b>–<b>35</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="+" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="+"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">HRMS (ESI): <i>m</i>/<i>z</i></th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd.</th><th class="colsep0 rowsep0" align="center" char=".">x-fold hydro-trifluoroacetate</th><th class="colsep0 rowsep0" align="center" char="+">MW</th><th class="colsep0 rowsep0" align="center" char=".">overall yield (%)</th><th class="colsep0 rowsep0" align="center">RP-HPLC purity (%)/<i>t</i><sub>R</sub> [min]/<i>k</i></th><th class="colsep0 rowsep0" align="center">calcd for</th><th class="colsep0 rowsep0" align="center" char=".">calcd</th><th class="colsep0 rowsep0" align="center" char=".">found</th><th class="colsep0 rowsep0" align="center">NMR<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char="+">925.11 + 456.09</td><td class="colsep0 rowsep0" align="char" char=".">23</td><td class="colsep0 rowsep0" align="left">97/9.1/1.8</td><td class="colsep0 rowsep0" align="left">[M + 3H]<sup>3+</sup></td><td class="colsep0 rowsep0" align="char" char=".">309.1875</td><td class="colsep0 rowsep0" align="char" char=".">309.1884</td><td class="colsep0 rowsep0" align="left"><sup>1</sup>H, <sup>13</sup>C, 2D</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char="+">951.10 + 342.07</td><td class="colsep0 rowsep0" align="char" char=".">25</td><td class="colsep0 rowsep0" align="left">98/19.4/5.0</td><td class="colsep0 rowsep0" align="left">[M + 3H]<sup>3+</sup></td><td class="colsep0 rowsep0" align="char" char=".">317.8472</td><td class="colsep0 rowsep0" align="char" char=".">317.8483</td><td class="colsep0 rowsep0" align="left"><sup>1</sup>H, <sup>13</sup>C, 2D</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char="+">869.00 + 456.09</td><td class="colsep0 rowsep0" align="char" char=".">33</td><td class="colsep0 rowsep0" align="left">99/6.3/1.0</td><td class="colsep0 rowsep0" align="left">[M + 3H]<sup>3+</sup></td><td class="colsep0 rowsep0" align="char" char=".">290.4999</td><td class="colsep0 rowsep0" align="char" char=".">290.5008</td><td class="colsep0 rowsep0" align="left"><sup>1</sup>H, <sup>13</sup>C, 2D</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char="+">883.03 + 456.09</td><td class="colsep0 rowsep0" align="char" char=".">27</td><td class="colsep0 rowsep0" align="left">99/7.1/1.2</td><td class="colsep0 rowsep0" align="left">[M + 3H]<sup>3+</sup></td><td class="colsep0 rowsep0" align="char" char=".">295.1718</td><td class="colsep0 rowsep0" align="char" char=".">295.1730</td><td class="colsep0 rowsep0" align="left"><sup>1</sup>H, <sup>13</sup>C, 2D</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char="+">1040.20 + 342.07</td><td class="colsep0 rowsep0" align="char" char=".">35</td><td class="colsep0 rowsep0" align="left">97/17.0/4.3</td><td class="colsep0 rowsep0" align="left">[M + 3H]<sup>3+</sup></td><td class="colsep0 rowsep0" align="char" char=".">347.5227</td><td class="colsep0 rowsep0" align="char" char=".">347.5240</td><td class="colsep0 rowsep0" align="left"><sup>1</sup>H</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char="+">998.16 + 456.09</td><td class="colsep0 rowsep0" align="char" char=".">32</td><td class="colsep0 rowsep0" align="left">96/16.0/4.0</td><td class="colsep0 rowsep0" align="left">[M + 3H]<sup>3+</sup></td><td class="colsep0 rowsep0" align="char" char=".">333.5192</td><td class="colsep0 rowsep0" align="char" char=".">333.5206</td><td class="colsep0 rowsep0" align="left"><sup>1</sup>H, <sup>13</sup>C, 2D</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char="+">926.09 + 456.09</td><td class="colsep0 rowsep0" align="char" char=".">35</td><td class="colsep0 rowsep0" align="left">98/10.8/2.4</td><td class="colsep0 rowsep0" align="left">[M + 3H]<sup>3+</sup></td><td class="colsep0 rowsep0" align="char" char=".">309.5155</td><td class="colsep0 rowsep0" align="char" char=".">309.5166</td><td class="colsep0 rowsep0" align="left"><sup>1</sup>H, <sup>13</sup>C, 2D</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char="+">968.13 + 342.07</td><td class="colsep0 rowsep0" align="char" char=".">42</td><td class="colsep0 rowsep0" align="left">97/16.0/4.0</td><td class="colsep0 rowsep0" align="left">[M + 3H]<sup>3+</sup></td><td class="colsep0 rowsep0" align="char" char=".">323.5190</td><td class="colsep0 rowsep0" align="char" char=".">323.5202</td><td class="colsep0 rowsep0" align="left"><sup>1</sup>H, <sup>13</sup>C, 2D</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char="+">926.09 + 456.09</td><td class="colsep0 rowsep0" align="char" char=".">39</td><td class="colsep0 rowsep0" align="left">97/14.0/3.4</td><td class="colsep0 rowsep0" align="left">[M + 3H]<sup>3+</sup></td><td class="colsep0 rowsep0" align="char" char=".">309.5155</td><td class="colsep0 rowsep0" align="char" char=".">309.5164</td><td class="colsep0 rowsep0" align="left"><sup>1</sup>H, <sup>13</sup>C, 2D</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char="+">990.19 + 342.07</td><td class="colsep0 rowsep0" align="char" char=".">33</td><td class="colsep0 rowsep0" align="left">96/15.9/3.9</td><td class="colsep0 rowsep0" align="left">[M + 2H]<sup>2+</sup></td><td class="colsep0 rowsep0" align="char" char=".">495.7909</td><td class="colsep0 rowsep0" align="char" char=".">495.7912</td><td class="colsep0 rowsep0" align="left"><sup>1</sup>H, <sup>13</sup>C, 2D</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char="+">951.15 + 342.07</td><td class="colsep0 rowsep0" align="char" char=".">40</td><td class="colsep0 rowsep0" align="left">98/15.5/3.8</td><td class="colsep0 rowsep0" align="left">[M + 2H]<sup>2+</sup></td><td class="colsep0 rowsep0" align="char" char=".">476.2854</td><td class="colsep0 rowsep0" align="char" char=".">476.2856</td><td class="colsep0 rowsep0" align="left"><sup>1</sup>H, <sup>13</sup>C, 2D</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char="+">861.02 + 342.07</td><td class="colsep0 rowsep0" align="char" char=".">23</td><td class="colsep0 rowsep0" align="left">97/9.0/1.8</td><td class="colsep0 rowsep0" align="left">[M + 2H]<sup>2+</sup></td><td class="colsep0 rowsep0" align="char" char=".">431.2619</td><td class="colsep0 rowsep0" align="char" char=".">431.2625</td><td class="colsep0 rowsep0" align="left"><sup>1</sup>H, <sup>13</sup>C, 2D</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char="+">1053.24 + 342.07</td><td class="colsep0 rowsep0" align="char" char=".">37</td><td class="colsep0 rowsep0" align="left">97/15.0/3.7</td><td class="colsep0 rowsep0" align="left">[M + 3H]<sup>3+</sup></td><td class="colsep0 rowsep0" align="char" char=".">342.5262</td><td class="colsep0 rowsep0" align="char" char=".">342.5273</td><td class="colsep0 rowsep0" align="left"><sup>1</sup>H, <sup>13</sup>C, 2D</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char="+">803.97 + 342.07</td><td class="colsep0 rowsep0" align="char" char=".">23</td><td class="colsep0 rowsep0" align="left">97/7.7/1.4</td><td class="colsep0 rowsep0" align="left">[M + 2H]<sup>2+</sup></td><td class="colsep0 rowsep0" align="char" char=".">405.7512</td><td class="colsep0 rowsep0" align="char" char=".">405.7518</td><td class="colsep0 rowsep0" align="left"><sup>1</sup>H</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char="+">791.96 + 342.07</td><td class="colsep0 rowsep0" align="char" char=".">37</td><td class="colsep0 rowsep0" align="left">99/18.1/4.6</td><td class="colsep0 rowsep0" align="left">[M + 2H]<sup>2+</sup></td><td class="colsep0 rowsep0" align="char" char=".">396.7350</td><td class="colsep0 rowsep0" align="char" char=".">396.7362</td><td class="colsep0 rowsep0" align="left"><sup>1</sup>H, <sup>13</sup>C, 2D</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char="+">1024.20 + 342.07</td><td class="colsep0 rowsep0" align="char" char=".">70</td><td class="colsep0 rowsep0" align="left">97/16.4/4.1</td><td class="colsep0 rowsep0" align="left">[M + 3H]<sup>3+</sup></td><td class="colsep0 rowsep0" align="char" char=".">342.1982</td><td class="colsep0 rowsep0" align="char" char=".">342.1996</td><td class="colsep0 rowsep0" align="left"><sup>1</sup>H, <sup>13</sup>C, 2D</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char="+">1109.31 + 342.07</td><td class="colsep0 rowsep0" align="char" char=".">34</td><td class="colsep0 rowsep0" align="left">96/16.3/4.1</td><td class="colsep0 rowsep0" align="left">[M + 3H]<sup>3+</sup></td><td class="colsep0 rowsep0" align="char" char=".">370.5491</td><td class="colsep0 rowsep0" align="char" char=".">370.5503</td><td class="colsep0 rowsep0" align="left"><sup>1</sup>H, <sup>13</sup>C, 2D</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char="+">1097.25 + 342.07</td><td class="colsep0 rowsep0" align="char" char=".">44</td><td class="colsep0 rowsep0" align="left">96/14.1/3.4</td><td class="colsep0 rowsep0" align="left">[M + 3H]<sup>3+</sup></td><td class="colsep0 rowsep0" align="char" char=".">366.5299</td><td class="colsep0 rowsep0" align="char" char=".">366.5320</td><td class="colsep0 rowsep0" align="left"><sup>1</sup>H, <sup>13</sup>C, 2D</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char="+">1120.29 + 342.07</td><td class="colsep0 rowsep0" align="char" char=".">41</td><td class="colsep0 rowsep0" align="left">98/17.0/4.3</td><td class="colsep0 rowsep0" align="left">[M + 3H]<sup>3+</sup></td><td class="colsep0 rowsep0" align="char" char=".">374.2019</td><td class="colsep0 rowsep0" align="char" char=".">374.2034</td><td class="colsep0 rowsep0" align="left"><sup>1</sup>H</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char="+">1047.24 + 342.07</td><td class="colsep0 rowsep0" align="char" char=".">40</td><td class="colsep0 rowsep0" align="left">96/17.1/4.3</td><td class="colsep0 rowsep0" align="left">[M + 2H]<sup>2+</sup></td><td class="colsep0 rowsep0" align="char" char=".">524.3016</td><td class="colsep0 rowsep0" align="char" char=".">524.3043</td><td class="colsep0 rowsep0" align="left"><sup>1</sup>H, <sup>13</sup>C, 2D</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char="+">1125.31 + 342.07</td><td class="colsep0 rowsep0" align="char" char=".">30</td><td class="colsep0 rowsep0" align="left">96/14.5/3.5</td><td class="colsep0 rowsep0" align="left">[M + 3H]<sup>3+</sup></td><td class="colsep0 rowsep0" align="char" char=".">375.8737</td><td class="colsep0 rowsep0" align="char" char=".">375.8760</td><td class="colsep0 rowsep0" align="left"><sup>1</sup>H, <sup>13</sup>C, 2D</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char="+">605.75 + 342.07</td><td class="colsep0 rowsep0" align="char" char=".">34</td><td class="colsep0 rowsep0" align="left">98/5.9/0.8</td><td class="colsep0 rowsep0" align="left">[M + 2H]<sup>2+</sup></td><td class="colsep0 rowsep0" align="char" char=".">303.6954</td><td class="colsep0 rowsep0" align="char" char=".">303.6964</td><td class="colsep0 rowsep0" align="left"><sup>1</sup>H, <sup>13</sup>C, 2D</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char="+">678.80 + 342.07</td><td class="colsep0 rowsep0" align="char" char=".">30</td><td class="colsep0 rowsep0" align="left">97/9.4/1.9</td><td class="colsep0 rowsep0" align="left">[M + 2H]<sup>2+</sup></td><td class="colsep0 rowsep0" align="char" char=".">340.1930</td><td class="colsep0 rowsep0" align="char" char=".">340.1940</td><td class="colsep0 rowsep0" align="left"><sup>1</sup>H</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char="+">605.75 + 342.07</td><td class="colsep0 rowsep0" align="char" char=".">21</td><td class="colsep0 rowsep0" align="left">98/8.8/1.7</td><td class="colsep0 rowsep0" align="left">[M + 2H]<sup>2+</sup></td><td class="colsep0 rowsep0" align="char" char=".">303.6954</td><td class="colsep0 rowsep0" align="char" char=".">303.6965</td><td class="colsep0 rowsep0" align="left"><sup>1</sup>H, <sup>13</sup>C, 2D</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char="+">605.75 + 342.07</td><td class="colsep0 rowsep0" align="char" char=".">45</td><td class="colsep0 rowsep0" align="left">98/8.5/1.6</td><td class="colsep0 rowsep0" align="left">[M + 2H]<sup>2+</sup></td><td class="colsep0 rowsep0" align="char" char=".">303.6954</td><td class="colsep0 rowsep0" align="char" char=".">303.6962</td><td class="colsep0 rowsep0" align="left"><sup>1</sup>H, <sup>13</sup>C, 2D</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char="+">605.75 + 342.07</td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="left">99/7.9/1.4</td><td class="colsep0 rowsep0" align="left">[M +2H]<sup>2+</sup></td><td class="colsep0 rowsep0" align="char" char=".">303.6954</td><td class="colsep0 rowsep0" align="char" char=".">303.6958</td><td class="colsep0 rowsep0" align="left"><sup>1</sup>H, <sup>13</sup>C, 2D</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char="+">605.75 + 342.07</td><td class="colsep0 rowsep0" align="char" char=".">22</td><td class="colsep0 rowsep0" align="left">97/8.6/1.6</td><td class="colsep0 rowsep0" align="left">[M + 2H]<sup>2+</sup></td><td class="colsep0 rowsep0" align="char" char=".">303.6954</td><td class="colsep0 rowsep0" align="char" char=".">303.6959</td><td class="colsep0 rowsep0" align="left"><sup>1</sup>H, <sup>13</sup>C, 2D</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char="+">619.77 + 228.04</td><td class="colsep0 rowsep0" align="char" char=".">19</td><td class="colsep0 rowsep0" align="left">98/10.9/2.4</td><td class="colsep0 rowsep0" align="left">[M + 2H]<sup>2+</sup></td><td class="colsep0 rowsep0" align="char" char=".">310.7037</td><td class="colsep0 rowsep0" align="char" char=".">310.7038</td><td class="colsep0 rowsep0" align="left"><sup>1</sup>H, <sup>13</sup>C, 2D</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">2D-NMR: HSQC, HMBC, and COSY.</p></div></div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Screening for Pan-Assay Interference Compounds</h3><div class="NLM_p last">Screening of all target compounds (<b>8</b>–<b>35</b>) for pan-assay interference compounds (PAINS) via the public tool <a href="http://zinc15.docking.org/patterns/home" class="extLink">http://zinc15.docking.org/patterns/home</a> gave no hits.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> General Procedure for SPPS: Experimental Protocols and Analytical Data</h3><div class="NLM_p">Peptides were synthesized by manual SPPS according to the Fmoc strategy. Five milliliter Injekt Solo (B. Braun, Melsungen, Germany) or NPRM-JECT (Henke Sass Wolf, Tuttlingen, Germany) syringes equipped with polyethylene frits (pore size: 35 μm) (Roland Vetter Laborbedarf, Ammerbuch, Germany) were used as reaction vessels. DMF/NMP (8:2 v/v) was used as a solvent for the coupling reactions, Fmoc deprotection, and N-terminal acetylation/succinylation. For the initial Fmoc deprotection of the resin and swelling, the resin was treated with 20% piperidine in the solvent at rt for 2 × 20 min. Fmoc-protected <span class="smallcaps smallerCapital">l</span>-amino acids were used in 5-fold excess and preactivated with HBTU (4.9 equiv)/HOBt (5 equiv)/DIPEA (10 equiv) in polypropylene reaction vessels for at least 5 min prior to addition to the resin (volume of the solvent: ca. 2.2 mL/mmol Fmoc amino acid). “Double” coupling (2 × 45 min) was performed at 35 °C for all amino acids using a Multi Reax shaker (Heidolph, Schwabach, Germany) covered with a box equipped with a thermostat-controlled heater. After completing the coupling of an Fmoc amino acid, the resin was washed with the solvent (4×) and treated with 20% piperidine in the solvent at rt for 2 × 10 min, followed by washing of the resin with the solvent (6×). N-Terminally acylated peptides were prepared by treatment of the resin-bound completely elongated peptide with acetic anhydride (10 equiv)/DIPEA (10 equiv) or succinic anhydride (10 equiv)/DIPEA (10 equiv) (<b>20</b>) in the solvent at rt for 35 min. After coupling and Fmoc deprotection of the final amino acid or after acylation of the N-terminus, the resin was washed with the solvent (6×) and CH<sub>2</sub>Cl<sub>2</sub> (treated with K<sub>2</sub>CO<sub>3</sub>) (4×), followed by cleavage of the resin with CH<sub>2</sub>Cl<sub>2</sub>/TFA (3:1 v/v) at rt (2 × 20 min). The liquid was separated from the resin by filtration, and the resin was washed once with the cleavage reagent. The filtrates were combined in a round-bottom flask, and the volatiles were removed by rotary evaporation. The residue was dissolved in TFA/H<sub>2</sub>O (95:5 v/v), and the mixture was stirred at rt for 5 h (full side-chain deprotection) and transferred to a 100 mL flask containing water (40 mL), followed by lyophilization and subsequent purification by preparative HPLC.</div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> Arg-Tyr-Arg-Leu-Arg-Tyr-Amide Tetrakis(hydrotrifluoroacetate) (<b>8</b>)</h4><div class="NLM_p last">Peptide <b>8</b> was synthesized on a Sieber-amide-PS resin (40 mg, 0.65 mmol/g) according to the general procedure. Purification by preparative HPLC (system 1, gradient: 0–18 min MeCN/0.1% aq TFA 3:97 to 42:58, <i>t</i><sub>R</sub> = 12 min) yielded <b>8</b> as a white solid (8.3 mg, 23%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 0.80–0.91 (m, 6H), 1.37–1.54 (m, 10H), 1.58–1.76 (m, 5H), 2.63–2.75 (m, 2H), 1.82–2.89 (m, 1H), 2.90–2.96 (m, 1H), 3.02–3.15 (m, 6H), 3.74–3.81 (m, 1H), 4.18–4.24 (m, 1H), 4.25–4.30 (m, 1H), 4.30–4.36 (m, 2H), 4.51–4.57 (m, 1H), 6.60–6.68 (m, 4H), 6.80–7.55 (br s, 12H, interfering with the next three listed signals), 6.96–6.99 (m, 2H), 7.05–7.07 (m, 2H), 7.36–7.40 (m, 2H), 7.63–7.67 (m, 1H), 7.71–7.75 (m, 1H), 7.76–7.84 (m, 2H), 7.93–7.98 (m, 1H), 8.05–8.16 (m, 4H), 8.35–8.40 (m, 1H), 8.47–8.53 (m, 1H), 9.24 (br s, 2H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 21.4, 23.1, 24.0, 24.1, 24.9, 25.1, 28.5, 28.6, 29.0, 36.6, 36.8, 40.2, 40.43, 40.45, 40.8, 50.9, 51.6, 52.2, 52.3, 53.9, 54.3, 114.86 (two carbon signals), 114.92 (two carbon signals), 116.0 (TFA), 118.0 (TFA), 127.4, 127.5, 130.0 (two carbon signals), 130.1 (two carbon signals), 155.9 (two carbon signals), 156.77, 156.83, 156.87, 158.7 (q, <i>J</i> 32.0 Hz) (TFA), 168.5, 170.84, 170.85, 171.1, 172.0, 172.7. HRMS (ESI) <i>m</i>/<i>z</i>: [M + 3H]<sup>3+</sup> calcd for [C<sub>42</sub>H<sub>71</sub>N<sub>16</sub>O<sub>8</sub>]<sup>3+</sup>, 309.1875; found, 309.1884. Anal. RP-HPLC (220 nm): 97% (<i>t</i><sub>R</sub> = 9.1 min, <i>k</i> = 1.8). C<sub>42</sub>H<sub>68</sub>N<sub>16</sub>O<sub>8</sub>·C<sub>8</sub>H<sub>4</sub>F<sub>12</sub>O<sub>8</sub> (925.11 + 456.09).</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> Ac-Arg-Tyr-Arg-Pro-Arg-Tyr-Amide Tris(hydrotrifluoroacetate) (<b>9</b>)</h4><div class="NLM_p last">Peptide <b>9</b> was synthesized on a Sieber-amide-PS resin (40 mg, 0.65 mmol/g) according to the general procedure. Purification by preparative HPLC (system 1, gradient: 0–18 min MeCN/0.1% aq TFA 3:97 to 42:58, <i>t</i><sub>R</sub> = 11 min) yielded <b>9</b> as a white solid (7.3 mg, 25%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 1.36–1.60 (m, 10H), 1.61–1.72 (m, 2H), 1.74–1.90 (m, 6H), 1.98–2.05 (m, 1H), 2.64–2.75 (m, 2H), 2.85–2.92 (m, 2H), 3.00–3.14 (m, 6H), 3.48–3.54 (m, 1H), 3.55–3.60 (m, 1H), 4.10–4.19 (m, 2H), 4.31–4.36 (m, 2H), 4.42–4.50 (m, 2H), 6.59–6.65 (m, 4H), 6.80–7.53 (br s, 12H, interfering with the next three listed signals), 6.94–6.98 (m, 4H), 7.07–7.09 (m, 1H), 7.36–7.38 (m, 1H), 7.62–7.73 (m, 4H), 7.74–7.78 (m, 1H), 8.03–8.08 (m, 1H), 8.12–8.19 (m, 2H), 9,23 (br s, 2H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 22.5, 24.4, 24.6, 25.0 (two carbon signals), 28.1, 28.7, 28.8, 29.2, 36.5, 36.8, 40.37, 40.38, 40.5, 46.9, 50.0, 52.3, 52.6, 53.6, 53.8, 59.3, 114.8 (two carbon signals), 114.9 (two carbon signals), 115.9 (TFA), 117.9 (TFA), 127.4, 127.6, 130.0 (two carbon signals), 130.1 (two carbon signals), 155.8 (two carbon signals), 156.80, 156.82, 156.9, 158.9 (q, <i>J</i> 32.0 Hz) (TFA), 169.6, 169.7, 170.7, 170.9, 171.2, 171.6, 172.8. HRMS (ESI) <i>m</i>/<i>z</i>: [M + 3H]<sup>3+</sup> calcd for [C<sub>43</sub>H<sub>69</sub>N<sub>16</sub>O<sub>9</sub>]<sup>3+</sup>, 317.8472; found, 317.8483. Anal. RP-HPLC (220 nm): 98% (<i>t</i><sub>R</sub> = 19.4 min, <i>k</i> = 5.0). C<sub>43</sub>H<sub>66</sub>N<sub>16</sub>O<sub>9</sub>·C<sub>6</sub>H<sub>3</sub>F<sub>9</sub>O<sub>6</sub> (951.10 + 342.07).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> Arg-Tyr-Arg-Gly-Arg-Tyr-Amide Tetrakis(hydrotrifluoroacetate) (<b>10</b>)</h4><div class="NLM_p">Peptide <b>10</b> was synthesized on a Sieber-amide-PS resin (40 mg, 0.59 mmol/g) according to the general procedure. Purification by preparative HPLC (system 1, gradient: 0–18 min MeCN/0.1% aq TFA 3:97 to 42:58, <i>t</i><sub>R</sub> = 9 min) yielded <b>10</b> as a white solid (10.2 mg, 33%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 1.38–1.57 (m, 8H), 1.59–1.66 (m, 1H), 1.66–1.76 (m, 3H), 2.64–2.74 (m, 2H), 2.84–2.91 (m, 1H), 2.94–3.00 (m, 1H), 3.02–3.07 (m, 2H), 3.07–3.14 (m, 4H), 3.68–3.75 (m, 1H), 3.75–3.83 (m, 2H), 4.22–4.29 (m, 2H), 4.30–4.35 (m, 1H), 4.48–4.55 (m, 1H), 6.61–6.68 (m, 4H), 6.80–7.55 (br s, 12H, interfering with the next four listed signals), 6.98–7.01 (m, 2H), 7.03–7.04 (m, 1H), 7.07–7.09 (m, 2H), 7.34–7.35 (m, 1H), 7.61–7.66 (m, 1H), 7.70–7.74 (m, 1H), 7.76–7.81 (m, 1H), 7.91–7.95 (m, 1H), 8.04–8.08 (m, 1H), 8.08–8.14 (m, 4H), 8.32–8.36 (m, 1H), 8.51–8.56 (m, 1H), 9.25 (br s, 2H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 23.9, 24.8, 25.0, 28.5, 29.1, 29.2, 36.4, 36.7, 40.2, 40.39, 40.42, 41.8, 51.6, 52.2, 52.4, 54.2, 54.5, 114.86 (two carbon signals), 114.94 (two carbon signals), 116.0 (TFA), 118.0 (TFA), 127.5, 127.7, 130.04 (two carbon signals), 130.05 (two carbon signals), 155.8, 155.9, 156.76, 156.82, 156.85, 158.7 (q, <i>J</i> 32.0 Hz) (TFA), 168.5, 168.7, 170.9, 171.0, 171.6, 172.9. HRMS (ESI) <i>m</i>/<i>z</i>: [M + 3H]<sup>3+</sup> calcd for [C<sub>38</sub>H<sub>63</sub>N<sub>16</sub>O<sub>8</sub>]<sup>3+</sup>, 290.4999; found, 290.5008. Anal. RP-HPLC (220 nm): 99% (<i>t</i><sub>R</sub> = 6.3 min, <i>k</i> = 1.0). C<sub>38</sub>H<sub>60</sub>N<sub>16</sub>O<sub>8</sub>·C<sub>8</sub>H<sub>4</sub>F<sub>12</sub>O<sub>8</sub> (869.00 + 456.09).</div><div id="sec4_5_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i21" class="anchor-spacer"></div><h5 class="article-section__title" id="_i21"> Arg-Tyr-Arg-Ala-Arg-Tyr-Amide Tetrakis(hydrotrifluoroacetate) (<b>11</b>)</h5><div class="NLM_p last">Peptide <b>11</b> was synthesized on a Sieber-amide-PS resin (40 mg, 0.59 mmol/g) according to the general procedure. Purification by preparative HPLC (system 1, gradient: 0–18 min MeCN/0.1% aq TFA 3:97 to 42:58, <i>t</i><sub>R</sub> = 9 min) yielded <b>11</b> as a white solid (8.5 mg, 27%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 1.17–1.22 (m, 3H), 1.37–1.46 (m, 2H), 1.46–1.57 (m, 6H), 1.59–1.77 (m, 4H), 2.64–2.74 (m, 2H), 2.83–2.89 (m, 1H), 2.91–2.97 (m, 1H), 3.03–3.14 (m, 6H), 3.78–3-79 (m, 1H), 4.17–4.21 (m, 1H), 4.23–4.30 (m, 2H), 4.31–4.37 (m, 1H), 4.49–4.54 (m, 1H), 6.61–6.67 (m, 4H), 6.80–7.56 (br s, 12H, interfering with the next three listed signals), 6.96–6.98 (m, 2H), 7.06–7.08 (m, 3H), 7.39–7.41 (m, 1H), 7.64–7.68 (m, 1H), 7.72–7.77 (m, 2H), 7.80–7.84 (m, 1H), 7.99–8.03 (m, 1H), 8.07–8.16 (m, 4H), 8.31–8.34 (m, 1H), 8.49–8.53 (m, 1H), 9.23 (br s, 2H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 18.3, 23.9, 24.9, 25.0, 28.5, 28.99, 29.04, 36.5, 36.9, 40.2, 40.4, 40.5, 48.1, 51.6, 52.1, 52.4, 53.8, 54.4, 114.85 (two carbon signals), 114.93 (two carbon signals), 115.9 (TFA), 117.9 (TFA), 127.4, 127.5, 130.07 (two carbon signals), 131.0 (two carbon signals), 155.8, 156.0, 156.81, 156.85, 156.89, 158.8 (q, <i>J</i> 32.0 Hz) (TFA), 168.5, 170.8, 170.87, 171.89, 172.1, 172.7. HRMS (ESI) <i>m</i>/<i>z</i>: [M + 3H]<sup>3+</sup> calcd for [C<sub>39</sub>H<sub>65</sub>N<sub>16</sub>O<sub>8</sub>]<sup>3+</sup>, 295.1718; found, 295.1730. Anal. RP-HPLC (220 nm): 99% (<i>t</i><sub>R</sub> = 7.1 min, <i>k</i> = 1.2). C<sub>39</sub>H<sub>62</sub>N<sub>16</sub>O<sub>8</sub>·C<sub>8</sub>H<sub>4</sub>F<sub>12</sub>O<sub>8</sub> (883.03 + 456.09).</div></div><div id="sec4_5_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i22" class="anchor-spacer"></div><h5 class="article-section__title" id="_i22"> Ac-Arg-Tyr-Arg-Trp-Arg-Tyr-Amide Tris(hydrotrifluoroacetate) (<b>12</b>)</h5><div class="NLM_p last">Peptide <b>12</b> was synthesized on a Sieber-amide-PS resin (40 mg, 0.65 mmol/g) according to the general procedure. Purification by preparative HPLC (system 1, gradient: 0–18 min MeCN/0.1% aq TFA 3:97 to 42:58, <i>t</i><sub>R</sub> = 13 min) yielded <b>12</b> as a white solid (12.5 mg, 35%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 1.33–1.58 (m, 10H), 1.61–1.68 (m, 2H), 1.84 (s, 3H), 2.63–2.69 (m, 1H), 2.69–2.75 (m, 1H), 2.85–2.91 (m, 2H), 2.94–3.09 (m, 7H), 3.11–3.17 (m, 1H), 4.11–4.17 (m, 1H), 4.20–4.27 (m, 2H), 4.33–4.39 (m, 1H), 4.39–4.44 (m, 1H), 4.56–4.61 (m, 1H), 6.59–6.68 (m, 4H), 6.75–7.50 (br s, 12H, interfering with the next seven listed signals), 6.90–6.93 (m, 1H), 6.97–7.01 (m, 4H), 7.02–7.04 (m, 1H), 7.06–7.08 (m, 1H), 7.11–7.12 (m, 1H), 7.29–7.31 (m, 1H), 7.38–7.39 (m, 1H), 7.54–7.63 (m, 4H), 7.76–7.83 (m, 2H), 7.91–7.96 (m, 1H), 8.01–8.08 (m, 2H), 8.13–8.18 (m, 1H), 9.18 (br s, 2H), 10.76 (s, 1H). HRMS (ESI) <i>m</i>/<i>z</i>: [M + 3H]<sup>3+</sup> calcd for [C<sub>49</sub>H<sub>72</sub>N<sub>17</sub>O<sub>9</sub>]<sup>3+</sup>, 347.5227; found, 347.5240. Anal. RP-HPLC (220 nm): 97% (<i>t</i><sub>R</sub> = 17.0 min, <i>k</i> = 4.3). C<sub>49</sub>H<sub>69</sub>N<sub>17</sub>O<sub>9</sub>·C<sub>6</sub>H<sub>3</sub>F<sub>9</sub>O<sub>6</sub> (1040.20 + 342.07).</div></div><div id="sec4_5_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i23" class="anchor-spacer"></div><h5 class="article-section__title" id="_i23"> Arg-Tyr-Arg-Trp-Arg-Tyr-Amide Tetrakis(hydrotrifluoroacetate) (<b>13</b>)</h5><div class="NLM_p last">Peptide <b>13</b> was synthesized on a Sieber-amide-PS resin (40 mg, 0.65 mmol/g) according to the general procedure. Purification by preparative HPLC (system 1, gradient: 0–18 min MeCN/0.1% aq TFA 3:97 to 42:58, <i>t</i><sub>R</sub> = 13 min) yielded <b>13</b> as a white solid (9.6 mg, 32%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 1.39–1.55 (m, 8H), 1.60–1.75 (m, 4H), 2.59–2.66 (m, 1H), 2.69–2.75 (m, 1H), 2.84–2.91 (m, 2H), 2.93–3.00 (m, 1H), 3.02–3.10 (m, 6H), 3.11–3.17 (m, 1H), 3.74–3.78 (m, 1H), 4.20–4.29 (m, 2H), 4.33–4.40 (m, 1H), 4.47–4.53 (m, 1H), 4.59–4.65 (m, 1H), 6.64 (d, 4H, <i>J</i> 8.3 Hz), 6.78–7.53 (br s, 12H, interfering with the next seven signals), 6.90–6.93 (m, 1H), 6.99–7.01 (m, 2H), 7.02–7.04 (m, 1H), 7.05–7.08 (m, 3H), 7.09–7.11 (m, 1H), 7.29–7.31 (m, 1H), 7.40–7.41 (m, 1H), 7.58 (d, 1H, <i>J</i> 8.1 Hz), 7.60–7.64 (m, 1H), 7.66–7.72 (m, 1H), 7.76–7.81 (m, 1H), 7.83 (d, 1H, <i>J</i> 7.8 Hz), 7.94 (d, 1H, <i>J</i> 7.6 Hz), 8.04–8.15 (m, 3H), 8.22 (d, 1H, <i>J</i> 7.6 Hz), 8.31 (d, 1H, <i>J</i> 7.9 Hz), 8.49 (d, 1H, <i>J</i> 7.6 Hz), 9.23 (br s, 2H), 10.76 (s, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 23.9, 24.8, 25.0, 27.9, 28.5, 29.1, 36.4, 38.9, 40.2, 40.5 (two carbon signals), 51.6, 52.3, 52.4, 53.0, 54.1, 54.4, 109.7, 111.2, 114.87 (two carbon signals), 114.92 (two carbon signals), 116.0 (TFA), 118.0 (TFA), 118.2, 118.5, 120.0, 123.5, 127.3, 127.5, 130.0 (two carbon signals), 130.1 (two carbon signals), 136.0, 155.84, 155.89, 156.77, 156.80, 156.84, 158.7 (q, <i>J</i> 31.9 Hz) (TFA), 168.5, 170.9, 171.0, 171.2, 171.3, 172.8. HRMS (ESI) <i>m</i>/<i>z</i>: [M + 3H]<sup>3+</sup> calcd for [C<sub>47</sub>H<sub>70</sub>N<sub>17</sub>O<sub>8</sub>]<sup>3+</sup>, 333.5192; found, 333.5206. Anal. RP-HPLC (220 nm): 96% (<i>t</i><sub>R</sub> = 16.0 min, <i>k</i> = 4.0). C<sub>47</sub>H<sub>67</sub>N<sub>17</sub>O<sub>8</sub>·C<sub>8</sub>H<sub>4</sub>F<sub>12</sub>O<sub>8</sub> (998.16 + 456.09).</div></div><div id="sec4_5_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i24" class="anchor-spacer"></div><h5 class="article-section__title" id="_i24"> Cit-Tyr-Arg-Leu-Arg-Tyr-Amide Tetrakis(hydrotrifluoroacetate) (<b>14</b>)</h5><div class="NLM_p last">Peptide <b>14</b> was synthesized on a Sieber-amide-PS resin (40 mg, 0.59 mmol/g) according to the general procedure. Purification by preparative HPLC (system 1, gradient: 0–18 min MeCN/0.1% aq TFA 3:97 to 42:58, <i>t</i><sub>R</sub> = 12 min) yielded <b>14</b> as a white solid (10.4 mg, 35%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 0.81–0.89 (m, 6H), 1.36–1.55 (m, 10H), 1.56–1.73 (m, 5H), 2.62–2.75 (m, 2H), 2.80–3.01 (m, 4H), 3.01–3.14 (m, 4H), 3.70–3.79 (m, 1H), 4.18–4.23 (m, 1H), 4.28–4.34 (m, 3H), 4.49–4.54 (m, 1H), 5.53 (br s, 2H), 6.13 (s, 1H), 6.60–6.66 (m, 4H), 6.80–7.20 (br s, 4H, interfering with the next two listed signals), 6.95–6.97 (m, 2H), 7.03–7.06 (m, 3H), 7.20–7.55 (br s, 4H, interfering with the next listed signal), 7.36–7.38 (m, 1H), 7.63–7.70 (m, 2H), 7.76–7.80 (m, 1H), 7.94–8.00 (m, 1H), 8.01–8.12 (m, 4H), 8.27–8.32 (m, 1H), 8.51–8.57 (m, 1H), 9.21 (br s, 2H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 21.4, 23.1, 24.2, 24.9, 25.0, 25.6, 28.9, 29.0, 29.1, 36.6, 36.8, 38.5, 40.40, 40.43, 40.8, 50.9, 51.8, 52.0, 52.3, 53.9, 54.4, 114.87 (two carbon signals), 114.94 (two carbon signals), 115.8 (TFA), 117.8 (TFA), 127.46, 127.47, 130.0 (two carbon signals), 130.1 (two carbon signals), 155.8, 155.9, 156.79, 156.83, 158.6 (q, <i>J</i> 32.3 Hz) (TFA), 159.1, 168.7, 170.8, 170.9, 171.0, 172.0, 172.7. HRMS (ESI) <i>m</i>/<i>z</i>: [M + 3H]<sup>3+</sup> calcd for [C<sub>42</sub>H<sub>70</sub>N<sub>15</sub>O<sub>9</sub>]<sup>3+</sup>, 309.5155; found, 309.5166. Anal. RP-HPLC (220 nm): 98% (<i>t</i><sub>R</sub> = 10.8 min, <i>k</i> = 2.4). C<sub>42</sub>H<sub>67</sub>N<sub>15</sub>O<sub>9</sub>·C<sub>8</sub>H<sub>4</sub>F<sub>12</sub>O<sub>8</sub> (926.09 + 456.09).</div></div><div id="sec4_5_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i25" class="anchor-spacer"></div><h5 class="article-section__title" id="_i25"> Ac-Arg-Tyr-Cit-Leu-Arg-Tyr-Amide Tris(hydrotrifluoroacetate) (<b>15</b>)</h5><div class="NLM_p last">Peptide <b>15</b> was synthesized on a Sieber-amide-PS resin (40 mg, 0.65 mmol/g) according to the general procedure. Purification by preparative HPLC (system 1, gradient: 0–18 min MeCN/0.1% aq TFA 3:97 to 42:58, <i>t</i><sub>R</sub> = 13 min) yielded <b>15</b> as a white solid (14.4 mg, 42%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 0.81–0.91 (m, 6H), 1.23–1.71 (m, 16H), 1.83 (s, 3H), 2.64–2.74 (m, 2H), 2.82–2.99 (m, 4H), 3.01–3.11 (m, 4H), 4.19–4.36 (m, 5H), 4.41–4.47 (m, 1H), 5.47 (br s, 2H), 6.05 (s, 1H), 6.58–6.65 (m, 4H), 6.73–7.20 (br s, 4H, interfering with the next two listed signals), 6.96–6.99 (m, 4H), 7.03–7.05 (m, 1H), 7.20–7.50 (br s, 4H, interfering with the next listed signal), 7.36–7.38 (m, 1H), 7.53–7.60 (m, 2H), 7.80 (t, 2H, <i>J</i> 8.4 Hz), 7.94–7.99 (m, 2H), 8.01–8.07 (m, 2H), 9.17 (br s, 2H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 21.5, 22.4, 23.1, 24.1, 24.8, 25.0, 26.5, 28.9, 29.1, 29.4, 36.4, 36.8, 38.9, 40.4 (two carbon signals), 40.6, 51.0, 52.13 (two carbon signals), 52.17, 53.8, 53.9, 114.8 (two carbon signals), 114.9 (two carbon signals), 115.8 (TFA), 117.8 (TFA), 127.5 (two carbon signals), 130.0 (two carbon signals), 130.1 (two carbon signals), 155.78, 155.80, 156.71, 156.72, 158.4 (q, <i>J</i> 32.5 Hz) (TFA), 159.0, 169.5, 170.8, 170.9, 171.3, 171.4, 171.9, 172.7. HRMS (ESI) <i>m</i>/<i>z</i>: [M + 3H]<sup>3+</sup> calcd for [C<sub>44</sub>H<sub>72</sub>N<sub>15</sub>O<sub>10</sub>]<sup>3+</sup>, 323.5190; found, 323.5202. Anal. RP-HPLC (220 nm): 97% (<i>t</i><sub>R</sub> = 16.0 min, <i>k</i> = 4.0). C<sub>44</sub>H<sub>69</sub>N<sub>15</sub>O<sub>10</sub>·C<sub>6</sub>H<sub>3</sub>F<sub>9</sub>O<sub>6</sub> (968.13 + 342.07).</div></div><div id="sec4_5_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26"> Arg-Tyr-Arg-Leu-Cit-Tyr-Amide Tetrakis(hydrotrifluoroacetate) (<b>16</b>)</h5><div class="NLM_p last">Peptide <b>16</b> was synthesized on a Sieber-amide-PS resin (40 mg, 0.59 mmol/g) according to the general procedure. Purification by preparative HPLC (system 1, gradient: 0–18 min MeCN/0.1% aq TFA 3:97 to 42:58, <i>t</i><sub>R</sub> = 12 min) yielded <b>16</b> as a white solid (11.8 mg, 39%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 0.82–0.90 (m, 6H), 1.24–1.38 (m, 2H), 1.39–1.77 (m, 14H), 2.64–2.74 (m, 2H), 2.82–2.99 (m, 4H), 3.07–3.13 (m, 4H), 3.77–3.79 (m, 1H), 4.18–4.22 (m, 1H), 4.25–4.36 (m, 3H), 4.51–4.56 (m, 1H), 5.46 (br s, 2H), 6.04 (s, 1H), 6.60–6.67 (m, 4H), 6.80–7.20 (br s, 4H, interfering with the next three listed signals), 6.96–6.99 (m, 2H), 7.03–7.04 (m, 1H), 7.05–7.07 (m, 2H), 7.20–7.55 (br s, 4H, interfering with the next listed signal), 7.33–7.35 (m, 1H), 7.65–7.69 (m, 1H), 7.72–7.75 (m, 1H), 7.77–7.80 (m, 1H), 7.95–7.99 (m, 1H), 8.02–8.06 (m, 1H), 8.06–8.14 (m, 3H), 8.34–8.38 (m, 1H), 8.49–8.53 (m, 1H), 9.21 (br s, 2H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 21.6, 23.1, 24.0, 24.2, 25.1, 26.4, 28.6, 29.1, 36.6, 36.8, 38.8, 40.2, 40.5, 40.7, 50.9, 51.6, 52.2, 52.4, 53.9, 54.3, 114.87 (two carbon signals), 114.93 (two carbon signals), 115.8 (TFA), 117.8 (TFA), 127.4, 127.6, 130.06 (two carbon signals), 130.11 (two carbon signals), 155.8, 155.9, 156.8, 156.9, 157.7 (q, <i>J</i> 32.1 Hz) (TFA), 159.0, 168.5, 170.8, 171.0, 171.0, 171.1, 171.9, 172.7. HRMS (ESI) <i>m</i>/<i>z</i>: [M + 3H]<sup>3+</sup> calcd for [C<sub>42</sub>H<sub>70</sub>N<sub>15</sub>O<sub>9</sub>]<sup>3+</sup>, 309.5155; found, 309.5164. Anal. RP-HPLC (220 nm): 97% (<i>t</i><sub>R</sub> = 14.0 min, <i>k</i> = 3.4). C<sub>42</sub>H<sub>67</sub>N<sub>15</sub>O<sub>9</sub>·C<sub>8</sub>H<sub>4</sub>F<sub>12</sub>O<sub>8</sub> (926.09 + 456.09).</div></div><div id="sec4_5_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> Acetyl-Arg-Trp-Arg-Leu-Arg-Tyr-Amide Tris(hydrotrifluoroacetate) (<b>17</b>)</h5><div class="NLM_p last">Peptide <b>17</b> was synthesized on a Sieber-amide-PS resin (40 mg, 0.65 mmol/g) according to the general procedure. Purification by preparative HPLC (system 1, gradient: 0–18 min MeCN/0.1% aq TFA 3:97 to 42:58, <i>t</i><sub>R</sub> = 14 min) yielded <b>17</b> as a white solid (10.9 mg, 33%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 0.81–0.91 (m, 6H), 1.32–1.72 (m, 15H), 1.81 (s, 3H), 2.69–2.75 (m, 1H), 2.83–2.89 (m, 1H), 2.97–3.10 (m, 7H), 3.12–3.17 (m, 1H), 4.12–4.16 (m, 1H), 4.18–4.42 (m, 4H), 4.50–4.55 (m, 1H), 6.64 (d, 2H, <i>J</i> 8.4 Hz), 6.72–7.48 (br s, 12H, interfering with the next five listed signals), 6.96–6.99 (m, 2H), 7.05–7.08 (m, 2H), 7.09–7.12 (m, 1H), 7.13–7.14 (m, 1H), 7.31–7.33 (m, 1H), 7.36–7.39 (m, 1H), 7.48–7.62 (m, 4H), 7.68–7.76 (m, 1H), 7.82–7.92 (m, 2H), 8.00–8.12 (m, 3H), 9.19 (br s, 1H), 10.81 (s, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 21.4, 22.4, 23.1, 24.1, 24.9, 25.0, 27.3, 28.6, 28.7, 28.8, 29.0, 36.8, 40.1, 40.4, 40.5, 40.7, 51.1, 52.3, 52.6, 53.3, 53.6, 54.0, 109.7, 111.3, 114.9 (two carbon signals), 116.0 (TFA), 118.2, 118.3, 120.2, 123.6, 127.3, 127.5, 130.0 (two carbon signals), 136.0, 155.8, 156.7 (three carbon signals), 158.4 (q, <i>J</i> 32.1 Hz) (TFA), 170.0, 170.8, 171.2, 171.6, 171.7, 172.1, 172.7. HRMS (ESI) <i>m</i>/<i>z</i>: [M + 2H]<sup>2+</sup> calcd for [C<sub>46</sub>H<sub>73</sub>N<sub>17</sub>O<sub>8</sub>]<sup>2+</sup>, 495.7909; found, 495.7912. Anal. RP-HPLC (220 nm): 96% (<i>t</i><sub>R</sub> = 15.9 min, <i>k</i> = 3.9). C<sub>46</sub>H<sub>71</sub>N<sub>17</sub>O<sub>8</sub>·C<sub>6</sub>H<sub>3</sub>F<sub>9</sub>O<sub>6</sub> (990.19 + 342.07).</div></div><div id="sec4_5_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28"> Acetyl-Arg-Phe-Arg-Leu-Arg-Tyr-Amide Tris(hydrotrifluoroacetate) (<b>18</b>)</h5><div class="NLM_p last">Peptide <b>18</b> was synthesized on a Sieber-amide-PS resin (40 mg, 0.65 mmol/g) according to the general procedure. Purification by preparative HPLC (system 1, gradient: 0–18 min MeCN/0.1% aq TFA 3:97 to 42:58, <i>t</i><sub>R</sub> = 13 min) yielded <b>18</b> as a white solid (13.5 mg, 40%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 0.83–0.91 (m, 6H), 1.28–1.75 (m, 16H), 1.84 (s, 3H), 2.77–2.90 (m, 2H), 2.99–3.13 (m, 7H), 4.10–4.14 (m, 1H), 4.18–4.23 (m, 1H), 4.24–4.42 (m, 3H), 4.49–4.57 (m, 1H), 6.63 (d, 2H, <i>J</i> 8.4 Hz), 6.75–7.50 (br s, 12H, interfering with the next five signals), 6.97–6.99 (m, 1H), 7.06–7.07 (m, 1H), 7.09–7.13 (m, 1H), 7.18–7.24 (m, 5H), 7.37–7.40 (m, 1H), 7.55–7.65 (m, 3H), 7.69–7.77 (m, 1H), 7.83–7.89 (m, 1H), 7.89–7.96 (m, 1H), 8.01–8.09 (m, 2H), 8.09–8.15 (m, 1H), 9.24 (br s, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 21.4, 22.5, 23.1, 24.1, 24.9, 25.0, 28.6, 28.7, 28.9, 36.7, 37.1, 40.3, 40.4, 40.5, 40.7, 51.0, 51.1, 52.6, 53.5, 53.6, 53.9, 114.9 (two carbon signals), 116.0 (TFA), 118.0 (TFA), 126.3, 127.5, 128.0 (two carbon signals), 129.2 (two carbon signals), 129.5, 130.0 (two carbon signals), 155.8, 156.7 (three carbon signals), 158.6 (q, <i>J</i> 31.9 Hz) (TFA), 169.9, 170.8, 170.9, 171.1, 171.4, 172.6, 172.7. HRMS (ESI) <i>m</i>/<i>z</i>: [M + 2H]<sup>2+</sup> calcd for [C<sub>44</sub>H<sub>72</sub>N<sub>16</sub>O<sub>8</sub>]<sup>2+</sup>, 476.2854; found, 476.2856. Anal. RP-HPLC (220 nm): 98% (<i>t</i><sub>R</sub> = 15.5 min, <i>k</i> = 3.8). C<sub>44</sub>H<sub>70</sub>N<sub>16</sub>O<sub>8</sub>·C<sub>6</sub>H<sub>3</sub>F<sub>9</sub>O<sub>6</sub> (951.15 + 342.07).</div></div><div id="sec4_5_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> Acetyl-Arg-Gly-Arg-Leu-Arg-Tyr-Amide Tris(hydrotrifluoroacetate) (<b>19</b>)</h5><div class="NLM_p last">Peptide <b>19</b> was synthesized on a Sieber-amide-PS resin (40 mg, 0.65 mmol/g) according to the general procedure. Purification by preparative HPLC (system 1, gradient: 0–18 min MeCN/0.1% aq TFA 3:97 to 42:58, <i>t</i><sub>R</sub> = 11 min) yielded <b>19</b> as a white solid (7.2 mg, 23%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 0.79–0.90 (m, 6H), 1.40–1.56 (m, 10H), 1.57–1.75 (m, 4H), 1.85–1.88 (m, 3H), 2.68–2.74 (m, 1H), 2.83–2.90 (m, 1H), 3.01–3.13 (m, 6H), 3.68–3.70 (m, 1H), 3.74–3.79 (m, 1H), 4.13–4.21 (m, 2H), 4.22–4.29 (m, 2H), 4.29–4.34 (m, 1H), 6.63–6.61 (m, 2H), 6.80–7.55 (br s, 12H, interfering with the next four listed signals), 6.96–6.99 (m, 2H), 7.05–7.07 (m, 1H), 7.09–7.13 (m, 1H), 7.34–7.37 (m, 1H), 7.58–7.68 (m, 2H), 7.68–7.76 (m, 2H), 7.87–7.95 (m, 2H), 7.95–8.01 (m, 1H), 8.16–8.21 (m, 1H), 8.29–8.35 (m, 1H), 9.25 (br s, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 21.4, 22.4, 23.1, 24.1, 24.9, 25.0, 25.1, 28.6, 28.9, 29.0, 36.8, 40.4 (two carbon signals), 40.4 (two carbon signals), 42.1, 51.1, 52.3, 52.3, 52.8, 54.0, 114.9 (two carbon signals), 115.9 (TFA), 117.9 (TFA), 127.5, 130.0 (two carbon signals), 155.8, 156.7, 156.76, 156.79, 158.8 (q, <i>J</i> 32.2 Hz) (TFA), 169.0, 170.1, 170.9, 171.3, 172.1, 172.2, 172.7. HRMS (ESI) <i>m</i>/<i>z</i>: [M + 2H]<sup>2+</sup> calcd for [C<sub>37</sub>H<sub>66</sub>N<sub>16</sub>O<sub>8</sub>]<sup>2+</sup>, 431.2619; found, 431.2625. Anal. RP-HPLC (220 nm): 97% (<i>t</i><sub>R</sub> = 9.0 min, <i>k</i> = 1.8). C<sub>37</sub>H<sub>64</sub>N<sub>16</sub>O<sub>8</sub>·C<sub>6</sub>H<sub>3</sub>F<sub>9</sub>O<sub>6</sub> (861.02 + 342.07).</div></div><div id="sec4_5_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> <i>N</i><sup>α</sup>-Succinyl-Arg-Tyr-Arg-Leu-Arg-Tyr-Amide Tris(hydrotrifluoroacetate) (<b>20</b>)</h5><div class="NLM_p last">Peptide <b>20</b> was synthesized on a Sieber-amide-PS resin (40 mg, 0.65 mmol/g) according to the general procedure. After coupling of the last amino acid and subsequent Fmoc deprotection, the resin was treated with a salutation of succinic anhydride (27.9 mg, 0.236 mmol) and DIPEA (41.1 μL, 0.236 mmol) in DMF/NMP 80:20 v/v (500 μL) at 35 °C for 30 min. The resin was washed with DMF/NMP 80:20 v/v (6×) and CH<sub>2</sub>Cl<sub>2</sub> (3×), followed by cleavage of the resin and deprotection according to the general procedure. Purification by preparative HPLC (system 1, gradient: 0–18 min MeCN/0.1% aq TFA 3:97 to 42:58, <i>t</i><sub>R</sub> = 13 min) yielded <b>20</b> as a white solid (11.0 mg, 37%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 0.81–0.90 (m, 6H), 1.34–1.57 (m, 11H), 1.57–1.67 (m, 3H), 1.67–1.76 (m, 1H), 2.34–2.47 (m, 4H), 2.67–2.76 (m, 2H), 2.83–2.95 (m, 2H), 2.98–3.13 (m, 6H), 4.11–4.17 (m, 1H), 4.17–4.23 (m, 1H), 4.24–4.35 (m, 3H), 4.38–4.45 (m, 1H), 6.60–6.68 (m, 4H), 6.75–7.55 (br s, 12H, interfering with the next four listed signals, 6.96–7.00 (m, 4H), 7.05–7.07 (m, 1H), 7.09–7.13 (m, 1H), 7.35–7.37 (m, 1H), 7.56–7.66 (m, 3H), 7.69–7.73 (m, 1H), 7.73–7.78 (m, 1H), 7.84–7.89 (m, 1H), 7.99–8.05 (m, 1H), 8.06–8.11 (m, 1H), 8.12–8.17 (m, 1H), 9.31 (br s, 2H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 21.4, 23.1, 24.1, 24.9, 24.99, 25.02, 28.7, 28.95, 28.96, 29.1, 29.9, 36.3, 36.8, 40.39, 40.41, 40.43, 40.6, 51.0, 52.1, 52.3, 52.6, 54.0, 54.1, 114.86 (two carbon signals), 114.88 (two carbon signals), 115.5 (TFA), 117.5 (TFA), 127.49, 127.51, 130.04 (two carbon signals), 130.07 (two carbon signals), 155.82, 155.85, 156.8 (three carbon signals), 158.7 (q, <i>J</i> 33.6 Hz) (TFA), 170.9, 171.11, 171.14, 171.4, 171.8, 172.0, 172.7, 174.0. HRMS (ESI) <i>m</i>/<i>z</i>: [M + 3H]<sup>3+</sup> calcd for [C<sub>46</sub>H<sub>75</sub>N<sub>16</sub>O<sub>11</sub>]<sup>3+</sup>, 342.5262; found, 342.5273. Anal. RP-HPLC (220 nm): 97% (<i>t</i><sub>R</sub> = 15.0 min, <i>k</i> = 3.7). C<sub>46</sub>H<sub>72</sub>N<sub>16</sub>O<sub>11</sub>·C<sub>6</sub>H<sub>3</sub>F<sub>9</sub>O<sub>6</sub> (1053.24 + 342.07).</div></div><div id="sec4_5_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> Acetyl-Arg-Arg-Leu-Arg-Tyr-Amide Tris(hydrotrifluoroacetate) (<b>21</b>)</h5><div class="NLM_p last">Peptide <b>21</b> was synthesized on a Sieber-amide-PS resin (40 mg, 0.65 mmol/g) according to the general procedure. Purification by preparative HPLC (system 1, gradient: 0–18 min MeCN/0.1% aq TFA 3:97 to 42:58, <i>t</i><sub>R</sub> = 11 min) yielded <b>21</b> as a white solid (6.8 mg, 23%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 0.80–0.84 (m, 3H), 0.85–0.89 (m, 3H), 1.38–1.56 (m, 11H), 1.56–1.73 (m, 4H), 1.86 (s, 3H), 2.69–2.75 (m, 1H), 2.82–2.90 (m, 1H), 3.03–3.12 (m, 6H), 4.17–4.30 (m, 4H), 4.30–4.35 (m, 1H), 6.60–6.66 (m, 2H), 6.75–7.50 (br s, 12H, interfering with the next four listed signals), 6.96–6.98 (m, 2H), 7.05–7.07 (m, 1H), 7.09–7.14 (m, 1H), 7.36–7.38 (m, 1H), 7.59–7.63 (m, 2H), 7.75–7.79 (m, 1H), 7.85–7.91 (m, 1H), 7.98–8.03 (m, 1H), 8.04–8.14 (m, 2H), 9.19 (br s, 1H). HRMS (ESI) <i>m</i>/<i>z</i>: [M + 2H]<sup>2+</sup> calcd for [C<sub>35</sub>H<sub>63</sub>N<sub>15</sub>O<sub>7</sub>]<sup>2+</sup>, 405.7512; found, 402.7518. Anal. RP-HPLC (220 nm): 97% (<i>t</i><sub>R</sub> = 7.7 min, <i>k</i> = 1.4). C<sub>35</sub>H<sub>61</sub>N<sub>15</sub>O<sub>7</sub>·C<sub>6</sub>H<sub>3</sub>F<sub>9</sub>O<sub>6</sub> (803.97 + 342.07).</div></div><div id="sec4_5_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> Trp-Arg-Leu-Arg-Tyr-Amide Tris(hydrotrifluoroacetate) (<b>22</b>)</h5><div class="NLM_p last">Peptide <b>22</b> was synthesized on a Sieber-amide-PS resin (60 mg, 0.59 mmol/g) according to the general procedure. Purification by preparative HPLC (system 2, gradient: 0–18 min MeCN/0.1% aq TFA 3:97 to 42:58, <i>t</i><sub>R</sub> = 12 min) yielded <b>22</b> as a white solid (11.8 mg, 37%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 0.82–0.91 (m, 6H), 1.38–1.61 (m, 8H), 1.61–1.68 (m, 2H), 1.68–1.77 (m, 1H), 2.69–2.75 (m, 1H), 2.82–2.88 (m, 1H), 2.97–3.04 (m, 1H), 3.04–3.15 (m, 4H), 3.19–3.25 (m, 1H), 4.03–4.09 (m, 1H), 4.19–4.25 (m, 1H), 4.30–4.37 (m, 2H), 4.38–4.43 (m, 1H), 6.63 (d, 2H, <i>J</i> 8.3 Hz), 6.80–7.20 (br s, 4H, interfering with the next four listed signals), 6.96–6.98 (m, 2H), 6.99–7.02 (m, 1H), 7.05–7.07 (m, 1H), 7.09–7.11 (m, 1H), 7.20–7.55 (br s, 4H, interfering with the next two listed signals), 7.20–7.22 (m, 1H), 7.36–7.40 (m, 2H), 7.60–7.64 (m, 1H), 7.68–7.73 (m, 2H), 7.78 (d, 1H, <i>J</i> 7.8 Hz), 7.95–8.16 (m, 3H), 8.07 (d, 1H, <i>J</i> 7.7 Hz), 8.13 (d, 1H, <i>J</i> 7.8 Hz), 8.84 (d, 1H, <i>J</i> 7.9 Hz), 9.19 (br s, 1H), 11.01 (s, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 21.4, 23.1 24.2, 24.9, 25.0, 27.5, 29.0, 29.3, 36.8, 40.4 (two carbon signals), 40.7, 51.0, 52.27 (two carbon signals), 52.33, 53.9, 106.6, 111.5, 114.9 (two carbon signals), 116.0 (TFA), 118.0 (TFA), 118.4, 118.5, 121.2, 125.1, 127.0, 127,4, 130.0 (two carbon signals), 136.4, 155.8, 156.72, 156.79, 158.3 (q, <i>J</i> 31.8 Hz) (TFA), 168.5, 170.7, 170.8, 172.0, 172.6. HRMS (ESI) <i>m</i>/<i>z</i>: [M + 2H]<sup>2+</sup> calcd for [C<sub>38</sub>H<sub>59</sub>N<sub>13</sub>O<sub>6</sub>]<sup>2+</sup>, 396.7350; found, 396.7362. Anal. RP-HPLC (220 nm): 99% (<i>t</i><sub>R</sub> = 18.1 min, <i>k</i> = 4.6). C<sub>38</sub>H<sub>57</sub>N<sub>13</sub>O<sub>6</sub>·C<sub>6</sub>H<sub>3</sub>F<sub>9</sub>O<sub>6</sub> (791.96 + 342.07).</div></div><div id="sec4_5_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> Ac-Arg-Gly-Tyr-Arg-Leu-Arg-Tyr-Amide Tris(hydrotrifluoroacetate) (<b>23</b>)</h5><div class="NLM_p last">Peptide <b>23</b> was synthesized on a Sieber-amide-PS resin (40 mg, 0.65 mmol/g) according to the general procedure. Purification by preparative HPLC (system 1, gradient: 0–18 min MeCN/0.1% aq TFA 3:97 to 42:58, <i>t</i><sub>R</sub> = 12 min) yielded <b>23</b> as a white solid (25.0 mg, 70%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 0.81–0.91 (m, 6H), 1.37–1.58 (m, 11H), 1.58–1.68 (m, 3H), 1.70–1.75 (m, 1H), 1.83–1.88 (m, 3H), 2.60–2.68 (m, 1H), 2.69–2.76 (m, 1H), 2.81–2.92 (m, 2H), 3.01–3.14 (m, 6H), 3.51–3.57 (m, 1H), 3.73–3.79 (m, 1H), 4.18–4.22 (m, 2H), 4.25–4.34 (m, 3H), 4.42–4.47 (m, 1H), 6.59–6.67 (m, 4H), 6.80–7.50 (br s, 12H, interfering with the next four listed signals), 6.96–7.01 (m, 4H), 7.05–7.06 (m, 1H), 7.10–7.13 (m, 1H); 7.35–7.37 (m, 1H), 7.56–7.69 (m, 3H), 7.73–7.79 (m, 1H), 7.86–7.91 (m, 1H), 7.91–7.97 (m, 1H), 8.01–8.04 (m, 1H), 8.10–8.14 (m, 1H), 8.17–8.25 (m, 2H), 9.22 (br s, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 21.40, 21.43, 23.1, 24.1, 24.47, 24.49, 24.9, 25.1, 28.9, 29.0, 36.71, 36.79, 40.36, 40.39, 40.43, 40.7, 41.8, 51.0, 52.2, 52.3, 52.5, 54.0, 54.3, 114.9 (four carbon signals), 115.7 (TFA), 117.7 (TFA), 127.5, 127.7, 130.0 (four carbon signals), 155.81, 155.83, 156,75, 156.79 (two carbon signals), 158.7 (q, <i>J</i> 32.7 Hz) (TFA), 168.6, 168.8, 169.8, 170.9, 171.2, 171.4, 172.0, 172.7. HRMS (ESI) <i>m</i>/<i>z</i>: [M + 3H]<sup>3+</sup> calcd for [C<sub>46</sub>H<sub>76</sub>N<sub>17</sub>O<sub>10</sub>]<sup>3+</sup>, 342.1982; found, 342.1996. Anal. RP-HPLC (220 nm): 97% (<i>t</i><sub>R</sub> = 16.4 min, <i>k</i> = 4.1). C<sub>46</sub>H<sub>73</sub>N<sub>17</sub>O<sub>10</sub>·C<sub>6</sub>H<sub>3</sub>F<sub>9</sub>O<sub>6</sub> (1024.20 + 342.07).</div></div><div id="sec4_5_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34"> Ac-Arg-GABA-Gly-Tyr-Arg-Leu-Arg-Tyr-Amide Tris(hydrotrifluoroacetate) (<b>24</b>)</h5><div class="NLM_p last">Peptide <b>24</b> was synthesized on a Sieber-amide-PS resin (40 mg, 0.65 mmol/g) according to the general procedure. Purification by preparative HPLC (system 1, gradient: 0–18 min MeCN/0.1% aq TFA 3:97 to 42:58, <i>t</i><sub>R</sub> = 13 min) yielded <b>24</b> as a white solid (12.7 mg, 34%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 0.82–0.90 (m, 6H), 1.35–1.56 (m, 11H), 1.56–1.74 (m, 6H), 1.81–1.88 (m, 3H), 2.07–2.12 (m, 2H), 2.60–2.67 (m, 1H), 2.69–2.75 (m, 1H), 2.83–2.90 (m, 2H), 3.00–3.13 (m, 8H), 3.52–3.58 (m, 1H), 3.69–3.75 (m, 1H), 4.16–4.24 (m, 2H), 4.24–4.35 (m, 3H), 4.43–4.48 (m, 1H), 6.59–6.67 (m, 4H), 6.73–7.54 (br s, 12H, interfering with the next four listed signals), 6.96–7.01 (m, 4H), 7.05–7.06 (m, 1H), 7.09–7.12 (m, 1H), 7.35–7.37 (m, 1H), 7.59–7.64 (m, 2H), 7.65–7.69 (m, 1H), 7.74–7.78 (m, 1H), 7.87–7.91 (m, 1H), 7.96–8.04 (m, 4H), 8.19–8.26 (m, 1H), 9.24 (br s, 2H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 21.4, 22.5, 23.1, 24.1, 24.9, 25.1, 25.16, 25.22, 28.9, 29.0, 29.3, 32.5, 36.7, 36.8, 38.1, 40.36 (two carbon signals), 40.42, 40.7, 41.8, 51.0, 52.1, 52.2, 52.3, 54.0, 54.1, 114.9 (four carbon signals), 115.6 (TFA), 117.6 (TFA), 127.5, 127.6, 130.0 (two carbon signals), 130.1 (two carbon signals), 155.8 (two carbon peaks), 156.7, 156.8 (two carbon signals), 158.7 (q, <i>J</i> 33.3 Hz) (TFA), 168.9, 169.4, 170.8, 171.1, 171.3, 171.4, 172.0, 172.3, 172.7. HRMS (ESI) <i>m</i>/<i>z</i>: [M + 3H]<sup>3+</sup> calcd for [C<sub>50</sub>H<sub>83</sub>N<sub>18</sub>O<sub>11</sub>]<sup>3+</sup>, 370.5491; found, 370.5503. Anal. RP-HPLC (220 nm): 96% (<i>t</i><sub>R</sub> = 16.3 min, <i>k</i> = 4.1). C<sub>50</sub>H<sub>80</sub>N<sub>18</sub>O<sub>11</sub>·C<sub>6</sub>H<sub>3</sub>F<sub>9</sub>O<sub>6</sub> (1109.31 + 342.07).</div></div><div id="sec4_5_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> Acetyl-Arg-Gly-Tyr-Arg-Leu-Arg-Tyr-Amide Tris(hydrotrifluoroacetate) (<b>25</b>)</h5><div class="NLM_p last">Peptide <b>25</b> was synthesized on Sieber-amide-PS resin (40 mg, 0.65 mmol/g) according to the general procedure. Purification by preparative HPLC (system 1, gradient: 0–18 min MeCN/0.1% aq TFA 3:97 to 42:58, <i>t</i><sub>R</sub> = 12 min) yielded <b>25</b> as a white solid (16.5 mg, 44%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 1.35–1.56 (m, 9H), 1.58–1.68 (m, 3H), 1.85 (s, 3H), 2.58–2.64 (m, 1H), 2.68–2.74 (m, 1H), 2.80–2.90 (m, 2H), 2.93–2.99 (m, 1H), 3.00–3.10 (m, 6H), 3.10–3.17 (m, 1H), 3.51–3.53 (m, 1H), 3.72–3.77 (m, 1H), 4.16–4.27 (m, 3H), 4.32–4.37 (m, 1H), 4.39–4.45 (m, 1H), 4.54–4.59 (m, 1H), 6.58–6.66 (m, 4H), 6.75–7.50 (br s, 12H, interfering with the next six listed signals), 6.89–6.92 (m, 1H), 6.97–7.03 (m, 6H), 7.05–7.07 (m, 1H), 7.11–7.12 (m, 1H), 7.28–7.30 (m, 1H), 7.36–7.38 (m, 1H), 7.54–7.60 (m, 3H), 7.62–7.67 (m, 1H), 7.78–7.82 (m, 1H), 7.88–7.96 (m, 2H), 8.11–8.19 (m, 3H), 9.18 (br s, 2H), 10.74 (s, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 22.5, 24.8, 25.0, 25.1, 27.7, 28.8, 29.0, 29.1, 36.6, 36.8, 40.3, 40.39, 40.44, 41.7, 52.2, 52.42, 52.44, 53.2, 54.1, 54.3, 109.8, 111.2, 114.8 (two carbon signals), 114.9 (two carbon signals), 116.0 (TFA), 118.0 (TFA), 118.2, 118.5, 120.8, 123.5, 127.3, 127.6, 127.8, 130.0 (two carbon signals), 130.1 (two carbon signals), 155.7, 155.8, 156.8 (three carbon signals), 158.7 (q, <i>J</i> 31.9 Hz) (TFA), 168.6, 169.8, 170.9, 171.2, 171.37, 171.42, 172.0, 172.8. HRMS (ESI) <i>m</i>/<i>z</i>: [M + 3H]<sup>3+</sup> calcd for [C<sub>51</sub>H<sub>75</sub>N<sub>18</sub>O<sub>10</sub>]<sup>3+</sup>, 366.5299; found, 366.5320. Anal. RP-HPLC (220 nm): 96% (<i>t</i><sub>R</sub> = 14.1 min, <i>k</i> = 3.4). C<sub>51</sub>H<sub>72</sub>N<sub>18</sub>O<sub>10</sub>·C<sub>6</sub>H<sub>3</sub>F<sub>9</sub>O<sub>6</sub> (1097.25 + 342.07).</div></div><div id="sec4_5_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> Acetyl-Arg-Gly-Tyr-Arg-Trp-Arg-Trp-Amide Tris(hydrotrifluoroacetate) (<b>26</b>)</h5><div class="NLM_p last">Peptide <b>26</b> was synthesized on a Sieber-amide-PS resin (40 mg, 0.65 mmol/g) according to the general procedure. Purification by preparative HPLC (system 1, gradient: 0–18 min MeCN/0.1% aq TFA 3:97 to 42:58, <i>t</i><sub>R</sub> = 15 min) yielded <b>26</b> as a white solid (14.1 mg, 41%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 1.35–1.55 (m, 10H), 1.60–1.69 (m, 3H), 1.85 (s, 3H), 2.80–2.85 (m, 1H), 2.95–3.01 (m, 2H), 3.02–3.09 (m, 6H), 3.11–3.16 (m, 2H), 3.51–3.54 (m, 1H), 3.73–3.79 (m, 1H), 4.17–4.22 (m, 1H), 4.23–4.29 (m, 2H), 4.41–4.46 (m, 1H), 4.47–4.52 (m, 1H), 4.57–4.62 (m, 1H), 6.60–6.64 (m, 2H), 6.70–7.50 (br s, 12H, interfering with the next seven listed signals), 6.89–6.91 (m, 1H), 6.95–6.98 (m, 1H), 6.99–7.07 (m, 5H), 7.11–7.13 (m, 2H), 7.28–7.32 (m, 2H), 7.41–7.44 (m, 1H), 7.45–7.50 (m, 2H), 7.51–7.54 (m, 1H), 7.54–7.61 (m, 2H), 7.87–7.97 (m, 3H), 8.08–8.21 (m, 4H), 9.18 (s, 1H), 10.71–10.75 (m, 1H), 10.76–10.80 (m, 1H). HRMS (ESI) <i>m</i>/<i>z</i>: [M + 3H]<sup>3+</sup> calcd for [C<sub>53</sub>H<sub>76</sub>N<sub>19</sub>O<sub>9</sub>]<sup>3+</sup>, 374.2019; found, 374.2034. Anal. RP-HPLC (220 nm): 98% (<i>t</i><sub>R</sub> = 17.0 min, <i>k</i> = 4.3). C<sub>53</sub>H<sub>73</sub>N<sub>19</sub>O<sub>9</sub>·C<sub>6</sub>H<sub>3</sub>F<sub>9</sub>O<sub>6</sub> (1120.29 + 342.07).</div></div><div id="sec4_5_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i37" class="anchor-spacer"></div><h5 class="article-section__title" id="_i37"> Acetyl-Arg-Gly-Tyr-Arg-Leu-Arg-Trp-Amide Tris(hydrotrifluoroacetate) (<b>27</b>)</h5><div class="NLM_p last">Peptide <b>27</b> was synthesized on a Sieber-amide-PS resin (40 mg, 0.65 mmol/g) according to the general procedure. Purification by preparative HPLC (system 1, gradient: 0–18 min MeCN/0.1% aq TFA 3:97 to 42:58, <i>t</i><sub>R</sub> = 14 min) yielded <b>27</b> as a white solid (14.1 mg, 40%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 0.78–0.88 (m, 6H), 1.37–1.56 (m, 11H), 1.59–1.73 (m, 4H), 1.84–1.87 (m, 3H), 2.61–2.67 (m, 1H), 2.83–2.90 (m, 1H), 2.95–3.00 (m, 1H), 3.03–3.13 (m, 7H), 3.51–3.56 (m, 1H), 3.73–3.79 (m, 1H), 4.17–4.33 (m, 4H), 4.40–4.49 (m, 2H), 6.59–6.65 (m, 2H), 6.70–7.50 (br s, 12H, interfering with the next six signals), 6.95–6.97 (m, 1H), 6.99–7.01 (m, 2H), 7.04–7.06 (m, 2H), 7.10–7.11 (m, 1H), 7.30–7.32 (m, 1H), 7.37–7.39 (m, 1H), 7.54–7.63 (m, 4H), 7.82–7.89 (m, 2H), 7.91–7.97 (m, 1H), 8.00–8.04 (m, 1H), 8.09–8.14 (m, 1H), 8.16–8.25 (m, 2H), 9.21 (br s, 1H), 10.78 (s, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 21.4, 22.5, 23.1, 24.1, 24.9, 25.0 (two carbon signals), 27.8, 28.9 (two carbon signals), 29.0, 36.7, 40.36, 40.38, 40.44, 40.7, 41.8, 51.0, 52.2, 52.3, 52.4, 53.2, 54.2, 109.8, 111.2, 114.9 (two carbon signals), 116.0 (TFA), 118.0 (TFA), 118.2, 118.4, 120.8, 123.5, 127.4, 127.7, 130.1 (two carbon signals), 136.0, 155.8, 156.7 (three carbon signals), 158.5 (q, <i>J</i> 31.8 Hz) (TFA), 168.6, 169.8, 171.0, 171.1, 171.4, 172.00, 172.03, 173.07. HRMS (ESI) <i>m</i>/<i>z</i>: [M + 2H]<sup>2+</sup> calcd for [C<sub>48</sub>H<sub>76</sub>N<sub>18</sub>O<sub>9</sub>]<sup>2+</sup>, 524.3016; found, 524.3043. Anal. RP-HPLC (220 nm): 96% (<i>t</i><sub>R</sub> = 17.1 min, <i>k</i> = 4.3). C<sub>48</sub>H<sub>74</sub>N<sub>18</sub>O<sub>9</sub>·C<sub>6</sub>H<sub>3</sub>F<sub>9</sub>O<sub>6</sub> (1047.24 + 342.07).</div></div><div id="sec4_5_18" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> Acetyl-Arg-GABA-Tyr-Arg-Trp-Arg-Tyr-Amide Tris(hydrotrifluoroacetate) (<b>28</b>)</h5><div class="NLM_p last">Peptide <b>28</b> was synthesized on a Sieber-amide-PS resin (40 mg, 0.65 mmol/g) according to the general procedure. Purification by preparative HPLC (system 1, gradient: 0–18 min MeCN/0.1% aq TFA 3:97 to 42:58, <i>t</i><sub>R</sub> = 13 min) yielded <b>28</b> as a white solid (11.3 mg, 30%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 1.34–1.55 (m, 12H), 1.58–1.68 (m, 3H), 1.83–1.86 (s, 3H), 1.99–2.05 (m, 2H), 2.56–2.61 (m, 1H), 2.69–2.74 (m, 1H), 2.80–2.85 (m, 1H), 2.85–2.90 (m, 1H), 2.91–2.99 (m, 3H), 3.03–3.10 (m, 6H), 3.11–3.17 (m, 1H), 4.14–4.20 (m, 1H), 4.20–4.28 (m, 2H), 4.34–4.38 (m, 1H), 4.38–4.44 (m, 1H), 4.56–4.61 (m, 1H), 6.59–6.65 (m, 4H), 6.75–7.48 (br s, 12 H, interfering with the next six listed signals), 6.91–6.93 (m, 1H), 6.99–7.03 (m, 5H), 7.06–7.08 (m, 1H), 7.11–7.12 (m, 1H), 7.29–7.31 (m, 1H), 7.37–7.40 (m, 1H), 7.53–7.59 (m, 3H), 7.62–7.66 (m, 1H), 7.78–7.83 (m, 1H), 7.91–7.93 (m, 1H), 7.95–7.98 (m, 1H), 8.00–8.04 (m, 1H), 8.11–8.19 (m, 2H), 9.18 (br s, 2H), 10.76 (s, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 22.5, 24.8, 24.9, 25.2, 25.3, 27.7, 29.08, 29.10, 29.2, 32.6, 36.5, 36.8, 38.1, 40.36, 40.40, 40.43, 52.15, 52.18, 52.4, 53.1, 54.1, 54.2, 109.8, 111.2, 114.8 (two carbon signals), 114.9 (two carbon signals), 116.1 (TFA), 118.1 (TFA), 118.2, 118.5, 120.8, 123.5, 127.3, 127.6, 128.0, 130.0 (two carbon signals), 130.1 (two carbon signals), 136.0, 155.7, 155.8, 156.7 (three carbon signals), 158.5 (q, <i>J</i> 31.6 Hz) (TFA), 169.4, 170.9, 171.2, 171.4 (two carbon signals), 171.8, 171.9, 172.8. HRMS (ESI) <i>m</i>/<i>z</i>: [M + 3H]<sup>3+</sup> calcd for [C<sub>53</sub>H<sub>79</sub>N<sub>18</sub>O<sub>10</sub>]<sup>3+</sup>, 375.8737; found, 375.8760. Anal. RP-HPLC (220 nm): 96% (<i>t</i><sub>R</sub> = 14.5 min, <i>k</i> = 3.5). C<sub>53</sub>H<sub>76</sub>N<sub>18</sub>O<sub>10</sub>·C<sub>6</sub>H<sub>3</sub>F<sub>9</sub>O<sub>6</sub> (1125.31 + 342.07).</div></div><div id="sec4_5_19" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> Arg-Leu-Arg-Tyr-Amide Tris(hydrotrifluoroacetate) (<b>29</b>)</h5><div class="NLM_p last">Peptide <b>29</b> was synthesized on a Sieber-amide-PS resin (40 mg, 0.65 mmol/g) according to the general procedure. Purification by preparative HPLC (system 1, gradient: 0–18 min MeCN/0.1% aq TFA 3:97 to 42:58, <i>t</i><sub>R</sub> = 10 min) yielded <b>29</b> as a white solid (8.4 mg, 34%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 0.83–0.92 (m, 6H), 1.37–1.57 (m, 7H), 1.61–1.74 (m, 4H), 2.69–2.75 (m, 1H), 2.82–2.87 (m, 1H), 3.03–3.14 (m, 4H), 3.80–3.83 (m, 1H), 4.17–4.22 (m, 1H), 4.31–4.37 (m, 2H), 6.61–6.65 (m, 2H), 6.80–7.20 (br s, 4H, interfering with the next two listed signals), 6.95–6.99 (m, 2H), 7.05–7.08 (m, 1H), 7.20–7.55 (br s, 4H, interfering with the next listed signal), 7.39–7.41 (m, 1H), 7.67–7.72 (m, 1H), 7.72–7.79 (m, 2H), 8.14–8.23 (m, 4H), 8.47–8.54 (m, 1H), 9.22 (br s, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 21.3, 23.1, 24.0 (two carbon signals), 25.0, 28.4, 28.9, 36.8, 40.2, 40.5, 40.6, 51.2, 51.7, 52.5, 53.8, 114.9 (two carbon signals), 115.9 (TFA), 117.9 (TFA), 127.4, 130.0 (two carbon signals), 155.8, 156.8, 156.9, 158.7 (q, <i>J</i> 32.0 Hz) (TFA), 168.3, 170.8, 171.7, 172.7.HRMS (ESI) <i>m</i>/<i>z</i>: [M + 2H]<sup>2+</sup> calcd for [C<sub>27</sub>H<sub>49</sub>N<sub>11</sub>O<sub>5</sub>]<sup>2+</sup>, 303.6954; found, 303.6964. Anal. RP-HPLC (220 nm): 98% (<i>t</i><sub>R</sub> = 5.9 min, <i>k</i> = 0.8). C<sub>27</sub>H<sub>47</sub>N<sub>11</sub>O<sub>5</sub>·C<sub>6</sub>H<sub>3</sub>F<sub>9</sub>O<sub>6</sub> (605.75 + 342.07).</div></div><div id="sec4_5_20" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40"> Arg-Trp-Arg-Tyr-Amide Tris(hydrotrifluoroacetate) (<b>30</b>)</h5><div class="NLM_p last">Peptide <b>30</b> was synthesized on a Sieber-amide-PS resin (40 mg, 0.65 mmol/g) according to the general procedure. Purification by preparative HPLC (system 1, gradient: 0–18 min MeCN/0.1% aq TFA 3:97 to 42:58, <i>t</i><sub>R</sub> = 12 min) yielded <b>30</b> as a white solid (7.9 mg, 30%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 1.40–1.58 (m, 5H), 1.64–1.76 (m, 3H), 2.70–2.77 (m, 1H), 2.86–2.91 (m, 1H), 2.92–2.98 (m, 1H), 3.05–3.13 (m, 4H), 3.16–3.20 (m, 1H), 3.73–3.78 (m, 1H), 4.21–4.25 (m, 1H), 4.36–4.41 (m, 1H), 4.62–4.67 (m, 1H), 6.62–6.66 (m, 2H), 6.80–7.20 (br s, 4H, interfering with the next four listed signals), 6.95–6.97 (m, 1H), 6.99–7.01 (m, 2H), 7.05–7.09 (m, 2H), 7.16–7.18 (m, 1H), 7.20–7.50 (br s, 4H, interfering with the next two listed signals), 7.32–7.34 (m, 1H), 7.42–7.44 (m, 1H), 7.61–7.65 (m, 1H), 7.67–7.72 (m, 2H), 7.77–7.81 (m, 1H), 8.05–8.12 (m, 3H), 8.36–8.41 (m, 1H), 8.54–8.59 (m, 1H), 9.20 (s, 1H), 10.82–10.87 (m, 1H). HRMS (ESI) <i>m</i>/<i>z</i>: [M + 2H]<sup>2+</sup> calcd for [C<sub>32</sub>H<sub>48</sub>N<sub>12</sub>O<sub>5</sub>]<sup>2+</sup>, 340.1930; found, 340.1940. Anal. RP-HPLC (220 nm): 97% (<i>t</i><sub>R</sub> = 9.4 min, <i>k</i> = 1.9). C<sub>32</sub>H<sub>46</sub>N<sub>12</sub>O<sub>5</sub>·C<sub>6</sub>H<sub>3</sub>F<sub>9</sub>O<sub>6</sub> (678.80 + 342.07).</div></div><div id="sec4_5_21" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> <span class="smallcaps smallerCapital">d</span>-Arg-Leu-Arg-Tyr-Amide Tris(hydrotrifluoroacetate) (<b>31</b>)</h5><div class="NLM_p last">Peptide <b>31</b> was synthesized on a Sieber-amide-PS resin (100 mg, 0.59 mmol/g) according to the general procedure. Purification by preparative HPLC (system 1, gradient: 0–30 min MeCN/0.1% aq TFA 8:92 to 45:58, <i>t</i><sub>R</sub> = 9 min) yielded <b>31</b> as a white solid (12.1 mg, 21%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 0.82–0.89 (m, 6H), 1.37–1.58 (m, 8H), 1.62–1.68 (m, 1H), 1.69–1.74 (m, 2H), 2.70–2.74 (m, 1H), 2.82–2.87 (m, 1H), 3.04–3.10 (m, 2H), 3.10–3.15 (m, 2H), 3.81–3.87 (m, 1H), 4.17–4.23 (m, 1H), 4.32–4.37 (m, 1H), 4.40–4.45 (m, 1H), 6.61–6.65 (m, 2H), 6.90–7.60 (br s, 8H, interfering with the next three listed signals), 6.96–7.00 (m, 2H), 7.07 (s, 1H), 7.40 (s, 1H), 7.69–7.75 (m, 2H), 7.88 (t, 1H, <i>J</i> 11.6 Hz), 8.12–8.21 (m, 3H), 8.31 (d, 1H, <i>J</i> 7.7 Hz), 8.65 (d, 1H, <i>J</i> 8.4 Hz), 9.20 br s, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 21.2, 23.1, 24.1, 24.2, 25.1, 28.5, 28.9, 36.9, 40.0, 40.5, 41.1, 50.9, 51.8, 52.5, 53.8, 114.8 (two carbon signals), 127.5, 130.1 (two carbon signals), 155.8, 156.8, 156.9, 168.1, 170.7, 171.6, 172.7. HRMS (ESI) <i>m</i>/<i>z</i>: [M + 2H]<sup>2+</sup> calcd for [C<sub>27</sub>H<sub>49</sub>N<sub>11</sub>O<sub>5</sub>]<sup>2+</sup>, 303.6954; found, 303.6965. Anal. RP-HPLC (220 nm): 98% (<i>t</i><sub>R</sub> = 8.8 min, <i>k</i> = 1.7). C<sub>27</sub>H<sub>47</sub>N<sub>11</sub>O<sub>5</sub>·C<sub>6</sub>H<sub>3</sub>F<sub>9</sub>O<sub>6</sub> (605.75 + 342.07).</div></div><div id="sec4_5_22" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> Arg-<span class="smallcaps smallerCapital">d</span>-Leu-Arg-Tyr-Amide Tris(hydrotrifluoroacetate) (<b>32</b>)</h5><div class="NLM_p last">Peptide <b>32</b> was synthesized on a Sieber-amide-PS resin (100 mg, 0.59 mmol/g) according to the general procedure. Purification by preparative HPLC (system 1, gradient: 0–30 min MeCN/0.1% aq TFA 8:92 to 45:58, <i>t</i><sub>R</sub> = 9 min) yielded <b>32</b> as a white solid (26.1 mg, 45%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 0.84 (d, 3H, <i>J</i> 6.4 Hz), 0.88 (d, 3H, <i>J</i> 6.3 Hz), 1.36–1.51 (m, 8H), 1.60–1.74 (m, 3H), 2.66–2.71 (m, 1H), 2.82–2.88 (m, 1H), 3.02–3.08 (m, 2H), 3.09–3.15 (m, 2H), 3.81–3.86 (m, 1H), 4.20–4.25 (m, 1H), 4.31–4.37 (m, 1H), 4.45–4.51 (m, 1H), 6.63–6.67 (m, 2H), 6.90–7.60 (br s, 8H, interfering with the next three listed signals), 7.02–7.04 (m, 2H), 7.08 (s, 1H), 7.54 (s, 1H), 7.70 (t, 1H, <i>J</i> 10.8 Hz),7.84–7.87 (m, 1H), 7.88–7.92 (t, 1H, <i>J</i> 11.8 Hz), 8.14–8.19 (m, 3H), 8.46 (d, 1H, <i>J</i> 8.5 Hz), 8.71 (d, 1H, <i>J</i> 8.6 Hz), 9.26 (br s, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 21.2, 23.1, 24.1, 24.2, 25.1, 28.5, 28.9, 36.9, 40.0, 40.5, 41.1, 50.9, 51.8, 52.5, 53.8, 114.8 (two carbon signals), 127.5, 130.1 (two carbon signals), 155.8, 156.8, 156.9, 168.1, 170.7, 171.6, 172.7. HRMS (ESI) <i>m</i>/<i>z</i>: [M + 2H]<sup>2+</sup> calcd for [C<sub>27</sub>H<sub>49</sub>N<sub>11</sub>O<sub>5</sub>]<sup>2+</sup>, 303.6954; found, 303.6962. Anal. RP-HPLC (220 nm): 98% (<i>t</i><sub>R</sub> = 8.5 min, <i>k</i> = 1.6). C<sub>27</sub>H<sub>47</sub>N<sub>11</sub>O<sub>5</sub>·C<sub>6</sub>H<sub>3</sub>F<sub>9</sub>O<sub>6</sub> (605.75 + 342.07).</div></div><div id="sec4_5_23" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43"> Arg-Leu-<span class="smallcaps smallerCapital">d</span>-Arg-Tyr-Amide Tris(hydrotrifluoroacetate) (<b>33</b>)</h5><div class="NLM_p last">Peptide <b>33</b> was synthesized on a Sieber-amide-PS resin (100 mg, 0.59 mmol/g) according to the general procedure. Purification by preparative HPLC (system 1, gradient: 0–30 min MeCN/0.1% aq TFA 8:92 to 45:58, <i>t</i><sub>R</sub> = 9 min) yielded <b>32</b> as a white solid (8.4 mg, 14%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 0.85–0.89 (m, 6H), 1.14–1.21 (m, 1H), 1.21–1.29 (m, 1H), 1.29–1.37 (m, 1H), 1.38–1.54 (m, 5H), 1.55–1.63 (m, 1H), 1.63–1.71 (m, 2H), 2.61–2.67 (m, 1H), 2.91–2.95 (m, 1H), 2.96–3.03 (m, 2H), 3.05–3.12 (m, 2H), 3.77–3.84 (m, 1H), 4.22–4.27 (m, 1H), 4.32–4.37 (m, 1H), 4.41–4.46 (m, 1H), 6.62–6.66 (m, 2H), 6.80–7.60 (br s, 8H, interfering with the next three listed signals), 6.99–7.02 (m, 2H), 7.09–7.13 (m, 1H), 7.45–7.48 (m, 1H), 7.62 (t, 1H, <i>J</i> 11.4 Hz), 7.69 (t, 1H, <i>J</i> 11.5 Hz), 8.13–8.20 (m, 4H), 8.36 (d, 1H, <i>J</i> 7.8 Hz), 8.51 (d, 1H, <i>J</i> 7.9 Hz), 9.20 (s, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 22.1, 23.4, 24.5, 24.6, 25.2, 28.8, 29.6, 37.4, 40.4, 40.5, 41.6, 51.6, 52.2, 52.5, 54.6, 115.3 (two carbon signals), 128.4, 130.6 (two carbon signals), 156.3, 157.2, 157.3, 168.6, 171.3, 172.0, 173.8. HRMS (ESI) <i>m</i>/<i>z</i>: [M + 2H]<sup>2+</sup> calcd for [C<sub>27</sub>H<sub>49</sub>N<sub>11</sub>O<sub>5</sub>]<sup>2+</sup>, 303.6954; found, 303.6958. Anal. RP-HPLC (220 nm): 99% (<i>t</i><sub>R</sub> = 7.9 min, <i>k</i> = 1.4). C<sub>27</sub>H<sub>47</sub>N<sub>11</sub>O<sub>5</sub>·C<sub>6</sub>H<sub>3</sub>F<sub>9</sub>O<sub>6</sub> (605.75 + 342.07).</div></div><div id="sec4_5_24" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44"> Arg-Leu-Arg-<span class="smallcaps smallerCapital">d</span>-Tyr-Amide Tris(hydrotrifluoroacetate) (<b>34</b>)</h5><div class="NLM_p last">Peptide <b>34</b> was synthesized on a Sieber-amide-PS resin (100 mg, 0.59 mmol/g) according to the general procedure. Purification by preparative HPLC (system 1, gradient: 0–30 min MeCN/0.1% aq TFA 8:92 to 45:58, <i>t</i><sub>R</sub> = 9 min) yielded <b>34</b> as a white solid (13.7 mg, 22%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 0.87 (d, 6H, <i>J</i> 6.6 Hz), 1.34–1.41 (m, 1H), 1.41–1.46 (m, 2H), 1.49–1.57 (m, 3H), 1.61–1.67 (m, 1H), 1.66–1.72 (m, 2H), 2.58–2.65 (m, 1H), 2.91–2.96 (m, 1H), 3.00 (q, 2H, <i>J</i> 6.8 Hz), 3.06–3.14 (m, 2H), 3.77–3.85 (m, 1H), 4.15 (q, 1H, <i>J</i> 7.2 Hz), 4.29–4.37 (m, 2H), 6.60–6.66 (m, 2H), 6.80–7.50 (br s, 8H, interfering with the next three listed signals), 6.96–7.01 (m, 2H), 7.09–7.12 (m, 1H), 7.36–7.40 (m, 2H), 7.64 (t, 1H, <i>J</i> 5.7 Hz), 7.78 (t, 1H, <i>J</i> 5.9 Hz), 8.05 (d, 1H, <i>J</i> 8.5 Hz), 8.14–8.21 (m, 4H), 8.52 (d, 1H, <i>J</i> 7.5 Hz), 9.22 (s, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 21.4, 23.1, 24.0, 24.1, 24.7, 28.4, 28.7, 36.9, 40.3, 40.7, 43.7, 51.3, 51.7, 52.5, 54.1, 114.9 (two carbon signals), 127.9, 130.1 (two carbon signals), 155.8, 156.8, 156.9, 168.3, 170.9, 171.8, 173.1. HRMS (ESI) <i>m</i>/<i>z</i>: [M + 2H]<sup>2+</sup> calcd for [C<sub>27</sub>H<sub>49</sub>N<sub>11</sub>O<sub>5</sub>]<sup>2+</sup>, 303.6954; found, 303.6959. Anal. RP-HPLC (220 nm): 97% (<i>t</i><sub>R</sub> = 8.6 min, <i>k</i> = 1.6). C<sub>27</sub>H<sub>47</sub>N<sub>11</sub>O<sub>5</sub>·C<sub>6</sub>H<sub>3</sub>F<sub>9</sub>O<sub>6</sub> (605.75 + 342.07).</div></div><div id="sec4_5_25" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45"> <i>N</i><sup>α</sup>-Methyl-Arg-Leu-Arg-Tyr-Amide Tris(hydrotrifluoroacetate) (<b>35</b>)</h5><div class="NLM_p last">Peptide <b>35</b> was synthesized on a Sieber-amide-PS resin (100 mg, 0.59 mmol/g) according to the general procedure. Purification by preparative HPLC (system 1, gradient: 0–30 min MeCN/0.1% aq TFA 8:92 to 45:58, <i>t</i><sub>R</sub> = 9 min) yielded <b>35</b> as a white solid (11.4 mg, 19%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 0.85–0.91 (m, 6H), 1.36–1.55 (m, 7H), 1.57–1.73 (m, 4H), 1.73–1.78 (m, 1H), 2.47 (s, 3H), 2.69–2.75 (m, 1H), 2.82–2.88 (m, 1H), 3.04–3.14 (m, 4H), 3.76 (s, 1H), 4.20 (q, 1H, <i>J</i> 7.7 Hz), 4.34 (q, 1H, <i>J</i> 7.8 Hz), 4.38–4.44 (m, 1H), 6.61–6.65 (m, 2H), 6.80–7.50 (br s, 8H, interfering with the next three listed signals), 6.95–6.98 (m, 2H), 7.05–7.08 (m, 1H), 7.40–7.42 (m, 1H), 7.64 (t, 1H, <i>J</i> 5.7 Hz), 7.71–7.77 (m, 2H), 8.22 (d, 1H, <i>J</i> 7.6 Hz), 8.68–8.77 (m, 1H), 9.19 (s, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 21.1, 23.1, 23.8, 24.2, 25.0, 26.9, 28.9, 31.1, 36.9, 40.0, 40.4, 40.5, 51.2, 52.5, 53.8, 60.0, 114.9 (two carbon signals), 127.4, 130.0 (two carbon signals), 155.8, 156.8, 156.9, 167.0, 170.8, 171.5, 172.7. HRMS (ESI) <i>m</i>/<i>z</i>: [M + 2H]<sup>2+</sup> calcd for [C<sub>28</sub>H<sub>51</sub>N<sub>11</sub>O<sub>5</sub>]<sup>2+</sup>, 310.7037; found, 310.7038. Anal. RP-HPLC (220 nm): 98% (<i>t</i><sub>R</sub> = 10.9 min, <i>k</i> = 2.4). C<sub>28</sub>H<sub>49</sub>N<sub>11</sub>O<sub>5</sub>·C<sub>4</sub>H<sub>2</sub>F<sub>6</sub>O<sub>4</sub> (619.77 + 228.04).</div></div></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> Cell Culture</h3><div class="NLM_p last">Cells were cultured in 75 cm<sup>2</sup> flasks (Sarstedt, Nümbrecht, Germany) in a humidified atmosphere (95% air, 5% CO<sub>2</sub>) at 37 °C. SK-N-MC neuroblastoma cells,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> CHO-hY<sub>4</sub>-G<sub>qi5</sub>-mtAEQ cells,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> HEC-1B-hY<sub>5</sub>R cells,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> HEK293T-ARRB1-hY<sub>4</sub>R cells, and HEK293T-ARRB2-hY<sub>4</sub>R cells<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> were cultured as described previously. CHO-hY<sub>2</sub>R cells (Perkin Elmer, Rodgau, Germany) were cultured in Ham’s F-12 supplemented with 5% fetal calf serum (FCS) and 400 μg/mL of G418 (Fisher Scientific).</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> Buffers and Media Used for Binding and Functional Assays</h3><div class="NLM_p last">Buffer I: a hypotonic sodium-free HEPES buffer (25 mM HEPES, 2.5 mM CaCl<sub>2</sub>, and 1 mM MgCl<sub>2</sub>, pH 7.4) supplemented with 1% BSA (Serva, Heidelberg, Germany) and 0.1 mg/mL of bacitracin (Serva) used for binding experiments at Y<sub>2</sub>R and Y<sub>4</sub>R. Buffer II: an isotonic sodium-containing HEPES buffer (150 mM NaCl, 10 mM HEPES, 25 mM NaHCO<sub>3</sub>, 2.5 mM CaCl<sub>2</sub>, and 5 mM KCl) supplemented with 1% BSA used for binding experiments at Y<sub>1</sub>R and Y<sub>5</sub>R. Buffer III: an isotonic sodium-containing HEPES buffer supplemented with 120 mM NaCl, 25 mM HEPES, 1.5 mM CaCl<sub>2</sub>, 1 mM MgCl<sub>2</sub>, 5 mM KCl, and 10 mM <span class="smallcaps smallerCapital">d</span>-glucose used for the functional Ca<sup>2+</sup>–aequorin Y<sub>4</sub>R assay. L15 medium: phenol red-free Leibovitz’s L-15 medium (140 mM NaCl, 1.3 mM CaCl<sub>2</sub>, 1 mM MgCl<sub>2</sub>, various amino acids, and vitamins, pH 7.4) (Thermo Fischer Scientific, Nidderau, Germany) supplemented with 10 mM HEPES and 5% FCS used for the seeding of cells 1 day prior to the β-arrestin 1 and β-arrestin 2 recruitment assays.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> Radioligand Binding Assays</h3><div id="sec4_8_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> Y<sub>1</sub>R Binding</h4><div class="NLM_p last">Radioligand competition binding experiments at Y<sub>1</sub>R-expressing SK-N-MC neuroblastoma cells were performed in buffer II as described previously using [<sup>3</sup>H]<b>36</b> (<i>K</i><sub>d</sub> = 0.044 nM and <i>c</i> = 0.15 nM) as a radioligand.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> For each compound, three independent experiments were performed in triplicate.</div></div><div id="sec4_8_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> Y<sub>2</sub>R Binding</h4><div class="NLM_p">Competition binding studies at hY<sub>2</sub>R were performed on CHO-hY<sub>2</sub>R cells (purchased from PerkinElmer, product no. ES-352-C, lot no. 460-167-A) at 23 ± 1 °C using [<sup>3</sup>H]propionyl-pNPY (specific activity 37.5 Ci/mmol) as a radioligand. One day prior to the experiment, cells were seeded in tissue culture (TC)-treated white 96-well plates with a clear bottom (Corning, catalog no. 3610) at a density that gave 80–90% confluency on the day of experiment. The culture medium was removed by suction and the cells were washed with buffer I (without BSA and bacitracin) (200 μL) and covered with 160 μL (competition and unspecific binding) and 180 μL (total binding) of buffer I. To determine total binding, a 5 nM solution of [<sup>3</sup>H]propionyl-pNPY (20 μL) in buffer I [prepared in “siliconized” (Sigmacote, Sigma) polypropylene tubes] was added. To determine the displacing effect of a compound of interest and to determine unspecific binding, buffer I (20 μL), containing the compound of interest (10-fold concentrated), or a mixture of BIIE0246 and JNJ31020028 (each 50 μM, final concentration 5 μM) (unspecific binding) was added, followed by addition of a 5 nM solution of [<sup>3</sup>H]propionyl-pNPY (20 μL) in buffer I. During the incubation period of 2 h, the plates were gently shaken. After incubation, the binding buffer was removed by suction, and the cells were washed twice with ice-cold phosphate-buffered saline. To each well, 25 μL of lysis solution (8 M urea, 3 M acetic acid, and 1% Triton-X-100 in water) was added, the plates were shaken for 30 min, and liquid scintillator (Ultima Gold, PerkinElmer) (200 μL) was added to each well. Plates were sealed with a transparent sealing tape (permanent seal for microplates, PerkinElmer, product no. 1450-461) and turned upside down several times to achieve complete mixing. The plates were kept in the dark for 1 h, followed by measurement of radioactivity (ccpm) with a MicroBeta2 plate counter (PerkinElmer). For each compound, three independent experiments were performed in triplicate.</div><div class="NLM_p last">Prior to the competition binding experiments, the <i>K</i><sub>d</sub> value of [<sup>3</sup>H]propionyl-pNPY was determined by saturation binding applying the same conditions (buffer, temperature, incubation time, unspecific binding, etc.) (for saturation isotherms, see Figure S7A, <a href="/doi/suppl/10.1021/acs.jmedchem.0c00426/suppl_file/jm0c00426_si_001.pdf" class="ext-link">Supporting Information</a>). The obtained <i>K</i><sub>d</sub> value amounted to 0.14 ± 0.03 nM [mean value ± standard error of the mean (SEM) from three independent determinations performed in triplicate]. For assay validation, the Y<sub>2</sub>R affinity of the standard Y<sub>2</sub>R ligand BIIE0246 was determined by competition binding with [<sup>3</sup>H]propionyl-pNPY (for radioligand displacement curve, see Figure S7B, <a href="/doi/suppl/10.1021/acs.jmedchem.0c00426/suppl_file/jm0c00426_si_001.pdf" class="ext-link">Supporting Information</a>). The obtained p<i>K</i><sub>i</sub> value amounted to 8.0 ± 0.05 (mean ± SEM from two independent experiments performed in triplicate), being in good agreement with the reported Y<sub>2</sub>R affinities of BIIE0246 (<i>K</i><sub>i</sub>: 2.6 nM<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> and p<i>K</i><sub>i</sub>: 8.0<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a>).</div></div><div id="sec4_8_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> Y<sub>4</sub>R Binding</h4><div class="NLM_p last">Radioligand competition binding experiments at Y<sub>4</sub>R were performed in buffer I as reported previously using CHO-hY<sub>4</sub>R-G<sub>qi5</sub>-mtAEQ cells and [<sup>3</sup>H]<b>37</b> (<i>K</i><sub>d</sub> = 0.67 nM and <i>c</i> = 1 nM) as a radioligand.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Three (<b>8</b>–<b>12</b>, <b>14</b>–<b>16</b>, <b>18</b>–<b>24</b>, <b>26</b>–<b>29</b>, and <b>31</b>–<b>35</b>) or four (<b>13</b>, <b>17</b>, <b>25</b>, and <b>30</b>) independent experiments were performed in triplicate.</div></div><div id="sec4_8_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> Y<sub>5</sub>R Binding</h4><div class="NLM_p last">Radioligand competition binding experiments at Y<sub>5</sub>R were performed as described previously in buffer II at 23 ± 1 °C using HEC-1B-hY<sub>5</sub>R cells and [<sup>3</sup>H]propionyl-pNPY (specific activity: 27.4 Ci/mmol) (<i>K</i><sub>d</sub> = 4.8 nM and <i>c</i> = 4 nM) as a radioligand.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> For each compound, three independent experiments were performed in triplicate. Specific binding data (Y<sub>4</sub>R) were analyzed by a four-parameter logistic fit [log (inhibitor) vs response–variable slope; GraphPad Prism 5.0, GraphPad Software, San Diego, CA) to obtain pIC<sub>50</sub> values. The latter were converted to p<i>K</i><sub>i</sub> values according to the Cheng–Prusoff equation<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> (logarithmic form).</div></div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> β-Arrestin Recruitment Assay</h3><div class="NLM_p last">One day before the experiment, HEK293T-ARRB1-Y<sub>4</sub>R and HEK293T-ARRB2-Y<sub>4</sub>R cells<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> were trypsinized, centrifugated, and resuspended in L15 medium at a density of 1.0 Mio cells/mL (agonist mode) or 1.25 Mio cells/mL (antagonist mode). For seeding of the cells in white, TC-treated, flat-bottom 96-well microtiter plates [VWR (catalog no. 736–0119), Ismaning, Germany], 80 μL (agonist mode) or 70 μL (antagonist mode) of the respective cell suspension were added to each well, and the plates were kept in a humidified atmosphere (95% air and 5% CO<sub>2</sub>) at 37 °C overnight. The microtiter plates were removed from the incubator and kept for 5 min at rt. For agonist mode, <span class="smallcaps smallerCapital">d</span>-luciferin (potassium salt) (10 μL of a 10 mM stock solution) was added to each well, followed by immediate baseline acquisition for 20 min (10 plate reads) using a preheated (37 °C) EnSpire multimode plate reader (PerkinElmer, Rodgau, Germany) (settings: 1 s per well measurement time, by rows bidirectional). Subsequently, the compound of interest (10 μL of a 10-fold concentrated solution in L15 medium) was added [controls: addition of 10 μL of neat L15 medium (0% effect) and 10 μL of a 10 μM hPP solution (100% effect)], and bioluminescence was recorded for 40 min (20 plate reads). For the antagonist mode, <span class="smallcaps smallerCapital">d</span>-luciferin (potassium salt) (10 μL of a 10 mM stock solution) and the compound of interest (10 μL of a 10-fold concentrated solution in L15 medium) were added, followed by baseline acquisition for 20 min. hPP (10 μL of a 100 nM solution in L15 medium) was added [controls: addition of 10 μL of neat L15 medium instead of the antagonist and 10 μL of a 100 nM hPP solution (100% effect) or another 10 μL of neat L15 medium (0% effect)] immediately, followed by data acquisition (20 entire plate reads). For each compound, three independent experiments were performed in triplicate. Relative luminescences [100% = 1 μM hPP (agonist mode) or 10 nM hPP (antagonist mode), 0% = neat buffer] were plotted against log(concentration of agonist or antagonist) and analyzed by four-parameter logistic fits (GraphPad Prism 5.0) to obtain pEC<sub>50</sub> (agonists) or pIC<sub>50</sub> values. The latter were converted to p<i>K</i><sub>b</sub> values according to the Cheng–Prusoff equation<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> (logarithmic form) using the pEC<sub>50</sub> values of hPP determined in the absence of antagonist [pEC<sub>50</sub> (β-arrestin 1) = 8.66 and pEC<sub>50</sub> (β-arrestin 2) = 8.37]. Efficacies α (maximum effect relative to 1 μM hPP) of (partial) agonists were calculated from the upper plateaus of the CECs. In the case of rightward shifted concentration–response curves in the presence of <b>13</b> (fixed concentration: 10 μM), the pEC<sub>50</sub> shift of hPP was used to estimate the antagonist p<i>K</i><sub>b</sub> according to the Gaddum equation<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> (β-arrestin 1 assay).</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> Ca<sup>2+</sup>–Aequorin Assay</h3><div class="NLM_p last">CHO-hY<sub>4</sub>-G<sub>qi5</sub>-mtAEQ cells<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> were grown to 80–90% confluency, trypsinized, and centrifuged at 1200 rpm for 5 min. The supernatant was removed, cells were resuspended in phenol red-free Dulbecco’s modified Eagle’s medium supplemented with 1% FCS, and adjusted to a density of 10 Mio cells/mL. Coelenterazine h (1 mM stock solution in MeOH) was added (final concentration: 2 μM), and the cell suspension was incubated at rt for 2 h in the dark, followed by dilution with buffer III, to reach a density of 0.5 Mio cells/mL, and incubated under gentle stirring at rt for 3 h in the dark. White 96-well plates (Lumitrac 200, Greiner Bio-One, Frickenhausen, Germany) were prefilled with 18 μL of a solution of the compound of interest (10-fold concentrated compared to the final concentration) in buffer III supplemented with 1% BSA and 100 μg/mL of bacitracin [controls: 18 μL of a solution of hPP (10 μM, resulting in a final concentration of 1 μM) in buffer III supplemented with 1% BSA and 100 μg/mL of bacitracin (maximum effect) and 18 μL of “neat” buffer III supplemented with 1% BSA and 100 μg/mL of bacitracin (0% control)]. Measurements were performed with a GENios Pro plate reader (Tecan, Salzburg, Austria). The cell suspension (162 μL) was injected into each well of the plate, and the emitted luminescence was recorded for 43 s in kinetic mode (peak 1), followed by injection of 1% Triton-X-100 in buffer III (20 μL) (cell lysis to release the remaining aequorin) and recording of the signal for 22 s (peak 2). For the antagonist mode, the compound of interest (2 μL of a 100-fold concentrated solution in buffer III supplemented with 1% BSA and 100 μg/mL of bacitracin) was added to the empty wells of a white 96-well plate, followed by the addition of 178 μL of the cell suspension [controls: 2 μL of “neat” buffer III supplemented with 1% BSA and 100 μg/mL of bacitracin instead of antagonist (reference effect in the absence of antagonist) and 22 μL of “neat” buffer III supplemented with 1% BSA and 100 μg/mL of bacitracin (no addition of hPP, 0% control)]. After a preincubation period of 15 min, the measurement was started by injecting 20 μL of a 1 μM solution of hPP (final concentration: 100 nM) in buffer III supplemented with 1% BSA and 100 μg/mL of bacitracin, and signals were recorded as in the agonist mode (Triton X-100 added after 43 s). For each compound, three independent experiments were performed in triplicate. Areas under the curve were calculated using GraphPad Prism 5.0 (GraphPad software). Fractional luminescences [calculated by dividing the area of peak 1 by the total area (peaks 1 and 2)] were normalized (100% = fractional luminescence obtained from 1 μM hPP, 0% = basal effect in the absence of agonist and antagonist; GraphPad Prism 5.0), and relative responses were plotted against log(concentration of agonist) or log(concentration of antagonist), followed by fitting according to a four-parameter logistic equation [log(agonist) vs response–variable slope or log(inhibitor) vs response–variable slope; GraphPad Prism 5.0] to obtain pEC<sub>50</sub> and pIC<sub>50</sub> values, respectively. The latter were converted to p<i>K</i><sub>b</sub> values according to the Cheng–Prusoff equation<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> (logarithmic form) using the pEC<sub>50</sub> value of hPP determined in the absence of antagonist (pEC<sub>50</sub> = 7.96). Efficacies α (maximum effect relative to 1 μM hPP) of (partial) agonists were calculated from the upper plateaus of the CECs. In the case of rightward-shifted CECs in the presence of <b>13</b> (fixed concentration: 10 μM), the pEC<sub>50</sub> shift of hPP was used to estimate the antagonist p<i>K</i><sub>b</sub> according to the Gaddum equation.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> Induced-Fit Docking at Y<sub>4</sub>R</h3><div class="NLM_p">Two homology models of hY<sub>4</sub>R were prepared based on the inactive state hY<sub>1</sub>R (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5ZBQ">5ZBQ</a>)<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and the active state κ opioid receptor (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6B73">6B73</a>, chain A)<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> crystal structures using Modeller<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> within the UCSF Chimera package version 1.13 (Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco, CA).<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> The receptor models contained disulfide bridges between Cys114<sup>3.25</sup> and Cys201<sup>ECL2</sup> and between the N-terminal Cys<sup>34</sup> and Cys298<sup>7.29</sup> in TM7. Coordinates other than ligand and receptor molecules were removed. The Y<sub>4</sub>R models were further refined using the protein preparation wizard (Schrödinger LLC, Portland, OR, USA). The N- and C-termini were capped by the introduction of acetyl and methylamide groups, respectively, and amino acid side chains containing hydrogen bond donors and acceptors were optimized for hydrogen bonding. Histidine residues were simulated in the uncharged form as the N<sup>ε</sup>–H tautomer. Residues other than histidine were simulated in their dominant protonation state at pH 7. Ligand (<b>1</b>, <b>13</b>, and <b>29</b>) geometries were energetically optimized using the LigPrep module (Schrödinger LLC). Guanidine groups and primary amine groups in <b>1</b>, <b>13</b>, and <b>29</b> were protonated, resulting in net charges of +3, +4, and +3, respectively.</div><div class="NLM_p last">Induced-fit docking of <b>1</b> and <b>29</b> to the active state Y<sub>4</sub>R model and of <b>13</b> to the inactive state Y<sub>4</sub>R model was performed using the induced-fit docking module (Schrödinger LLC). Initially, ligands were docked within a box of 46 × 46 × 46 Å<sup>3</sup> around the crystallographic binding poses of the cocrystallized ligands using the standard protocol. Redocking was performed in the extended precision mode. From the obtained induced-fit docking results of each Y<sub>4</sub>R model/ligand combination, the pose (ligand–receptor complex) corresponding to the lowest XP GlideScore (reflecting the lowest free energy of binding) was selected for analysis. Figures showing molecular structures of Y<sub>4</sub>R in complex with <b>1</b>, <b>13</b>, or <b>29</b> were generated with PyMOL molecular graphics system, version 2.3.0 (Schrödinger LLC). Apparent molecular interactions (H-bonds, salt bridges, π–π, and π-cation) between the ligands and Y<sub>4</sub>R were determined with the Maestro interface (Schrödinger LLC).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i56"><a href="/doi/suppl/10.1021/acs.jmedchem.0c00426" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82241" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82241" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c00426?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00426</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Figures S1−S6, [<sup>3</sup>H]propionyl-pNPY: Y<sub>2</sub>R saturation binding curves and competition binding with BIIE0246 (Figure S7), RP-HPLC chromatograms of compounds <b>8</b>–<b>35</b>, <sup>1</sup>H NMR spectra of compounds <b>8</b>–<b>35</b>, and <sup>13</sup>C NMR spectra of compounds <b>8</b>–<b>11</b>, <b>13</b>–<b>20</b>, <b>22</b>–<b>25</b>, <b>27</b>–<b>29</b>, and <b>31</b>–<b>35</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00426/suppl_file/jm0c00426_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and Y<sub>4</sub>R receptor binding data (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00426/suppl_file/jm0c00426_si_002.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Coordinates of the homology models of hY<sub>4</sub>R, which were prepared based on the reported crystal structure of the active state κ-opioid receptor (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6B73">6B73</a>)<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00426/suppl_file/jm0c00426_si_003.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Coordinates of the homology models of hY<sub>4</sub>R, which were prepared based on the reported crystal structure of the inactive state hY<sub>1</sub>R (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5ZBQ">5ZBQ</a><a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a>) (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00426/suppl_file/jm0c00426_si_004.pdb" class="ext-link">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00426/suppl_file/jm0c00426_si_001.pdf">jm0c00426_si_001.pdf (7.1 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00426/suppl_file/jm0c00426_si_002.csv">jm0c00426_si_002.csv (4.19 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00426/suppl_file/jm0c00426_si_003.pdb">jm0c00426_si_003.pdb (192.28 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00426/suppl_file/jm0c00426_si_004.pdb">jm0c00426_si_004.pdb (207.21 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c00426" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62588" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62588" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Max Keller</span> - <span class="hlFld-Affiliation affiliation">Institute of Pharmacy, Faculty of Chemistry
and Pharmacy, University of Regensburg, Universitätsstr. 31, D-93053 Regensburg, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8095-8627" title="Orcid link">http://orcid.org/0000-0002-8095-8627</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#1b767a6335707e77777e695b6e69357f7e"><span class="__cf_email__" data-cfemail="e28f839acc89878e8e8790a29790cc8687">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Adam Konieczny</span> - <span class="hlFld-Affiliation affiliation">Institute of Pharmacy, Faculty of Chemistry
and Pharmacy, University of Regensburg, Universitätsstr. 31, D-93053 Regensburg, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Diana Braun</span> - <span class="hlFld-Affiliation affiliation">Institute of Pharmacy, Faculty of Chemistry
and Pharmacy, University of Regensburg, Universitätsstr. 31, D-93053 Regensburg, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Wifling</span> - <span class="hlFld-Affiliation affiliation">Institute of Pharmacy, Faculty of Chemistry
and Pharmacy, University of Regensburg, Universitätsstr. 31, D-93053 Regensburg, Germany</span>; 
    <span>Present Address:
                        Leibniz Supercomputing Centre of the Bavarian Academy of Sciences and Humanities, Boltzmannstraße 1, 85748 Garching, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Günther Bernhardt</span> - <span class="hlFld-Affiliation affiliation">Institute of Pharmacy, Faculty of Chemistry
and Pharmacy, University of Regensburg, Universitätsstr. 31, D-93053 Regensburg, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6491-9874" title="Orcid link">http://orcid.org/0000-0001-6491-9874</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>A.K. and D.B. synthesized the peptides and characterized them analytically and pharmacologically. D.W. performed induced-fit docking studies. M.K. initiated and planned the project. M.K. and G.B. supervised the research. A.K., M.K., D.W., and G.B. wrote the manuscript. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i59">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70127" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70127" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Dita Fritsch, Brigitte Wenzel, Susanne Bollwein, Maria Beer-Krön, and Lydia Schneider for excellent technical assistance and Johannes Konrad and Simon Gross for supporting computational chemistry studies. This work was funded by Deutsche Forschungsgemeinschaft (Graduate Training Program GRK 1910).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">br s</td><td class="NLM_def"><p class="first last">broad singlet</p></td></tr><tr><td class="NLM_term">Cit</td><td class="NLM_def"><p class="first last">citrulline</p></td></tr><tr><td class="NLM_term">CHO</td><td class="NLM_def"><p class="first last">Chinese hamster ovary</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">FCS</td><td class="NLM_def"><p class="first last">fetal calf serum</p></td></tr><tr><td class="NLM_term">Fmoc-aa</td><td class="NLM_def"><p class="first last"><i>N</i><sup>α</sup>-Fmoc-protected and side-chain-protected (if required) amino acid including <i>N</i>-Fmoc-4-aminobutyric acid</p></td></tr><tr><td class="NLM_term">HBTU</td><td class="NLM_def"><p class="first last">3-[bis(dimethylamino)methyliumyl]-3<i>H</i>-benzotriazol-1-oxide hexafluorophosphate</p></td></tr><tr><td class="NLM_term">HEC</td><td class="NLM_def"><p class="first last">human endometrial cancer</p></td></tr><tr><td class="NLM_term">HEPES</td><td class="NLM_def"><p class="first last">4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last">hydroxybenzotriazole</p></td></tr><tr><td class="NLM_term">hPP</td><td class="NLM_def"><p class="first last">human pancreatic polypeptide</p></td></tr><tr><td class="NLM_term"><i>k</i></td><td class="NLM_def"><p class="first last">retention (or capacity) factor (HPLC)</p></td></tr><tr><td class="NLM_term">MeCN</td><td class="NLM_def"><p class="first last">acetonitrile</p></td></tr><tr><td class="NLM_term">MeOH</td><td class="NLM_def"><p class="first last">methanol</p></td></tr><tr><td class="NLM_term">Pbf</td><td class="NLM_def"><p class="first last">2,2,4,6,7-pentamethyl-dihydrobenzofuran-5-sulfonyl</p></td></tr><tr><td class="NLM_term">PBS</td><td class="NLM_def"><p class="first last">phosphate-buffered saline</p></td></tr><tr><td class="NLM_term">p<i>K</i><sub>b</sub></td><td class="NLM_def"><p class="first last">negative logarithm of the dissociation constant <i>K</i><sub>b</sub> obtained from functional assays</p></td></tr><tr><td class="NLM_term">p<i>K</i><sub>i</sub></td><td class="NLM_def"><p class="first last">negative logarithm of the dissociation constant <i>K</i><sub>i</sub> (in M) obtained from a competition binding experiment</p></td></tr><tr><td class="NLM_term">pNPY</td><td class="NLM_def"><p class="first last">porcine neuropeptide Y</p></td></tr><tr><td class="NLM_term">PS</td><td class="NLM_def"><p class="first last">polystyrene</p></td></tr><tr><td class="NLM_term">PYY</td><td class="NLM_def"><p class="first last">peptide YY</p></td></tr><tr><td class="NLM_term">RP</td><td class="NLM_def"><p class="first last">reversed phase</p></td></tr><tr><td class="NLM_term">SEM</td><td class="NLM_def"><p class="first last">standard error of the mean</p></td></tr><tr><td class="NLM_term">SPPS</td><td class="NLM_def"><p class="first last">solid-phase peptide synthesis</p></td></tr><tr><td class="NLM_term"><i>t</i><sub>R</sub></td><td class="NLM_def"><p class="first last">retention time</p></td></tr><tr><td class="NLM_term">Y<sub>1,2,4,5</sub>R</td><td class="NLM_def"><p class="first last">NPY Y<sub>1,2,4,5</sub> receptor</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i61">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55762" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55762" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 35 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramaniam, A.</span></span> <span> </span><span class="NLM_article-title">Neuropeptide Y family of hormones: receptor subtypes and antagonists</span>. <i>Peptides</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">445</span>– <span class="NLM_lpage">457</span>, <span class="refDoi"> DOI: 10.1016/s0196-9781(96)00347-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1016%2FS0196-9781%2896%2900347-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=9145434" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADyaK2sXivFCrsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1997&pages=445-457&author=A.+Balasubramaniam&title=Neuropeptide+Y+family+of+hormones%3A+receptor+subtypes+and+antagonists&doi=10.1016%2Fs0196-9781%2896%2900347-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Neuropeptide Y family of hormones: receptor subtypes and antagonists</span></div><div class="casAuthors">Balasubramaniam, Ambikaipakan</div><div class="citationInfo"><span class="NLM_cas:title">Peptides (Tarrytown, New York)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">445-457</span>CODEN:
                <span class="NLM_cas:coden">PPTDD5</span>;
        ISSN:<span class="NLM_cas:issn">0196-9781</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review, with 158 refs.  Neuropeptide Y (NPY) is the most abundant peptide present in the mammalian central and peripheral nervous system.  NPY exhibits a variety of potent central and peripheral effects including those on feeding, memory, blood pressure, cardiac contractility and intestinal secretions.  Classical pharmacol. studies have shown that NPY effects are mediated by four different receptor subtypes, Y-1, Y-1-like, Y-2, and Y-3.  However, the existence of numerous atypical activities provide strong evidence for the occurrence of addnl. NPY receptor subtypes.  Pharmacol. studies have further been facilitated by the recent cloning and expression of Y-1, Y-2, Y-4 (PP-1) and Y-5 receptors.  Moreover, the cloned Y-5 receptor has been suggested to be the long awaited Y-1-like receptor involved in feeding.  Structure-activity studies have laid a good foundation towards the development of receptor selective compds., and to date potent Y-1 selective peptide and nonpeptide antagonists have been developed.  The need to clone numerous receptor subtypes and to develop receptor selective compds. for physiol. and perhaps clin. use is expected to keep NPY research active for many years to come.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqgwtwgwhq97Vg90H21EOLACvtfcHk0lihZbeSLM1dmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXivFCrsbo%253D&md5=28c9951c2704cb3aef8af788ab548b6b</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0196-9781%2896%2900347-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0196-9781%252896%252900347-6%26sid%3Dliteratum%253Aachs%26aulast%3DBalasubramaniam%26aufirst%3DA.%26atitle%3DNeuropeptide%2520Y%2520family%2520of%2520hormones%253A%2520receptor%2520subtypes%2520and%2520antagonists%26jtitle%3DPeptides%26date%3D1997%26volume%3D18%26spage%3D445%26epage%3D457%26doi%3D10.1016%2Fs0196-9781%2896%2900347-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cabrele, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck-Sickinger, A. G.</span></span> <span> </span><span class="NLM_article-title">Molecular characterization of the ligand-receptor interaction of the neuropeptide Y family</span>. <i>J. Pept. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">97</span>– <span class="NLM_lpage">122</span>, <span class="refDoi"> DOI: 10.1002/(sici)1099-1387(200003)6:3<97::aid-psc236>3.0.co;2-e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1002%2F%28SICI%291099-1387%28200003%296%3A3%3C97%3A%3AAID-PSC236%3E3.0.CO%3B2-E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10759209" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BD3cXitlGitrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=97-122&author=C.+Cabreleauthor=A.+G.+Beck-Sickinger&title=Molecular+characterization+of+the+ligand-receptor+interaction+of+the+neuropeptide+Y+family&doi=10.1002%2F%28sici%291099-1387%28200003%296%3A3%3C97%3A%3Aaid-psc236%3E3.0.co%3B2-e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular characterization of the ligand-receptor interaction of the neuropeptide Y family</span></div><div class="casAuthors">Cabrele, Chiara; Beck-Sickinger, Annette G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Peptide Science</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">97-122</span>CODEN:
                <span class="NLM_cas:coden">JPSIEI</span>;
        ISSN:<span class="NLM_cas:issn">1075-2617</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review with 105 refs.  Neuropeptide Y (NPY), peptide YY (PYY) and pancreatic polypeptide (PP) belong to the NPY hormone family and activate a class of receptors called the Y-receptors, and also belong to the large superfamily of the G-protein coupled receptors.  Structure-affinity and structure-activity relationship studies of peptide analogs, combined with studies based on site-directed mutagenesis and anti-receptor antibodies, have given insight into the individual characterization of each receptor subtype relative to its interaction with the ligand, as well as to its biol. function.  A no. of selective antagonists at the Y1-receptor are available whose structures resemble that of the C-terminus of NPY.  Some of these compds., like BIBP3226, BIBO3304 and GW1229, have recently been used for in vivo investigations of the NPY-induced increase in food intake.  Y2-receptor selective agonists are the analog cyclo-(28/32)-Ac[Lys28-Glu32]-(25-36)-pNPY and the TASP mol. contg. two units of the NPY segment 21-36.  Now the first antagonist with nanomolar affinity for the Y2-receptor is also known, BIIE0246.  So far, the native peptide PP has been shown to be the most potent ligand at the Y4-receptor.  However, by the design of PP/NPY chimera, some analogs have been found that bind not only to the Y4-, but also to the Y5-receptor with subnanomolar affinities, and are as potent as NPY at the Y1-receptor.  For the characterization of the Y5-receptor in vitro and in vivo, a new class of highly selective agonists is now available.  This consists of analogs of NPY and of PP/NPY chimera which all contain the motif Ala31-Aib32.  This motif has been shown to induce a 310-helical turn in the region 28-31 of NPY and is suggested to be the key motif for high Y5-receptor selectivity.  The results of feeding expts. in rats treated with the first highly specific Y5-receptor agonists support the hypothesis that this receptor plays a role in the NPY-induced stimulation of food intake.  In conclusion, the selective compds. for the different Y-receptor subtypes known so far are promising tools for a better understanding of the physiol. properties of the hormones of the NPY family and related receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTTPSBO6cl_rVg90H21EOLACvtfcHk0lh8byKoK-VNKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXitlGitrs%253D&md5=4a0fbcaeb80999b6f6a8f0575c78f1f3</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291099-1387%28200003%296%3A3%3C97%3A%3AAID-PSC236%3E3.0.CO%3B2-E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291099-1387%2528200003%25296%253A3%253C97%253A%253AAID-PSC236%253E3.0.CO%253B2-E%26sid%3Dliteratum%253Aachs%26aulast%3DCabrele%26aufirst%3DC.%26aulast%3DBeck-Sickinger%26aufirst%3DA.%2BG.%26atitle%3DMolecular%2520characterization%2520of%2520the%2520ligand-receptor%2520interaction%2520of%2520the%2520neuropeptide%2520Y%2520family%26jtitle%3DJ.%2520Pept.%2520Sci.%26date%3D2000%26volume%3D6%26spage%3D97%26epage%3D122%26doi%3D10.1002%2F%28sici%291099-1387%28200003%296%3A3%3C97%3A%3Aaid-psc236%3E3.0.co%3B2-e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cerdá-Reverter, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larhammar, D.</span></span> <span> </span><span class="NLM_article-title">cNeuropeptide Y family of peptides: Structure, anatomical expression, function, and molecular evolution</span>. <i>Biochem. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">371</span>– <span class="NLM_lpage">392</span>, <span class="refDoi"> DOI: 10.1139/o00-004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1139%2Fo00-004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10949087" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BD3cXltlKntbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2000&pages=371-392&author=J.+M.+Cerd%C3%A1-Reverterauthor=D.+Larhammar&title=cNeuropeptide+Y+family+of+peptides%3A+Structure%2C+anatomical+expression%2C+function%2C+and+molecular+evolution&doi=10.1139%2Fo00-004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Neuropeptide Y family of peptides: structure, anatomical expression, function, and molecular evolution</span></div><div class="casAuthors">Cerda-Reverter, Jose Miguel; Larhammar, Dan</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry and Cell Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">371-392</span>CODEN:
                <span class="NLM_cas:coden">BCBIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0829-8211</span>.
    
            (<span class="NLM_cas:orgname">National Research Council of Canada</span>)
        </div><div class="casAbstract">A review with ∼195 refs.  Evolutionary relationships between neuroendocrine peptides are often difficult to resolve across divergent phyla due to independent duplication events in different lineages.  Thanks to peptide purifn. and mol. cloning in many different species, the situation is beginning to clear for the neuropeptide Y (NPY) family, which also includes peptide YY (PYY), the tetrapod pancreatic polypeptide (PP) and the fish pancreatic peptide Y (PY).  It has long been assumed that the first duplication to occur in vertebrate evolution generated NPY and PYY, as both of these are found in all gnathostomes as well as lamprey.  Evidence from other gene families show that this duplication was probably a chromosome duplication event.  The origin of a second PYY peptide found in lamprey remains to be explained.  The authors' recent cloning of NPY, PYY and PY in the sea bass proves that fish PY is a sep. gene product.  The authors favor the hypothesis that PY is a duplicate of the PYY gene and that it may have occurred late in fish evolution, as PY has so far only been found in acanthomorph fishes.  Thus, this duplication seems to be independent of the one that generate PP from PYY in tetrapods, although both tetrapod PP and fish PY are expressed in the pancreas.  Studies in the sea bass and other fish show that PY, in contrast to PP, is expressed in the nervous system.  The authors review the literature on the distribution and functional aspects of the various NPY-family peptides in vertebrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDB2kgzc6rSLVg90H21EOLACvtfcHk0lh8byKoK-VNKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXltlKntbw%253D&md5=170569e4b124d78cca3ed3f83cc2337f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1139%2Fo00-004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1139%252Fo00-004%26sid%3Dliteratum%253Aachs%26aulast%3DCerd%25C3%25A1-Reverter%26aufirst%3DJ.%2BM.%26aulast%3DLarhammar%26aufirst%3DD.%26atitle%3DcNeuropeptide%2520Y%2520family%2520of%2520peptides%253A%2520Structure%252C%2520anatomical%2520expression%252C%2520function%252C%2520and%2520molecular%2520evolution%26jtitle%3DBiochem.%2520Cell%2520Biol.%26date%3D2000%26volume%3D78%26spage%3D371%26epage%3D392%26doi%3D10.1139%2Fo00-004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bijker, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herzog, H.</span></span> <span> </span><span class="NLM_article-title">The neuropeptide Y system: pathophysiological and therapeutic implications in obesity and cancer</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">91</span>– <span class="NLM_lpage">113</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2011.03.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1016%2Fj.pharmthera.2011.03.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=21439311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsVyltbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2011&pages=91-113&author=L.+Zhangauthor=M.+S.+Bijkerauthor=H.+Herzog&title=The+neuropeptide+Y+system%3A+pathophysiological+and+therapeutic+implications+in+obesity+and+cancer&doi=10.1016%2Fj.pharmthera.2011.03.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The neuropeptide Y system: Pathophysiological and therapeutic implications in obesity and cancer</span></div><div class="casAuthors">Zhang, Lei; Bijker, Martijn S.; Herzog, Herbert</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-113</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The neuropeptide Y (NPY) system - comprising of neuropeptide Y, peptide YY, pancreatic polypeptide and the corresponding Y receptors through which they act (Y1, Y2, Y4, Y5 and y6) - is well known for its role in the regulation of energy homeostasis and assocd. processes.  Dysfunctions of the system have been implicated in human diseases such as obesity and cancer, raising the possibility that correction of the system may provide therapeutic benefits for these diseases.  In addn. to the regulation of appetite and satiety that has attracted most attention during the past years, insight has also been gained into the crit. role of NPY in the control of energy expenditure, oxidative fuel selection and bone metab.  Studies using conditional knockout models further shed light on the central vs. peripheral, and hypothalamic vs. extra-hypothalamic mechanisms of these regulatory effects of NPY.  Moreover, a role of NPY family peptides and Y receptors in modulating the growth of tumors has emerged.  These findings provide the basis for novel NPY system-targeted strategies to treat obesity as well as cancer.  Such strategies include modifying both sides of the energy balance equation - energy intake vs. energy expenditure - to achieve a greater wt./fat loss by particularly modulating peripheral Y receptor(s) to ameliorate metabolic conditions without interfering with central functions of Y receptors.  In addn., targeting multiple Y receptors and/or multiple systems involved in the regulation of energy balance will have greater beneficial effects.  However, long-term interference with the NPY system to target obesity or cancer related aspects needs to consider potential side effects on bone health.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnPMeJgSGUdLVg90H21EOLACvtfcHk0lh8byKoK-VNKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsVyltbY%253D&md5=9817e55c615e9d6084fe17b71ff85d7d</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2011.03.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2011.03.011%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DBijker%26aufirst%3DM.%2BS.%26aulast%3DHerzog%26aufirst%3DH.%26atitle%3DThe%2520neuropeptide%2520Y%2520system%253A%2520pathophysiological%2520and%2520therapeutic%2520implications%2520in%2520obesity%2520and%2520cancer%26jtitle%3DPharmacol.%2520Ther.%26date%3D2011%26volume%3D131%26spage%3D91%26epage%3D113%26doi%3D10.1016%2Fj.pharmthera.2011.03.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lundell, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blomqvist, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berglund, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schober, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Statnick, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gadski, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gehlert, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larhammar, D.</span></span> <span> </span><span class="NLM_article-title">Cloning of a human receptor of the NPY receptor family with high affinity for pancreatic polypeptide and peptide YY</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>270</i></span>,  <span class="NLM_fpage">29123</span>– <span class="NLM_lpage">29128</span>, <span class="refDoi"> DOI: 10.1074/jbc.270.49.29123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1074%2Fjbc.270.49.29123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=7493937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADyaK2MXpvVOhur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=29123-29128&author=I.+Lundellauthor=A.+G.+Blomqvistauthor=M.+M.+Berglundauthor=D.+A.+Schoberauthor=D.+Johnsonauthor=M.+A.+Statnickauthor=R.+A.+Gadskiauthor=D.+R.+Gehlertauthor=D.+Larhammar&title=Cloning+of+a+human+receptor+of+the+NPY+receptor+family+with+high+affinity+for+pancreatic+polypeptide+and+peptide+YY&doi=10.1074%2Fjbc.270.49.29123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning of a human receptor of the NPY receptor family with high affinity for pancreatic polypeptide and peptide YY</span></div><div class="casAuthors">Lundell, Ingrid; Blomqvist, Anders G.; Berglund, Magnus M.; Schober, Douglas A.; Johnson, Dwayne; Statnick, Michael A.; Gadski, Robert A.; Gehlert, Donald R.; Larhammar, Dan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">270</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">29123-8</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Neuropeptide Y (NPY), peptide YY (PYY), and pancreatic polypeptide (PP) are structurally related peptides found in all higher vertebrates.  NPY is expressed exclusively in neurons, whereas PYY and PP are produced primarily in gut endocrine cells.  Several receptor subtypes have been identified pharmacol., but only the NPY/PYY receptor of subtype Y1 has been cloned.  This is a heptahelix receptor that couples to G proteins.  Y1 sequence information from several species was used to clone a novel human receptor with 43% amino acid sequence identity to human Y1 and 53% identity in the transmembrane regions.  The novel receptor displays a pharmacol. profile that distinguishes it from all previously described NPY family receptors.  It binds PP with an affinity (Ki) of 13.8 pM, PYY with 1.44 nM, and NPY with 9.9 nM.  Because these data may identify the receptor as primarily a PP receptor, it was named PP1.  In stably transfected Chinese hamster ovary cells the PP1 receptor inhibits forskolin-stimulated cAMP synthesis.  Northern hybridization detected mRNA in colon, small intestine, pancreas, and prostate.  As all 3 peptides are present in the gut through either endocrine release or innervation, all 3 peptides may be physiol. ligands to the novel NPY family receptor PP1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnHHWYcnZBWbVg90H21EOLACvtfcHk0lh8byKoK-VNKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXpvVOhur0%253D&md5=561908b5e42dd89fe52df37f27f3f9d8</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1074%2Fjbc.270.49.29123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.270.49.29123%26sid%3Dliteratum%253Aachs%26aulast%3DLundell%26aufirst%3DI.%26aulast%3DBlomqvist%26aufirst%3DA.%2BG.%26aulast%3DBerglund%26aufirst%3DM.%2BM.%26aulast%3DSchober%26aufirst%3DD.%2BA.%26aulast%3DJohnson%26aufirst%3DD.%26aulast%3DStatnick%26aufirst%3DM.%2BA.%26aulast%3DGadski%26aufirst%3DR.%2BA.%26aulast%3DGehlert%26aufirst%3DD.%2BR.%26aulast%3DLarhammar%26aufirst%3DD.%26atitle%3DCloning%2520of%2520a%2520human%2520receptor%2520of%2520the%2520NPY%2520receptor%2520family%2520with%2520high%2520affinity%2520for%2520pancreatic%2520polypeptide%2520and%2520peptide%2520YY%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1995%26volume%3D270%26spage%3D29123%26epage%3D29128%26doi%3D10.1074%2Fjbc.270.49.29123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thieme, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jolly, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madsen, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellmann-Sickert, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holst, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck-Sickinger, A. G.</span></span> <span> </span><span class="NLM_article-title">High molecular weight PEGylation of human pancreatic polypeptide at position 22 improves stability and reduces food intake in mice</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>173</i></span>,  <span class="NLM_fpage">3208</span>– <span class="NLM_lpage">3221</span>, <span class="refDoi"> DOI: 10.1111/bph.13582</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1111%2Fbph.13582" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=27545829" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlOmurvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2016&pages=3208-3221&author=V.+Thiemeauthor=N.+Jollyauthor=A.+N.+Madsenauthor=K.+Bellmann-Sickertauthor=T.+W.+Schwartzauthor=B.+Holstauthor=H.+M.+Coxauthor=A.+G.+Beck-Sickinger&title=High+molecular+weight+PEGylation+of+human+pancreatic+polypeptide+at+position+22+improves+stability+and+reduces+food+intake+in+mice&doi=10.1111%2Fbph.13582"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">High molecular weight PEGylation of human pancreatic polypeptide at position 22 improves stability and reduces food intake in mice</span></div><div class="casAuthors">Thieme, V.; Jolly, N.; Madsen, A. N.; Bellmann-Sickert, K.; Schwartz, T. W.; Holst, B.; Cox, H. M.; Beck-Sickinger, A. G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">3208-3221</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Human pancreatic polypeptide (hPP) is known to suppress appetite and food intake, thereby representing a potential therapeutic approach against obesity and assocd. metabolic disorders.  The aim of this study was to improve hPP stability by covalent PEGylation with diverse mol. wt. polyethylene glycols (PEG) at two positions using promising lead structures while maintaining target activity.  Modified peptides were synthesized by combined solid- and soln.-phase peptide synthesis.  Their potency was investigated in constitutively expressing human epithelial cells and isolated human colonic mucosa as well as receptor-transfected artificial cell lines.  Human blood plasma and porcine liver homogenates were used to examine the in vitro stability of the analogs.  The most promising variants were injected s.c. in C57BL/6JRj mice to monitor fasting-induced food intake and bioavailability.  In human epithelia and colonic mucosal prepns., activity dependence on the core sequence and latency related to PEG size were obsd.  Peptides modified with a 22 kDa PEG (PEG22) remained intact in blood plasma and homogenized liver exts. for more than 96 h.  Finally, hPP2-36, K22[(PEG22)]hPP2-36 and [K22(PEG22),Q34]hPP significantly reduced cumulative food intake in mice over 16 h after s.c. administration.  Modification with PEG22 at position 22 stabilizes hPP significantly while extending its biol. activities and could be used in drug development prospectively.  This article is protected by copyright.  All rights reserved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZRUEJebIUzLVg90H21EOLACvtfcHk0ljFjBgPjSQO1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlOmurvE&md5=22d740a69e600df695bed4261db53186</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1111%2Fbph.13582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.13582%26sid%3Dliteratum%253Aachs%26aulast%3DThieme%26aufirst%3DV.%26aulast%3DJolly%26aufirst%3DN.%26aulast%3DMadsen%26aufirst%3DA.%2BN.%26aulast%3DBellmann-Sickert%26aufirst%3DK.%26aulast%3DSchwartz%26aufirst%3DT.%2BW.%26aulast%3DHolst%26aufirst%3DB.%26aulast%3DCox%26aufirst%3DH.%2BM.%26aulast%3DBeck-Sickinger%26aufirst%3DA.%2BG.%26atitle%3DHigh%2520molecular%2520weight%2520PEGylation%2520of%2520human%2520pancreatic%2520polypeptide%2520at%2520position%252022%2520improves%2520stability%2520and%2520reduces%2520food%2520intake%2520in%2520mice%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2016%26volume%3D173%26spage%3D3208%26epage%3D3221%26doi%3D10.1111%2Fbph.13582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asakawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaolu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoshiki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ushikai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheriff, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramaniam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inui, A.</span></span> <span> </span><span class="NLM_article-title">Regulatory effects of Y<sub>4</sub> receptor agonist (BVD-74D) on food intake</span>. <i>Peptides</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1706</span>– <span class="NLM_lpage">1710</span>, <span class="refDoi"> DOI: 10.1016/j.peptides.2010.06.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1016%2Fj.peptides.2010.06.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=20600429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVaqurrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=1706-1710&author=J.-B.+Liauthor=A.+Asakawaauthor=M.+Terashiauthor=K.+Chengauthor=H.+Chaoluauthor=T.+Zoshikiauthor=M.+Ushikaiauthor=S.+Sheriffauthor=A.+Balasubramaniamauthor=A.+Inui&title=Regulatory+effects+of+Y4+receptor+agonist+%28BVD-74D%29+on+food+intake&doi=10.1016%2Fj.peptides.2010.06.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Regulatory effects of Y4 receptor agonist (BVD-74D) on food intake</span></div><div class="casAuthors">Li, Jiang-Bo; Asakawa, Akihiro; Terashi, Mutsumi; Cheng, Kai-Chun; Chaolu, Huhe; Zoshiki, Takahiro; Ushikai, Miharu; Sheriff, Sulaiman; Balasubramaniam, Ambikaipakan; Inui, Akio</div><div class="citationInfo"><span class="NLM_cas:title">Peptides (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1706-1710</span>CODEN:
                <span class="NLM_cas:coden">PPTDD5</span>;
        ISSN:<span class="NLM_cas:issn">0196-9781</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The objective of this study was to clarify the role of a novel agonist with high selectivity and affinity for Y4 receptors in the regulation of food intake.  The Y4 receptor agonist BVD-74D was administered to C57BL/6J mice that were fed with a normal or high-fat diet, and to fatty liver Shionogi (FLS)-ob/ob mice; the food intake, water intake, and body wt. gain were measured in these mice.  In the mice fed with a normal diet, the cumulative food intake significantly decreased at 20 min and 1 h after the administration of 1 mg/kg of BVD-74D and at 1, 2, 4, 8, and 24 h after the administration of 10 mg/kg of BVD-74D.  Moreover, the cumulative water intake and body wt. gain significantly decreased in these mice.  Among the mice that were fed with a high-fat diet, the cumulative food intake and water intake significantly decreased 1, 2, and 4 h after BVD-74D (10 mg/kg) administration.  Furthermore, the cumulative food intake significantly decreased 2 and 4 h after BVD-74D (10 mg/kg) administration in the FLS-ob/ob mice.  Thus, we propose that the novel Y4 receptor agonist BVD-74D has suppressive effects on food intake, water intake, and wt. gain in normal mice fed with normal diets and on food intake in normal mice fed with high-fat diets and in FLS-ob/ob mice.  These findings indicate that the Y4 receptor and its agonist would be promising targets for obesity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW_wflLPQ547Vg90H21EOLACvtfcHk0ljFjBgPjSQO1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVaqurrO&md5=f635cff89758abe4c785cb8477e5f347</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.peptides.2010.06.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.peptides.2010.06.011%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.-B.%26aulast%3DAsakawa%26aufirst%3DA.%26aulast%3DTerashi%26aufirst%3DM.%26aulast%3DCheng%26aufirst%3DK.%26aulast%3DChaolu%26aufirst%3DH.%26aulast%3DZoshiki%26aufirst%3DT.%26aulast%3DUshikai%26aufirst%3DM.%26aulast%3DSheriff%26aufirst%3DS.%26aulast%3DBalasubramaniam%26aufirst%3DA.%26aulast%3DInui%26aufirst%3DA.%26atitle%3DRegulatory%2520effects%2520of%2520Y4%2520receptor%2520agonist%2520%2528BVD-74D%2529%2520on%2520food%2520intake%26jtitle%3DPeptides%26date%3D2010%26volume%3D31%26spage%3D1706%26epage%3D1710%26doi%3D10.1016%2Fj.peptides.2010.06.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Painsipp, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wultsch, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edelsbrunner, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tasan, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singewald, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herzog, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holzer, P.</span></span> <span> </span><span class="NLM_article-title">Reduced anxiety-like and depression-related behavior in neuropeptide Y Y<sub>4</sub> receptor knockout mice</span>. <i>Genes, Brain Behav.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">532</span>– <span class="NLM_lpage">542</span>, <span class="refDoi"> DOI: 10.1111/j.1601-183x.2008.00389.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1111%2Fj.1601-183X.2008.00389.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=18221379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A280%3ADC%252BD1cvosl2huw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=532-542&author=E.+Painsippauthor=T.+Wultschauthor=M.+E.+Edelsbrunnerauthor=R.+O.+Tasanauthor=N.+Singewaldauthor=H.+Herzogauthor=P.+Holzer&title=Reduced+anxiety-like+and+depression-related+behavior+in+neuropeptide+Y+Y4+receptor+knockout+mice&doi=10.1111%2Fj.1601-183x.2008.00389.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Reduced anxiety-like and depression-related behavior in neuropeptide Y Y4 receptor knockout mice</span></div><div class="casAuthors">Painsipp E; Wultsch T; Edelsbrunner M E; Tasan R O; Singewald N; Herzog H; Holzer P</div><div class="citationInfo"><span class="NLM_cas:title">Genes, brain, and behavior</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">532-42</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Neuropeptide Y (NPY) acting through Y1 receptors reduces anxiety- and depression-like behavior in rodents, whereas Y2 receptor stimulation has the opposite effect.  This study addressed the implication of Y4 receptors in emotional behavior by comparing female germ line Y4 knockout (Y4-/-) mice with control and germ line Y2-/- animals.  Anxiety- and depression-like behavior was assessed with the open field (OF), elevated plus maze (EPM), stress-induced hyperthermia (SIH) and tail suspension tests (TST), respectively.  Learning and memory were evaluated with the object recognition test (ORT).  In the OF and EPM, both Y4-/- and Y2-/- mice exhibited reduced anxiety-related behavior and enhanced locomotor activity relative to control animals.  Locomotor activity in a familiar environment was unchanged in Y4-/- but reduced in Y2-/- mice.  The basal rectal temperature exhibited diurnal and genotype-related alterations.  Control mice had temperature minima at noon and midnight, whereas Y4-/- and Y2-/- mice displayed only one temperature minimum at noon.  The magnitude of SIH was related to time of the day and genotype in a complex manner.  In the TST, the duration of immobility was significantly shorter in Y4-/- and Y2-/- mice than in controls.  Object memory 6 h after initial exposure to the ORT was impaired in Y2-/- but not in Y4-/- mice, relative to control mice.  These results show that genetic deletion of Y4 receptors, like that of Y2 receptors, reduces anxiety-like and depression-related behavior.  Unlike Y2 receptor knockout, Y4 receptor knockout does not impair object memory.  We propose that Y4 receptors play an important role in the regulation of behavioral homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ5o5Ddy9v0ayXXDYhVZBdlfW6udTcc2ebcmyrsr3oWXLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cvosl2huw%253D%253D&md5=2ac07540935848f0063184fbf299ae6a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1111%2Fj.1601-183X.2008.00389.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1601-183X.2008.00389.x%26sid%3Dliteratum%253Aachs%26aulast%3DPainsipp%26aufirst%3DE.%26aulast%3DWultsch%26aufirst%3DT.%26aulast%3DEdelsbrunner%26aufirst%3DM.%2BE.%26aulast%3DTasan%26aufirst%3DR.%2BO.%26aulast%3DSingewald%26aufirst%3DN.%26aulast%3DHerzog%26aufirst%3DH.%26aulast%3DHolzer%26aufirst%3DP.%26atitle%3DReduced%2520anxiety-like%2520and%2520depression-related%2520behavior%2520in%2520neuropeptide%2520Y%2520Y4%2520receptor%2520knockout%2520mice%26jtitle%3DGenes%252C%2520Brain%2520Behav.%26date%3D2008%26volume%3D7%26spage%3D532%26epage%3D542%26doi%3D10.1111%2Fj.1601-183x.2008.00389.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tasan, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hetzenauer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singewald, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herzog, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperk, G.</span></span> <span> </span><span class="NLM_article-title">Increased novelty-induced motor activity and reduced depression-like behavior in neuropeptide Y (NPY)–Y<sub>4</sub> receptor knockout mice</span>. <i>Neuroscience</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>158</i></span>,  <span class="NLM_fpage">1717</span>– <span class="NLM_lpage">1730</span>, <span class="refDoi"> DOI: 10.1016/j.neuroscience.2008.11.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1016%2Fj.neuroscience.2008.11.048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=19121371" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1Oisrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2009&pages=1717-1730&author=R.+O.+Tasanauthor=S.+Linauthor=A.+Hetzenauerauthor=N.+Singewaldauthor=H.+Herzogauthor=G.+Sperk&title=Increased+novelty-induced+motor+activity+and+reduced+depression-like+behavior+in+neuropeptide+Y+%28NPY%29%E2%80%93Y4+receptor+knockout+mice&doi=10.1016%2Fj.neuroscience.2008.11.048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Increased novelty-induced motor activity and reduced depression-like behavior in neuropeptide Y (NPY)-Y4 receptor knockout mice</span></div><div class="casAuthors">Tasan, R. O.; Lin, S.; Hetzenauer, A.; Singewald, N.; Herzog, H.; Sperk, G.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1717-1730</span>CODEN:
                <span class="NLM_cas:coden">NRSCDN</span>;
        ISSN:<span class="NLM_cas:issn">0306-4522</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">There is growing evidence that neuropeptide Y (NPY) acting through Y1 and Y2 receptors has a prominent role in modulating anxiety- and depression-like behavior in rodents.  However, a role of other Y-receptors like that of Y4 receptors in this process is poorly understood.  We now investigated male Y2, Y4 single and Y2/Y4 double knockout mice in behavioral paradigms for changes in motor activity, anxiety and depression-like behavior.  Motor activity was increased in Y2, Y4 and Y2/Y4 knockout mice under changing and stressful conditions, but not altered in a familiar environment.  Y4 and Y2 knockout mice revealed an anxiolytic phenotype in the light/dark test, marble burying test and in stress-induced hyperthermia, and reduced depression-like behavior in the forced swim and tail suspension tests.  In Y2/Y4 double knockout mice, the response in the light/dark test and in the forced swim test was further enhanced compared with Y4 and Y2 knockout mice, resp.  High levels of Y4 binding sites were obsd. in brain stem nuclei including nucleus of solitary tract and area postrema.  Lower levels were found in the medial amygdala and hypothalamus.  Peripheral administration of pancreatic polypeptide (PP) induced Y4 receptor-dependent c-Fos expression in brain stem, hypothalamus and amygdala.  PP released peripherally from the pancreas in response to food intake, may act not only as a satiety signal but also modulate anxiety-related locomotion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6HTeFUWj6ArVg90H21EOLACvtfcHk0li4BwPf5uFMGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1Oisrs%253D&md5=e197d23e11cdb0fdf46acaf192c67e0f</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2008.11.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2008.11.048%26sid%3Dliteratum%253Aachs%26aulast%3DTasan%26aufirst%3DR.%2BO.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DHetzenauer%26aufirst%3DA.%26aulast%3DSingewald%26aufirst%3DN.%26aulast%3DHerzog%26aufirst%3DH.%26aulast%3DSperk%26aufirst%3DG.%26atitle%3DIncreased%2520novelty-induced%2520motor%2520activity%2520and%2520reduced%2520depression-like%2520behavior%2520in%2520neuropeptide%2520Y%2520%2528NPY%2529%25E2%2580%2593Y4%2520receptor%2520knockout%2520mice%26jtitle%3DNeuroscience%26date%3D2009%26volume%3D158%26spage%3D1717%26epage%3D1730%26doi%3D10.1016%2Fj.neuroscience.2008.11.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pedragosa-Badia, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sliwoski, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong Nguyen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stichel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaufmann, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meiler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck-Sickinger, A. G.</span></span> <span> </span><span class="NLM_article-title">Pancreatic polypeptide is recognized by two hydrophobic domains of the human Y<sub>4</sub> receptor binding pocket</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">5846</span>– <span class="NLM_lpage">5859</span>, <span class="refDoi"> DOI: 10.1074/jbc.m113.502021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1074%2Fjbc.M113.502021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=24375409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjsVKktL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=5846-5859&author=X.+Pedragosa-Badiaauthor=G.+R.+Sliwoskiauthor=E.+Dong+Nguyenauthor=D.+Lindnerauthor=J.+Stichelauthor=K.+W.+Kaufmannauthor=J.+Meilerauthor=A.+G.+Beck-Sickinger&title=Pancreatic+polypeptide+is+recognized+by+two+hydrophobic+domains+of+the+human+Y4+receptor+binding+pocket&doi=10.1074%2Fjbc.m113.502021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Pancreatic Polypeptide Is Recognized by Two Hydrophobic Domains of the Human Y4 Receptor Binding Pocket</span></div><div class="casAuthors">Pedragosa-Badia, Xavier; Sliwoski, Gregory R.; Nguyen, Elizabeth Dong; Lindner, Diana; Stichel, Jan; Kaufmann, Kristian W.; Meiler, Jens; Beck-Sickinger, Annette G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">5846-5859</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Structural characterization of the human Y4 receptor (hY4R) interaction with human pancreatic polypeptide (hPP) is crucial, not only for understanding its biol. function but also for testing treatment strategies for obesity that target this interaction.  Here, the interaction of receptor mutants with pancreatic polypeptide analogs was studied through double-cycle mutagenesis.  To guide mutagenesis and interpret results, a three-dimensional comparative model of the hY4R-hPP complex was constructed based on all available class A G protein-coupled receptor crystal structures and refined using exptl. data.  Our study reveals that residues of the hPP and the hY4R form a complex network consisting of ionic interactions, hydrophobic interactions, and hydrogen binding.  Residues Tyr2.64, Asp2.68, Asn6.55, Asn7.32, and Phe7.35 of Y4R are found to be important in receptor activation by hPP.  Specifically, Tyr2.64 interacts with Tyr27 of hPP through hydrophobic contacts.  Asn7.32 is affected by modifications on position Arg33 of hPP, suggesting a hydrogen bond between these two residues.  Likewise, we find that Phe7.35 is affected by modifications of hPP at positions 33 and 36, indicating interactions between these three amino acids.  Taken together, we demonstrate that the top of transmembrane helix 2 (TM2) and the top of transmembrane helixes 6 and 7 (TM6-TM7) form the core of the peptide binding pocket.  These findings will contribute to the rational design of ligands that bind the receptor more effectively to produce an enhanced agonistic or antagonistic effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkLgd7H3oyYrVg90H21EOLACvtfcHk0li4BwPf5uFMGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjsVKktL4%253D&md5=cf4bf542381418e47815b8b139c8f99b</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.502021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.502021%26sid%3Dliteratum%253Aachs%26aulast%3DPedragosa-Badia%26aufirst%3DX.%26aulast%3DSliwoski%26aufirst%3DG.%2BR.%26aulast%3DDong%2BNguyen%26aufirst%3DE.%26aulast%3DLindner%26aufirst%3DD.%26aulast%3DStichel%26aufirst%3DJ.%26aulast%3DKaufmann%26aufirst%3DK.%2BW.%26aulast%3DMeiler%26aufirst%3DJ.%26aulast%3DBeck-Sickinger%26aufirst%3DA.%2BG.%26atitle%3DPancreatic%2520polypeptide%2520is%2520recognized%2520by%2520two%2520hydrophobic%2520domains%2520of%2520the%2520human%2520Y4%2520receptor%2520binding%2520pocket%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D5846%26epage%3D5859%26doi%3D10.1074%2Fjbc.m113.502021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dukorn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernhardt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buschauer, A.</span></span> <span> </span><span class="NLM_article-title">In search of NPY Y<sub>4</sub>R antagonists: incorporation of carbamoylated arginine, aza-amino acids, or d-amino acids into oligopeptides derived from the C-termini of the endogenous agonists</span>. <i>ACS Omega</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">3616</span>– <span class="NLM_lpage">3631</span>, <span class="refDoi"> DOI: 10.1021/acsomega.7b00451</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsomega.7b00451" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFKhu7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2017&pages=3616-3631&author=K.+K.+Kuhnauthor=T.+Littmannauthor=S.+Dukornauthor=M.+Tanakaauthor=M.+Kellerauthor=T.+Ozawaauthor=G.+Bernhardtauthor=A.+Buschauer&title=In+search+of+NPY+Y4R+antagonists%3A+incorporation+of+carbamoylated+arginine%2C+aza-amino+acids%2C+or+d-amino+acids+into+oligopeptides+derived+from+the+C-termini+of+the+endogenous+agonists&doi=10.1021%2Facsomega.7b00451"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">In Search of NPY Y4R Antagonists: Incorporation of Carbamoylated Arginine, Aza-Amino Acids, or D-Amino Acids into Oligopeptides Derived from the C-Termini of the Endogenous Agonists</span></div><div class="casAuthors">Kuhn, Kilian K.; Littmann, Timo; Dukorn, Stefanie; Tanaka, Miho; Keller, Max; Ozawa, Takeaki; Bernhardt, Guenther; Buschauer, Armin</div><div class="citationInfo"><span class="NLM_cas:title">ACS Omega</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3616-3631</span>CODEN:
                <span class="NLM_cas:coden">ACSODF</span>;
        ISSN:<span class="NLM_cas:issn">2470-1343</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The crosslinked pentapeptides (2R,7R)-diaminooctanedioyl-bis(Tyr-Arg-Leu-Arg-Tyr-amide) ((2R,7R)-BVD-74D, (2R,7R)-1) and octanedioyl-bis(Tyr-Arg-Leu-Arg-Tyr-amide) (2) as well as the pentapeptide Ac-Tyr-Arg-Leu-Arg-Tyr-amide (3) were previously described as neuropeptide Y Y4 receptor (Y4R) partial agonists.  Here the authors report on a series of analogs of (2R,7R)-1 and 2 in which Arg2, Leu3 or Arg4 were replaced by the resp. aza-amino acids.  The replacement of Arg2 in 3 with a carbamoylated arginine building block and the extension of the N-terminus by an addnl. arginine led to the high-affinity hexapeptide Ac-Arg-Tyr-Nω-[(4-aminobutyl)aminocarbonyl]Arg-Leu-Arg-Tyr-amide that was used as a precursor for a D-amino acid scan.  The target compds. were investigated for Y4R functional activity in assays with complementary readouts: aequorin Ca2+ and β-arrestin 1 or β-arrestin 2 assays.  In contrast to the parent compds., which are Y4R agonists, several ligands were able to suppress the effect elicited by the endogenous ligand pancreatic polypeptide and therefore represent a novel class of peptide Y4R antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAufjWqDJZnrVg90H21EOLACvtfcHk0ljUegqt0iWghw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFKhu7bE&md5=970422192d233703cda161e6e476b3e5</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Facsomega.7b00451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsomega.7b00451%26sid%3Dliteratum%253Aachs%26aulast%3DKuhn%26aufirst%3DK.%2BK.%26aulast%3DLittmann%26aufirst%3DT.%26aulast%3DDukorn%26aufirst%3DS.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DKeller%26aufirst%3DM.%26aulast%3DOzawa%26aufirst%3DT.%26aulast%3DBernhardt%26aufirst%3DG.%26aulast%3DBuschauer%26aufirst%3DA.%26atitle%3DIn%2520search%2520of%2520NPY%2520Y4R%2520antagonists%253A%2520incorporation%2520of%2520carbamoylated%2520arginine%252C%2520aza-amino%2520acids%252C%2520or%2520d-amino%2520acids%2520into%2520oligopeptides%2520derived%2520from%2520the%2520C-termini%2520of%2520the%2520endogenous%2520agonists%26jtitle%3DACS%2520Omega%26date%3D2017%26volume%3D2%26spage%3D3616%26epage%3D3631%26doi%3D10.1021%2Facsomega.7b00451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ertl, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dukorn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernhardt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiser, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buschauer, A.</span></span> <span> </span><span class="NLM_article-title">High affinity agonists of the neuropeptide Y (NPY) Y<sub>4</sub> receptor derived from the C-terminal pentapeptide of human pancreatic polypeptide (hPP): synthesis, stereochemical discrimination, and radiolabeling</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">6045</span>– <span class="NLM_lpage">6058</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00309</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00309" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BC28XosFSmtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6045-6058&author=K.+K.+Kuhnauthor=T.+Ertlauthor=S.+Dukornauthor=M.+Kellerauthor=G.+Bernhardtauthor=O.+Reiserauthor=A.+Buschauer&title=High+affinity+agonists+of+the+neuropeptide+Y+%28NPY%29+Y4+receptor+derived+from+the+C-terminal+pentapeptide+of+human+pancreatic+polypeptide+%28hPP%29%3A+synthesis%2C+stereochemical+discrimination%2C+and+radiolabeling&doi=10.1021%2Facs.jmedchem.6b00309"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">High Affinity Agonists of the Neuropeptide Y (NPY) Y4 Receptor Derived from the C-Terminal Pentapeptide of Human Pancreatic Polypeptide (hPP): Synthesis, Stereochemical Discrimination, and Radiolabeling</span></div><div class="casAuthors">Kuhn, Kilian K.; Ertl, Thomas; Dukorn, Stefanie; Keller, Max; Bernhardt, Guenther; Reiser, Oliver; Buschauer, Armin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6045-6058</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The diastereomeric mixt. of D/L-2,7-diaminooctanedioyl-bis(YRLRY-NH2) (BVD-74D, 2) was described in the literature as a high affinity Y4 receptor agonist.  Here we report on the synthesis and pharmacol. characterization of the pure diastereomers (2R,7R)- and (2S,7S)-2 and a series of homo- and heterodimeric analogs in which octanedioic acid was used as an achiral linker.  To investigate the role of the Arg residues, one or two arginines were replaced by Ala.  Moreover, Nω-(6-aminohexylaminocarbonyl)Arg was introduced as an arginine replacement (17). (2R,7R)-2 was superior to (2S,7S)-2 in binding and functional cellular assays and equipotent with 17. [3H]Propionylation of one amino group in the linker of (2R,7R)-2 or at the primary amino group in 17 resulted in high affinity Y4R radioligands ([3H]-(2R,7R)-10, [3H]18) with subnanomolar Kd values.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqa_pLfg6qLerVg90H21EOLACvtfcHk0ljUegqt0iWghw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XosFSmtrc%253D&md5=ee7279c046d467c5ec6919187eb0f3aa</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00309%26sid%3Dliteratum%253Aachs%26aulast%3DKuhn%26aufirst%3DK.%2BK.%26aulast%3DErtl%26aufirst%3DT.%26aulast%3DDukorn%26aufirst%3DS.%26aulast%3DKeller%26aufirst%3DM.%26aulast%3DBernhardt%26aufirst%3DG.%26aulast%3DReiser%26aufirst%3DO.%26aulast%3DBuschauer%26aufirst%3DA.%26atitle%3DHigh%2520affinity%2520agonists%2520of%2520the%2520neuropeptide%2520Y%2520%2528NPY%2529%2520Y4%2520receptor%2520derived%2520from%2520the%2520C-terminal%2520pentapeptide%2520of%2520human%2520pancreatic%2520polypeptide%2520%2528hPP%2529%253A%2520synthesis%252C%2520stereochemical%2520discrimination%252C%2520and%2520radiolabeling%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D6045%26epage%3D6058%26doi%3D10.1021%2Facs.jmedchem.6b00309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slepetis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viveros, O. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tadepalli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrington, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heyer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landavazo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leban, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spaltenstein, A.</span></span> <span> </span><span class="NLM_article-title">High-affinity neuropeptide Y receptor antagonists</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">9067</span>– <span class="NLM_lpage">9071</span>, <span class="refDoi"> DOI: 10.1073/pnas.92.20.9067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1073%2Fpnas.92.20.9067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=7568074" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADyaK2MXosVWlsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1995&pages=9067-9071&author=A.+J.+Danielsauthor=J.+E.+Matthewsauthor=R.+J.+Slepetisauthor=M.+Jansenauthor=O.+H.+Viverosauthor=A.+Tadepalliauthor=W.+Harringtonauthor=D.+Heyerauthor=A.+Landavazoauthor=J.+J.+Lebanauthor=A.+Spaltenstein&title=High-affinity+neuropeptide+Y+receptor+antagonists&doi=10.1073%2Fpnas.92.20.9067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">High-affinity neuropeptide Y receptor antagonists</span></div><div class="casAuthors">Daniels, Alejandro J.; Matthews, Jessica E.; Slepetis, Ruta J.; Jansen, Marilyn; Viveros, O. Humberto; Tadepalli, Anjaneyulu; Harrington, Wallace; Heyer, Dennis; Landavazo, Antonio; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">9067-71</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Neuropeptide Y (NPY) is one of the most abundant peptide transmitters in the mammalian brain.  In the periphery it is costored and coreleased with norepinephrine from sympathetic nerve terminals.  However, the physiol. functions of this peptide remain unclear because of the absence of specific high-affinity receptor antagonists.  Three potent NPY receptor antagonists were synthesized and tested for their biol. activity in in vitro, ex vivo, and in vivo functional assays.  We describe here the effects of these antagonists inhibiting specific radiolabeled NPY binding at Y1 and Y2 receptors and antagonizing the effects of NPY in human erythroleukemia cell intracellular calcium mobilization, perfusion pressure in the isolated rat kidney, and mean arterial blood pressure in anesthetized rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTDEaNKfTQ1LVg90H21EOLACvtfcHk0ljUegqt0iWghw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXosVWlsL0%253D&md5=a517184b11d0c71715f5b543ea4e8fe8</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1073%2Fpnas.92.20.9067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.92.20.9067%26sid%3Dliteratum%253Aachs%26aulast%3DDaniels%26aufirst%3DA.%2BJ.%26aulast%3DMatthews%26aufirst%3DJ.%2BE.%26aulast%3DSlepetis%26aufirst%3DR.%2BJ.%26aulast%3DJansen%26aufirst%3DM.%26aulast%3DViveros%26aufirst%3DO.%2BH.%26aulast%3DTadepalli%26aufirst%3DA.%26aulast%3DHarrington%26aufirst%3DW.%26aulast%3DHeyer%26aufirst%3DD.%26aulast%3DLandavazo%26aufirst%3DA.%26aulast%3DLeban%26aufirst%3DJ.%2BJ.%26aulast%3DSpaltenstein%26aufirst%3DA.%26atitle%3DHigh-affinity%2520neuropeptide%2520Y%2520receptor%2520antagonists%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1995%26volume%3D92%26spage%3D9067%26epage%3D9071%26doi%3D10.1073%2Fpnas.92.20.9067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaske, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holzammer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernhardt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buschauer, A.</span></span> <span> </span><span class="NLM_article-title">Dimeric argininamide-type neuropeptide Y receptor antagonists: chiral discrimination between Y<sub>1</sub> and Y<sub>4</sub> receptors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">6303</span>– <span class="NLM_lpage">6322</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2013.08.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1016%2Fj.bmc.2013.08.065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=24074877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFemtLzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=6303-6322&author=M.+Kellerauthor=M.+Kaskeauthor=T.+Holzammerauthor=G.+Bernhardtauthor=A.+Buschauer&title=Dimeric+argininamide-type+neuropeptide+Y+receptor+antagonists%3A+chiral+discrimination+between+Y1+and+Y4+receptors&doi=10.1016%2Fj.bmc.2013.08.065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Dimeric argininamide-type neuropeptide Y receptor antagonists: Chiral discrimination between Y1 and Y4 receptors</span></div><div class="casAuthors">Keller, Max; Kaske, Melanie; Holzammer, Tobias; Bernhardt, Guenther; Buschauer, Armin</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6303-6322</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The structurally related peptides neuropeptide Y (NPY), peptide YY (PYY) and pancreatic polypeptide (PP) are endogenous agonists of the NPY receptor (YR) family, which in humans comprises four functionally expressed subtypes, designated Y1R, Y2R, Y4R and Y5R.  Nonpeptide antagonists with high affinity and selectivity have been described for the Y1R, Y2R and Y5R, but such compds. are still lacking for the Y4R.  In this work, the structures of the high affinity selective (R)-argininamide-type Y1R antagonists BIBP3226 and BIBO3304 were linked via the guanidine or urea moieties to give homo-dimeric argininamides with linker lengths ranging from 31 to 41 atoms.  Interestingly, the twin compds. proved to be by far less selective for the Y1R than the R-configured monovalent parent compds.  The decrease in selectivity ratio was most pronounced for Y1R vs. Y4R subtype, resulting in comparable affinities of bivalent ligands for Y1R and Y4R (e.g. UR-MK177 [(R,R)-I (R1 = (CH2O)2CH2CH2X, Y = CH2NHC(O)NH2)]: Ki = 230 nM (Y1R) and 290 nM (Y4R)).  With a Ki value of 130 nM and a Kb value of 20 nM, UR-MK188 [(R,R)-II (R2 = CH2(CH2OCH2)2CH2X, Y = OH)] was superior to all Y4R antagonists known to date.  The S,S-configured optical antipodes of UR-MK177 and UR-MK188 (UR-MEK381 ((S,S)-I) and UR-MEK388 ((S,S)-II)) were synthesized to investigate the stereochem. discrimination by the different receptor subtypes.  Whereas preference for R,R-configured argininamides was characteristic of the Y1R, stereochem. discrimination by the Y4R was not obsd.  This may pave the way to selective Y4R antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRAhCQ0Gt1nLVg90H21EOLACvtfcHk0ljP3dRbxlbBtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFemtLzL&md5=5ca4d29cdb12eb2c4ea26396b1c569df</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.08.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.08.065%26sid%3Dliteratum%253Aachs%26aulast%3DKeller%26aufirst%3DM.%26aulast%3DKaske%26aufirst%3DM.%26aulast%3DHolzammer%26aufirst%3DT.%26aulast%3DBernhardt%26aufirst%3DG.%26aulast%3DBuschauer%26aufirst%3DA.%26atitle%3DDimeric%2520argininamide-type%2520neuropeptide%2520Y%2520receptor%2520antagonists%253A%2520chiral%2520discrimination%2520between%2520Y1%2520and%2520Y4%2520receptors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D6303%26epage%3D6322%26doi%3D10.1016%2Fj.bmc.2013.08.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rudolf, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eberlein, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wieland, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willim, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Entzeroth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wienen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck-Sickinger, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doods, H. N.</span></span> <span> </span><span class="NLM_article-title">The first highly potent and selective non-peptide neuropeptide Y Y<sub>1</sub> receptor antagonist: BIBP3226</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>271</i></span>,  <span class="NLM_fpage">R11</span>– <span class="NLM_lpage">R13</span>, <span class="refDoi"> DOI: 10.1016/0014-2999(94)90822-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1016%2F0014-2999%2894%2990822-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=7705422" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADyaK2MXjt1Sntrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1994&pages=R11-R13&author=K.+Rudolfauthor=W.+Eberleinauthor=W.+Engelauthor=H.+A.+Wielandauthor=K.+D.+Willimauthor=M.+Entzerothauthor=W.+Wienenauthor=A.+G.+Beck-Sickingerauthor=H.+N.+Doods&title=The+first+highly+potent+and+selective+non-peptide+neuropeptide+Y+Y1+receptor+antagonist%3A+BIBP3226&doi=10.1016%2F0014-2999%2894%2990822-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226</span></div><div class="casAuthors">Rudolf, Klaus; Eberlein, Wolfgang; Engel, Wolfhard; Wieland, Heike A.; Willim, Klaus D.; Entzeroth, Michael; Wienen, Wolfgang; Beck-Sickinger, Annette G.; Doods, Henri N.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">2/3</span>),
    <span class="NLM_cas:pages">R11-R13</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The design and subsequent in vitro and in vivo biol. characterization of the first potent and selective non-peptide neuropeptide Y Y1 receptor antagonist, BIBP3226 (I; (R)-N2-(diphenylacetyl)-N-[(4- hydroxyphenyl)methyl]-argininamide) is reported.  BIBP3226 displaced 125I-labeled neuropeptide Y with high affinity (Ki = 7 nM) from the human neuropeptide Y Y1 receptor and proved to be highly selective.  BIBP3226 displayed potent antagonistic properties both in in vitro and in vivo models and thus represents the first selective non-peptide neuropeptide Y Y1 receptor antagonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy6B_rW0NxBLVg90H21EOLACvtfcHk0ljP3dRbxlbBtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjt1Sntrw%253D&md5=d0c87027fe726aacc2146433884d163a</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2894%2990822-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252894%252990822-2%26sid%3Dliteratum%253Aachs%26aulast%3DRudolf%26aufirst%3DK.%26aulast%3DEberlein%26aufirst%3DW.%26aulast%3DEngel%26aufirst%3DW.%26aulast%3DWieland%26aufirst%3DH.%2BA.%26aulast%3DWillim%26aufirst%3DK.%2BD.%26aulast%3DEntzeroth%26aufirst%3DM.%26aulast%3DWienen%26aufirst%3DW.%26aulast%3DBeck-Sickinger%26aufirst%3DA.%2BG.%26aulast%3DDoods%26aufirst%3DH.%2BN.%26atitle%3DThe%2520first%2520highly%2520potent%2520and%2520selective%2520non-peptide%2520neuropeptide%2520Y%2520Y1%2520receptor%2520antagonist%253A%2520BIBP3226%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1994%26volume%3D271%26spage%3DR11%26epage%3DR13%26doi%3D10.1016%2F0014-2999%2894%2990822-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berlicki, Ł.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaske, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutiérrez-Abad, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernhardt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Illa, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortuño, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabrele, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buschauer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiser, O.</span></span> <span> </span><span class="NLM_article-title">Replacement of Thr<sup>32</sup>and Gln<sup>34</sup> in the C-terminal neuropeptide Y fragment 25–36 by cis-cyclobutane and cis-cyclopentane β-amino acids shifts selectivity toward the Y<sub>4</sub> receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">8422</span>– <span class="NLM_lpage">8431</span>, <span class="refDoi"> DOI: 10.1021/jm4008505</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4008505" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFOju7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8422-8431&author=%C5%81.+Berlickiauthor=M.+Kaskeauthor=R.+Guti%C3%A9rrez-Abadauthor=G.+Bernhardtauthor=O.+Illaauthor=R.+M.+Ortu%C3%B1oauthor=C.+Cabreleauthor=A.+Buschauerauthor=O.+Reiser&title=Replacement+of+Thr32and+Gln34+in+the+C-terminal+neuropeptide+Y+fragment+25%E2%80%9336+by+cis-cyclobutane+and+cis-cyclopentane+%CE%B2-amino+acids+shifts+selectivity+toward+the+Y4+receptor&doi=10.1021%2Fjm4008505"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Replacement of Thr32 and Gln34 in the C-Terminal Neuropeptide Y Fragment 25-36 by cis-Cyclobutane and cis-Cyclopentane β Amino Acids Shifts Selectivity toward the Y4 Receptor</span></div><div class="casAuthors">Berlicki, Lukasz; Kaske, Melanie; Gutierrez-Abad, Raquel; Bernhardt, Guenther; Illa, Ona; Ortuno, Rosa M.; Cabrele, Chiara; Buschauer, Armin; Reiser, Oliver</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8422-8431</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Neuropeptide Y (NPY) and pancreatic polypeptide (PUP) control central and peripheral processes by activating the G protein coupled receptors YxR (x = 1, 2, 4, 5).  We present analogs of the C-terminal fragments 25-36 and 32-36 of NPY and PP contg. (1R,2S)-cyclobutane (βCbu) or (1R,2S)-cyclopentane (βCpe) β-amino acids, which display exclusively Y4R affinity.  In particular, [βCpe34]-NPY-(25-36) is a Y4R selective partial agonist (EC50 41 nM, Emax 71%) that binds Y4R with a Ki of 10 nM and a selectivity >100-fold relative to Y1R and Y2R and >50-fold relative to Y5R.  Comparably, [Y32, βCpe34]-NPY-(PP)-(32-36) selectively binds and activates Y4R (EC50 94 nM, Emax 73%).  The NMR structure of [βCpe34]-NPY-(25-36) in dodecylphosphatidylcholine micelles shows a short helix at residues 27-32, while the C-terminal segment R33βCpe34R35Y36 is extended.  The biol. properties of the βCbu- or βCpe-contg. NPY and PP C-terminal fragments encourage the future application of these β-amino acids in the synthesis of selective Y4R ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqc86lNhWkxe7Vg90H21EOLACvtfcHk0ljP3dRbxlbBtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFOju7bO&md5=8b70c960e83a6193794b2badc9760206</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm4008505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4008505%26sid%3Dliteratum%253Aachs%26aulast%3DBerlicki%26aufirst%3D%25C5%2581.%26aulast%3DKaske%26aufirst%3DM.%26aulast%3DGuti%25C3%25A9rrez-Abad%26aufirst%3DR.%26aulast%3DBernhardt%26aufirst%3DG.%26aulast%3DIlla%26aufirst%3DO.%26aulast%3DOrtu%25C3%25B1o%26aufirst%3DR.%2BM.%26aulast%3DCabrele%26aufirst%3DC.%26aulast%3DBuschauer%26aufirst%3DA.%26aulast%3DReiser%26aufirst%3DO.%26atitle%3DReplacement%2520of%2520Thr32and%2520Gln34%2520in%2520the%2520C-terminal%2520neuropeptide%2520Y%2520fragment%252025%25E2%2580%259336%2520by%2520cis-cyclobutane%2520and%2520cis-cyclopentane%2520%25CE%25B2-amino%2520acids%2520shifts%2520selectivity%2520toward%2520the%2520Y4%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D8422%26epage%3D8431%26doi%3D10.1021%2Fjm4008505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lachmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konieczny, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">König, B.</span></span> <span> </span><span class="NLM_article-title">Photochromic peptidic NPY Y<sub>4</sub> receptor ligands</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">2467</span>– <span class="NLM_lpage">2478</span>, <span class="refDoi"> DOI: 10.1039/c8ob03221a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1039%2FC8OB03221A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=30747188" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlOns7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2019&pages=2467-2478&author=D.+Lachmannauthor=A.+Koniecznyauthor=M.+Kellerauthor=B.+K%C3%B6nig&title=Photochromic+peptidic+NPY+Y4+receptor+ligands&doi=10.1039%2Fc8ob03221a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Photochromic peptidic NPY Y4 receptor ligands</span></div><div class="casAuthors">Lachmann, D.; Konieczny, A.; Keller, M.; Koenig, B.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2467-2478</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The neuropeptide Y (NPY) Y4 receptor is a G protein coupled receptor, which is targeted by pancreatic polypeptide, a homolog of NPY.  Selective Y4R agonists were suggested as potential therapeutics for the treatment of obesity.  Highly potent dimeric peptidic Y4R agonists, constituting two pentapeptide moieties connected through an aliph. linker, represent an interesting class of Y4R ligands.  Based on this compd. class, photoresponsive Y4R ligands, contg. an azobenzene, azopyrazole, diethienylethene or a fulgimide chromophore were prepd. to explore structural requirements of such Y4R agonists on Y4R binding.  The synthesized Y4R ligands, contg. a non-aliph. rigid photochromic linker, switch reversibly in aq. buffer and exhibited high Y4R affinity throughout.  This demonstrated that the replacement of the highly flexible aliph. linker by a considerably less flexible photochromic linker was well tolerated with respect to Y4R binding.  Differences in Y4R affinity and activity between the individual photoisomers (varying in spatial orientation and flexibility) were marginal suggesting that the linking element in the dimeric ligands is less crit. for the adaptation of high-affinity binding modes at the receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrN56yENztvRbVg90H21EOLACvtfcHk0litvVWVDyddig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlOns7Y%253D&md5=0298469321545b84520948d7efc2ba4e</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1039%2FC8OB03221A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8OB03221A%26sid%3Dliteratum%253Aachs%26aulast%3DLachmann%26aufirst%3DD.%26aulast%3DKonieczny%26aufirst%3DA.%26aulast%3DKeller%26aufirst%3DM.%26aulast%3DK%25C3%25B6nig%26aufirst%3DB.%26atitle%3DPhotochromic%2520peptidic%2520NPY%2520Y4%2520receptor%2520ligands%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2019%26volume%3D17%26spage%3D2467%26epage%3D2478%26doi%3D10.1039%2Fc8ob03221a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ziemek, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabrele, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck-Sickinger, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernhardt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buschauer, A.</span></span> <span> </span><span class="NLM_article-title">Determination of affinity and activity of ligands at the human neuropeptide Y Y<sub>4</sub> receptor by flow cytometry and aequorin luminescence</span>. <i>J. Recept. Signal Transduction Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">217</span>– <span class="NLM_lpage">233</span>, <span class="refDoi"> DOI: 10.1080/10799890701505206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1080%2F10799890701505206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=17885919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A280%3ADC%252BD2srmsF2htw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=217-233&author=R.+Ziemekauthor=E.+Schneiderauthor=A.+Krausauthor=C.+Cabreleauthor=A.+G.+Beck-Sickingerauthor=G.+Bernhardtauthor=A.+Buschauer&title=Determination+of+affinity+and+activity+of+ligands+at+the+human+neuropeptide+Y+Y4+receptor+by+flow+cytometry+and+aequorin+luminescence&doi=10.1080%2F10799890701505206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of affinity and activity of ligands at the human neuropeptide Y Y4 receptor by flow cytometry and aequorin luminescence</span></div><div class="casAuthors">Ziemek Ralf; Schneider Erich; Kraus Anja; Cabrele Chiara; Beck-Sickinger Annette G; Bernhardt Gunther; Buschauer Armin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of receptor and signal transduction research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">217-33</span>
        ISSN:<span class="NLM_cas:issn">1079-9893</span>.
    </div><div class="casAbstract">Fluorescence-labeled neuropeptide Y (NPY) has been used in flow cytometric binding assays for the determination of affinity constants of NPY Y1, Y2, and Y5 receptor ligands.  Because the binding of fluorescent NPY is insufficient for competition studies at the human Y4 receptor (hY4R), we replaced Glu-4 in hPP with Lys for the derivatization with cyanine-5.  Because cy5-[K(4)]hPP has high affinity (Kd 5.6 nM) to the hY4R, it was used as a probe in a flow cytometric binding assay.  Specific binding of cy5-[K(4)]hPP to hY4R was visualized by confocal microscopy.  The hY(4)R, the chimeric G protein G(qi5) and mitochondrially targeted apoaequorin were stably coexpressed in CHO cells.  Aequorin luminescence was quantified in a microplate reader and by a CCD camera.  By application of these methods 3-cyclohexyl-N-[(3-1H-imidazol-4-ylpropylamino)(imino)methyl]propanamide (UR-AK49) was discovered as the first nonpeptidic Y4R antagonist (pKi 4.17), a lead to be optimized in terms of potency and selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSyMWGV-E2m5Uh5eUSa2oe_fW6udTcc2eZSEcnO5BMtKrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2srmsF2htw%253D%253D&md5=01182c83c0ba95e88a143720dc3cef30</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1080%2F10799890701505206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10799890701505206%26sid%3Dliteratum%253Aachs%26aulast%3DZiemek%26aufirst%3DR.%26aulast%3DSchneider%26aufirst%3DE.%26aulast%3DKraus%26aufirst%3DA.%26aulast%3DCabrele%26aufirst%3DC.%26aulast%3DBeck-Sickinger%26aufirst%3DA.%2BG.%26aulast%3DBernhardt%26aufirst%3DG.%26aulast%3DBuschauer%26aufirst%3DA.%26atitle%3DDetermination%2520of%2520affinity%2520and%2520activity%2520of%2520ligands%2520at%2520the%2520human%2520neuropeptide%2520Y%2520Y4%2520receptor%2520by%2520flow%2520cytometry%2520and%2520aequorin%2520luminescence%26jtitle%3DJ.%2520Recept.%2520Signal%2520Transduction%2520Res.%26date%3D2007%26volume%3D27%26spage%3D217%26epage%3D233%26doi%3D10.1080%2F10799890701505206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bartleson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graves, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, B. L.</span></span> <span> </span><span class="NLM_article-title">Arginine to citrulline replacement in substrates of phosphorylase kinase</span>. <i>Biochim. Biophys. Acta, Protein Struct. Mol. Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>1480</i></span>,  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">28</span>, <span class="refDoi"> DOI: 10.1016/s0167-4838(00)00100-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1016%2FS0167-4838%2800%2900100-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=11004553" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BD3cXks12qt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1480&publication_year=2000&pages=23-28&author=C.+Bartlesonauthor=S.+Luoauthor=D.+J.+Gravesauthor=B.+L.+Martin&title=Arginine+to+citrulline+replacement+in+substrates+of+phosphorylase+kinase&doi=10.1016%2Fs0167-4838%2800%2900100-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Arginine to citrulline replacement in substrates of phosphorylase kinase</span></div><div class="casAuthors">Bartleson, C.; Luo, S.; Graves, D. J.; Martin, B. L.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Protein Structure and Molecular Enzymology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">1480</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">23-28</span>CODEN:
                <span class="NLM_cas:coden">BBAEDZ</span>;
        ISSN:<span class="NLM_cas:issn">0167-4838</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Synthetic peptides based on residues 9 to 18 of glycogen phosphorylase were prepd. contg. citrulline at position 10 or 16, or at both positions 10 and 16.  The peptides were compared as substrates for a recombinant, truncated form of the catalytic subunit of phosphorylase kinase (residues 1-300).  The peptide having citrulline at position 10 was phosphorylated the same as the parent peptide.  Both the peptides with a single citrulline at position 16 and with two citrullines were phosphorylated less effectively than the parent peptide; kcat/Km values were approx. 20% the value with the parent peptide.  Incorporation of the second citrulline had little change in the effectiveness of the peptide as a substrate although the kinetic parameters with the citrulline peptides did show differences.  The change in peptide phosphorylation use as substrates for the phosphorylase kinase synthetic peptides based on residues 9 to 18 of glycogen phosphorylase contg. citrulline at position 10 or 16, or at both positions 10 and 16 did not seem to result from a change in peptide structure.  Two-dimensional NMR studies of di-citrulline peptide are reported and showed no change in the soln. structure of the peptide compared to the parent peptide.  Thus, the change in kinetic parameters with the modified peptides seemed an effect of arginine replacement and was likely a consequence of the loss of charge inasmuch as the size of arginine and citrulline are similar.  Arginine-16 was concluded to be more important for phosphorylase kinase recognition than arginine-10.  These findings were consistent with the earlier studies using alanine replacement of arginine in synthetic peptides as substrates for the holoenzyme form of phosphorylase kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwr7X_fenggbVg90H21EOLACvtfcHk0litvVWVDyddig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXks12qt74%253D&md5=d752e7f6d1697c044b041a1743e74db1</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS0167-4838%2800%2900100-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0167-4838%252800%252900100-X%26sid%3Dliteratum%253Aachs%26aulast%3DBartleson%26aufirst%3DC.%26aulast%3DLuo%26aufirst%3DS.%26aulast%3DGraves%26aufirst%3DD.%2BJ.%26aulast%3DMartin%26aufirst%3DB.%2BL.%26atitle%3DArginine%2520to%2520citrulline%2520replacement%2520in%2520substrates%2520of%2520phosphorylase%2520kinase%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Protein%2520Struct.%2520Mol.%2520Enzymol.%26date%3D2000%26volume%3D1480%26spage%3D23%26epage%3D28%26doi%3D10.1016%2Fs0167-4838%2800%2900100-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutzler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollereau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dukorn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schindler, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernhardt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">König, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buschauer, A.</span></span> <span> </span><span class="NLM_article-title">N<sup>ω</sup>-Carbamoylation of the argininamide moiety: an avenue to insurmountable NPY Y<sub>1</sub> receptor antagonists and a radiolabeled selective high-affinity molecular tool ([<sup>3</sup>H]UR-MK299) with extended residence time</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8834</span>– <span class="NLM_lpage">8849</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00925</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00925" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Cqsb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8834-8849&author=M.+Kellerauthor=S.+Weissauthor=C.+Hutzlerauthor=K.+K.+Kuhnauthor=C.+Mollereauauthor=S.+Dukornauthor=L.+Schindlerauthor=G.+Bernhardtauthor=B.+K%C3%B6nigauthor=A.+Buschauer&title=N%CF%89-Carbamoylation+of+the+argininamide+moiety%3A+an+avenue+to+insurmountable+NPY+Y1+receptor+antagonists+and+a+radiolabeled+selective+high-affinity+molecular+tool+%28%5B3H%5DUR-MK299%29+with+extended+residence+time&doi=10.1021%2Facs.jmedchem.5b00925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Nω-Carbamoylation of the Argininamide Moiety: An Avenue to Insurmountable NPY Y1 Receptor Antagonists and a Radiolabeled Selective High-Affinity Molecular Tool ([3H]UR-MK299) with Extended Residence Time</span></div><div class="casAuthors">Keller, Max; Weiss, Stefan; Hutzler, Christoph; Kuhn, Kilian K.; Mollereau, Catherine; Dukorn, Stefanie; Schindler, Lisa; Bernhardt, Guenther; Koenig, Burkhard; Buschauer, Armin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8834-8849</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Analogs of the argininamide-type NPY Y1 receptor (Y1R) antagonist BIBP3226, bearing carbamoyl moieties at the guanidine group, revealed subnanomolar Ki values and caused depression of the maximal response to NPY (calcium assay) by up to 90% in a concn.- and time-dependent manner, suggesting insurmountable antagonism.  To gain insight into the mechanism of binding of the synthesized compds., a tritiated antagonist, (R)-Nα-diphenylacetyl-Nω-[2-([2,3-3H]propionylamino)ethyl]aminocarbonyl-(4-hydroxybenzyl)arginin-amide ([3H]UR-MK299, [3H]38), was prepd. [3H]38 revealed a dissocn. const. in the picomolar range (Kd 0.044 nM, SK-N-MC cells) and very high Y1R selectivity.  Apart from superior affinity, a considerably lower target off-rate (t1/2 95 min) was characteristic of [3H]38 compared to that of the higher homolog contg. a tetramethylene instead of an ethylene spacer (t1/2 3 min, Kd 2.0 nM).  Y1R binding of [3H]38 was fully reversible and fully displaceable by nonpeptide antagonists and the agonist pNPY.  Therefore, the insurmountable antagonism obsd. in the functional assay has to be attributed to the extended target-residence time, a phenomenon of relevance in drug research beyond the NPY receptor field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3S1Ipo2hZQ7Vg90H21EOLACvtfcHk0litvVWVDyddig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Cqsb3J&md5=8117957cafc33319d6bc6f37aeb142df</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00925%26sid%3Dliteratum%253Aachs%26aulast%3DKeller%26aufirst%3DM.%26aulast%3DWeiss%26aufirst%3DS.%26aulast%3DHutzler%26aufirst%3DC.%26aulast%3DKuhn%26aufirst%3DK.%2BK.%26aulast%3DMollereau%26aufirst%3DC.%26aulast%3DDukorn%26aufirst%3DS.%26aulast%3DSchindler%26aufirst%3DL.%26aulast%3DBernhardt%26aufirst%3DG.%26aulast%3DK%25C3%25B6nig%26aufirst%3DB.%26aulast%3DBuschauer%26aufirst%3DA.%26atitle%3DN%25CF%2589-Carbamoylation%2520of%2520the%2520argininamide%2520moiety%253A%2520an%2520avenue%2520to%2520insurmountable%2520NPY%2520Y1%2520receptor%2520antagonists%2520and%2520a%2520radiolabeled%2520selective%2520high-affinity%2520molecular%2520tool%2520%2528%255B3H%255DUR-MK299%2529%2520with%2520extended%2520residence%2520time%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8834%26epage%3D8849%26doi%3D10.1021%2Facs.jmedchem.5b00925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moser, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernhardt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buschauer, A.</span></span> <span> </span><span class="NLM_article-title">Cloning and functional expression of the hNPY Y<sub>5</sub> receptor in human endometrial cancer (HEC-1B) cells</span>. <i>Can. J. Physiol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">134</span>– <span class="NLM_lpage">142</span>, <span class="refDoi"> DOI: 10.1139/y99-125</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1139%2Fy99-125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10737676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhsVKnsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2000&pages=134-142&author=C.+Moserauthor=G.+Bernhardtauthor=J.+Michelauthor=H.+Schwarzauthor=A.+Buschauer&title=Cloning+and+functional+expression+of+the+hNPY+Y5+receptor+in+human+endometrial+cancer+%28HEC-1B%29+cells&doi=10.1139%2Fy99-125"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning and functional expression of the hNPY Y5 receptor in human endometrial cancer (HEC-1B) cells</span></div><div class="casAuthors">Moser, C.; Bernhardt, G.; Michel, J.; Schwarz, H.; Buschauer, A.</div><div class="citationInfo"><span class="NLM_cas:title">Canadian Journal of Physiology and Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">134-142</span>CODEN:
                <span class="NLM_cas:coden">CJPPA3</span>;
        ISSN:<span class="NLM_cas:issn">0008-4212</span>.
    
            (<span class="NLM_cas:orgname">National Research Council of Canada</span>)
        </div><div class="casAbstract">Aiming to develop a functional assay for the human NPY Y5 receptor based on adenylyl cyclase activity, HEC-1B cells, in which cAMP synthesis can be efficiently stimulated with forskolin, were selected for the transfection with the pcDNA3-Y5-FLAG and the pcDEF3-Y5 vectors.  After optimization of the transfection procedure, the binding of [3H]propionyl-NPY to transiently and stably expressed Y5 receptors was detd.  The affinities of NPY, NPY derivs., and rPP (pNPY ≥ p(Leu31Pro34)NPY = p(2-36)NPY ≥ p(D-Trp32)NPY > p(13-36)NPY > rPP) were in accordance with the NPY Y5 receptor subtype.  For [3H]propionyl-pNPY approx. 1.7×105 and 1×106 binding sites per transiently and stably transfected cell, resp., were detd.  The KD values were 2.4±0.4 and 1.7±0.2 nM, resp.  Due to the high expression of the receptor protein, both stably and transiently transfected cells can be conveniently used in routine radioligand binding studies.  By contrast, functional assays were only feasible with HEC-1B cells stably expressing the Y5 receptor.  In these cells, 10 nM pNPY inhibited the forskolin-stimulated cAMP synthesis by 75%.  This effect was partially antagonized by the Y5 antagonist N-{trans-[4-(2-naphthylmethylamino)-methyl]cyclohexylmethyl}naphthalene-2-sulfonamide.  Although the genetic variability of cancer cells is in principle incompatible with a stable phenotype, both ligand binding characteristics and functionality of the Y5 receptor remained unchanged for more than 30 passages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrumOHtt-8PLrVg90H21EOLACvtfcHk0li07t3_Bu1Cbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhsVKnsr4%253D&md5=8dffd503ecf2b3c39adaba2932b82bca</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1139%2Fy99-125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1139%252Fy99-125%26sid%3Dliteratum%253Aachs%26aulast%3DMoser%26aufirst%3DC.%26aulast%3DBernhardt%26aufirst%3DG.%26aulast%3DMichel%26aufirst%3DJ.%26aulast%3DSchwarz%26aufirst%3DH.%26aulast%3DBuschauer%26aufirst%3DA.%26atitle%3DCloning%2520and%2520functional%2520expression%2520of%2520the%2520hNPY%2520Y5%2520receptor%2520in%2520human%2520endometrial%2520cancer%2520%2528HEC-1B%2529%2520cells%26jtitle%3DCan.%2520J.%2520Physiol.%2520Pharmacol.%26date%3D2000%26volume%3D78%26spage%3D134%26epage%3D142%26doi%3D10.1139%2Fy99-125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dukorn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabrele, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumeister, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernhardt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buschauer, A.</span></span> <span> </span><span class="NLM_article-title">Fluorescence- and radiolabeling of [Lys<sup>4</sup>,Nle<sup>17</sup>,<sup>30</sup>]hPP yields molecular tools for the NPY Y<sub>4</sub> receptor</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1291</span>– <span class="NLM_lpage">1304</span>, <span class="refDoi"> DOI: 10.1021/acs.bioconjchem.7b00103</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.7b00103" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkvFWjurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2017&pages=1291-1304&author=S.+Dukornauthor=T.+Littmannauthor=M.+Kellerauthor=K.+Kuhnauthor=C.+Cabreleauthor=P.+Baumeisterauthor=G.+Bernhardtauthor=A.+Buschauer&title=Fluorescence-+and+radiolabeling+of+%5BLys4%2CNle17%2C30%5DhPP+yields+molecular+tools+for+the+NPY+Y4+receptor&doi=10.1021%2Facs.bioconjchem.7b00103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorescence- and Radiolabeling of [Lys4,Nle17,30]hPP Yields Molecular Tools for the NPY Y4 Receptor</span></div><div class="casAuthors">Dukorn, Stefanie; Littmann, Timo; Keller, Max; Kuhn, Kilian; Cabrele, Chiara; Baumeister, Paul; Bernhardt, Guenther; Buschauer, Armin</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1291-1304</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The neuropeptide Y (NPY) Y4 receptor (Y4R) is involved in energy homeostasis and considered a potential drug target for the treatment of obesity.  Only a few mol. tools, i.e., radiolabeled and fluorescent ligands, for the investigation of the Y4R were reported.  Previously, [Lys4]hPP proved to be an appropriate full-length PP analog to prep. a fluorescent ligand by derivatization at the ε-amino group.  To preclude oxidn. upon long-term storage, the authors replaced the two methionine residues in [Lys4]hPP by norleucine and prepd. the corresponding [3H]propionylated ([3H]12) and cyanine labeled (13) peptides, which were characterized and compared with a set of ref. compds. in binding (Y1, Y2, Y4, and Y5 receptors) and functional (luciferase gene reporter, beta-arrestin-1,2) Y4R assays.  Both mol. probes proved to be useful in radiochem. and flow cytometric satn. and competition Y4R binding expts.  Most strikingly, there was a different influence of the compn. of buffer on equil. binding and kinetics: [3H]12 affinity (Kd in Na+-free buffer: 1.1 nM) clearly decreased with increasing sodium ion concn., whereas dissocn. and Y4R-mediated internalization of 13 (Kd in Na+-free buffer: 10.8 nM) were strongly affected by the osmolarity of the buffer as demonstrated by confocal microscopy.  Displacement of [3H]12 and 13 revealed a tendency to higher apparent affinities for a set of ref. peptides in hypotonic (Na+-free) compared to isotonic buffers.  The differences were negligible in the case of hPP but up to 270-fold in the case of GW1229 (GR231118).  By contrast, no relevant influence of Na+ on Y5R affinity became obvious, when the radioligands [H]12 and [3H]propionyl-pNPY were investigated in satn. binding and competition binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpo94U0V9fONbVg90H21EOLACvtfcHk0li07t3_Bu1Cbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkvFWjurw%253D&md5=6063243552bb6e134949d63f6e451c1d</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.7b00103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.7b00103%26sid%3Dliteratum%253Aachs%26aulast%3DDukorn%26aufirst%3DS.%26aulast%3DLittmann%26aufirst%3DT.%26aulast%3DKeller%26aufirst%3DM.%26aulast%3DKuhn%26aufirst%3DK.%26aulast%3DCabrele%26aufirst%3DC.%26aulast%3DBaumeister%26aufirst%3DP.%26aulast%3DBernhardt%26aufirst%3DG.%26aulast%3DBuschauer%26aufirst%3DA.%26atitle%3DFluorescence-%2520and%2520radiolabeling%2520of%2520%255BLys4%252CNle17%252C30%255DhPP%2520yields%2520molecular%2520tools%2520for%2520the%2520NPY%2520Y4%2520receptor%26jtitle%3DBioconjugate%2520Chem.%26date%3D2017%26volume%3D28%26spage%3D1291%26epage%3D1304%26doi%3D10.1021%2Facs.bioconjchem.7b00103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenalti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abola, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span> <span> </span><span class="NLM_article-title">Allosteric sodium in class A GPCR signaling</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">233</span>– <span class="NLM_lpage">244</span>, <span class="refDoi"> DOI: 10.1016/j.tibs.2014.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1016%2Fj.tibs.2014.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=24767681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsFCqs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=233-244&author=V.+Katritchauthor=G.+Fenaltiauthor=E.+E.+Abolaauthor=B.+L.+Rothauthor=V.+Cherezovauthor=R.+C.+Stevens&title=Allosteric+sodium+in+class+A+GPCR+signaling&doi=10.1016%2Fj.tibs.2014.03.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric sodium in class A GPCR signaling</span></div><div class="casAuthors">Katritch, Vsevolod; Fenalti, Gustavo; Abola, Enrique E.; Roth, Bryan L.; Cherezov, Vadim; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biochemical Sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">233-244</span>CODEN:
                <span class="NLM_cas:coden">TBSCDB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Despite their functional and structural diversity, G-protein-coupled receptors (GPCRs) share a common mechanism of signal transduction via conformational changes in the seven-transmembrane (7TM) helical domain.  New major insights into this mechanism come from the recent crystallog. discoveries of a partially hydrated sodium ion that is specifically bound in the middle of the 7TM bundle of multiple class A GPCRs.  This review discusses the remarkable structural conservation and distinct features of the Na+ pocket in this most populous GPCR class, as well as the conformational collapse of the pocket upon receptor activation.  New insights help to explain allosteric effects of sodium on GPCR agonist binding and activation, and sodium's role as a potential co-factor in class A GPCR function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_QJ04qVNc3LVg90H21EOLACvtfcHk0li07t3_Bu1Cbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsFCqs7k%253D&md5=c217e7eb69c93b1c76559cc587b318b5</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2014.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2014.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DFenalti%26aufirst%3DG.%26aulast%3DAbola%26aufirst%3DE.%2BE.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DAllosteric%2520sodium%2520in%2520class%2520A%2520GPCR%2520signaling%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2014%26volume%3D39%26spage%3D233%26epage%3D244%26doi%3D10.1016%2Fj.tibs.2014.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">White, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eddy, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Z.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lian, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deary, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span> <span> </span><span class="NLM_article-title">Structural connection between activation microswitch and allosteric sodium site in GPCR signaling</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">259</span>– <span class="NLM_lpage">269</span>, <span class="refDoi"> DOI: 10.1016/j.str.2017.12.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1016%2Fj.str.2017.12.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=29395784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVSjs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=259-269&author=K.+L.+Whiteauthor=M.+T.+Eddyauthor=Z.-G.+Gaoauthor=G.+W.+Hanauthor=T.+Lianauthor=A.+Dearyauthor=N.+Patelauthor=K.+A.+Jacobsonauthor=V.+Katritchauthor=R.+C.+Stevens&title=Structural+connection+between+activation+microswitch+and+allosteric+sodium+site+in+GPCR+signaling&doi=10.1016%2Fj.str.2017.12.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Connection between Activation Microswitch and Allosteric Sodium Site in GPCR Signaling</span></div><div class="casAuthors">White, Kate L.; Eddy, Matthew T.; Gao, Zhan-Guo; Han, Gye Won; Lian, Tiffany; Deary, Alexander; Patel, Nilkanth; Jacobson, Kenneth A.; Katritch, Vsevolod; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">259-269.e5</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Sodium ions are endogenous allosteric modulators of many G-protein-coupled receptors (GPCRs).  Mutation of key residues in the sodium binding motif causes a striking effect on G-protein signaling.  We report the crystal structures of agonist complexes for two variants in the first sodium coordination shell of the human A2A adenosine receptor, D522.50N and S913.39A.  Both structures present an overall active-like conformation; however, the variants show key changes in the activation motif NPxxY.  Changes in the hydrogen bonding network in this microswitch suggest a possible mechanism for modified G-protein signaling and enhanced thermal stability.  These structures, signaling data, and thermal stability anal. with a panel of pharmacol. ligands provide a basis for understanding the role of the sodium-coordinating residues on stability and G-protein signaling.  Utilizing the D2.50N variant is a promising method for stabilizing class A GPCRs to accelerate structural efforts and drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo18IDIJKugCrVg90H21EOLACvtfcHk0liD4Hpf6u34dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVSjs70%253D&md5=916e644534536f2a995288d207328c4d</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2017.12.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2017.12.013%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DK.%2BL.%26aulast%3DEddy%26aufirst%3DM.%2BT.%26aulast%3DGao%26aufirst%3DZ.-G.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DLian%26aufirst%3DT.%26aulast%3DDeary%26aufirst%3DA.%26aulast%3DPatel%26aufirst%3DN.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructural%2520connection%2520between%2520activation%2520microswitch%2520and%2520allosteric%2520sodium%2520site%2520in%2520GPCR%2520signaling%26jtitle%3DStructure%26date%3D2018%26volume%3D26%26spage%3D259%26epage%3D269%26doi%3D10.1016%2Fj.str.2017.12.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaddum, J. H.</span></span> <span> </span><span class="NLM_article-title">Quantitative effects of antagonistic drugs</span>. <i>J. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">1937</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">7</span>– <span class="NLM_lpage">9</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADyaA2sXivVCqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1937&pages=7-9&author=J.+H.+Gaddum&title=Quantitative+effects+of+antagonistic+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative effects of antagonistic drugs</span></div><div class="casAuthors">Gaddum, J. H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physiology (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">1937</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7-9P</span>CODEN:
                <span class="NLM_cas:coden">JPHYA7</span>;
        ISSN:<span class="NLM_cas:issn">0022-3751</span>.
    </div><div class="casAbstract">Discussion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobw0kH9VTVFLVg90H21EOLACvtfcHk0liD4Hpf6u34dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaA2sXivVCqtA%253D%253D&md5=c97615ffd3a9b147e671f31beb55d527</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGaddum%26aufirst%3DJ.%2BH.%26atitle%3DQuantitative%2520effects%2520of%2520antagonistic%2520drugs%26jtitle%3DJ.%2520Physiol.%26date%3D1937%26volume%3D89%26spage%3D7%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Che, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majumdar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaidi, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ondachi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosier, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uprety, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vardy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krumm, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steyaert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strachan, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tribo, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasternak, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, F. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wacker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span> <span> </span><span class="NLM_article-title">Structure of the Nanobody-Stabilized Active State of the Kappa Opioid Receptor</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>172</i></span>,  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">67</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2017.12.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1016%2Fj.cell.2017.12.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=29307491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BC1cXkslehtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2018&pages=55-67&author=T.+Cheauthor=S.+Majumdarauthor=S.+A.+Zaidiauthor=P.+Ondachiauthor=J.+D.+McCorvyauthor=S.+Wangauthor=P.+D.+Mosierauthor=R.+Upretyauthor=E.+Vardyauthor=B.+E.+Krummauthor=G.+W.+Hanauthor=M.-Y.+Leeauthor=E.+Pardonauthor=J.+Steyaertauthor=X.-P.+Huangauthor=R.+T.+Strachanauthor=A.+R.+Triboauthor=G.+W.+Pasternakauthor=F.+I.+Carrollauthor=R.+C.+Stevensauthor=V.+Cherezovauthor=V.+Katritchauthor=D.+Wackerauthor=B.+L.+Roth&title=Structure+of+the+Nanobody-Stabilized+Active+State+of+the+Kappa+Opioid+Receptor&doi=10.1016%2Fj.cell.2017.12.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the nanobody-stabilized active state of the Kappa opioid receptor</span></div><div class="casAuthors">Che, Tao; Majumdar, Susruta; Zaidi, Saheem A.; Ondachi, Pauline; McCorvy, John D.; Wang, Sheng; Mosier, Philip D.; Uprety, Rajendra; Vardy, Eyal; Krumm, Brian E.; Han, Gye Won; Lee, Ming-Yue; Pardon, Els; Steyaert, Jan; Huang, Xi-Ping; Strachan, Ryan T.; Tribo, Alexandra R.; Pasternak, Gavril W.; Carroll, F. Ivy; Stevens, Raymond C.; Cherezov, Vadim; Katritch, Vsevolod; Wacker, Daniel; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">55-67.e15</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The κ-opioid receptor (KOP) mediates the actions of opioids with hallucinogenic, dysphoric, and analgesic activities.  The design of KOP analgesics devoid of hallucinatory and dysphoric effects has been hindered by an incomplete structural and mechanistic understanding of KOP agonist actions.  Here, we provide a crystal structure of human KOP in complex with the potent epoxymorphinan opioid agonist MP1104 and an active-state-stabilizing nanobody.  Comparisons between inactive- and active-state opioid receptor structures reveal substantial conformational changes in the binding pocket and intracellular and extracellular regions.  Extensive structural anal. and exptl. validation illuminate key residues that propagate larger-scale structural rearrangements and transducer binding that, collectively, elucidate the structural determinants of KOP pharmacol., function, and biased signaling.  These mol. insights promise to accelerate the structure-guided design of safer and more effective κ-opioid receptor therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyTsV2u04FCbVg90H21EOLACvtfcHk0liD4Hpf6u34dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXkslehtg%253D%253D&md5=eb0399dc1e7e4e0cf21771243875abc9</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2017.12.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2017.12.011%26sid%3Dliteratum%253Aachs%26aulast%3DChe%26aufirst%3DT.%26aulast%3DMajumdar%26aufirst%3DS.%26aulast%3DZaidi%26aufirst%3DS.%2BA.%26aulast%3DOndachi%26aufirst%3DP.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DMosier%26aufirst%3DP.%2BD.%26aulast%3DUprety%26aufirst%3DR.%26aulast%3DVardy%26aufirst%3DE.%26aulast%3DKrumm%26aufirst%3DB.%2BE.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DLee%26aufirst%3DM.-Y.%26aulast%3DPardon%26aufirst%3DE.%26aulast%3DSteyaert%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DX.-P.%26aulast%3DStrachan%26aufirst%3DR.%2BT.%26aulast%3DTribo%26aufirst%3DA.%2BR.%26aulast%3DPasternak%26aufirst%3DG.%2BW.%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DWacker%26aufirst%3DD.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DStructure%2520of%2520the%2520Nanobody-Stabilized%2520Active%2520State%2520of%2520the%2520Kappa%2520Opioid%2520Receptor%26jtitle%3DCell%26date%3D2018%26volume%3D172%26spage%3D55%26epage%3D67%26doi%3D10.1016%2Fj.cell.2017.12.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bender, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosse, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burkert, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kögler, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wifling, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernhardt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plank, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larhammar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huster, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meiler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck-Sickinger, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buschauer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B.</span></span> <span> </span><span class="NLM_article-title">Structural basis of ligand binding modes at the neuropeptide Y Y<sub>1</sub> receptor</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>556</i></span>,  <span class="NLM_fpage">520</span>– <span class="NLM_lpage">524</span>, <span class="refDoi"> DOI: 10.1038/s41586-018-0046-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1038%2Fs41586-018-0046-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=29670288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BC1cXosVCgur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=556&publication_year=2018&pages=520-524&author=Z.+Yangauthor=S.+Hanauthor=M.+Kellerauthor=A.+Kaiserauthor=B.+J.+Benderauthor=M.+Bosseauthor=K.+Burkertauthor=L.+M.+K%C3%B6glerauthor=D.+Wiflingauthor=G.+Bernhardtauthor=N.+Plankauthor=T.+Littmannauthor=P.+Schmidtauthor=C.+Yiauthor=B.+Liauthor=S.+Yeauthor=R.+Zhangauthor=B.+Xuauthor=D.+Larhammarauthor=R.+C.+Stevensauthor=D.+Husterauthor=J.+Meilerauthor=Q.+Zhaoauthor=A.+G.+Beck-Sickingerauthor=A.+Buschauerauthor=B.+Wu&title=Structural+basis+of+ligand+binding+modes+at+the+neuropeptide+Y+Y1+receptor&doi=10.1038%2Fs41586-018-0046-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of ligand binding modes at the neuropeptide Y Y1 receptor</span></div><div class="casAuthors">Yang, Zhenlin; Han, Shuo; Keller, Max; Kaiser, Anette; Bender, Brian J.; Bosse, Mathias; Burkert, Kerstin; Kogler, Lisa M.; Wifling, David; Bernhardt, Guenther; Plank, Nicole; Littmann, Timo; Schmidt, Peter; Yi, Cuiying; Li, Beibei; Ye, Sheng; Zhang, Rongguang; Xu, Bo; Larhammar, Dan; Stevens, Raymond C.; Huster, Daniel; Meiler, Jens; Zhao, Qiang; Beck-Sickinger, Annette G.; Buschauer, Armin; Wu, Beili</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">556</span>
        (<span class="NLM_cas:issue">7702</span>),
    <span class="NLM_cas:pages">520-524</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Neuropeptide Y (NPY) receptors belong to the G-protein-coupled receptor superfamily and have important roles in food intake, anxiety and cancer biol.1,2.  The NPY-Y receptor system has emerged as one of the most complex networks with three peptide ligands (NPY, peptide YY and pancreatic polypeptide) binding to four receptors in most mammals, namely the Y1, Y2, Y4 and Y5 receptors, with different affinity and selectivity3.  NPY is the most powerful stimulant of food intake and this effect is primarily mediated by the Y1 receptor (Y1R)4.  A no. of peptides and small-mol. compds. have been characterized as Y1R antagonists and have shown clin. potential in the treatment of obesity4, tumor1 and bone loss5.  However, their clin. usage has been hampered by low potency and selectivity, poor brain penetration ability or lack of oral bioavailability6.  Here we report crystal structures of the human Y1R bound to the two selective antagonists UR-MK299 and BMS-193885 at 2.7 and 3.0 Å resoln., resp.  The structures combined with mutagenesis studies reveal the binding modes of Y1R to several structurally diverse antagonists and the determinants of ligand selectivity.  The Y1R structure and mol. docking of the endogenous agonist NPY, together with NMR, photo-crosslinking and functional studies, provide insights into the binding behavior of the agonist and for the first time, to our knowledge, det. the interaction of its N terminus with the receptor.  These insights into Y1R can enable structure-based drug discovery that targets NPY receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr584bBD3wdnbVg90H21EOLACvtfcHk0ljjw5ovs8XnoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXosVCgur8%253D&md5=79289fb85d5f65b94fbf873ec4ea31f3</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fs41586-018-0046-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-018-0046-x%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DKeller%26aufirst%3DM.%26aulast%3DKaiser%26aufirst%3DA.%26aulast%3DBender%26aufirst%3DB.%2BJ.%26aulast%3DBosse%26aufirst%3DM.%26aulast%3DBurkert%26aufirst%3DK.%26aulast%3DK%25C3%25B6gler%26aufirst%3DL.%2BM.%26aulast%3DWifling%26aufirst%3DD.%26aulast%3DBernhardt%26aufirst%3DG.%26aulast%3DPlank%26aufirst%3DN.%26aulast%3DLittmann%26aufirst%3DT.%26aulast%3DSchmidt%26aufirst%3DP.%26aulast%3DYi%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DYe%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DLarhammar%26aufirst%3DD.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DHuster%26aufirst%3DD.%26aulast%3DMeiler%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DBeck-Sickinger%26aufirst%3DA.%2BG.%26aulast%3DBuschauer%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DB.%26atitle%3DStructural%2520basis%2520of%2520ligand%2520binding%2520modes%2520at%2520the%2520neuropeptide%2520Y%2520Y1%2520receptor%26jtitle%3DNature%26date%3D2018%26volume%3D556%26spage%3D520%26epage%3D524%26doi%3D10.1038%2Fs41586-018-0046-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manglik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruse, A. C.</span></span> <span> </span><span class="NLM_article-title">Structural basis for G protein-coupled receptor activation</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">5628</span>– <span class="NLM_lpage">5634</span>, <span class="refDoi"> DOI: 10.1021/acs.biochem.7b00747</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biochem.7b00747" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFygsbzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=5628-5634&author=A.+Manglikauthor=A.+C.+Kruse&title=Structural+basis+for+G+protein-coupled+receptor+activation&doi=10.1021%2Facs.biochem.7b00747"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for G Protein-Coupled Receptor Activation</span></div><div class="casAuthors">Manglik, Aashish; Kruse, Andrew C.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">5628-5634</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  G protein-coupled receptors (GPCRs) are crit. regulators of human physiol. and make up the largest single class of therapeutic drug targets.  Although GPCRs regulate highly diverse physiol., they share a common signaling mechanism whereby extracellular stimuli induce conformational changes in the receptor that enable activation of heterotrimeric G proteins and other intracellular effectors.  Advances in GPCR structural biol. have made it possible to examine ligand-induced GPCR activation at an unprecedented level of detail.  Here, we review the structural basis for family A GPCR activation, with a focus on GPCRs for which structures are available in both active or active-like states and inactive states.  Crystallog. and other biophys. data show how chem. diverse ligands stabilize highly conserved conformational changes on the intracellular side of the receptors, allowing many different extracellular stimuli to utilize shared downstream signaling mols.  Finally, we discuss the remaining challenges in understanding GPCR activation and signaling and highlight new technologies that may allow unanswered questions to be resolved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpo0hYowj_TOrVg90H21EOLACvtfcHk0ljjw5ovs8XnoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFygsbzE&md5=a60243e522dcfe8279d0f74213adfd41</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facs.biochem.7b00747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biochem.7b00747%26sid%3Dliteratum%253Aachs%26aulast%3DManglik%26aufirst%3DA.%26aulast%3DKruse%26aufirst%3DA.%2BC.%26atitle%3DStructural%2520basis%2520for%2520G%2520protein-coupled%2520receptor%2520activation%26jtitle%3DBiochemistry%26date%3D2017%26volume%3D56%26spage%3D5628%26epage%3D5634%26doi%3D10.1021%2Facs.biochem.7b00747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weis, W. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, B. K.</span></span> <span> </span><span class="NLM_article-title">The Molecular Basis of G Protein-Coupled Receptor Activation</span>. <i>Annu. Rev. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">897</span>– <span class="NLM_lpage">919</span>, <span class="refDoi"> DOI: 10.1146/annurev-biochem-060614-033910</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1146%2Fannurev-biochem-060614-033910" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=29925258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFOrsrvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2018&pages=897-919&author=W.+I.+Weisauthor=B.+K.+Kobilka&title=The+Molecular+Basis+of+G+Protein-Coupled+Receptor+Activation&doi=10.1146%2Fannurev-biochem-060614-033910"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The Molecular Basis of G Protein-Coupled Receptor Activation</span></div><div class="casAuthors">Weis, William I.; Kobilka, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">897-919</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  G protein-coupled receptors (GPCRs) mediate the majority of cellular responses to external stimuli.  Upon activation by a ligand, the receptor binds to a partner heterotrimeric G protein and promotes exchange of GTP for GDP, leading to dissocn. of the G protein into α and βγ subunits that mediate downstream signals.  GPCRs can also activate distinct signaling pathways through arrestins.  Active states of GPCRs form by small rearrangements of the ligand-binding, or orthosteric, site that are amplified into larger conformational changes.  Mol. understanding of the allosteric coupling between ligand binding and G protein or arrestin interaction is emerging from structures of several GPCRs crystd. in inactive and active states, spectroscopic data, and computer simulations.  The coupling is loose, rather than concerted, and agonist binding does not fully stabilize the receptor in an active conformation.  Distinct intermediates whose populations are shifted by ligands of different efficacies underlie the complex pharmacol. of GPCRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfSIylPxq7yLVg90H21EOLACvtfcHk0ljjw5ovs8XnoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFOrsrvM&md5=71f1f2d3c1d9be27da70dd472d7d44f2</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1146%2Fannurev-biochem-060614-033910&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-biochem-060614-033910%26sid%3Dliteratum%253Aachs%26aulast%3DWeis%26aufirst%3DW.%2BI.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26atitle%3DThe%2520Molecular%2520Basis%2520of%2520G%2520Protein-Coupled%2520Receptor%2520Activation%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2018%26volume%3D87%26spage%3D897%26epage%3D919%26doi%3D10.1146%2Fannurev-biochem-060614-033910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pluym, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennauer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziemek, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pop, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernhardt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buschauer, A.</span></span> <span> </span><span class="NLM_article-title">Application of the guanidine-acylguanidine bioisosteric approach to argininamide-type NPY Y<sub>2</sub> receptor antagonists</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1727</span>– <span class="NLM_lpage">1738</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201100241</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1002%2Fcmdc.201100241" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=21692185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BC3MXns1Ohu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=1727-1738&author=N.+Pluymauthor=A.+Brennauerauthor=M.+Kellerauthor=R.+Ziemekauthor=N.+Popauthor=G.+Bernhardtauthor=A.+Buschauer&title=Application+of+the+guanidine-acylguanidine+bioisosteric+approach+to+argininamide-type+NPY+Y2+receptor+antagonists&doi=10.1002%2Fcmdc.201100241"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Application of the Guanidine-Acylguanidine Bioisosteric Approach to Argininamide-Type NPY Y2 Receptor Antagonists</span></div><div class="casAuthors">Pluym, Nikola; Brennauer, Albert; Keller, Max; Ziemek, Ralf; Pop, Nathalie; Bernhardt, Guenther; Buschauer, Armin</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1727-1738</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Strongly basic groups such as guanidine moieties are crucial structural elements, but they compromise the drug-likeness of numerous biol. active compds., including ligands of G-protein-coupled receptors (GPCRs).  As part of a project focused on the search for guanidine bioisosteres, argininamide-type neuropeptide Y (NPY) Y2 receptor (Y2R) antagonists related to BIIE0246 were synthesized.  Starting from ornithine derivs., NG-acylated argininamides were obtained by guanidinylation with tailor-made mono-Boc-protected N-acyl-S-methylisothioureas.  The compds. were investigated for Y2R antagonism (calcium assays), Y2R affinity, and NPY receptor subtype selectivity (flow cytometric binding assays).  Most of the NG-substituted (S)-argininamides showed Y2R antagonistic activities and binding affinities similar to those of the parent compd., whereas NG-acylated or -carbamoylated analogs with a terminal amine were superior (Y2R: Ki and KB values in the low nanomolar range).  This demonstrates that the basicity of the compds., although 4-5 orders of magnitude lower than that of guanidines, is sufficient to form key interactions with acidic amino acids of the Y2R.  The acylguanidines bind with high affinity and selectivity to Y2R over the Y1, Y4, and Y5 receptors.  As derivatization of the amino group is tolerated, these compds. can be considered building blocks for the prepn. of versatile fluorescent and radiolabeled pharmacol. tools for in vitro studies of the Y2R.  The results support the concept of bioisosteric guanidine-acylguanidine exchange as a broadly applicable approach to retain pharmacol. activity despite decreased basicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZjDsh58LHYrVg90H21EOLACvtfcHk0lg_cpjN2ITNKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXns1Ohu7Y%253D&md5=949897e2266924e232bceb29e4c368ec</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201100241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201100241%26sid%3Dliteratum%253Aachs%26aulast%3DPluym%26aufirst%3DN.%26aulast%3DBrennauer%26aufirst%3DA.%26aulast%3DKeller%26aufirst%3DM.%26aulast%3DZiemek%26aufirst%3DR.%26aulast%3DPop%26aufirst%3DN.%26aulast%3DBernhardt%26aufirst%3DG.%26aulast%3DBuschauer%26aufirst%3DA.%26atitle%3DApplication%2520of%2520the%2520guanidine-acylguanidine%2520bioisosteric%2520approach%2520to%2520argininamide-type%2520NPY%2520Y2%2520receptor%2520antagonists%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26spage%3D1727%26epage%3D1738%26doi%3D10.1002%2Fcmdc.201100241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ziemek, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennauer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabrele, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck-Sickinger, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernhardt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buschauer, A.</span></span> <span> </span><span class="NLM_article-title">Fluorescence- and luminescence-based methods for the determination of affinity and activity of neuropeptide Y<sub>2</sub> receptor ligands</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>551</i></span>,  <span class="NLM_fpage">10</span>– <span class="NLM_lpage">18</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2006.08.075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1016%2Fj.ejphar.2006.08.075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=17027743" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFKmtbjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=551&publication_year=2006&pages=10-18&author=R.+Ziemekauthor=A.+Brennauerauthor=E.+Schneiderauthor=C.+Cabreleauthor=A.+G.+Beck-Sickingerauthor=G.+Bernhardtauthor=A.+Buschauer&title=Fluorescence-+and+luminescence-based+methods+for+the+determination+of+affinity+and+activity+of+neuropeptide+Y2+receptor+ligands&doi=10.1016%2Fj.ejphar.2006.08.075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorescence- and luminescence-based methods for the determination of affinity and activity of neuropeptide Y2 receptor ligands</span></div><div class="casAuthors">Ziemek, Ralf; Brennauer, Albert; Schneider, Erich; Cabrele, Chiara; Beck-Sickinger, Annette G.; Bernhardt, Guenther; Buschauer, Armin</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">551</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">10-18</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">With respect to the discovery and characterization of neuropeptide Y2 receptor ligands as pharmacol. tools or potential drugs, fluorescence- and luminescence-based assays were developed to det. both the affinity and the activity of receptor agonists and antagonists.  A flow cytometric binding assay is described for the hY2 receptor stably expressed in CHO cells using cy5-labeled porcine neuropeptide Y and compared with a radioligand binding assay.  Binding of the fluorescent ligand was visualized by confocal microscopy.  Stable co-transfection with the chimeric G protein Gqi5 enabled the establishment of a spectrofluorimetric fura-2 and a flow cytometric fluo-4 calcium assay.  Further stable expression of apoaequorin targeted to the mitochondria allowed the establishment of an aequorin assay which could be performed in the 96-well format.  The shape of the concn.-response curves of porcine neuropeptide Y in the presence of the Y2-selective receptor antagonist BIIE0246, characteristic of either competitive or insurmountable antagonism, depended on the period of incubation with the cells.  Functional data of Y2 receptor agonists and antagonists detd. in the fluorescence- and luminescence-based assays were in good agreement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoH4uRfPgP7ErVg90H21EOLACvtfcHk0lg_cpjN2ITNKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFKmtbjP&md5=775c7fe7a28fc6832d5ad54f518dc8a6</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2006.08.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2006.08.075%26sid%3Dliteratum%253Aachs%26aulast%3DZiemek%26aufirst%3DR.%26aulast%3DBrennauer%26aufirst%3DA.%26aulast%3DSchneider%26aufirst%3DE.%26aulast%3DCabrele%26aufirst%3DC.%26aulast%3DBeck-Sickinger%26aufirst%3DA.%2BG.%26aulast%3DBernhardt%26aufirst%3DG.%26aulast%3DBuschauer%26aufirst%3DA.%26atitle%3DFluorescence-%2520and%2520luminescence-based%2520methods%2520for%2520the%2520determination%2520of%2520affinity%2520and%2520activity%2520of%2520neuropeptide%2520Y2%2520receptor%2520ligands%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D551%26spage%3D10%26epage%3D18%26doi%3D10.1016%2Fj.ejphar.2006.08.075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goumain, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voisin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorinet, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ducroc, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsocas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rozé, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouet-Benzineb, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herzog, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramaniam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laburthe, M.</span></span> <span> </span><span class="NLM_article-title">The peptide YY-preferring receptor mediating inhibition of small intestinal secretion is a peripheral Y<sub>2</sub> receptor: pharmacological evidence and molecular cloning</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">124</span>– <span class="NLM_lpage">134</span>, <span class="refDoi"> DOI: 10.1124/mol.60.1.124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1124%2Fmol.60.1.124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=11408607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BD3MXks1CrtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2001&pages=124-134&author=M.+Goumainauthor=T.+Voisinauthor=A.-M.+Lorinetauthor=R.+Ducrocauthor=A.+Tsocasauthor=C.+Roz%C3%A9author=P.+Rouet-Benzinebauthor=H.+Herzogauthor=A.+Balasubramaniamauthor=M.+Laburthe&title=The+peptide+YY-preferring+receptor+mediating+inhibition+of+small+intestinal+secretion+is+a+peripheral+Y2+receptor%3A+pharmacological+evidence+and+molecular+cloning&doi=10.1124%2Fmol.60.1.124"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">The peptide YY-preferring receptor mediating inhibition of small intestinal secretion is a peripheral Y2 receptor: pharmacological evidence and molecular cloning</span></div><div class="casAuthors">Goumain, Mathieu; Voisin, Thierry; Lorinet, Anne-Marie; Ducroc, Robert; Tsocas, Annick; Roze, Claude; Rouet-Benzineb, Patricia; Herzog, Herbert; Balasubramaniam, Ambikaipakan; Laburthe, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">124-134</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A peptide YY (PYY)-preferring receptor [PYY > neuropeptide Y (NPY)] was previously characterized in rat small intestinal crypt cells, where it mediates inhibition of fluid secretion.  Here, the authors investigated the possible status of this receptor as a peripheral Y2 receptor in rats.  Typical Y2 agonists (PYY3-36, NPY3-36, NPY13-36, C2-NPY) and very short PYY analogs (N-α-Ac-PYY22-36 and N-α-Ac-PYY25-36) acting at the intestinal PYY receptor were tested for their ability to inhibit the binding of 125I-PYY to membranes of rat intestinal crypt cells and of CHO cells stably transfected with the rat hippocampal Y2 receptor cDNA.  Similar PYY preference was obsd. and all analogs exhibited comparable high affinity in both binding assays.  The same held true for the specific Y2 antagonist BIIE0246 with a Ki value of 6.5 and 9.0 nM, resp.  BIIE0246 completely abolished the inhibition of cAMP prodn. by PYY in crypt cells and transfected CHO cells.  Moreover, the antagonist considerably reversed the PYY-induced redn. of short-circuit current in rat jejunum mucosa in Ussing chamber and completely abolished the antisecretory action of PYY on vasoactive intestinal peptide (VIP)-induced fluid secretion in rat jejunum in vivo.  Quant. reverse transcription-polymerase chain reaction (RT-PCR) expts. showed that Y2 receptor transcripts were present in intestinal crypt cells (3 × 102 mols./100 ng RNAT) with no expression in villus cells, in complete agreement with the exclusive binding of PYY in crypt cells.  Finally, a full-length Y2 receptor was cloned by RT-PCR from rat intestinal crypt cells and also from human small intestine.  The authors conclude that the so-called PYY-preferring receptor mediating inhibition of intestinal secretion is a peripheral Y2 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxlCwE5p5P77Vg90H21EOLACvtfcHk0lg_cpjN2ITNKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXks1CrtLs%253D&md5=02c2f86e29970d5481e1f76968b8e384</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1124%2Fmol.60.1.124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.60.1.124%26sid%3Dliteratum%253Aachs%26aulast%3DGoumain%26aufirst%3DM.%26aulast%3DVoisin%26aufirst%3DT.%26aulast%3DLorinet%26aufirst%3DA.-M.%26aulast%3DDucroc%26aufirst%3DR.%26aulast%3DTsocas%26aufirst%3DA.%26aulast%3DRoz%25C3%25A9%26aufirst%3DC.%26aulast%3DRouet-Benzineb%26aufirst%3DP.%26aulast%3DHerzog%26aufirst%3DH.%26aulast%3DBalasubramaniam%26aufirst%3DA.%26aulast%3DLaburthe%26aufirst%3DM.%26atitle%3DThe%2520peptide%2520YY-preferring%2520receptor%2520mediating%2520inhibition%2520of%2520small%2520intestinal%2520secretion%2520is%2520a%2520peripheral%2520Y2%2520receptor%253A%2520pharmacological%2520evidence%2520and%2520molecular%2520cloning%26jtitle%3DMol.%2520Pharmacol.%26date%3D2001%26volume%3D60%26spage%3D124%26epage%3D134%26doi%3D10.1124%2Fmol.60.1.124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yung-Chi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prusoff, W. H.</span></span> <span> </span><span class="NLM_article-title">Relationship between the inhibition constant (K<sub>I</sub>) and the concentration of inhibitor which causes 50 per cent inhibition (IC<sub>50</sub>) of an enzymatic reaction</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">3099</span>– <span class="NLM_lpage">3108</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(73)90196-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1016%2F0006-2952%2873%2990196-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=4202581" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&author=C.+Yung-Chiauthor=W.+H.+Prusoff&title=Relationship+between+the+inhibition+constant+%28KI%29+and+the+concentration+of+inhibitor+which+causes+50+per+cent+inhibition+%28IC50%29+of+an+enzymatic+reaction&doi=10.1016%2F0006-2952%2873%2990196-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2873%2990196-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252873%252990196-2%26sid%3Dliteratum%253Aachs%26aulast%3DYung-Chi%26aufirst%3DC.%26aulast%3DPrusoff%26aufirst%3DW.%2BH.%26atitle%3DRelationship%2520between%2520the%2520inhibition%2520constant%2520%2528KI%2529%2520and%2520the%2520concentration%2520of%2520inhibitor%2520which%2520causes%252050%2520per%2520cent%2520inhibition%2520%2528IC50%2529%2520of%2520an%2520enzymatic%2520reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26spage%3D3099%26epage%3D3108%26doi%3D10.1016%2F0006-2952%2873%2990196-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Šali, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blundell, T. L.</span></span> <span> </span><span class="NLM_article-title">Comparative protein modelling by satisfaction of spatial restraints</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>234</i></span>,  <span class="NLM_fpage">779</span>– <span class="NLM_lpage">815</span>, <span class="refDoi"> DOI: 10.1006/jmbi.1993.1626</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1006%2Fjmbi.1993.1626" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=8254673" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADyaK2cXnt1ylug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=234&publication_year=1993&pages=779-815&author=A.+%C5%A0aliauthor=T.+L.+Blundell&title=Comparative+protein+modelling+by+satisfaction+of+spatial+restraints&doi=10.1006%2Fjmbi.1993.1626"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative protein modeling by satisfaction of spatial restraints</span></div><div class="casAuthors">Sali, Andrej; Blundell, Tom L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">234</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">779-815</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    </div><div class="casAbstract">The authors describe a comparative protein modeling method designed to find the most probable structure for a sequence given its alignment with related structures.  The three-dimensional (3D) model is obtained by optimally satisfying spatial restraints derived from the alignment and expressed as probability d. functions (pdfs) for the features restrained.  For example, the probabilities for main-chain conformations of a modelled residue may be restrained by its residue type, main-chain conformation of an equiv. residue in a related protein, and the local similarity between the two sequences.  Several such pdfs are obtained from the correlations between structural features in 17 families of homologous proteins which have been aligned on the basis of their 3D structures.  The pdfs restrain Cα-Cα distances, main-chain N-O distances, main-chain and side-chain dihedral angles.  A smoothing procedure is used in the derivation of these relationships to minimize the problem of a sparse database.  The 3D model of a protein is obtained by optimization of the mol. pdf such that the model violates the input restraints as little as possible.  The mol. pdf is derived as a combination of pdfs restraining individual spatial features of the whole mol.  The optimization procedure is a variable target function method that applies the conjugate gradients algorithm to positions of all non-hydrogen atoms.  The method is automated and is illustrated by the modeling of trypsin from two other serine proteinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC4wGhwZvib7Vg90H21EOLACvtfcHk0lgAPK1xcRct8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXnt1ylug%253D%253D&md5=d4a3c39b2205e36221dc187a3d1a478b</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1993.1626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1993.1626%26sid%3Dliteratum%253Aachs%26aulast%3D%25C5%25A0ali%26aufirst%3DA.%26aulast%3DBlundell%26aufirst%3DT.%2BL.%26atitle%3DComparative%2520protein%2520modelling%2520by%2520satisfaction%2520of%2520spatial%2520restraints%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1993%26volume%3D234%26spage%3D779%26epage%3D815%26doi%3D10.1006%2Fjmbi.1993.1626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pettersen, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goddard, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couch, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenblatt, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrin, T. E.</span></span> <span> </span><span class="NLM_article-title">UCSF Chimera?A visualization system for exploratory research and analysis</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1605</span>– <span class="NLM_lpage">1612</span>, <span class="refDoi"> DOI: 10.1002/jcc.20084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1002%2Fjcc.20084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=15264254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvVOhsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=1605-1612&author=E.+F.+Pettersenauthor=T.+D.+Goddardauthor=C.+C.+Huangauthor=G.+S.+Couchauthor=D.+M.+Greenblattauthor=E.+C.+Mengauthor=T.+E.+Ferrin&title=UCSF+Chimera%3FA+visualization+system+for+exploratory+research+and+analysis&doi=10.1002%2Fjcc.20084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">UCSF Chimera-A visualization system for exploratory research and analysis</span></div><div class="casAuthors">Pettersen, Eric F.; Goddard, Thomas D.; Huang, Conrad C.; Couch, Gregory S.; Greenblatt, Daniel M.; Meng, Elaine C.; Ferrin, Thomas E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1605-1612</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The design, implementation, and capabilities of an extensible visualization system, UCSF Chimera, are discussed.  Chimera is segmented into a core that provides basic services and visualization, and extensions that provide most higher level functionality.  This architecture ensures that the extension mechanism satisfies the demands of outside developers who wish to incorporate new features.  Two unusual extensions are presented: Multiscale, which adds the ability to visualize large-scale mol. assemblies such as viral coats, and Collab., which allows researchers to share a Chimera session interactively despite being at sep. locales.  Other extensions include Multalign Viewer, for showing multiple sequence alignments and assocd. structures; ViewDock, for screening docked ligand orientations; Movie, for replaying mol. dynamics trajectories; and Vol. Viewer, for display and anal. of volumetric data.  A discussion of the usage of Chimera in real-world situations is given, along with anticipated future directions.  Chimera includes full user documentation, is free to academic and nonprofit users, and is available for Microsoft Windows, Linux, Apple Mac OS X, SGI IRIX, and HP Tru64 Unix from http://www.cgl.ucsf.edu/chimera/.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFmD4M5S0cPbVg90H21EOLACvtfcHk0lgAPK1xcRct8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvVOhsbs%253D&md5=944b175f440c1ff323705987cf937ee7</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2Fjcc.20084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.20084%26sid%3Dliteratum%253Aachs%26aulast%3DPettersen%26aufirst%3DE.%2BF.%26aulast%3DGoddard%26aufirst%3DT.%2BD.%26aulast%3DHuang%26aufirst%3DC.%2BC.%26aulast%3DCouch%26aufirst%3DG.%2BS.%26aulast%3DGreenblatt%26aufirst%3DD.%2BM.%26aulast%3DMeng%26aufirst%3DE.%2BC.%26aulast%3DFerrin%26aufirst%3DT.%2BE.%26atitle%3DUCSF%2520Chimera%253FA%2520visualization%2520system%2520for%2520exploratory%2520research%2520and%2520analysis%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2004%26volume%3D25%26spage%3D1605%26epage%3D1612%26doi%3D10.1002%2Fjcc.20084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 2 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Tobias F. Fischer, Clara T. Schoeder, Tristan Zellmann, Jan Stichel, Jens Meiler, <span class="NLM_string-name hlFld-ContribAuthor">Annette G. Beck-Sickinger</span>. </span><span class="cited-content_cbyCitation_article-title">Cyclic Analogues of the Chemerin C-Terminus Mimic a Loop Conformation Essential for Activating the Chemokine-like Receptor 1. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (6)
                                     , 3048-3058. <a href="https://doi.org/10.1021/acs.jmedchem.0c01804" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01804</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01804%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCyclic%252BAnalogues%252Bof%252Bthe%252BChemerin%252BC-Terminus%252BMimic%252Ba%252BLoop%252BConformation%252BEssential%252Bfor%252BActivating%252Bthe%252BChemokine-like%252BReceptor%252B1%26aulast%3DFischer%26aufirst%3DTobias%2BF.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D15102020%26date%3D11032021%26volume%3D64%26issue%3D6%26spage%3D3048%26epage%3D3058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Corinna Schüß, Oanh Vu, Mario Schubert, Yu Du, Nigam M. Mishra, Iain R. Tough, Jan Stichel, C. David Weaver, Kyle A. Emmitte, Helen M. Cox, Jens Meiler, <span class="NLM_string-name hlFld-ContribAuthor">Annette G. Beck-Sickinger</span>. </span><span class="cited-content_cbyCitation_article-title">Highly Selective Y4 Receptor Antagonist Binds in an Allosteric Binding Pocket. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (5)
                                     , 2801-2814. <a href="https://doi.org/10.1021/acs.jmedchem.0c02000" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02000</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02000%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHighly%252BSelective%252BY4%252BReceptor%252BAntagonist%252BBinds%252Bin%252Ban%252BAllosteric%252BBinding%252BPocket%26aulast%3DSch%25C3%25BC%25C3%259F%26aufirst%3DCorinna%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D30112020%26date%3D17022021%26volume%3D64%26issue%3D5%26spage%3D2801%26epage%3D2814" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00426/20200806/images/medium/jm0c00426_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00426/20200806/images/large/jm0c00426_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00426&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00426/20200806/images/medium/jm0c00426_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00426/20200806/images/large/jm0c00426_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures and reported Y<sub>4</sub>R affinities of hPP, the Y<sub>4</sub>R (partial) agonists <b>1</b>–<b>6</b>, and the nonpeptide Y<sub>4</sub>R antagonist <b>7</b>. <sup>a</sup>Kuhn et al.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a><sup>b</sup>Kuhn et al.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a><sup>c</sup>Daniels et al.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a><sup>d</sup>Keller et al.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00426/20200806/images/large/jm0c00426_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00426&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00426/20200806/images/medium/jm0c00426_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00426/20200806/images/large/jm0c00426_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Peptide sequences of the lead compound <b>1</b> and the synthesized analogues <b>8</b>–<b>35</b>. Amino acid replacements or insertions are highlighted in blue (compared to <b>1</b>) and red (compared to compound <b>29</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00426/20200806/images/large/jm0c00426_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00426&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00426/20200806/images/medium/jm0c00426_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00426/20200806/images/large/jm0c00426_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of the Oligopeptides <b>8</b>–<b>35</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00426/20200806/images/large/jm0c00426_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00426&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) peptide elongation, amino acid coupling: Fmoc amino acid/HOBt/HBTU/DIPEA (5/5/4.9/10 equiv), DMF/NMP (8:2), 35 °C, and 2 × 45 min (“double” coupling); Fmoc deprotection: 20% piperidine in DMF/NMP (8:2), rt, and 2 × 10 min; (b) (1) TFA/CH<sub>2</sub>Cl<sub>2</sub> (1:3), rt, and 2 × 20 min; (2) TFA/H<sub>2</sub>O (95:5), rt, and 5 h; (c) acetic anhydride/DIPEA (10/10 equiv), DMF/NMP (8:2), 35 °C, and 45 min; (d) succinic anhydride/DIPEA (10/10 equiv), DMF/NMP (8:2), 35 °C, and 45 min; and (e) Fmoc-N(Me)-Arg(Pbf)-OH/HOBt/HBTU/DIPEA (5/5/4.9/10 equiv), DMF/NMP (8:2), 35 °C, and 24 h (single coupling); for overall yields of peptide syntheses, see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>.</p></p></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00426/20200806/images/medium/jm0c00426_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00426/20200806/images/large/jm0c00426_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. CECs of hPP, <b>1</b>, <b>13</b>, <b>17</b>, <b>23</b>, <b>25</b>, and <b>29</b> obtained from a hY<sub>4</sub>R β-arrestin 1 recruitment (A), hY<sub>4</sub>R β-arrestin 2 recruitment (B), and hY<sub>4</sub>R Ca<sup>2+</sup>–aequorin (C) assay performed with live HEK293T-ARRB1-Y<sub>4</sub>R cells, HEK293T-ARRB2-Y<sub>4</sub>R cells, and CHO-hY<sub>4</sub>-G<sub>qi5</sub>-mtAEQ cells, respectively. Data represent means ± SEM from at least three independent experiments, each performed in triplicate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00426/20200806/images/large/jm0c00426_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00426&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00426/20200806/images/medium/jm0c00426_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00426/20200806/images/large/jm0c00426_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Inhibitory effects of <b>12</b>, <b>13</b>, <b>25</b>, <b>26</b>, and <b>28</b> on hPP-stimulated hY<sub>4</sub>R activation determined in hY<sub>4</sub>R β-arrestin 1 (A,B), hY<sub>4</sub>R β-arrestin 2 (C), and hY<sub>4</sub>R Ca<sup>2+</sup>–aequorin (D,E) assay performed with live HEK293T-ARRB1-Y<sub>4</sub>R cells, HEK293T-ARRB2-Y<sub>4</sub>R cells, and CHO-hY<sub>4</sub>R-G<sub>qi5</sub>-mtAEQ cells, respectively. (A) Inhibition of β-arrestin 1 recruitment, elicited by 10 nM hPP, by <b>12</b>, <b>13</b>, <b>25</b>, <b>26</b>, and <b>28</b>. (B) Effect of <b>13</b> (10 μM) on the β-arrestin 1 recruitment CEC of hPP. The p<i>K</i><sub>b</sub> value of <b>13</b>, calculated based on the rightward shift of the CEC according to the Gaddum equation,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> amounted to 6.63 ± 0.03 (mean ± SEM from three independent experiments). (C) Inhibition of β-arrestin 2 recruitment, elicited by 10 nM hPP, by <b>12</b>, <b>13</b>, <b>25</b>, <b>26</b>, and <b>28</b>. (D) Inhibition of the intracellular Ca<sup>2+</sup> mobilization, induced by 100 nM hPP, by <b>12</b>, <b>13</b>, <b>25</b>, <b>26</b>, and <b>28</b>. (E) Effect of <b>13</b> (10 μM) on the intracellular Ca<sup>2+</sup> mobilization CEC of hPP. The p<i>K</i><sub>b</sub> value of <b>13</b>, calculated based on the rightward shift of the CEC according to the Gaddum equation,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> amounted to 7.05 ± 0.05 (mean ± SEM from three independent experiments). Data in A–E represent means ± SEM from at least three independent experiments performed in triplicate. Note: Because of higher apparent potencies of hPP in the arrestin assays (pEC<sub>50</sub> = 8.66 and 8.37, respectively), compared to the Ca<sup>2+</sup> aequorin assay (pEC<sub>50</sub> = 7.96), different hPP concentrations (10 vs 100 nM) were used for the antagonist mode.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00426/20200806/images/large/jm0c00426_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00426&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00426/20200806/images/medium/jm0c00426_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00426/20200806/images/large/jm0c00426_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Induced-fit docking poses of the Y<sub>4</sub>R agonists <b>1</b> and <b>29</b> as well as of the antagonist <b>13</b> at the homology models of hY<sub>4</sub>R. (A) Binding pose of <b>1</b> (shown in cyan) at a Y<sub>4</sub>R homology model generated from the active state κ opioid receptor crystal structure (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6B73">6B73</a>, chain A).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> (B) Binding pose of <b>29</b> (shown in purple) at the active state Y<sub>4</sub>R homology model used for docking of <b>1</b> (A). (C) Binding pose of <b>13</b> (shown in green) at a Y<sub>4</sub>R homology model generated from the inactive state hY<sub>1</sub>R crystal structure (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5ZBQ">5ZBQ</a>).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Nitrogen and oxygen atoms are shown in blue and red, respectively. Carbon atoms of receptor amino acids are shown in gray. Yellow dashed lines indicate the H-bonds and salt bridges.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00426/20200806/images/large/jm0c00426_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00426&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i61">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34536" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34536" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 35 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramaniam, A.</span></span> <span> </span><span class="NLM_article-title">Neuropeptide Y family of hormones: receptor subtypes and antagonists</span>. <i>Peptides</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">445</span>– <span class="NLM_lpage">457</span>, <span class="refDoi"> DOI: 10.1016/s0196-9781(96)00347-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1016%2FS0196-9781%2896%2900347-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=9145434" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADyaK2sXivFCrsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1997&pages=445-457&author=A.+Balasubramaniam&title=Neuropeptide+Y+family+of+hormones%3A+receptor+subtypes+and+antagonists&doi=10.1016%2Fs0196-9781%2896%2900347-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Neuropeptide Y family of hormones: receptor subtypes and antagonists</span></div><div class="casAuthors">Balasubramaniam, Ambikaipakan</div><div class="citationInfo"><span class="NLM_cas:title">Peptides (Tarrytown, New York)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">445-457</span>CODEN:
                <span class="NLM_cas:coden">PPTDD5</span>;
        ISSN:<span class="NLM_cas:issn">0196-9781</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review, with 158 refs.  Neuropeptide Y (NPY) is the most abundant peptide present in the mammalian central and peripheral nervous system.  NPY exhibits a variety of potent central and peripheral effects including those on feeding, memory, blood pressure, cardiac contractility and intestinal secretions.  Classical pharmacol. studies have shown that NPY effects are mediated by four different receptor subtypes, Y-1, Y-1-like, Y-2, and Y-3.  However, the existence of numerous atypical activities provide strong evidence for the occurrence of addnl. NPY receptor subtypes.  Pharmacol. studies have further been facilitated by the recent cloning and expression of Y-1, Y-2, Y-4 (PP-1) and Y-5 receptors.  Moreover, the cloned Y-5 receptor has been suggested to be the long awaited Y-1-like receptor involved in feeding.  Structure-activity studies have laid a good foundation towards the development of receptor selective compds., and to date potent Y-1 selective peptide and nonpeptide antagonists have been developed.  The need to clone numerous receptor subtypes and to develop receptor selective compds. for physiol. and perhaps clin. use is expected to keep NPY research active for many years to come.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqgwtwgwhq97Vg90H21EOLACvtfcHk0lifeFkCPyzQTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXivFCrsbo%253D&md5=28c9951c2704cb3aef8af788ab548b6b</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0196-9781%2896%2900347-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0196-9781%252896%252900347-6%26sid%3Dliteratum%253Aachs%26aulast%3DBalasubramaniam%26aufirst%3DA.%26atitle%3DNeuropeptide%2520Y%2520family%2520of%2520hormones%253A%2520receptor%2520subtypes%2520and%2520antagonists%26jtitle%3DPeptides%26date%3D1997%26volume%3D18%26spage%3D445%26epage%3D457%26doi%3D10.1016%2Fs0196-9781%2896%2900347-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cabrele, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck-Sickinger, A. G.</span></span> <span> </span><span class="NLM_article-title">Molecular characterization of the ligand-receptor interaction of the neuropeptide Y family</span>. <i>J. Pept. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">97</span>– <span class="NLM_lpage">122</span>, <span class="refDoi"> DOI: 10.1002/(sici)1099-1387(200003)6:3<97::aid-psc236>3.0.co;2-e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1002%2F%28SICI%291099-1387%28200003%296%3A3%3C97%3A%3AAID-PSC236%3E3.0.CO%3B2-E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10759209" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BD3cXitlGitrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=97-122&author=C.+Cabreleauthor=A.+G.+Beck-Sickinger&title=Molecular+characterization+of+the+ligand-receptor+interaction+of+the+neuropeptide+Y+family&doi=10.1002%2F%28sici%291099-1387%28200003%296%3A3%3C97%3A%3Aaid-psc236%3E3.0.co%3B2-e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular characterization of the ligand-receptor interaction of the neuropeptide Y family</span></div><div class="casAuthors">Cabrele, Chiara; Beck-Sickinger, Annette G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Peptide Science</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">97-122</span>CODEN:
                <span class="NLM_cas:coden">JPSIEI</span>;
        ISSN:<span class="NLM_cas:issn">1075-2617</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review with 105 refs.  Neuropeptide Y (NPY), peptide YY (PYY) and pancreatic polypeptide (PP) belong to the NPY hormone family and activate a class of receptors called the Y-receptors, and also belong to the large superfamily of the G-protein coupled receptors.  Structure-affinity and structure-activity relationship studies of peptide analogs, combined with studies based on site-directed mutagenesis and anti-receptor antibodies, have given insight into the individual characterization of each receptor subtype relative to its interaction with the ligand, as well as to its biol. function.  A no. of selective antagonists at the Y1-receptor are available whose structures resemble that of the C-terminus of NPY.  Some of these compds., like BIBP3226, BIBO3304 and GW1229, have recently been used for in vivo investigations of the NPY-induced increase in food intake.  Y2-receptor selective agonists are the analog cyclo-(28/32)-Ac[Lys28-Glu32]-(25-36)-pNPY and the TASP mol. contg. two units of the NPY segment 21-36.  Now the first antagonist with nanomolar affinity for the Y2-receptor is also known, BIIE0246.  So far, the native peptide PP has been shown to be the most potent ligand at the Y4-receptor.  However, by the design of PP/NPY chimera, some analogs have been found that bind not only to the Y4-, but also to the Y5-receptor with subnanomolar affinities, and are as potent as NPY at the Y1-receptor.  For the characterization of the Y5-receptor in vitro and in vivo, a new class of highly selective agonists is now available.  This consists of analogs of NPY and of PP/NPY chimera which all contain the motif Ala31-Aib32.  This motif has been shown to induce a 310-helical turn in the region 28-31 of NPY and is suggested to be the key motif for high Y5-receptor selectivity.  The results of feeding expts. in rats treated with the first highly specific Y5-receptor agonists support the hypothesis that this receptor plays a role in the NPY-induced stimulation of food intake.  In conclusion, the selective compds. for the different Y-receptor subtypes known so far are promising tools for a better understanding of the physiol. properties of the hormones of the NPY family and related receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTTPSBO6cl_rVg90H21EOLACvtfcHk0lifeFkCPyzQTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXitlGitrs%253D&md5=4a0fbcaeb80999b6f6a8f0575c78f1f3</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291099-1387%28200003%296%3A3%3C97%3A%3AAID-PSC236%3E3.0.CO%3B2-E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291099-1387%2528200003%25296%253A3%253C97%253A%253AAID-PSC236%253E3.0.CO%253B2-E%26sid%3Dliteratum%253Aachs%26aulast%3DCabrele%26aufirst%3DC.%26aulast%3DBeck-Sickinger%26aufirst%3DA.%2BG.%26atitle%3DMolecular%2520characterization%2520of%2520the%2520ligand-receptor%2520interaction%2520of%2520the%2520neuropeptide%2520Y%2520family%26jtitle%3DJ.%2520Pept.%2520Sci.%26date%3D2000%26volume%3D6%26spage%3D97%26epage%3D122%26doi%3D10.1002%2F%28sici%291099-1387%28200003%296%3A3%3C97%3A%3Aaid-psc236%3E3.0.co%3B2-e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cerdá-Reverter, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larhammar, D.</span></span> <span> </span><span class="NLM_article-title">cNeuropeptide Y family of peptides: Structure, anatomical expression, function, and molecular evolution</span>. <i>Biochem. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">371</span>– <span class="NLM_lpage">392</span>, <span class="refDoi"> DOI: 10.1139/o00-004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1139%2Fo00-004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10949087" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BD3cXltlKntbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2000&pages=371-392&author=J.+M.+Cerd%C3%A1-Reverterauthor=D.+Larhammar&title=cNeuropeptide+Y+family+of+peptides%3A+Structure%2C+anatomical+expression%2C+function%2C+and+molecular+evolution&doi=10.1139%2Fo00-004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Neuropeptide Y family of peptides: structure, anatomical expression, function, and molecular evolution</span></div><div class="casAuthors">Cerda-Reverter, Jose Miguel; Larhammar, Dan</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry and Cell Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">371-392</span>CODEN:
                <span class="NLM_cas:coden">BCBIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0829-8211</span>.
    
            (<span class="NLM_cas:orgname">National Research Council of Canada</span>)
        </div><div class="casAbstract">A review with ∼195 refs.  Evolutionary relationships between neuroendocrine peptides are often difficult to resolve across divergent phyla due to independent duplication events in different lineages.  Thanks to peptide purifn. and mol. cloning in many different species, the situation is beginning to clear for the neuropeptide Y (NPY) family, which also includes peptide YY (PYY), the tetrapod pancreatic polypeptide (PP) and the fish pancreatic peptide Y (PY).  It has long been assumed that the first duplication to occur in vertebrate evolution generated NPY and PYY, as both of these are found in all gnathostomes as well as lamprey.  Evidence from other gene families show that this duplication was probably a chromosome duplication event.  The origin of a second PYY peptide found in lamprey remains to be explained.  The authors' recent cloning of NPY, PYY and PY in the sea bass proves that fish PY is a sep. gene product.  The authors favor the hypothesis that PY is a duplicate of the PYY gene and that it may have occurred late in fish evolution, as PY has so far only been found in acanthomorph fishes.  Thus, this duplication seems to be independent of the one that generate PP from PYY in tetrapods, although both tetrapod PP and fish PY are expressed in the pancreas.  Studies in the sea bass and other fish show that PY, in contrast to PP, is expressed in the nervous system.  The authors review the literature on the distribution and functional aspects of the various NPY-family peptides in vertebrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDB2kgzc6rSLVg90H21EOLACvtfcHk0lifeFkCPyzQTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXltlKntbw%253D&md5=170569e4b124d78cca3ed3f83cc2337f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1139%2Fo00-004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1139%252Fo00-004%26sid%3Dliteratum%253Aachs%26aulast%3DCerd%25C3%25A1-Reverter%26aufirst%3DJ.%2BM.%26aulast%3DLarhammar%26aufirst%3DD.%26atitle%3DcNeuropeptide%2520Y%2520family%2520of%2520peptides%253A%2520Structure%252C%2520anatomical%2520expression%252C%2520function%252C%2520and%2520molecular%2520evolution%26jtitle%3DBiochem.%2520Cell%2520Biol.%26date%3D2000%26volume%3D78%26spage%3D371%26epage%3D392%26doi%3D10.1139%2Fo00-004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bijker, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herzog, H.</span></span> <span> </span><span class="NLM_article-title">The neuropeptide Y system: pathophysiological and therapeutic implications in obesity and cancer</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">91</span>– <span class="NLM_lpage">113</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2011.03.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1016%2Fj.pharmthera.2011.03.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=21439311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsVyltbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2011&pages=91-113&author=L.+Zhangauthor=M.+S.+Bijkerauthor=H.+Herzog&title=The+neuropeptide+Y+system%3A+pathophysiological+and+therapeutic+implications+in+obesity+and+cancer&doi=10.1016%2Fj.pharmthera.2011.03.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The neuropeptide Y system: Pathophysiological and therapeutic implications in obesity and cancer</span></div><div class="casAuthors">Zhang, Lei; Bijker, Martijn S.; Herzog, Herbert</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-113</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The neuropeptide Y (NPY) system - comprising of neuropeptide Y, peptide YY, pancreatic polypeptide and the corresponding Y receptors through which they act (Y1, Y2, Y4, Y5 and y6) - is well known for its role in the regulation of energy homeostasis and assocd. processes.  Dysfunctions of the system have been implicated in human diseases such as obesity and cancer, raising the possibility that correction of the system may provide therapeutic benefits for these diseases.  In addn. to the regulation of appetite and satiety that has attracted most attention during the past years, insight has also been gained into the crit. role of NPY in the control of energy expenditure, oxidative fuel selection and bone metab.  Studies using conditional knockout models further shed light on the central vs. peripheral, and hypothalamic vs. extra-hypothalamic mechanisms of these regulatory effects of NPY.  Moreover, a role of NPY family peptides and Y receptors in modulating the growth of tumors has emerged.  These findings provide the basis for novel NPY system-targeted strategies to treat obesity as well as cancer.  Such strategies include modifying both sides of the energy balance equation - energy intake vs. energy expenditure - to achieve a greater wt./fat loss by particularly modulating peripheral Y receptor(s) to ameliorate metabolic conditions without interfering with central functions of Y receptors.  In addn., targeting multiple Y receptors and/or multiple systems involved in the regulation of energy balance will have greater beneficial effects.  However, long-term interference with the NPY system to target obesity or cancer related aspects needs to consider potential side effects on bone health.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnPMeJgSGUdLVg90H21EOLACvtfcHk0ljkS9qiM0leuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsVyltbY%253D&md5=9817e55c615e9d6084fe17b71ff85d7d</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2011.03.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2011.03.011%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DBijker%26aufirst%3DM.%2BS.%26aulast%3DHerzog%26aufirst%3DH.%26atitle%3DThe%2520neuropeptide%2520Y%2520system%253A%2520pathophysiological%2520and%2520therapeutic%2520implications%2520in%2520obesity%2520and%2520cancer%26jtitle%3DPharmacol.%2520Ther.%26date%3D2011%26volume%3D131%26spage%3D91%26epage%3D113%26doi%3D10.1016%2Fj.pharmthera.2011.03.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lundell, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blomqvist, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berglund, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schober, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Statnick, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gadski, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gehlert, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larhammar, D.</span></span> <span> </span><span class="NLM_article-title">Cloning of a human receptor of the NPY receptor family with high affinity for pancreatic polypeptide and peptide YY</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>270</i></span>,  <span class="NLM_fpage">29123</span>– <span class="NLM_lpage">29128</span>, <span class="refDoi"> DOI: 10.1074/jbc.270.49.29123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1074%2Fjbc.270.49.29123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=7493937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADyaK2MXpvVOhur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=29123-29128&author=I.+Lundellauthor=A.+G.+Blomqvistauthor=M.+M.+Berglundauthor=D.+A.+Schoberauthor=D.+Johnsonauthor=M.+A.+Statnickauthor=R.+A.+Gadskiauthor=D.+R.+Gehlertauthor=D.+Larhammar&title=Cloning+of+a+human+receptor+of+the+NPY+receptor+family+with+high+affinity+for+pancreatic+polypeptide+and+peptide+YY&doi=10.1074%2Fjbc.270.49.29123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning of a human receptor of the NPY receptor family with high affinity for pancreatic polypeptide and peptide YY</span></div><div class="casAuthors">Lundell, Ingrid; Blomqvist, Anders G.; Berglund, Magnus M.; Schober, Douglas A.; Johnson, Dwayne; Statnick, Michael A.; Gadski, Robert A.; Gehlert, Donald R.; Larhammar, Dan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">270</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">29123-8</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Neuropeptide Y (NPY), peptide YY (PYY), and pancreatic polypeptide (PP) are structurally related peptides found in all higher vertebrates.  NPY is expressed exclusively in neurons, whereas PYY and PP are produced primarily in gut endocrine cells.  Several receptor subtypes have been identified pharmacol., but only the NPY/PYY receptor of subtype Y1 has been cloned.  This is a heptahelix receptor that couples to G proteins.  Y1 sequence information from several species was used to clone a novel human receptor with 43% amino acid sequence identity to human Y1 and 53% identity in the transmembrane regions.  The novel receptor displays a pharmacol. profile that distinguishes it from all previously described NPY family receptors.  It binds PP with an affinity (Ki) of 13.8 pM, PYY with 1.44 nM, and NPY with 9.9 nM.  Because these data may identify the receptor as primarily a PP receptor, it was named PP1.  In stably transfected Chinese hamster ovary cells the PP1 receptor inhibits forskolin-stimulated cAMP synthesis.  Northern hybridization detected mRNA in colon, small intestine, pancreas, and prostate.  As all 3 peptides are present in the gut through either endocrine release or innervation, all 3 peptides may be physiol. ligands to the novel NPY family receptor PP1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnHHWYcnZBWbVg90H21EOLACvtfcHk0ljkS9qiM0leuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXpvVOhur0%253D&md5=561908b5e42dd89fe52df37f27f3f9d8</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1074%2Fjbc.270.49.29123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.270.49.29123%26sid%3Dliteratum%253Aachs%26aulast%3DLundell%26aufirst%3DI.%26aulast%3DBlomqvist%26aufirst%3DA.%2BG.%26aulast%3DBerglund%26aufirst%3DM.%2BM.%26aulast%3DSchober%26aufirst%3DD.%2BA.%26aulast%3DJohnson%26aufirst%3DD.%26aulast%3DStatnick%26aufirst%3DM.%2BA.%26aulast%3DGadski%26aufirst%3DR.%2BA.%26aulast%3DGehlert%26aufirst%3DD.%2BR.%26aulast%3DLarhammar%26aufirst%3DD.%26atitle%3DCloning%2520of%2520a%2520human%2520receptor%2520of%2520the%2520NPY%2520receptor%2520family%2520with%2520high%2520affinity%2520for%2520pancreatic%2520polypeptide%2520and%2520peptide%2520YY%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1995%26volume%3D270%26spage%3D29123%26epage%3D29128%26doi%3D10.1074%2Fjbc.270.49.29123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thieme, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jolly, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madsen, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellmann-Sickert, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holst, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck-Sickinger, A. G.</span></span> <span> </span><span class="NLM_article-title">High molecular weight PEGylation of human pancreatic polypeptide at position 22 improves stability and reduces food intake in mice</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>173</i></span>,  <span class="NLM_fpage">3208</span>– <span class="NLM_lpage">3221</span>, <span class="refDoi"> DOI: 10.1111/bph.13582</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1111%2Fbph.13582" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=27545829" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlOmurvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2016&pages=3208-3221&author=V.+Thiemeauthor=N.+Jollyauthor=A.+N.+Madsenauthor=K.+Bellmann-Sickertauthor=T.+W.+Schwartzauthor=B.+Holstauthor=H.+M.+Coxauthor=A.+G.+Beck-Sickinger&title=High+molecular+weight+PEGylation+of+human+pancreatic+polypeptide+at+position+22+improves+stability+and+reduces+food+intake+in+mice&doi=10.1111%2Fbph.13582"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">High molecular weight PEGylation of human pancreatic polypeptide at position 22 improves stability and reduces food intake in mice</span></div><div class="casAuthors">Thieme, V.; Jolly, N.; Madsen, A. N.; Bellmann-Sickert, K.; Schwartz, T. W.; Holst, B.; Cox, H. M.; Beck-Sickinger, A. G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">3208-3221</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Human pancreatic polypeptide (hPP) is known to suppress appetite and food intake, thereby representing a potential therapeutic approach against obesity and assocd. metabolic disorders.  The aim of this study was to improve hPP stability by covalent PEGylation with diverse mol. wt. polyethylene glycols (PEG) at two positions using promising lead structures while maintaining target activity.  Modified peptides were synthesized by combined solid- and soln.-phase peptide synthesis.  Their potency was investigated in constitutively expressing human epithelial cells and isolated human colonic mucosa as well as receptor-transfected artificial cell lines.  Human blood plasma and porcine liver homogenates were used to examine the in vitro stability of the analogs.  The most promising variants were injected s.c. in C57BL/6JRj mice to monitor fasting-induced food intake and bioavailability.  In human epithelia and colonic mucosal prepns., activity dependence on the core sequence and latency related to PEG size were obsd.  Peptides modified with a 22 kDa PEG (PEG22) remained intact in blood plasma and homogenized liver exts. for more than 96 h.  Finally, hPP2-36, K22[(PEG22)]hPP2-36 and [K22(PEG22),Q34]hPP significantly reduced cumulative food intake in mice over 16 h after s.c. administration.  Modification with PEG22 at position 22 stabilizes hPP significantly while extending its biol. activities and could be used in drug development prospectively.  This article is protected by copyright.  All rights reserved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZRUEJebIUzLVg90H21EOLACvtfcHk0ljkS9qiM0leuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlOmurvE&md5=22d740a69e600df695bed4261db53186</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1111%2Fbph.13582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.13582%26sid%3Dliteratum%253Aachs%26aulast%3DThieme%26aufirst%3DV.%26aulast%3DJolly%26aufirst%3DN.%26aulast%3DMadsen%26aufirst%3DA.%2BN.%26aulast%3DBellmann-Sickert%26aufirst%3DK.%26aulast%3DSchwartz%26aufirst%3DT.%2BW.%26aulast%3DHolst%26aufirst%3DB.%26aulast%3DCox%26aufirst%3DH.%2BM.%26aulast%3DBeck-Sickinger%26aufirst%3DA.%2BG.%26atitle%3DHigh%2520molecular%2520weight%2520PEGylation%2520of%2520human%2520pancreatic%2520polypeptide%2520at%2520position%252022%2520improves%2520stability%2520and%2520reduces%2520food%2520intake%2520in%2520mice%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2016%26volume%3D173%26spage%3D3208%26epage%3D3221%26doi%3D10.1111%2Fbph.13582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asakawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaolu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoshiki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ushikai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheriff, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramaniam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inui, A.</span></span> <span> </span><span class="NLM_article-title">Regulatory effects of Y<sub>4</sub> receptor agonist (BVD-74D) on food intake</span>. <i>Peptides</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1706</span>– <span class="NLM_lpage">1710</span>, <span class="refDoi"> DOI: 10.1016/j.peptides.2010.06.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1016%2Fj.peptides.2010.06.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=20600429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVaqurrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=1706-1710&author=J.-B.+Liauthor=A.+Asakawaauthor=M.+Terashiauthor=K.+Chengauthor=H.+Chaoluauthor=T.+Zoshikiauthor=M.+Ushikaiauthor=S.+Sheriffauthor=A.+Balasubramaniamauthor=A.+Inui&title=Regulatory+effects+of+Y4+receptor+agonist+%28BVD-74D%29+on+food+intake&doi=10.1016%2Fj.peptides.2010.06.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Regulatory effects of Y4 receptor agonist (BVD-74D) on food intake</span></div><div class="casAuthors">Li, Jiang-Bo; Asakawa, Akihiro; Terashi, Mutsumi; Cheng, Kai-Chun; Chaolu, Huhe; Zoshiki, Takahiro; Ushikai, Miharu; Sheriff, Sulaiman; Balasubramaniam, Ambikaipakan; Inui, Akio</div><div class="citationInfo"><span class="NLM_cas:title">Peptides (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1706-1710</span>CODEN:
                <span class="NLM_cas:coden">PPTDD5</span>;
        ISSN:<span class="NLM_cas:issn">0196-9781</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The objective of this study was to clarify the role of a novel agonist with high selectivity and affinity for Y4 receptors in the regulation of food intake.  The Y4 receptor agonist BVD-74D was administered to C57BL/6J mice that were fed with a normal or high-fat diet, and to fatty liver Shionogi (FLS)-ob/ob mice; the food intake, water intake, and body wt. gain were measured in these mice.  In the mice fed with a normal diet, the cumulative food intake significantly decreased at 20 min and 1 h after the administration of 1 mg/kg of BVD-74D and at 1, 2, 4, 8, and 24 h after the administration of 10 mg/kg of BVD-74D.  Moreover, the cumulative water intake and body wt. gain significantly decreased in these mice.  Among the mice that were fed with a high-fat diet, the cumulative food intake and water intake significantly decreased 1, 2, and 4 h after BVD-74D (10 mg/kg) administration.  Furthermore, the cumulative food intake significantly decreased 2 and 4 h after BVD-74D (10 mg/kg) administration in the FLS-ob/ob mice.  Thus, we propose that the novel Y4 receptor agonist BVD-74D has suppressive effects on food intake, water intake, and wt. gain in normal mice fed with normal diets and on food intake in normal mice fed with high-fat diets and in FLS-ob/ob mice.  These findings indicate that the Y4 receptor and its agonist would be promising targets for obesity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW_wflLPQ547Vg90H21EOLACvtfcHk0lhqmEZmlaviPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVaqurrO&md5=f635cff89758abe4c785cb8477e5f347</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.peptides.2010.06.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.peptides.2010.06.011%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.-B.%26aulast%3DAsakawa%26aufirst%3DA.%26aulast%3DTerashi%26aufirst%3DM.%26aulast%3DCheng%26aufirst%3DK.%26aulast%3DChaolu%26aufirst%3DH.%26aulast%3DZoshiki%26aufirst%3DT.%26aulast%3DUshikai%26aufirst%3DM.%26aulast%3DSheriff%26aufirst%3DS.%26aulast%3DBalasubramaniam%26aufirst%3DA.%26aulast%3DInui%26aufirst%3DA.%26atitle%3DRegulatory%2520effects%2520of%2520Y4%2520receptor%2520agonist%2520%2528BVD-74D%2529%2520on%2520food%2520intake%26jtitle%3DPeptides%26date%3D2010%26volume%3D31%26spage%3D1706%26epage%3D1710%26doi%3D10.1016%2Fj.peptides.2010.06.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Painsipp, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wultsch, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edelsbrunner, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tasan, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singewald, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herzog, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holzer, P.</span></span> <span> </span><span class="NLM_article-title">Reduced anxiety-like and depression-related behavior in neuropeptide Y Y<sub>4</sub> receptor knockout mice</span>. <i>Genes, Brain Behav.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">532</span>– <span class="NLM_lpage">542</span>, <span class="refDoi"> DOI: 10.1111/j.1601-183x.2008.00389.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1111%2Fj.1601-183X.2008.00389.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=18221379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A280%3ADC%252BD1cvosl2huw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=532-542&author=E.+Painsippauthor=T.+Wultschauthor=M.+E.+Edelsbrunnerauthor=R.+O.+Tasanauthor=N.+Singewaldauthor=H.+Herzogauthor=P.+Holzer&title=Reduced+anxiety-like+and+depression-related+behavior+in+neuropeptide+Y+Y4+receptor+knockout+mice&doi=10.1111%2Fj.1601-183x.2008.00389.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Reduced anxiety-like and depression-related behavior in neuropeptide Y Y4 receptor knockout mice</span></div><div class="casAuthors">Painsipp E; Wultsch T; Edelsbrunner M E; Tasan R O; Singewald N; Herzog H; Holzer P</div><div class="citationInfo"><span class="NLM_cas:title">Genes, brain, and behavior</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">532-42</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Neuropeptide Y (NPY) acting through Y1 receptors reduces anxiety- and depression-like behavior in rodents, whereas Y2 receptor stimulation has the opposite effect.  This study addressed the implication of Y4 receptors in emotional behavior by comparing female germ line Y4 knockout (Y4-/-) mice with control and germ line Y2-/- animals.  Anxiety- and depression-like behavior was assessed with the open field (OF), elevated plus maze (EPM), stress-induced hyperthermia (SIH) and tail suspension tests (TST), respectively.  Learning and memory were evaluated with the object recognition test (ORT).  In the OF and EPM, both Y4-/- and Y2-/- mice exhibited reduced anxiety-related behavior and enhanced locomotor activity relative to control animals.  Locomotor activity in a familiar environment was unchanged in Y4-/- but reduced in Y2-/- mice.  The basal rectal temperature exhibited diurnal and genotype-related alterations.  Control mice had temperature minima at noon and midnight, whereas Y4-/- and Y2-/- mice displayed only one temperature minimum at noon.  The magnitude of SIH was related to time of the day and genotype in a complex manner.  In the TST, the duration of immobility was significantly shorter in Y4-/- and Y2-/- mice than in controls.  Object memory 6 h after initial exposure to the ORT was impaired in Y2-/- but not in Y4-/- mice, relative to control mice.  These results show that genetic deletion of Y4 receptors, like that of Y2 receptors, reduces anxiety-like and depression-related behavior.  Unlike Y2 receptor knockout, Y4 receptor knockout does not impair object memory.  We propose that Y4 receptors play an important role in the regulation of behavioral homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ5o5Ddy9v0ayXXDYhVZBdlfW6udTcc2ebe7fuO2hge_bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cvosl2huw%253D%253D&md5=2ac07540935848f0063184fbf299ae6a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1111%2Fj.1601-183X.2008.00389.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1601-183X.2008.00389.x%26sid%3Dliteratum%253Aachs%26aulast%3DPainsipp%26aufirst%3DE.%26aulast%3DWultsch%26aufirst%3DT.%26aulast%3DEdelsbrunner%26aufirst%3DM.%2BE.%26aulast%3DTasan%26aufirst%3DR.%2BO.%26aulast%3DSingewald%26aufirst%3DN.%26aulast%3DHerzog%26aufirst%3DH.%26aulast%3DHolzer%26aufirst%3DP.%26atitle%3DReduced%2520anxiety-like%2520and%2520depression-related%2520behavior%2520in%2520neuropeptide%2520Y%2520Y4%2520receptor%2520knockout%2520mice%26jtitle%3DGenes%252C%2520Brain%2520Behav.%26date%3D2008%26volume%3D7%26spage%3D532%26epage%3D542%26doi%3D10.1111%2Fj.1601-183x.2008.00389.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tasan, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hetzenauer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singewald, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herzog, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperk, G.</span></span> <span> </span><span class="NLM_article-title">Increased novelty-induced motor activity and reduced depression-like behavior in neuropeptide Y (NPY)–Y<sub>4</sub> receptor knockout mice</span>. <i>Neuroscience</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>158</i></span>,  <span class="NLM_fpage">1717</span>– <span class="NLM_lpage">1730</span>, <span class="refDoi"> DOI: 10.1016/j.neuroscience.2008.11.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1016%2Fj.neuroscience.2008.11.048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=19121371" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1Oisrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2009&pages=1717-1730&author=R.+O.+Tasanauthor=S.+Linauthor=A.+Hetzenauerauthor=N.+Singewaldauthor=H.+Herzogauthor=G.+Sperk&title=Increased+novelty-induced+motor+activity+and+reduced+depression-like+behavior+in+neuropeptide+Y+%28NPY%29%E2%80%93Y4+receptor+knockout+mice&doi=10.1016%2Fj.neuroscience.2008.11.048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Increased novelty-induced motor activity and reduced depression-like behavior in neuropeptide Y (NPY)-Y4 receptor knockout mice</span></div><div class="casAuthors">Tasan, R. O.; Lin, S.; Hetzenauer, A.; Singewald, N.; Herzog, H.; Sperk, G.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1717-1730</span>CODEN:
                <span class="NLM_cas:coden">NRSCDN</span>;
        ISSN:<span class="NLM_cas:issn">0306-4522</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">There is growing evidence that neuropeptide Y (NPY) acting through Y1 and Y2 receptors has a prominent role in modulating anxiety- and depression-like behavior in rodents.  However, a role of other Y-receptors like that of Y4 receptors in this process is poorly understood.  We now investigated male Y2, Y4 single and Y2/Y4 double knockout mice in behavioral paradigms for changes in motor activity, anxiety and depression-like behavior.  Motor activity was increased in Y2, Y4 and Y2/Y4 knockout mice under changing and stressful conditions, but not altered in a familiar environment.  Y4 and Y2 knockout mice revealed an anxiolytic phenotype in the light/dark test, marble burying test and in stress-induced hyperthermia, and reduced depression-like behavior in the forced swim and tail suspension tests.  In Y2/Y4 double knockout mice, the response in the light/dark test and in the forced swim test was further enhanced compared with Y4 and Y2 knockout mice, resp.  High levels of Y4 binding sites were obsd. in brain stem nuclei including nucleus of solitary tract and area postrema.  Lower levels were found in the medial amygdala and hypothalamus.  Peripheral administration of pancreatic polypeptide (PP) induced Y4 receptor-dependent c-Fos expression in brain stem, hypothalamus and amygdala.  PP released peripherally from the pancreas in response to food intake, may act not only as a satiety signal but also modulate anxiety-related locomotion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6HTeFUWj6ArVg90H21EOLACvtfcHk0lhqmEZmlaviPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1Oisrs%253D&md5=e197d23e11cdb0fdf46acaf192c67e0f</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2008.11.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2008.11.048%26sid%3Dliteratum%253Aachs%26aulast%3DTasan%26aufirst%3DR.%2BO.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DHetzenauer%26aufirst%3DA.%26aulast%3DSingewald%26aufirst%3DN.%26aulast%3DHerzog%26aufirst%3DH.%26aulast%3DSperk%26aufirst%3DG.%26atitle%3DIncreased%2520novelty-induced%2520motor%2520activity%2520and%2520reduced%2520depression-like%2520behavior%2520in%2520neuropeptide%2520Y%2520%2528NPY%2529%25E2%2580%2593Y4%2520receptor%2520knockout%2520mice%26jtitle%3DNeuroscience%26date%3D2009%26volume%3D158%26spage%3D1717%26epage%3D1730%26doi%3D10.1016%2Fj.neuroscience.2008.11.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pedragosa-Badia, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sliwoski, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong Nguyen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stichel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaufmann, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meiler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck-Sickinger, A. G.</span></span> <span> </span><span class="NLM_article-title">Pancreatic polypeptide is recognized by two hydrophobic domains of the human Y<sub>4</sub> receptor binding pocket</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">5846</span>– <span class="NLM_lpage">5859</span>, <span class="refDoi"> DOI: 10.1074/jbc.m113.502021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1074%2Fjbc.M113.502021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=24375409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjsVKktL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=5846-5859&author=X.+Pedragosa-Badiaauthor=G.+R.+Sliwoskiauthor=E.+Dong+Nguyenauthor=D.+Lindnerauthor=J.+Stichelauthor=K.+W.+Kaufmannauthor=J.+Meilerauthor=A.+G.+Beck-Sickinger&title=Pancreatic+polypeptide+is+recognized+by+two+hydrophobic+domains+of+the+human+Y4+receptor+binding+pocket&doi=10.1074%2Fjbc.m113.502021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Pancreatic Polypeptide Is Recognized by Two Hydrophobic Domains of the Human Y4 Receptor Binding Pocket</span></div><div class="casAuthors">Pedragosa-Badia, Xavier; Sliwoski, Gregory R.; Nguyen, Elizabeth Dong; Lindner, Diana; Stichel, Jan; Kaufmann, Kristian W.; Meiler, Jens; Beck-Sickinger, Annette G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">5846-5859</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Structural characterization of the human Y4 receptor (hY4R) interaction with human pancreatic polypeptide (hPP) is crucial, not only for understanding its biol. function but also for testing treatment strategies for obesity that target this interaction.  Here, the interaction of receptor mutants with pancreatic polypeptide analogs was studied through double-cycle mutagenesis.  To guide mutagenesis and interpret results, a three-dimensional comparative model of the hY4R-hPP complex was constructed based on all available class A G protein-coupled receptor crystal structures and refined using exptl. data.  Our study reveals that residues of the hPP and the hY4R form a complex network consisting of ionic interactions, hydrophobic interactions, and hydrogen binding.  Residues Tyr2.64, Asp2.68, Asn6.55, Asn7.32, and Phe7.35 of Y4R are found to be important in receptor activation by hPP.  Specifically, Tyr2.64 interacts with Tyr27 of hPP through hydrophobic contacts.  Asn7.32 is affected by modifications on position Arg33 of hPP, suggesting a hydrogen bond between these two residues.  Likewise, we find that Phe7.35 is affected by modifications of hPP at positions 33 and 36, indicating interactions between these three amino acids.  Taken together, we demonstrate that the top of transmembrane helix 2 (TM2) and the top of transmembrane helixes 6 and 7 (TM6-TM7) form the core of the peptide binding pocket.  These findings will contribute to the rational design of ligands that bind the receptor more effectively to produce an enhanced agonistic or antagonistic effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkLgd7H3oyYrVg90H21EOLACvtfcHk0libcBiTbk2PiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjsVKktL4%253D&md5=cf4bf542381418e47815b8b139c8f99b</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.502021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.502021%26sid%3Dliteratum%253Aachs%26aulast%3DPedragosa-Badia%26aufirst%3DX.%26aulast%3DSliwoski%26aufirst%3DG.%2BR.%26aulast%3DDong%2BNguyen%26aufirst%3DE.%26aulast%3DLindner%26aufirst%3DD.%26aulast%3DStichel%26aufirst%3DJ.%26aulast%3DKaufmann%26aufirst%3DK.%2BW.%26aulast%3DMeiler%26aufirst%3DJ.%26aulast%3DBeck-Sickinger%26aufirst%3DA.%2BG.%26atitle%3DPancreatic%2520polypeptide%2520is%2520recognized%2520by%2520two%2520hydrophobic%2520domains%2520of%2520the%2520human%2520Y4%2520receptor%2520binding%2520pocket%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D5846%26epage%3D5859%26doi%3D10.1074%2Fjbc.m113.502021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dukorn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernhardt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buschauer, A.</span></span> <span> </span><span class="NLM_article-title">In search of NPY Y<sub>4</sub>R antagonists: incorporation of carbamoylated arginine, aza-amino acids, or d-amino acids into oligopeptides derived from the C-termini of the endogenous agonists</span>. <i>ACS Omega</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">3616</span>– <span class="NLM_lpage">3631</span>, <span class="refDoi"> DOI: 10.1021/acsomega.7b00451</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsomega.7b00451" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFKhu7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2017&pages=3616-3631&author=K.+K.+Kuhnauthor=T.+Littmannauthor=S.+Dukornauthor=M.+Tanakaauthor=M.+Kellerauthor=T.+Ozawaauthor=G.+Bernhardtauthor=A.+Buschauer&title=In+search+of+NPY+Y4R+antagonists%3A+incorporation+of+carbamoylated+arginine%2C+aza-amino+acids%2C+or+d-amino+acids+into+oligopeptides+derived+from+the+C-termini+of+the+endogenous+agonists&doi=10.1021%2Facsomega.7b00451"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">In Search of NPY Y4R Antagonists: Incorporation of Carbamoylated Arginine, Aza-Amino Acids, or D-Amino Acids into Oligopeptides Derived from the C-Termini of the Endogenous Agonists</span></div><div class="casAuthors">Kuhn, Kilian K.; Littmann, Timo; Dukorn, Stefanie; Tanaka, Miho; Keller, Max; Ozawa, Takeaki; Bernhardt, Guenther; Buschauer, Armin</div><div class="citationInfo"><span class="NLM_cas:title">ACS Omega</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3616-3631</span>CODEN:
                <span class="NLM_cas:coden">ACSODF</span>;
        ISSN:<span class="NLM_cas:issn">2470-1343</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The crosslinked pentapeptides (2R,7R)-diaminooctanedioyl-bis(Tyr-Arg-Leu-Arg-Tyr-amide) ((2R,7R)-BVD-74D, (2R,7R)-1) and octanedioyl-bis(Tyr-Arg-Leu-Arg-Tyr-amide) (2) as well as the pentapeptide Ac-Tyr-Arg-Leu-Arg-Tyr-amide (3) were previously described as neuropeptide Y Y4 receptor (Y4R) partial agonists.  Here the authors report on a series of analogs of (2R,7R)-1 and 2 in which Arg2, Leu3 or Arg4 were replaced by the resp. aza-amino acids.  The replacement of Arg2 in 3 with a carbamoylated arginine building block and the extension of the N-terminus by an addnl. arginine led to the high-affinity hexapeptide Ac-Arg-Tyr-Nω-[(4-aminobutyl)aminocarbonyl]Arg-Leu-Arg-Tyr-amide that was used as a precursor for a D-amino acid scan.  The target compds. were investigated for Y4R functional activity in assays with complementary readouts: aequorin Ca2+ and β-arrestin 1 or β-arrestin 2 assays.  In contrast to the parent compds., which are Y4R agonists, several ligands were able to suppress the effect elicited by the endogenous ligand pancreatic polypeptide and therefore represent a novel class of peptide Y4R antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAufjWqDJZnrVg90H21EOLACvtfcHk0libcBiTbk2PiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFKhu7bE&md5=970422192d233703cda161e6e476b3e5</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Facsomega.7b00451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsomega.7b00451%26sid%3Dliteratum%253Aachs%26aulast%3DKuhn%26aufirst%3DK.%2BK.%26aulast%3DLittmann%26aufirst%3DT.%26aulast%3DDukorn%26aufirst%3DS.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DKeller%26aufirst%3DM.%26aulast%3DOzawa%26aufirst%3DT.%26aulast%3DBernhardt%26aufirst%3DG.%26aulast%3DBuschauer%26aufirst%3DA.%26atitle%3DIn%2520search%2520of%2520NPY%2520Y4R%2520antagonists%253A%2520incorporation%2520of%2520carbamoylated%2520arginine%252C%2520aza-amino%2520acids%252C%2520or%2520d-amino%2520acids%2520into%2520oligopeptides%2520derived%2520from%2520the%2520C-termini%2520of%2520the%2520endogenous%2520agonists%26jtitle%3DACS%2520Omega%26date%3D2017%26volume%3D2%26spage%3D3616%26epage%3D3631%26doi%3D10.1021%2Facsomega.7b00451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ertl, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dukorn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernhardt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiser, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buschauer, A.</span></span> <span> </span><span class="NLM_article-title">High affinity agonists of the neuropeptide Y (NPY) Y<sub>4</sub> receptor derived from the C-terminal pentapeptide of human pancreatic polypeptide (hPP): synthesis, stereochemical discrimination, and radiolabeling</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">6045</span>– <span class="NLM_lpage">6058</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00309</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00309" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BC28XosFSmtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6045-6058&author=K.+K.+Kuhnauthor=T.+Ertlauthor=S.+Dukornauthor=M.+Kellerauthor=G.+Bernhardtauthor=O.+Reiserauthor=A.+Buschauer&title=High+affinity+agonists+of+the+neuropeptide+Y+%28NPY%29+Y4+receptor+derived+from+the+C-terminal+pentapeptide+of+human+pancreatic+polypeptide+%28hPP%29%3A+synthesis%2C+stereochemical+discrimination%2C+and+radiolabeling&doi=10.1021%2Facs.jmedchem.6b00309"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">High Affinity Agonists of the Neuropeptide Y (NPY) Y4 Receptor Derived from the C-Terminal Pentapeptide of Human Pancreatic Polypeptide (hPP): Synthesis, Stereochemical Discrimination, and Radiolabeling</span></div><div class="casAuthors">Kuhn, Kilian K.; Ertl, Thomas; Dukorn, Stefanie; Keller, Max; Bernhardt, Guenther; Reiser, Oliver; Buschauer, Armin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6045-6058</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The diastereomeric mixt. of D/L-2,7-diaminooctanedioyl-bis(YRLRY-NH2) (BVD-74D, 2) was described in the literature as a high affinity Y4 receptor agonist.  Here we report on the synthesis and pharmacol. characterization of the pure diastereomers (2R,7R)- and (2S,7S)-2 and a series of homo- and heterodimeric analogs in which octanedioic acid was used as an achiral linker.  To investigate the role of the Arg residues, one or two arginines were replaced by Ala.  Moreover, Nω-(6-aminohexylaminocarbonyl)Arg was introduced as an arginine replacement (17). (2R,7R)-2 was superior to (2S,7S)-2 in binding and functional cellular assays and equipotent with 17. [3H]Propionylation of one amino group in the linker of (2R,7R)-2 or at the primary amino group in 17 resulted in high affinity Y4R radioligands ([3H]-(2R,7R)-10, [3H]18) with subnanomolar Kd values.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqa_pLfg6qLerVg90H21EOLACvtfcHk0libcBiTbk2PiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XosFSmtrc%253D&md5=ee7279c046d467c5ec6919187eb0f3aa</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00309%26sid%3Dliteratum%253Aachs%26aulast%3DKuhn%26aufirst%3DK.%2BK.%26aulast%3DErtl%26aufirst%3DT.%26aulast%3DDukorn%26aufirst%3DS.%26aulast%3DKeller%26aufirst%3DM.%26aulast%3DBernhardt%26aufirst%3DG.%26aulast%3DReiser%26aufirst%3DO.%26aulast%3DBuschauer%26aufirst%3DA.%26atitle%3DHigh%2520affinity%2520agonists%2520of%2520the%2520neuropeptide%2520Y%2520%2528NPY%2529%2520Y4%2520receptor%2520derived%2520from%2520the%2520C-terminal%2520pentapeptide%2520of%2520human%2520pancreatic%2520polypeptide%2520%2528hPP%2529%253A%2520synthesis%252C%2520stereochemical%2520discrimination%252C%2520and%2520radiolabeling%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D6045%26epage%3D6058%26doi%3D10.1021%2Facs.jmedchem.6b00309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slepetis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viveros, O. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tadepalli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrington, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heyer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landavazo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leban, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spaltenstein, A.</span></span> <span> </span><span class="NLM_article-title">High-affinity neuropeptide Y receptor antagonists</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">9067</span>– <span class="NLM_lpage">9071</span>, <span class="refDoi"> DOI: 10.1073/pnas.92.20.9067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1073%2Fpnas.92.20.9067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=7568074" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADyaK2MXosVWlsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1995&pages=9067-9071&author=A.+J.+Danielsauthor=J.+E.+Matthewsauthor=R.+J.+Slepetisauthor=M.+Jansenauthor=O.+H.+Viverosauthor=A.+Tadepalliauthor=W.+Harringtonauthor=D.+Heyerauthor=A.+Landavazoauthor=J.+J.+Lebanauthor=A.+Spaltenstein&title=High-affinity+neuropeptide+Y+receptor+antagonists&doi=10.1073%2Fpnas.92.20.9067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">High-affinity neuropeptide Y receptor antagonists</span></div><div class="casAuthors">Daniels, Alejandro J.; Matthews, Jessica E.; Slepetis, Ruta J.; Jansen, Marilyn; Viveros, O. Humberto; Tadepalli, Anjaneyulu; Harrington, Wallace; Heyer, Dennis; Landavazo, Antonio; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">9067-71</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Neuropeptide Y (NPY) is one of the most abundant peptide transmitters in the mammalian brain.  In the periphery it is costored and coreleased with norepinephrine from sympathetic nerve terminals.  However, the physiol. functions of this peptide remain unclear because of the absence of specific high-affinity receptor antagonists.  Three potent NPY receptor antagonists were synthesized and tested for their biol. activity in in vitro, ex vivo, and in vivo functional assays.  We describe here the effects of these antagonists inhibiting specific radiolabeled NPY binding at Y1 and Y2 receptors and antagonizing the effects of NPY in human erythroleukemia cell intracellular calcium mobilization, perfusion pressure in the isolated rat kidney, and mean arterial blood pressure in anesthetized rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTDEaNKfTQ1LVg90H21EOLACvtfcHk0lifaIRpG225AQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXosVWlsL0%253D&md5=a517184b11d0c71715f5b543ea4e8fe8</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1073%2Fpnas.92.20.9067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.92.20.9067%26sid%3Dliteratum%253Aachs%26aulast%3DDaniels%26aufirst%3DA.%2BJ.%26aulast%3DMatthews%26aufirst%3DJ.%2BE.%26aulast%3DSlepetis%26aufirst%3DR.%2BJ.%26aulast%3DJansen%26aufirst%3DM.%26aulast%3DViveros%26aufirst%3DO.%2BH.%26aulast%3DTadepalli%26aufirst%3DA.%26aulast%3DHarrington%26aufirst%3DW.%26aulast%3DHeyer%26aufirst%3DD.%26aulast%3DLandavazo%26aufirst%3DA.%26aulast%3DLeban%26aufirst%3DJ.%2BJ.%26aulast%3DSpaltenstein%26aufirst%3DA.%26atitle%3DHigh-affinity%2520neuropeptide%2520Y%2520receptor%2520antagonists%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1995%26volume%3D92%26spage%3D9067%26epage%3D9071%26doi%3D10.1073%2Fpnas.92.20.9067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaske, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holzammer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernhardt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buschauer, A.</span></span> <span> </span><span class="NLM_article-title">Dimeric argininamide-type neuropeptide Y receptor antagonists: chiral discrimination between Y<sub>1</sub> and Y<sub>4</sub> receptors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">6303</span>– <span class="NLM_lpage">6322</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2013.08.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1016%2Fj.bmc.2013.08.065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=24074877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFemtLzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=6303-6322&author=M.+Kellerauthor=M.+Kaskeauthor=T.+Holzammerauthor=G.+Bernhardtauthor=A.+Buschauer&title=Dimeric+argininamide-type+neuropeptide+Y+receptor+antagonists%3A+chiral+discrimination+between+Y1+and+Y4+receptors&doi=10.1016%2Fj.bmc.2013.08.065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Dimeric argininamide-type neuropeptide Y receptor antagonists: Chiral discrimination between Y1 and Y4 receptors</span></div><div class="casAuthors">Keller, Max; Kaske, Melanie; Holzammer, Tobias; Bernhardt, Guenther; Buschauer, Armin</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6303-6322</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The structurally related peptides neuropeptide Y (NPY), peptide YY (PYY) and pancreatic polypeptide (PP) are endogenous agonists of the NPY receptor (YR) family, which in humans comprises four functionally expressed subtypes, designated Y1R, Y2R, Y4R and Y5R.  Nonpeptide antagonists with high affinity and selectivity have been described for the Y1R, Y2R and Y5R, but such compds. are still lacking for the Y4R.  In this work, the structures of the high affinity selective (R)-argininamide-type Y1R antagonists BIBP3226 and BIBO3304 were linked via the guanidine or urea moieties to give homo-dimeric argininamides with linker lengths ranging from 31 to 41 atoms.  Interestingly, the twin compds. proved to be by far less selective for the Y1R than the R-configured monovalent parent compds.  The decrease in selectivity ratio was most pronounced for Y1R vs. Y4R subtype, resulting in comparable affinities of bivalent ligands for Y1R and Y4R (e.g. UR-MK177 [(R,R)-I (R1 = (CH2O)2CH2CH2X, Y = CH2NHC(O)NH2)]: Ki = 230 nM (Y1R) and 290 nM (Y4R)).  With a Ki value of 130 nM and a Kb value of 20 nM, UR-MK188 [(R,R)-II (R2 = CH2(CH2OCH2)2CH2X, Y = OH)] was superior to all Y4R antagonists known to date.  The S,S-configured optical antipodes of UR-MK177 and UR-MK188 (UR-MEK381 ((S,S)-I) and UR-MEK388 ((S,S)-II)) were synthesized to investigate the stereochem. discrimination by the different receptor subtypes.  Whereas preference for R,R-configured argininamides was characteristic of the Y1R, stereochem. discrimination by the Y4R was not obsd.  This may pave the way to selective Y4R antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRAhCQ0Gt1nLVg90H21EOLACvtfcHk0lifaIRpG225AQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFemtLzL&md5=5ca4d29cdb12eb2c4ea26396b1c569df</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.08.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.08.065%26sid%3Dliteratum%253Aachs%26aulast%3DKeller%26aufirst%3DM.%26aulast%3DKaske%26aufirst%3DM.%26aulast%3DHolzammer%26aufirst%3DT.%26aulast%3DBernhardt%26aufirst%3DG.%26aulast%3DBuschauer%26aufirst%3DA.%26atitle%3DDimeric%2520argininamide-type%2520neuropeptide%2520Y%2520receptor%2520antagonists%253A%2520chiral%2520discrimination%2520between%2520Y1%2520and%2520Y4%2520receptors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D6303%26epage%3D6322%26doi%3D10.1016%2Fj.bmc.2013.08.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rudolf, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eberlein, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wieland, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willim, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Entzeroth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wienen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck-Sickinger, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doods, H. N.</span></span> <span> </span><span class="NLM_article-title">The first highly potent and selective non-peptide neuropeptide Y Y<sub>1</sub> receptor antagonist: BIBP3226</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>271</i></span>,  <span class="NLM_fpage">R11</span>– <span class="NLM_lpage">R13</span>, <span class="refDoi"> DOI: 10.1016/0014-2999(94)90822-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1016%2F0014-2999%2894%2990822-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=7705422" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADyaK2MXjt1Sntrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1994&pages=R11-R13&author=K.+Rudolfauthor=W.+Eberleinauthor=W.+Engelauthor=H.+A.+Wielandauthor=K.+D.+Willimauthor=M.+Entzerothauthor=W.+Wienenauthor=A.+G.+Beck-Sickingerauthor=H.+N.+Doods&title=The+first+highly+potent+and+selective+non-peptide+neuropeptide+Y+Y1+receptor+antagonist%3A+BIBP3226&doi=10.1016%2F0014-2999%2894%2990822-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226</span></div><div class="casAuthors">Rudolf, Klaus; Eberlein, Wolfgang; Engel, Wolfhard; Wieland, Heike A.; Willim, Klaus D.; Entzeroth, Michael; Wienen, Wolfgang; Beck-Sickinger, Annette G.; Doods, Henri N.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">2/3</span>),
    <span class="NLM_cas:pages">R11-R13</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The design and subsequent in vitro and in vivo biol. characterization of the first potent and selective non-peptide neuropeptide Y Y1 receptor antagonist, BIBP3226 (I; (R)-N2-(diphenylacetyl)-N-[(4- hydroxyphenyl)methyl]-argininamide) is reported.  BIBP3226 displaced 125I-labeled neuropeptide Y with high affinity (Ki = 7 nM) from the human neuropeptide Y Y1 receptor and proved to be highly selective.  BIBP3226 displayed potent antagonistic properties both in in vitro and in vivo models and thus represents the first selective non-peptide neuropeptide Y Y1 receptor antagonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy6B_rW0NxBLVg90H21EOLACvtfcHk0lifaIRpG225AQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjt1Sntrw%253D&md5=d0c87027fe726aacc2146433884d163a</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2894%2990822-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252894%252990822-2%26sid%3Dliteratum%253Aachs%26aulast%3DRudolf%26aufirst%3DK.%26aulast%3DEberlein%26aufirst%3DW.%26aulast%3DEngel%26aufirst%3DW.%26aulast%3DWieland%26aufirst%3DH.%2BA.%26aulast%3DWillim%26aufirst%3DK.%2BD.%26aulast%3DEntzeroth%26aufirst%3DM.%26aulast%3DWienen%26aufirst%3DW.%26aulast%3DBeck-Sickinger%26aufirst%3DA.%2BG.%26aulast%3DDoods%26aufirst%3DH.%2BN.%26atitle%3DThe%2520first%2520highly%2520potent%2520and%2520selective%2520non-peptide%2520neuropeptide%2520Y%2520Y1%2520receptor%2520antagonist%253A%2520BIBP3226%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1994%26volume%3D271%26spage%3DR11%26epage%3DR13%26doi%3D10.1016%2F0014-2999%2894%2990822-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berlicki, Ł.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaske, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutiérrez-Abad, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernhardt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Illa, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortuño, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabrele, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buschauer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiser, O.</span></span> <span> </span><span class="NLM_article-title">Replacement of Thr<sup>32</sup>and Gln<sup>34</sup> in the C-terminal neuropeptide Y fragment 25–36 by cis-cyclobutane and cis-cyclopentane β-amino acids shifts selectivity toward the Y<sub>4</sub> receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">8422</span>– <span class="NLM_lpage">8431</span>, <span class="refDoi"> DOI: 10.1021/jm4008505</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4008505" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFOju7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8422-8431&author=%C5%81.+Berlickiauthor=M.+Kaskeauthor=R.+Guti%C3%A9rrez-Abadauthor=G.+Bernhardtauthor=O.+Illaauthor=R.+M.+Ortu%C3%B1oauthor=C.+Cabreleauthor=A.+Buschauerauthor=O.+Reiser&title=Replacement+of+Thr32and+Gln34+in+the+C-terminal+neuropeptide+Y+fragment+25%E2%80%9336+by+cis-cyclobutane+and+cis-cyclopentane+%CE%B2-amino+acids+shifts+selectivity+toward+the+Y4+receptor&doi=10.1021%2Fjm4008505"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Replacement of Thr32 and Gln34 in the C-Terminal Neuropeptide Y Fragment 25-36 by cis-Cyclobutane and cis-Cyclopentane β Amino Acids Shifts Selectivity toward the Y4 Receptor</span></div><div class="casAuthors">Berlicki, Lukasz; Kaske, Melanie; Gutierrez-Abad, Raquel; Bernhardt, Guenther; Illa, Ona; Ortuno, Rosa M.; Cabrele, Chiara; Buschauer, Armin; Reiser, Oliver</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8422-8431</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Neuropeptide Y (NPY) and pancreatic polypeptide (PUP) control central and peripheral processes by activating the G protein coupled receptors YxR (x = 1, 2, 4, 5).  We present analogs of the C-terminal fragments 25-36 and 32-36 of NPY and PP contg. (1R,2S)-cyclobutane (βCbu) or (1R,2S)-cyclopentane (βCpe) β-amino acids, which display exclusively Y4R affinity.  In particular, [βCpe34]-NPY-(25-36) is a Y4R selective partial agonist (EC50 41 nM, Emax 71%) that binds Y4R with a Ki of 10 nM and a selectivity >100-fold relative to Y1R and Y2R and >50-fold relative to Y5R.  Comparably, [Y32, βCpe34]-NPY-(PP)-(32-36) selectively binds and activates Y4R (EC50 94 nM, Emax 73%).  The NMR structure of [βCpe34]-NPY-(25-36) in dodecylphosphatidylcholine micelles shows a short helix at residues 27-32, while the C-terminal segment R33βCpe34R35Y36 is extended.  The biol. properties of the βCbu- or βCpe-contg. NPY and PP C-terminal fragments encourage the future application of these β-amino acids in the synthesis of selective Y4R ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqc86lNhWkxe7Vg90H21EOLACvtfcHk0lhnlT3WSPWyQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFOju7bO&md5=8b70c960e83a6193794b2badc9760206</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm4008505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4008505%26sid%3Dliteratum%253Aachs%26aulast%3DBerlicki%26aufirst%3D%25C5%2581.%26aulast%3DKaske%26aufirst%3DM.%26aulast%3DGuti%25C3%25A9rrez-Abad%26aufirst%3DR.%26aulast%3DBernhardt%26aufirst%3DG.%26aulast%3DIlla%26aufirst%3DO.%26aulast%3DOrtu%25C3%25B1o%26aufirst%3DR.%2BM.%26aulast%3DCabrele%26aufirst%3DC.%26aulast%3DBuschauer%26aufirst%3DA.%26aulast%3DReiser%26aufirst%3DO.%26atitle%3DReplacement%2520of%2520Thr32and%2520Gln34%2520in%2520the%2520C-terminal%2520neuropeptide%2520Y%2520fragment%252025%25E2%2580%259336%2520by%2520cis-cyclobutane%2520and%2520cis-cyclopentane%2520%25CE%25B2-amino%2520acids%2520shifts%2520selectivity%2520toward%2520the%2520Y4%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D8422%26epage%3D8431%26doi%3D10.1021%2Fjm4008505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lachmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konieczny, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">König, B.</span></span> <span> </span><span class="NLM_article-title">Photochromic peptidic NPY Y<sub>4</sub> receptor ligands</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">2467</span>– <span class="NLM_lpage">2478</span>, <span class="refDoi"> DOI: 10.1039/c8ob03221a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1039%2FC8OB03221A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=30747188" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlOns7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2019&pages=2467-2478&author=D.+Lachmannauthor=A.+Koniecznyauthor=M.+Kellerauthor=B.+K%C3%B6nig&title=Photochromic+peptidic+NPY+Y4+receptor+ligands&doi=10.1039%2Fc8ob03221a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Photochromic peptidic NPY Y4 receptor ligands</span></div><div class="casAuthors">Lachmann, D.; Konieczny, A.; Keller, M.; Koenig, B.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2467-2478</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The neuropeptide Y (NPY) Y4 receptor is a G protein coupled receptor, which is targeted by pancreatic polypeptide, a homolog of NPY.  Selective Y4R agonists were suggested as potential therapeutics for the treatment of obesity.  Highly potent dimeric peptidic Y4R agonists, constituting two pentapeptide moieties connected through an aliph. linker, represent an interesting class of Y4R ligands.  Based on this compd. class, photoresponsive Y4R ligands, contg. an azobenzene, azopyrazole, diethienylethene or a fulgimide chromophore were prepd. to explore structural requirements of such Y4R agonists on Y4R binding.  The synthesized Y4R ligands, contg. a non-aliph. rigid photochromic linker, switch reversibly in aq. buffer and exhibited high Y4R affinity throughout.  This demonstrated that the replacement of the highly flexible aliph. linker by a considerably less flexible photochromic linker was well tolerated with respect to Y4R binding.  Differences in Y4R affinity and activity between the individual photoisomers (varying in spatial orientation and flexibility) were marginal suggesting that the linking element in the dimeric ligands is less crit. for the adaptation of high-affinity binding modes at the receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrN56yENztvRbVg90H21EOLACvtfcHk0lhnlT3WSPWyQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlOns7Y%253D&md5=0298469321545b84520948d7efc2ba4e</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1039%2FC8OB03221A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8OB03221A%26sid%3Dliteratum%253Aachs%26aulast%3DLachmann%26aufirst%3DD.%26aulast%3DKonieczny%26aufirst%3DA.%26aulast%3DKeller%26aufirst%3DM.%26aulast%3DK%25C3%25B6nig%26aufirst%3DB.%26atitle%3DPhotochromic%2520peptidic%2520NPY%2520Y4%2520receptor%2520ligands%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2019%26volume%3D17%26spage%3D2467%26epage%3D2478%26doi%3D10.1039%2Fc8ob03221a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ziemek, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabrele, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck-Sickinger, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernhardt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buschauer, A.</span></span> <span> </span><span class="NLM_article-title">Determination of affinity and activity of ligands at the human neuropeptide Y Y<sub>4</sub> receptor by flow cytometry and aequorin luminescence</span>. <i>J. Recept. Signal Transduction Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">217</span>– <span class="NLM_lpage">233</span>, <span class="refDoi"> DOI: 10.1080/10799890701505206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1080%2F10799890701505206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=17885919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A280%3ADC%252BD2srmsF2htw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=217-233&author=R.+Ziemekauthor=E.+Schneiderauthor=A.+Krausauthor=C.+Cabreleauthor=A.+G.+Beck-Sickingerauthor=G.+Bernhardtauthor=A.+Buschauer&title=Determination+of+affinity+and+activity+of+ligands+at+the+human+neuropeptide+Y+Y4+receptor+by+flow+cytometry+and+aequorin+luminescence&doi=10.1080%2F10799890701505206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of affinity and activity of ligands at the human neuropeptide Y Y4 receptor by flow cytometry and aequorin luminescence</span></div><div class="casAuthors">Ziemek Ralf; Schneider Erich; Kraus Anja; Cabrele Chiara; Beck-Sickinger Annette G; Bernhardt Gunther; Buschauer Armin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of receptor and signal transduction research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">217-33</span>
        ISSN:<span class="NLM_cas:issn">1079-9893</span>.
    </div><div class="casAbstract">Fluorescence-labeled neuropeptide Y (NPY) has been used in flow cytometric binding assays for the determination of affinity constants of NPY Y1, Y2, and Y5 receptor ligands.  Because the binding of fluorescent NPY is insufficient for competition studies at the human Y4 receptor (hY4R), we replaced Glu-4 in hPP with Lys for the derivatization with cyanine-5.  Because cy5-[K(4)]hPP has high affinity (Kd 5.6 nM) to the hY4R, it was used as a probe in a flow cytometric binding assay.  Specific binding of cy5-[K(4)]hPP to hY4R was visualized by confocal microscopy.  The hY(4)R, the chimeric G protein G(qi5) and mitochondrially targeted apoaequorin were stably coexpressed in CHO cells.  Aequorin luminescence was quantified in a microplate reader and by a CCD camera.  By application of these methods 3-cyclohexyl-N-[(3-1H-imidazol-4-ylpropylamino)(imino)methyl]propanamide (UR-AK49) was discovered as the first nonpeptidic Y4R antagonist (pKi 4.17), a lead to be optimized in terms of potency and selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSyMWGV-E2m5Uh5eUSa2oe_fW6udTcc2eZVYRmhBkrY3rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2srmsF2htw%253D%253D&md5=01182c83c0ba95e88a143720dc3cef30</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1080%2F10799890701505206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10799890701505206%26sid%3Dliteratum%253Aachs%26aulast%3DZiemek%26aufirst%3DR.%26aulast%3DSchneider%26aufirst%3DE.%26aulast%3DKraus%26aufirst%3DA.%26aulast%3DCabrele%26aufirst%3DC.%26aulast%3DBeck-Sickinger%26aufirst%3DA.%2BG.%26aulast%3DBernhardt%26aufirst%3DG.%26aulast%3DBuschauer%26aufirst%3DA.%26atitle%3DDetermination%2520of%2520affinity%2520and%2520activity%2520of%2520ligands%2520at%2520the%2520human%2520neuropeptide%2520Y%2520Y4%2520receptor%2520by%2520flow%2520cytometry%2520and%2520aequorin%2520luminescence%26jtitle%3DJ.%2520Recept.%2520Signal%2520Transduction%2520Res.%26date%3D2007%26volume%3D27%26spage%3D217%26epage%3D233%26doi%3D10.1080%2F10799890701505206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bartleson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graves, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, B. L.</span></span> <span> </span><span class="NLM_article-title">Arginine to citrulline replacement in substrates of phosphorylase kinase</span>. <i>Biochim. Biophys. Acta, Protein Struct. Mol. Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>1480</i></span>,  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">28</span>, <span class="refDoi"> DOI: 10.1016/s0167-4838(00)00100-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1016%2FS0167-4838%2800%2900100-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=11004553" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BD3cXks12qt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1480&publication_year=2000&pages=23-28&author=C.+Bartlesonauthor=S.+Luoauthor=D.+J.+Gravesauthor=B.+L.+Martin&title=Arginine+to+citrulline+replacement+in+substrates+of+phosphorylase+kinase&doi=10.1016%2Fs0167-4838%2800%2900100-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Arginine to citrulline replacement in substrates of phosphorylase kinase</span></div><div class="casAuthors">Bartleson, C.; Luo, S.; Graves, D. J.; Martin, B. L.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Protein Structure and Molecular Enzymology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">1480</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">23-28</span>CODEN:
                <span class="NLM_cas:coden">BBAEDZ</span>;
        ISSN:<span class="NLM_cas:issn">0167-4838</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Synthetic peptides based on residues 9 to 18 of glycogen phosphorylase were prepd. contg. citrulline at position 10 or 16, or at both positions 10 and 16.  The peptides were compared as substrates for a recombinant, truncated form of the catalytic subunit of phosphorylase kinase (residues 1-300).  The peptide having citrulline at position 10 was phosphorylated the same as the parent peptide.  Both the peptides with a single citrulline at position 16 and with two citrullines were phosphorylated less effectively than the parent peptide; kcat/Km values were approx. 20% the value with the parent peptide.  Incorporation of the second citrulline had little change in the effectiveness of the peptide as a substrate although the kinetic parameters with the citrulline peptides did show differences.  The change in peptide phosphorylation use as substrates for the phosphorylase kinase synthetic peptides based on residues 9 to 18 of glycogen phosphorylase contg. citrulline at position 10 or 16, or at both positions 10 and 16 did not seem to result from a change in peptide structure.  Two-dimensional NMR studies of di-citrulline peptide are reported and showed no change in the soln. structure of the peptide compared to the parent peptide.  Thus, the change in kinetic parameters with the modified peptides seemed an effect of arginine replacement and was likely a consequence of the loss of charge inasmuch as the size of arginine and citrulline are similar.  Arginine-16 was concluded to be more important for phosphorylase kinase recognition than arginine-10.  These findings were consistent with the earlier studies using alanine replacement of arginine in synthetic peptides as substrates for the holoenzyme form of phosphorylase kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwr7X_fenggbVg90H21EOLACvtfcHk0lh4ooveIyIpCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXks12qt74%253D&md5=d752e7f6d1697c044b041a1743e74db1</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS0167-4838%2800%2900100-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0167-4838%252800%252900100-X%26sid%3Dliteratum%253Aachs%26aulast%3DBartleson%26aufirst%3DC.%26aulast%3DLuo%26aufirst%3DS.%26aulast%3DGraves%26aufirst%3DD.%2BJ.%26aulast%3DMartin%26aufirst%3DB.%2BL.%26atitle%3DArginine%2520to%2520citrulline%2520replacement%2520in%2520substrates%2520of%2520phosphorylase%2520kinase%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Protein%2520Struct.%2520Mol.%2520Enzymol.%26date%3D2000%26volume%3D1480%26spage%3D23%26epage%3D28%26doi%3D10.1016%2Fs0167-4838%2800%2900100-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutzler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollereau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dukorn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schindler, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernhardt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">König, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buschauer, A.</span></span> <span> </span><span class="NLM_article-title">N<sup>ω</sup>-Carbamoylation of the argininamide moiety: an avenue to insurmountable NPY Y<sub>1</sub> receptor antagonists and a radiolabeled selective high-affinity molecular tool ([<sup>3</sup>H]UR-MK299) with extended residence time</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8834</span>– <span class="NLM_lpage">8849</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00925</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00925" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Cqsb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8834-8849&author=M.+Kellerauthor=S.+Weissauthor=C.+Hutzlerauthor=K.+K.+Kuhnauthor=C.+Mollereauauthor=S.+Dukornauthor=L.+Schindlerauthor=G.+Bernhardtauthor=B.+K%C3%B6nigauthor=A.+Buschauer&title=N%CF%89-Carbamoylation+of+the+argininamide+moiety%3A+an+avenue+to+insurmountable+NPY+Y1+receptor+antagonists+and+a+radiolabeled+selective+high-affinity+molecular+tool+%28%5B3H%5DUR-MK299%29+with+extended+residence+time&doi=10.1021%2Facs.jmedchem.5b00925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Nω-Carbamoylation of the Argininamide Moiety: An Avenue to Insurmountable NPY Y1 Receptor Antagonists and a Radiolabeled Selective High-Affinity Molecular Tool ([3H]UR-MK299) with Extended Residence Time</span></div><div class="casAuthors">Keller, Max; Weiss, Stefan; Hutzler, Christoph; Kuhn, Kilian K.; Mollereau, Catherine; Dukorn, Stefanie; Schindler, Lisa; Bernhardt, Guenther; Koenig, Burkhard; Buschauer, Armin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8834-8849</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Analogs of the argininamide-type NPY Y1 receptor (Y1R) antagonist BIBP3226, bearing carbamoyl moieties at the guanidine group, revealed subnanomolar Ki values and caused depression of the maximal response to NPY (calcium assay) by up to 90% in a concn.- and time-dependent manner, suggesting insurmountable antagonism.  To gain insight into the mechanism of binding of the synthesized compds., a tritiated antagonist, (R)-Nα-diphenylacetyl-Nω-[2-([2,3-3H]propionylamino)ethyl]aminocarbonyl-(4-hydroxybenzyl)arginin-amide ([3H]UR-MK299, [3H]38), was prepd. [3H]38 revealed a dissocn. const. in the picomolar range (Kd 0.044 nM, SK-N-MC cells) and very high Y1R selectivity.  Apart from superior affinity, a considerably lower target off-rate (t1/2 95 min) was characteristic of [3H]38 compared to that of the higher homolog contg. a tetramethylene instead of an ethylene spacer (t1/2 3 min, Kd 2.0 nM).  Y1R binding of [3H]38 was fully reversible and fully displaceable by nonpeptide antagonists and the agonist pNPY.  Therefore, the insurmountable antagonism obsd. in the functional assay has to be attributed to the extended target-residence time, a phenomenon of relevance in drug research beyond the NPY receptor field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3S1Ipo2hZQ7Vg90H21EOLACvtfcHk0lh4ooveIyIpCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Cqsb3J&md5=8117957cafc33319d6bc6f37aeb142df</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00925%26sid%3Dliteratum%253Aachs%26aulast%3DKeller%26aufirst%3DM.%26aulast%3DWeiss%26aufirst%3DS.%26aulast%3DHutzler%26aufirst%3DC.%26aulast%3DKuhn%26aufirst%3DK.%2BK.%26aulast%3DMollereau%26aufirst%3DC.%26aulast%3DDukorn%26aufirst%3DS.%26aulast%3DSchindler%26aufirst%3DL.%26aulast%3DBernhardt%26aufirst%3DG.%26aulast%3DK%25C3%25B6nig%26aufirst%3DB.%26aulast%3DBuschauer%26aufirst%3DA.%26atitle%3DN%25CF%2589-Carbamoylation%2520of%2520the%2520argininamide%2520moiety%253A%2520an%2520avenue%2520to%2520insurmountable%2520NPY%2520Y1%2520receptor%2520antagonists%2520and%2520a%2520radiolabeled%2520selective%2520high-affinity%2520molecular%2520tool%2520%2528%255B3H%255DUR-MK299%2529%2520with%2520extended%2520residence%2520time%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8834%26epage%3D8849%26doi%3D10.1021%2Facs.jmedchem.5b00925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moser, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernhardt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buschauer, A.</span></span> <span> </span><span class="NLM_article-title">Cloning and functional expression of the hNPY Y<sub>5</sub> receptor in human endometrial cancer (HEC-1B) cells</span>. <i>Can. J. Physiol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">134</span>– <span class="NLM_lpage">142</span>, <span class="refDoi"> DOI: 10.1139/y99-125</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1139%2Fy99-125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10737676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhsVKnsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2000&pages=134-142&author=C.+Moserauthor=G.+Bernhardtauthor=J.+Michelauthor=H.+Schwarzauthor=A.+Buschauer&title=Cloning+and+functional+expression+of+the+hNPY+Y5+receptor+in+human+endometrial+cancer+%28HEC-1B%29+cells&doi=10.1139%2Fy99-125"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning and functional expression of the hNPY Y5 receptor in human endometrial cancer (HEC-1B) cells</span></div><div class="casAuthors">Moser, C.; Bernhardt, G.; Michel, J.; Schwarz, H.; Buschauer, A.</div><div class="citationInfo"><span class="NLM_cas:title">Canadian Journal of Physiology and Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">134-142</span>CODEN:
                <span class="NLM_cas:coden">CJPPA3</span>;
        ISSN:<span class="NLM_cas:issn">0008-4212</span>.
    
            (<span class="NLM_cas:orgname">National Research Council of Canada</span>)
        </div><div class="casAbstract">Aiming to develop a functional assay for the human NPY Y5 receptor based on adenylyl cyclase activity, HEC-1B cells, in which cAMP synthesis can be efficiently stimulated with forskolin, were selected for the transfection with the pcDNA3-Y5-FLAG and the pcDEF3-Y5 vectors.  After optimization of the transfection procedure, the binding of [3H]propionyl-NPY to transiently and stably expressed Y5 receptors was detd.  The affinities of NPY, NPY derivs., and rPP (pNPY ≥ p(Leu31Pro34)NPY = p(2-36)NPY ≥ p(D-Trp32)NPY > p(13-36)NPY > rPP) were in accordance with the NPY Y5 receptor subtype.  For [3H]propionyl-pNPY approx. 1.7×105 and 1×106 binding sites per transiently and stably transfected cell, resp., were detd.  The KD values were 2.4±0.4 and 1.7±0.2 nM, resp.  Due to the high expression of the receptor protein, both stably and transiently transfected cells can be conveniently used in routine radioligand binding studies.  By contrast, functional assays were only feasible with HEC-1B cells stably expressing the Y5 receptor.  In these cells, 10 nM pNPY inhibited the forskolin-stimulated cAMP synthesis by 75%.  This effect was partially antagonized by the Y5 antagonist N-{trans-[4-(2-naphthylmethylamino)-methyl]cyclohexylmethyl}naphthalene-2-sulfonamide.  Although the genetic variability of cancer cells is in principle incompatible with a stable phenotype, both ligand binding characteristics and functionality of the Y5 receptor remained unchanged for more than 30 passages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrumOHtt-8PLrVg90H21EOLACvtfcHk0lh4ooveIyIpCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhsVKnsr4%253D&md5=8dffd503ecf2b3c39adaba2932b82bca</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1139%2Fy99-125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1139%252Fy99-125%26sid%3Dliteratum%253Aachs%26aulast%3DMoser%26aufirst%3DC.%26aulast%3DBernhardt%26aufirst%3DG.%26aulast%3DMichel%26aufirst%3DJ.%26aulast%3DSchwarz%26aufirst%3DH.%26aulast%3DBuschauer%26aufirst%3DA.%26atitle%3DCloning%2520and%2520functional%2520expression%2520of%2520the%2520hNPY%2520Y5%2520receptor%2520in%2520human%2520endometrial%2520cancer%2520%2528HEC-1B%2529%2520cells%26jtitle%3DCan.%2520J.%2520Physiol.%2520Pharmacol.%26date%3D2000%26volume%3D78%26spage%3D134%26epage%3D142%26doi%3D10.1139%2Fy99-125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dukorn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabrele, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumeister, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernhardt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buschauer, A.</span></span> <span> </span><span class="NLM_article-title">Fluorescence- and radiolabeling of [Lys<sup>4</sup>,Nle<sup>17</sup>,<sup>30</sup>]hPP yields molecular tools for the NPY Y<sub>4</sub> receptor</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1291</span>– <span class="NLM_lpage">1304</span>, <span class="refDoi"> DOI: 10.1021/acs.bioconjchem.7b00103</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.7b00103" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkvFWjurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2017&pages=1291-1304&author=S.+Dukornauthor=T.+Littmannauthor=M.+Kellerauthor=K.+Kuhnauthor=C.+Cabreleauthor=P.+Baumeisterauthor=G.+Bernhardtauthor=A.+Buschauer&title=Fluorescence-+and+radiolabeling+of+%5BLys4%2CNle17%2C30%5DhPP+yields+molecular+tools+for+the+NPY+Y4+receptor&doi=10.1021%2Facs.bioconjchem.7b00103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorescence- and Radiolabeling of [Lys4,Nle17,30]hPP Yields Molecular Tools for the NPY Y4 Receptor</span></div><div class="casAuthors">Dukorn, Stefanie; Littmann, Timo; Keller, Max; Kuhn, Kilian; Cabrele, Chiara; Baumeister, Paul; Bernhardt, Guenther; Buschauer, Armin</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1291-1304</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The neuropeptide Y (NPY) Y4 receptor (Y4R) is involved in energy homeostasis and considered a potential drug target for the treatment of obesity.  Only a few mol. tools, i.e., radiolabeled and fluorescent ligands, for the investigation of the Y4R were reported.  Previously, [Lys4]hPP proved to be an appropriate full-length PP analog to prep. a fluorescent ligand by derivatization at the ε-amino group.  To preclude oxidn. upon long-term storage, the authors replaced the two methionine residues in [Lys4]hPP by norleucine and prepd. the corresponding [3H]propionylated ([3H]12) and cyanine labeled (13) peptides, which were characterized and compared with a set of ref. compds. in binding (Y1, Y2, Y4, and Y5 receptors) and functional (luciferase gene reporter, beta-arrestin-1,2) Y4R assays.  Both mol. probes proved to be useful in radiochem. and flow cytometric satn. and competition Y4R binding expts.  Most strikingly, there was a different influence of the compn. of buffer on equil. binding and kinetics: [3H]12 affinity (Kd in Na+-free buffer: 1.1 nM) clearly decreased with increasing sodium ion concn., whereas dissocn. and Y4R-mediated internalization of 13 (Kd in Na+-free buffer: 10.8 nM) were strongly affected by the osmolarity of the buffer as demonstrated by confocal microscopy.  Displacement of [3H]12 and 13 revealed a tendency to higher apparent affinities for a set of ref. peptides in hypotonic (Na+-free) compared to isotonic buffers.  The differences were negligible in the case of hPP but up to 270-fold in the case of GW1229 (GR231118).  By contrast, no relevant influence of Na+ on Y5R affinity became obvious, when the radioligands [H]12 and [3H]propionyl-pNPY were investigated in satn. binding and competition binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpo94U0V9fONbVg90H21EOLACvtfcHk0li7WnkkLKk04g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkvFWjurw%253D&md5=6063243552bb6e134949d63f6e451c1d</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.7b00103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.7b00103%26sid%3Dliteratum%253Aachs%26aulast%3DDukorn%26aufirst%3DS.%26aulast%3DLittmann%26aufirst%3DT.%26aulast%3DKeller%26aufirst%3DM.%26aulast%3DKuhn%26aufirst%3DK.%26aulast%3DCabrele%26aufirst%3DC.%26aulast%3DBaumeister%26aufirst%3DP.%26aulast%3DBernhardt%26aufirst%3DG.%26aulast%3DBuschauer%26aufirst%3DA.%26atitle%3DFluorescence-%2520and%2520radiolabeling%2520of%2520%255BLys4%252CNle17%252C30%255DhPP%2520yields%2520molecular%2520tools%2520for%2520the%2520NPY%2520Y4%2520receptor%26jtitle%3DBioconjugate%2520Chem.%26date%3D2017%26volume%3D28%26spage%3D1291%26epage%3D1304%26doi%3D10.1021%2Facs.bioconjchem.7b00103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenalti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abola, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span> <span> </span><span class="NLM_article-title">Allosteric sodium in class A GPCR signaling</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">233</span>– <span class="NLM_lpage">244</span>, <span class="refDoi"> DOI: 10.1016/j.tibs.2014.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1016%2Fj.tibs.2014.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=24767681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsFCqs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=233-244&author=V.+Katritchauthor=G.+Fenaltiauthor=E.+E.+Abolaauthor=B.+L.+Rothauthor=V.+Cherezovauthor=R.+C.+Stevens&title=Allosteric+sodium+in+class+A+GPCR+signaling&doi=10.1016%2Fj.tibs.2014.03.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric sodium in class A GPCR signaling</span></div><div class="casAuthors">Katritch, Vsevolod; Fenalti, Gustavo; Abola, Enrique E.; Roth, Bryan L.; Cherezov, Vadim; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biochemical Sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">233-244</span>CODEN:
                <span class="NLM_cas:coden">TBSCDB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Despite their functional and structural diversity, G-protein-coupled receptors (GPCRs) share a common mechanism of signal transduction via conformational changes in the seven-transmembrane (7TM) helical domain.  New major insights into this mechanism come from the recent crystallog. discoveries of a partially hydrated sodium ion that is specifically bound in the middle of the 7TM bundle of multiple class A GPCRs.  This review discusses the remarkable structural conservation and distinct features of the Na+ pocket in this most populous GPCR class, as well as the conformational collapse of the pocket upon receptor activation.  New insights help to explain allosteric effects of sodium on GPCR agonist binding and activation, and sodium's role as a potential co-factor in class A GPCR function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_QJ04qVNc3LVg90H21EOLACvtfcHk0li7WnkkLKk04g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsFCqs7k%253D&md5=c217e7eb69c93b1c76559cc587b318b5</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2014.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2014.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DFenalti%26aufirst%3DG.%26aulast%3DAbola%26aufirst%3DE.%2BE.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DAllosteric%2520sodium%2520in%2520class%2520A%2520GPCR%2520signaling%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2014%26volume%3D39%26spage%3D233%26epage%3D244%26doi%3D10.1016%2Fj.tibs.2014.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">White, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eddy, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Z.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lian, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deary, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span> <span> </span><span class="NLM_article-title">Structural connection between activation microswitch and allosteric sodium site in GPCR signaling</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">259</span>– <span class="NLM_lpage">269</span>, <span class="refDoi"> DOI: 10.1016/j.str.2017.12.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1016%2Fj.str.2017.12.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=29395784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVSjs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=259-269&author=K.+L.+Whiteauthor=M.+T.+Eddyauthor=Z.-G.+Gaoauthor=G.+W.+Hanauthor=T.+Lianauthor=A.+Dearyauthor=N.+Patelauthor=K.+A.+Jacobsonauthor=V.+Katritchauthor=R.+C.+Stevens&title=Structural+connection+between+activation+microswitch+and+allosteric+sodium+site+in+GPCR+signaling&doi=10.1016%2Fj.str.2017.12.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Connection between Activation Microswitch and Allosteric Sodium Site in GPCR Signaling</span></div><div class="casAuthors">White, Kate L.; Eddy, Matthew T.; Gao, Zhan-Guo; Han, Gye Won; Lian, Tiffany; Deary, Alexander; Patel, Nilkanth; Jacobson, Kenneth A.; Katritch, Vsevolod; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">259-269.e5</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Sodium ions are endogenous allosteric modulators of many G-protein-coupled receptors (GPCRs).  Mutation of key residues in the sodium binding motif causes a striking effect on G-protein signaling.  We report the crystal structures of agonist complexes for two variants in the first sodium coordination shell of the human A2A adenosine receptor, D522.50N and S913.39A.  Both structures present an overall active-like conformation; however, the variants show key changes in the activation motif NPxxY.  Changes in the hydrogen bonding network in this microswitch suggest a possible mechanism for modified G-protein signaling and enhanced thermal stability.  These structures, signaling data, and thermal stability anal. with a panel of pharmacol. ligands provide a basis for understanding the role of the sodium-coordinating residues on stability and G-protein signaling.  Utilizing the D2.50N variant is a promising method for stabilizing class A GPCRs to accelerate structural efforts and drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo18IDIJKugCrVg90H21EOLACvtfcHk0li7WnkkLKk04g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVSjs70%253D&md5=916e644534536f2a995288d207328c4d</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2017.12.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2017.12.013%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DK.%2BL.%26aulast%3DEddy%26aufirst%3DM.%2BT.%26aulast%3DGao%26aufirst%3DZ.-G.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DLian%26aufirst%3DT.%26aulast%3DDeary%26aufirst%3DA.%26aulast%3DPatel%26aufirst%3DN.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructural%2520connection%2520between%2520activation%2520microswitch%2520and%2520allosteric%2520sodium%2520site%2520in%2520GPCR%2520signaling%26jtitle%3DStructure%26date%3D2018%26volume%3D26%26spage%3D259%26epage%3D269%26doi%3D10.1016%2Fj.str.2017.12.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaddum, J. H.</span></span> <span> </span><span class="NLM_article-title">Quantitative effects of antagonistic drugs</span>. <i>J. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">1937</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">7</span>– <span class="NLM_lpage">9</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADyaA2sXivVCqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1937&pages=7-9&author=J.+H.+Gaddum&title=Quantitative+effects+of+antagonistic+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative effects of antagonistic drugs</span></div><div class="casAuthors">Gaddum, J. H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physiology (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">1937</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7-9P</span>CODEN:
                <span class="NLM_cas:coden">JPHYA7</span>;
        ISSN:<span class="NLM_cas:issn">0022-3751</span>.
    </div><div class="casAbstract">Discussion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobw0kH9VTVFLVg90H21EOLACvtfcHk0ljSAYKmMwpYEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaA2sXivVCqtA%253D%253D&md5=c97615ffd3a9b147e671f31beb55d527</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGaddum%26aufirst%3DJ.%2BH.%26atitle%3DQuantitative%2520effects%2520of%2520antagonistic%2520drugs%26jtitle%3DJ.%2520Physiol.%26date%3D1937%26volume%3D89%26spage%3D7%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Che, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majumdar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaidi, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ondachi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosier, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uprety, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vardy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krumm, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steyaert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strachan, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tribo, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasternak, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, F. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wacker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span> <span> </span><span class="NLM_article-title">Structure of the Nanobody-Stabilized Active State of the Kappa Opioid Receptor</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>172</i></span>,  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">67</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2017.12.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1016%2Fj.cell.2017.12.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=29307491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BC1cXkslehtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2018&pages=55-67&author=T.+Cheauthor=S.+Majumdarauthor=S.+A.+Zaidiauthor=P.+Ondachiauthor=J.+D.+McCorvyauthor=S.+Wangauthor=P.+D.+Mosierauthor=R.+Upretyauthor=E.+Vardyauthor=B.+E.+Krummauthor=G.+W.+Hanauthor=M.-Y.+Leeauthor=E.+Pardonauthor=J.+Steyaertauthor=X.-P.+Huangauthor=R.+T.+Strachanauthor=A.+R.+Triboauthor=G.+W.+Pasternakauthor=F.+I.+Carrollauthor=R.+C.+Stevensauthor=V.+Cherezovauthor=V.+Katritchauthor=D.+Wackerauthor=B.+L.+Roth&title=Structure+of+the+Nanobody-Stabilized+Active+State+of+the+Kappa+Opioid+Receptor&doi=10.1016%2Fj.cell.2017.12.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the nanobody-stabilized active state of the Kappa opioid receptor</span></div><div class="casAuthors">Che, Tao; Majumdar, Susruta; Zaidi, Saheem A.; Ondachi, Pauline; McCorvy, John D.; Wang, Sheng; Mosier, Philip D.; Uprety, Rajendra; Vardy, Eyal; Krumm, Brian E.; Han, Gye Won; Lee, Ming-Yue; Pardon, Els; Steyaert, Jan; Huang, Xi-Ping; Strachan, Ryan T.; Tribo, Alexandra R.; Pasternak, Gavril W.; Carroll, F. Ivy; Stevens, Raymond C.; Cherezov, Vadim; Katritch, Vsevolod; Wacker, Daniel; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">55-67.e15</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The κ-opioid receptor (KOP) mediates the actions of opioids with hallucinogenic, dysphoric, and analgesic activities.  The design of KOP analgesics devoid of hallucinatory and dysphoric effects has been hindered by an incomplete structural and mechanistic understanding of KOP agonist actions.  Here, we provide a crystal structure of human KOP in complex with the potent epoxymorphinan opioid agonist MP1104 and an active-state-stabilizing nanobody.  Comparisons between inactive- and active-state opioid receptor structures reveal substantial conformational changes in the binding pocket and intracellular and extracellular regions.  Extensive structural anal. and exptl. validation illuminate key residues that propagate larger-scale structural rearrangements and transducer binding that, collectively, elucidate the structural determinants of KOP pharmacol., function, and biased signaling.  These mol. insights promise to accelerate the structure-guided design of safer and more effective κ-opioid receptor therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyTsV2u04FCbVg90H21EOLACvtfcHk0ljSAYKmMwpYEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXkslehtg%253D%253D&md5=eb0399dc1e7e4e0cf21771243875abc9</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2017.12.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2017.12.011%26sid%3Dliteratum%253Aachs%26aulast%3DChe%26aufirst%3DT.%26aulast%3DMajumdar%26aufirst%3DS.%26aulast%3DZaidi%26aufirst%3DS.%2BA.%26aulast%3DOndachi%26aufirst%3DP.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DMosier%26aufirst%3DP.%2BD.%26aulast%3DUprety%26aufirst%3DR.%26aulast%3DVardy%26aufirst%3DE.%26aulast%3DKrumm%26aufirst%3DB.%2BE.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DLee%26aufirst%3DM.-Y.%26aulast%3DPardon%26aufirst%3DE.%26aulast%3DSteyaert%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DX.-P.%26aulast%3DStrachan%26aufirst%3DR.%2BT.%26aulast%3DTribo%26aufirst%3DA.%2BR.%26aulast%3DPasternak%26aufirst%3DG.%2BW.%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DWacker%26aufirst%3DD.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DStructure%2520of%2520the%2520Nanobody-Stabilized%2520Active%2520State%2520of%2520the%2520Kappa%2520Opioid%2520Receptor%26jtitle%3DCell%26date%3D2018%26volume%3D172%26spage%3D55%26epage%3D67%26doi%3D10.1016%2Fj.cell.2017.12.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bender, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosse, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burkert, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kögler, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wifling, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernhardt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plank, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larhammar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huster, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meiler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck-Sickinger, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buschauer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B.</span></span> <span> </span><span class="NLM_article-title">Structural basis of ligand binding modes at the neuropeptide Y Y<sub>1</sub> receptor</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>556</i></span>,  <span class="NLM_fpage">520</span>– <span class="NLM_lpage">524</span>, <span class="refDoi"> DOI: 10.1038/s41586-018-0046-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1038%2Fs41586-018-0046-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=29670288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BC1cXosVCgur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=556&publication_year=2018&pages=520-524&author=Z.+Yangauthor=S.+Hanauthor=M.+Kellerauthor=A.+Kaiserauthor=B.+J.+Benderauthor=M.+Bosseauthor=K.+Burkertauthor=L.+M.+K%C3%B6glerauthor=D.+Wiflingauthor=G.+Bernhardtauthor=N.+Plankauthor=T.+Littmannauthor=P.+Schmidtauthor=C.+Yiauthor=B.+Liauthor=S.+Yeauthor=R.+Zhangauthor=B.+Xuauthor=D.+Larhammarauthor=R.+C.+Stevensauthor=D.+Husterauthor=J.+Meilerauthor=Q.+Zhaoauthor=A.+G.+Beck-Sickingerauthor=A.+Buschauerauthor=B.+Wu&title=Structural+basis+of+ligand+binding+modes+at+the+neuropeptide+Y+Y1+receptor&doi=10.1038%2Fs41586-018-0046-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of ligand binding modes at the neuropeptide Y Y1 receptor</span></div><div class="casAuthors">Yang, Zhenlin; Han, Shuo; Keller, Max; Kaiser, Anette; Bender, Brian J.; Bosse, Mathias; Burkert, Kerstin; Kogler, Lisa M.; Wifling, David; Bernhardt, Guenther; Plank, Nicole; Littmann, Timo; Schmidt, Peter; Yi, Cuiying; Li, Beibei; Ye, Sheng; Zhang, Rongguang; Xu, Bo; Larhammar, Dan; Stevens, Raymond C.; Huster, Daniel; Meiler, Jens; Zhao, Qiang; Beck-Sickinger, Annette G.; Buschauer, Armin; Wu, Beili</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">556</span>
        (<span class="NLM_cas:issue">7702</span>),
    <span class="NLM_cas:pages">520-524</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Neuropeptide Y (NPY) receptors belong to the G-protein-coupled receptor superfamily and have important roles in food intake, anxiety and cancer biol.1,2.  The NPY-Y receptor system has emerged as one of the most complex networks with three peptide ligands (NPY, peptide YY and pancreatic polypeptide) binding to four receptors in most mammals, namely the Y1, Y2, Y4 and Y5 receptors, with different affinity and selectivity3.  NPY is the most powerful stimulant of food intake and this effect is primarily mediated by the Y1 receptor (Y1R)4.  A no. of peptides and small-mol. compds. have been characterized as Y1R antagonists and have shown clin. potential in the treatment of obesity4, tumor1 and bone loss5.  However, their clin. usage has been hampered by low potency and selectivity, poor brain penetration ability or lack of oral bioavailability6.  Here we report crystal structures of the human Y1R bound to the two selective antagonists UR-MK299 and BMS-193885 at 2.7 and 3.0 Å resoln., resp.  The structures combined with mutagenesis studies reveal the binding modes of Y1R to several structurally diverse antagonists and the determinants of ligand selectivity.  The Y1R structure and mol. docking of the endogenous agonist NPY, together with NMR, photo-crosslinking and functional studies, provide insights into the binding behavior of the agonist and for the first time, to our knowledge, det. the interaction of its N terminus with the receptor.  These insights into Y1R can enable structure-based drug discovery that targets NPY receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr584bBD3wdnbVg90H21EOLACvtfcHk0ljSAYKmMwpYEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXosVCgur8%253D&md5=79289fb85d5f65b94fbf873ec4ea31f3</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fs41586-018-0046-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-018-0046-x%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DKeller%26aufirst%3DM.%26aulast%3DKaiser%26aufirst%3DA.%26aulast%3DBender%26aufirst%3DB.%2BJ.%26aulast%3DBosse%26aufirst%3DM.%26aulast%3DBurkert%26aufirst%3DK.%26aulast%3DK%25C3%25B6gler%26aufirst%3DL.%2BM.%26aulast%3DWifling%26aufirst%3DD.%26aulast%3DBernhardt%26aufirst%3DG.%26aulast%3DPlank%26aufirst%3DN.%26aulast%3DLittmann%26aufirst%3DT.%26aulast%3DSchmidt%26aufirst%3DP.%26aulast%3DYi%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DYe%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DLarhammar%26aufirst%3DD.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DHuster%26aufirst%3DD.%26aulast%3DMeiler%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DBeck-Sickinger%26aufirst%3DA.%2BG.%26aulast%3DBuschauer%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DB.%26atitle%3DStructural%2520basis%2520of%2520ligand%2520binding%2520modes%2520at%2520the%2520neuropeptide%2520Y%2520Y1%2520receptor%26jtitle%3DNature%26date%3D2018%26volume%3D556%26spage%3D520%26epage%3D524%26doi%3D10.1038%2Fs41586-018-0046-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manglik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruse, A. C.</span></span> <span> </span><span class="NLM_article-title">Structural basis for G protein-coupled receptor activation</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">5628</span>– <span class="NLM_lpage">5634</span>, <span class="refDoi"> DOI: 10.1021/acs.biochem.7b00747</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biochem.7b00747" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFygsbzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=5628-5634&author=A.+Manglikauthor=A.+C.+Kruse&title=Structural+basis+for+G+protein-coupled+receptor+activation&doi=10.1021%2Facs.biochem.7b00747"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for G Protein-Coupled Receptor Activation</span></div><div class="casAuthors">Manglik, Aashish; Kruse, Andrew C.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">5628-5634</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  G protein-coupled receptors (GPCRs) are crit. regulators of human physiol. and make up the largest single class of therapeutic drug targets.  Although GPCRs regulate highly diverse physiol., they share a common signaling mechanism whereby extracellular stimuli induce conformational changes in the receptor that enable activation of heterotrimeric G proteins and other intracellular effectors.  Advances in GPCR structural biol. have made it possible to examine ligand-induced GPCR activation at an unprecedented level of detail.  Here, we review the structural basis for family A GPCR activation, with a focus on GPCRs for which structures are available in both active or active-like states and inactive states.  Crystallog. and other biophys. data show how chem. diverse ligands stabilize highly conserved conformational changes on the intracellular side of the receptors, allowing many different extracellular stimuli to utilize shared downstream signaling mols.  Finally, we discuss the remaining challenges in understanding GPCR activation and signaling and highlight new technologies that may allow unanswered questions to be resolved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpo0hYowj_TOrVg90H21EOLACvtfcHk0lilOlqP9jYVnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFygsbzE&md5=a60243e522dcfe8279d0f74213adfd41</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facs.biochem.7b00747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biochem.7b00747%26sid%3Dliteratum%253Aachs%26aulast%3DManglik%26aufirst%3DA.%26aulast%3DKruse%26aufirst%3DA.%2BC.%26atitle%3DStructural%2520basis%2520for%2520G%2520protein-coupled%2520receptor%2520activation%26jtitle%3DBiochemistry%26date%3D2017%26volume%3D56%26spage%3D5628%26epage%3D5634%26doi%3D10.1021%2Facs.biochem.7b00747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weis, W. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, B. K.</span></span> <span> </span><span class="NLM_article-title">The Molecular Basis of G Protein-Coupled Receptor Activation</span>. <i>Annu. Rev. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">897</span>– <span class="NLM_lpage">919</span>, <span class="refDoi"> DOI: 10.1146/annurev-biochem-060614-033910</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1146%2Fannurev-biochem-060614-033910" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=29925258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFOrsrvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2018&pages=897-919&author=W.+I.+Weisauthor=B.+K.+Kobilka&title=The+Molecular+Basis+of+G+Protein-Coupled+Receptor+Activation&doi=10.1146%2Fannurev-biochem-060614-033910"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The Molecular Basis of G Protein-Coupled Receptor Activation</span></div><div class="casAuthors">Weis, William I.; Kobilka, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">897-919</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  G protein-coupled receptors (GPCRs) mediate the majority of cellular responses to external stimuli.  Upon activation by a ligand, the receptor binds to a partner heterotrimeric G protein and promotes exchange of GTP for GDP, leading to dissocn. of the G protein into α and βγ subunits that mediate downstream signals.  GPCRs can also activate distinct signaling pathways through arrestins.  Active states of GPCRs form by small rearrangements of the ligand-binding, or orthosteric, site that are amplified into larger conformational changes.  Mol. understanding of the allosteric coupling between ligand binding and G protein or arrestin interaction is emerging from structures of several GPCRs crystd. in inactive and active states, spectroscopic data, and computer simulations.  The coupling is loose, rather than concerted, and agonist binding does not fully stabilize the receptor in an active conformation.  Distinct intermediates whose populations are shifted by ligands of different efficacies underlie the complex pharmacol. of GPCRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfSIylPxq7yLVg90H21EOLACvtfcHk0lilOlqP9jYVnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFOrsrvM&md5=71f1f2d3c1d9be27da70dd472d7d44f2</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1146%2Fannurev-biochem-060614-033910&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-biochem-060614-033910%26sid%3Dliteratum%253Aachs%26aulast%3DWeis%26aufirst%3DW.%2BI.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26atitle%3DThe%2520Molecular%2520Basis%2520of%2520G%2520Protein-Coupled%2520Receptor%2520Activation%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2018%26volume%3D87%26spage%3D897%26epage%3D919%26doi%3D10.1146%2Fannurev-biochem-060614-033910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pluym, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennauer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziemek, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pop, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernhardt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buschauer, A.</span></span> <span> </span><span class="NLM_article-title">Application of the guanidine-acylguanidine bioisosteric approach to argininamide-type NPY Y<sub>2</sub> receptor antagonists</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1727</span>– <span class="NLM_lpage">1738</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201100241</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1002%2Fcmdc.201100241" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=21692185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BC3MXns1Ohu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=1727-1738&author=N.+Pluymauthor=A.+Brennauerauthor=M.+Kellerauthor=R.+Ziemekauthor=N.+Popauthor=G.+Bernhardtauthor=A.+Buschauer&title=Application+of+the+guanidine-acylguanidine+bioisosteric+approach+to+argininamide-type+NPY+Y2+receptor+antagonists&doi=10.1002%2Fcmdc.201100241"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Application of the Guanidine-Acylguanidine Bioisosteric Approach to Argininamide-Type NPY Y2 Receptor Antagonists</span></div><div class="casAuthors">Pluym, Nikola; Brennauer, Albert; Keller, Max; Ziemek, Ralf; Pop, Nathalie; Bernhardt, Guenther; Buschauer, Armin</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1727-1738</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Strongly basic groups such as guanidine moieties are crucial structural elements, but they compromise the drug-likeness of numerous biol. active compds., including ligands of G-protein-coupled receptors (GPCRs).  As part of a project focused on the search for guanidine bioisosteres, argininamide-type neuropeptide Y (NPY) Y2 receptor (Y2R) antagonists related to BIIE0246 were synthesized.  Starting from ornithine derivs., NG-acylated argininamides were obtained by guanidinylation with tailor-made mono-Boc-protected N-acyl-S-methylisothioureas.  The compds. were investigated for Y2R antagonism (calcium assays), Y2R affinity, and NPY receptor subtype selectivity (flow cytometric binding assays).  Most of the NG-substituted (S)-argininamides showed Y2R antagonistic activities and binding affinities similar to those of the parent compd., whereas NG-acylated or -carbamoylated analogs with a terminal amine were superior (Y2R: Ki and KB values in the low nanomolar range).  This demonstrates that the basicity of the compds., although 4-5 orders of magnitude lower than that of guanidines, is sufficient to form key interactions with acidic amino acids of the Y2R.  The acylguanidines bind with high affinity and selectivity to Y2R over the Y1, Y4, and Y5 receptors.  As derivatization of the amino group is tolerated, these compds. can be considered building blocks for the prepn. of versatile fluorescent and radiolabeled pharmacol. tools for in vitro studies of the Y2R.  The results support the concept of bioisosteric guanidine-acylguanidine exchange as a broadly applicable approach to retain pharmacol. activity despite decreased basicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZjDsh58LHYrVg90H21EOLACvtfcHk0lilOlqP9jYVnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXns1Ohu7Y%253D&md5=949897e2266924e232bceb29e4c368ec</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201100241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201100241%26sid%3Dliteratum%253Aachs%26aulast%3DPluym%26aufirst%3DN.%26aulast%3DBrennauer%26aufirst%3DA.%26aulast%3DKeller%26aufirst%3DM.%26aulast%3DZiemek%26aufirst%3DR.%26aulast%3DPop%26aufirst%3DN.%26aulast%3DBernhardt%26aufirst%3DG.%26aulast%3DBuschauer%26aufirst%3DA.%26atitle%3DApplication%2520of%2520the%2520guanidine-acylguanidine%2520bioisosteric%2520approach%2520to%2520argininamide-type%2520NPY%2520Y2%2520receptor%2520antagonists%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26spage%3D1727%26epage%3D1738%26doi%3D10.1002%2Fcmdc.201100241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ziemek, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennauer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabrele, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck-Sickinger, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernhardt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buschauer, A.</span></span> <span> </span><span class="NLM_article-title">Fluorescence- and luminescence-based methods for the determination of affinity and activity of neuropeptide Y<sub>2</sub> receptor ligands</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>551</i></span>,  <span class="NLM_fpage">10</span>– <span class="NLM_lpage">18</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2006.08.075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1016%2Fj.ejphar.2006.08.075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=17027743" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFKmtbjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=551&publication_year=2006&pages=10-18&author=R.+Ziemekauthor=A.+Brennauerauthor=E.+Schneiderauthor=C.+Cabreleauthor=A.+G.+Beck-Sickingerauthor=G.+Bernhardtauthor=A.+Buschauer&title=Fluorescence-+and+luminescence-based+methods+for+the+determination+of+affinity+and+activity+of+neuropeptide+Y2+receptor+ligands&doi=10.1016%2Fj.ejphar.2006.08.075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorescence- and luminescence-based methods for the determination of affinity and activity of neuropeptide Y2 receptor ligands</span></div><div class="casAuthors">Ziemek, Ralf; Brennauer, Albert; Schneider, Erich; Cabrele, Chiara; Beck-Sickinger, Annette G.; Bernhardt, Guenther; Buschauer, Armin</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">551</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">10-18</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">With respect to the discovery and characterization of neuropeptide Y2 receptor ligands as pharmacol. tools or potential drugs, fluorescence- and luminescence-based assays were developed to det. both the affinity and the activity of receptor agonists and antagonists.  A flow cytometric binding assay is described for the hY2 receptor stably expressed in CHO cells using cy5-labeled porcine neuropeptide Y and compared with a radioligand binding assay.  Binding of the fluorescent ligand was visualized by confocal microscopy.  Stable co-transfection with the chimeric G protein Gqi5 enabled the establishment of a spectrofluorimetric fura-2 and a flow cytometric fluo-4 calcium assay.  Further stable expression of apoaequorin targeted to the mitochondria allowed the establishment of an aequorin assay which could be performed in the 96-well format.  The shape of the concn.-response curves of porcine neuropeptide Y in the presence of the Y2-selective receptor antagonist BIIE0246, characteristic of either competitive or insurmountable antagonism, depended on the period of incubation with the cells.  Functional data of Y2 receptor agonists and antagonists detd. in the fluorescence- and luminescence-based assays were in good agreement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoH4uRfPgP7ErVg90H21EOLACvtfcHk0liPXAvmPepVqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFKmtbjP&md5=775c7fe7a28fc6832d5ad54f518dc8a6</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2006.08.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2006.08.075%26sid%3Dliteratum%253Aachs%26aulast%3DZiemek%26aufirst%3DR.%26aulast%3DBrennauer%26aufirst%3DA.%26aulast%3DSchneider%26aufirst%3DE.%26aulast%3DCabrele%26aufirst%3DC.%26aulast%3DBeck-Sickinger%26aufirst%3DA.%2BG.%26aulast%3DBernhardt%26aufirst%3DG.%26aulast%3DBuschauer%26aufirst%3DA.%26atitle%3DFluorescence-%2520and%2520luminescence-based%2520methods%2520for%2520the%2520determination%2520of%2520affinity%2520and%2520activity%2520of%2520neuropeptide%2520Y2%2520receptor%2520ligands%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D551%26spage%3D10%26epage%3D18%26doi%3D10.1016%2Fj.ejphar.2006.08.075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goumain, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voisin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorinet, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ducroc, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsocas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rozé, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouet-Benzineb, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herzog, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramaniam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laburthe, M.</span></span> <span> </span><span class="NLM_article-title">The peptide YY-preferring receptor mediating inhibition of small intestinal secretion is a peripheral Y<sub>2</sub> receptor: pharmacological evidence and molecular cloning</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">124</span>– <span class="NLM_lpage">134</span>, <span class="refDoi"> DOI: 10.1124/mol.60.1.124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1124%2Fmol.60.1.124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=11408607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BD3MXks1CrtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2001&pages=124-134&author=M.+Goumainauthor=T.+Voisinauthor=A.-M.+Lorinetauthor=R.+Ducrocauthor=A.+Tsocasauthor=C.+Roz%C3%A9author=P.+Rouet-Benzinebauthor=H.+Herzogauthor=A.+Balasubramaniamauthor=M.+Laburthe&title=The+peptide+YY-preferring+receptor+mediating+inhibition+of+small+intestinal+secretion+is+a+peripheral+Y2+receptor%3A+pharmacological+evidence+and+molecular+cloning&doi=10.1124%2Fmol.60.1.124"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">The peptide YY-preferring receptor mediating inhibition of small intestinal secretion is a peripheral Y2 receptor: pharmacological evidence and molecular cloning</span></div><div class="casAuthors">Goumain, Mathieu; Voisin, Thierry; Lorinet, Anne-Marie; Ducroc, Robert; Tsocas, Annick; Roze, Claude; Rouet-Benzineb, Patricia; Herzog, Herbert; Balasubramaniam, Ambikaipakan; Laburthe, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">124-134</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A peptide YY (PYY)-preferring receptor [PYY > neuropeptide Y (NPY)] was previously characterized in rat small intestinal crypt cells, where it mediates inhibition of fluid secretion.  Here, the authors investigated the possible status of this receptor as a peripheral Y2 receptor in rats.  Typical Y2 agonists (PYY3-36, NPY3-36, NPY13-36, C2-NPY) and very short PYY analogs (N-α-Ac-PYY22-36 and N-α-Ac-PYY25-36) acting at the intestinal PYY receptor were tested for their ability to inhibit the binding of 125I-PYY to membranes of rat intestinal crypt cells and of CHO cells stably transfected with the rat hippocampal Y2 receptor cDNA.  Similar PYY preference was obsd. and all analogs exhibited comparable high affinity in both binding assays.  The same held true for the specific Y2 antagonist BIIE0246 with a Ki value of 6.5 and 9.0 nM, resp.  BIIE0246 completely abolished the inhibition of cAMP prodn. by PYY in crypt cells and transfected CHO cells.  Moreover, the antagonist considerably reversed the PYY-induced redn. of short-circuit current in rat jejunum mucosa in Ussing chamber and completely abolished the antisecretory action of PYY on vasoactive intestinal peptide (VIP)-induced fluid secretion in rat jejunum in vivo.  Quant. reverse transcription-polymerase chain reaction (RT-PCR) expts. showed that Y2 receptor transcripts were present in intestinal crypt cells (3 × 102 mols./100 ng RNAT) with no expression in villus cells, in complete agreement with the exclusive binding of PYY in crypt cells.  Finally, a full-length Y2 receptor was cloned by RT-PCR from rat intestinal crypt cells and also from human small intestine.  The authors conclude that the so-called PYY-preferring receptor mediating inhibition of intestinal secretion is a peripheral Y2 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxlCwE5p5P77Vg90H21EOLACvtfcHk0liPXAvmPepVqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXks1CrtLs%253D&md5=02c2f86e29970d5481e1f76968b8e384</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1124%2Fmol.60.1.124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.60.1.124%26sid%3Dliteratum%253Aachs%26aulast%3DGoumain%26aufirst%3DM.%26aulast%3DVoisin%26aufirst%3DT.%26aulast%3DLorinet%26aufirst%3DA.-M.%26aulast%3DDucroc%26aufirst%3DR.%26aulast%3DTsocas%26aufirst%3DA.%26aulast%3DRoz%25C3%25A9%26aufirst%3DC.%26aulast%3DRouet-Benzineb%26aufirst%3DP.%26aulast%3DHerzog%26aufirst%3DH.%26aulast%3DBalasubramaniam%26aufirst%3DA.%26aulast%3DLaburthe%26aufirst%3DM.%26atitle%3DThe%2520peptide%2520YY-preferring%2520receptor%2520mediating%2520inhibition%2520of%2520small%2520intestinal%2520secretion%2520is%2520a%2520peripheral%2520Y2%2520receptor%253A%2520pharmacological%2520evidence%2520and%2520molecular%2520cloning%26jtitle%3DMol.%2520Pharmacol.%26date%3D2001%26volume%3D60%26spage%3D124%26epage%3D134%26doi%3D10.1124%2Fmol.60.1.124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yung-Chi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prusoff, W. H.</span></span> <span> </span><span class="NLM_article-title">Relationship between the inhibition constant (K<sub>I</sub>) and the concentration of inhibitor which causes 50 per cent inhibition (IC<sub>50</sub>) of an enzymatic reaction</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">3099</span>– <span class="NLM_lpage">3108</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(73)90196-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1016%2F0006-2952%2873%2990196-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=4202581" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&author=C.+Yung-Chiauthor=W.+H.+Prusoff&title=Relationship+between+the+inhibition+constant+%28KI%29+and+the+concentration+of+inhibitor+which+causes+50+per+cent+inhibition+%28IC50%29+of+an+enzymatic+reaction&doi=10.1016%2F0006-2952%2873%2990196-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2873%2990196-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252873%252990196-2%26sid%3Dliteratum%253Aachs%26aulast%3DYung-Chi%26aufirst%3DC.%26aulast%3DPrusoff%26aufirst%3DW.%2BH.%26atitle%3DRelationship%2520between%2520the%2520inhibition%2520constant%2520%2528KI%2529%2520and%2520the%2520concentration%2520of%2520inhibitor%2520which%2520causes%252050%2520per%2520cent%2520inhibition%2520%2528IC50%2529%2520of%2520an%2520enzymatic%2520reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26spage%3D3099%26epage%3D3108%26doi%3D10.1016%2F0006-2952%2873%2990196-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Šali, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blundell, T. L.</span></span> <span> </span><span class="NLM_article-title">Comparative protein modelling by satisfaction of spatial restraints</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>234</i></span>,  <span class="NLM_fpage">779</span>– <span class="NLM_lpage">815</span>, <span class="refDoi"> DOI: 10.1006/jmbi.1993.1626</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1006%2Fjmbi.1993.1626" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=8254673" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADyaK2cXnt1ylug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=234&publication_year=1993&pages=779-815&author=A.+%C5%A0aliauthor=T.+L.+Blundell&title=Comparative+protein+modelling+by+satisfaction+of+spatial+restraints&doi=10.1006%2Fjmbi.1993.1626"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative protein modeling by satisfaction of spatial restraints</span></div><div class="casAuthors">Sali, Andrej; Blundell, Tom L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">234</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">779-815</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    </div><div class="casAbstract">The authors describe a comparative protein modeling method designed to find the most probable structure for a sequence given its alignment with related structures.  The three-dimensional (3D) model is obtained by optimally satisfying spatial restraints derived from the alignment and expressed as probability d. functions (pdfs) for the features restrained.  For example, the probabilities for main-chain conformations of a modelled residue may be restrained by its residue type, main-chain conformation of an equiv. residue in a related protein, and the local similarity between the two sequences.  Several such pdfs are obtained from the correlations between structural features in 17 families of homologous proteins which have been aligned on the basis of their 3D structures.  The pdfs restrain Cα-Cα distances, main-chain N-O distances, main-chain and side-chain dihedral angles.  A smoothing procedure is used in the derivation of these relationships to minimize the problem of a sparse database.  The 3D model of a protein is obtained by optimization of the mol. pdf such that the model violates the input restraints as little as possible.  The mol. pdf is derived as a combination of pdfs restraining individual spatial features of the whole mol.  The optimization procedure is a variable target function method that applies the conjugate gradients algorithm to positions of all non-hydrogen atoms.  The method is automated and is illustrated by the modeling of trypsin from two other serine proteinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC4wGhwZvib7Vg90H21EOLACvtfcHk0liPXAvmPepVqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXnt1ylug%253D%253D&md5=d4a3c39b2205e36221dc187a3d1a478b</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1993.1626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1993.1626%26sid%3Dliteratum%253Aachs%26aulast%3D%25C5%25A0ali%26aufirst%3DA.%26aulast%3DBlundell%26aufirst%3DT.%2BL.%26atitle%3DComparative%2520protein%2520modelling%2520by%2520satisfaction%2520of%2520spatial%2520restraints%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1993%26volume%3D234%26spage%3D779%26epage%3D815%26doi%3D10.1006%2Fjmbi.1993.1626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pettersen, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goddard, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couch, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenblatt, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrin, T. E.</span></span> <span> </span><span class="NLM_article-title">UCSF Chimera?A visualization system for exploratory research and analysis</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1605</span>– <span class="NLM_lpage">1612</span>, <span class="refDoi"> DOI: 10.1002/jcc.20084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=10.1002%2Fjcc.20084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=15264254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvVOhsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=1605-1612&author=E.+F.+Pettersenauthor=T.+D.+Goddardauthor=C.+C.+Huangauthor=G.+S.+Couchauthor=D.+M.+Greenblattauthor=E.+C.+Mengauthor=T.+E.+Ferrin&title=UCSF+Chimera%3FA+visualization+system+for+exploratory+research+and+analysis&doi=10.1002%2Fjcc.20084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">UCSF Chimera-A visualization system for exploratory research and analysis</span></div><div class="casAuthors">Pettersen, Eric F.; Goddard, Thomas D.; Huang, Conrad C.; Couch, Gregory S.; Greenblatt, Daniel M.; Meng, Elaine C.; Ferrin, Thomas E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1605-1612</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The design, implementation, and capabilities of an extensible visualization system, UCSF Chimera, are discussed.  Chimera is segmented into a core that provides basic services and visualization, and extensions that provide most higher level functionality.  This architecture ensures that the extension mechanism satisfies the demands of outside developers who wish to incorporate new features.  Two unusual extensions are presented: Multiscale, which adds the ability to visualize large-scale mol. assemblies such as viral coats, and Collab., which allows researchers to share a Chimera session interactively despite being at sep. locales.  Other extensions include Multalign Viewer, for showing multiple sequence alignments and assocd. structures; ViewDock, for screening docked ligand orientations; Movie, for replaying mol. dynamics trajectories; and Vol. Viewer, for display and anal. of volumetric data.  A discussion of the usage of Chimera in real-world situations is given, along with anticipated future directions.  Chimera includes full user documentation, is free to academic and nonprofit users, and is available for Microsoft Windows, Linux, Apple Mac OS X, SGI IRIX, and HP Tru64 Unix from http://www.cgl.ucsf.edu/chimera/.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFmD4M5S0cPbVg90H21EOLACvtfcHk0lhk9tAm_OjXng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvVOhsbs%253D&md5=944b175f440c1ff323705987cf937ee7</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2Fjcc.20084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.20084%26sid%3Dliteratum%253Aachs%26aulast%3DPettersen%26aufirst%3DE.%2BF.%26aulast%3DGoddard%26aufirst%3DT.%2BD.%26aulast%3DHuang%26aufirst%3DC.%2BC.%26aulast%3DCouch%26aufirst%3DG.%2BS.%26aulast%3DGreenblatt%26aufirst%3DD.%2BM.%26aulast%3DMeng%26aufirst%3DE.%2BC.%26aulast%3DFerrin%26aufirst%3DT.%2BE.%26atitle%3DUCSF%2520Chimera%253FA%2520visualization%2520system%2520for%2520exploratory%2520research%2520and%2520analysis%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2004%26volume%3D25%26spage%3D1605%26epage%3D1612%26doi%3D10.1002%2Fjcc.20084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6B73" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6B73','PDB','6B73'); return false;">PDB: 6B73</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5ZBQ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5ZBQ','PDB','5ZBQ'); return false;">PDB: 5ZBQ</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i56"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00426">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_06158"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c00426?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00426</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Figures S1−S6, [<sup>3</sup>H]propionyl-pNPY: Y<sub>2</sub>R saturation binding curves and competition binding with BIIE0246 (Figure S7), RP-HPLC chromatograms of compounds <b>8</b>–<b>35</b>, <sup>1</sup>H NMR spectra of compounds <b>8</b>–<b>35</b>, and <sup>13</sup>C NMR spectra of compounds <b>8</b>–<b>11</b>, <b>13</b>–<b>20</b>, <b>22</b>–<b>25</b>, <b>27</b>–<b>29</b>, and <b>31</b>–<b>35</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00426/suppl_file/jm0c00426_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and Y<sub>4</sub>R receptor binding data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00426/suppl_file/jm0c00426_si_002.csv">CSV</a>)</p></li><li><p class="inline">Coordinates of the homology models of hY<sub>4</sub>R, which were prepared based on the reported crystal structure of the active state κ-opioid receptor (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6B73">6B73</a>)<a class="ref ref26" href="javascript:void(0);">(26)</a> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00426/suppl_file/jm0c00426_si_003.pdb">PDB</a>)</p></li><li><p class="inline">Coordinates of the homology models of hY<sub>4</sub>R, which were prepared based on the reported crystal structure of the inactive state hY<sub>1</sub>R (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5ZBQ">5ZBQ</a><a class="ref ref22" href="javascript:void(0);">(22)</a>) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00426/suppl_file/jm0c00426_si_004.pdb">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00426/suppl_file/jm0c00426_si_001.pdf">jm0c00426_si_001.pdf (7.1 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00426/suppl_file/jm0c00426_si_002.csv">jm0c00426_si_002.csv (4.19 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00426/suppl_file/jm0c00426_si_003.pdb">jm0c00426_si_003.pdb (192.28 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00426/suppl_file/jm0c00426_si_004.pdb">jm0c00426_si_004.pdb (207.21 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c00426&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-15%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c00426%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c00426" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799b6353b883c3a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
